data_1q8l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q8l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.278 0.561 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.85 152.69 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.689 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.19 127.12 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 124.082 0.864 . . . . 0.0 111.412 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.74 95.89 4.23 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.915 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -86.63 88.12 7.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 44.4 mtm -90.98 140.14 30.11 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.466 -1.697 . . . . 0.0 106.98 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -109.99 97.54 7.02 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.832 1.333 . . . . 0.0 114.051 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -63.39 169.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.799 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 31.5 tt0 -112.9 131.23 55.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 100.48 -3.896 . . . . 0.0 100.48 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.46 16.88 1.21 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.856 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.417 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 2.2 ttp . . . . . 0 N--CA 1.5 2.058 0 C-N-CA 124.087 0.955 . . . . 0.0 110.077 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 25' ' ' SER . 75.2 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.5 p 52.58 -8.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 23' ' ' CYS . 50.6 m -77.33 -38.59 50.08 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 102.974 -2.973 . . . . 0.0 102.974 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.6 p -69.13 -33.16 73.03 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.016 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -68.23 -31.38 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.124 0.89 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.94 -58.87 6.24 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.37 -20.74 77.08 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.708 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -70.84 -52.95 17.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -64.9 -34.38 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.254 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.82 -17.56 79.73 Favored Glycine 0 N--CA 1.487 2.08 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.156 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -95.54 1.52 53.9 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.4 mt -71.22 128.73 36.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.205 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -78.74 159.27 28.02 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.38 1.086 . . . . 0.0 112.639 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.62 14.74 70.15 Favored Glycine 0 N--CA 1.488 2.13 0 CA-C-N 112.145 -2.298 . . . . 0.0 110.517 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.77 133.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 114.778 -0.711 . . . . 0.0 111.635 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -93.36 -77.22 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -96.92 160.24 14.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.75 119.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.558 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -138.95 152.07 47.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -141.37 124.12 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -80.19 179.64 7.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 123.812 0.695 . . . . 0.0 110.714 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 44' ' ' LEU . 2.5 mm? -100.27 173.53 6.56 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.802 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 56.59 -86.47 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 124.293 0.996 . . . . 0.0 112.11 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.25 10.61 4.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.2 0.313 . . . . 0.0 110.634 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 33.87 52.18 0.43 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.356 1.035 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.48 95.66 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.629 -1.623 . . . . 0.0 107.849 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.03 126.71 31.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.728 -2.033 . . . . 0.0 110.78 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.9 m -126.48 88.25 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.6 mp -110.41 137.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.863 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.46 137.82 38.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.06 157.07 39.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.398 1.061 . . . . 0.0 111.312 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -78.95 143.22 61.35 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -85.71 40.14 0.75 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.019 2.479 . . . . 0.0 113.476 -162.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.505 ' CD2' HD23 ' A' ' 57' ' ' LEU . 32.3 p-80 -151.07 16.06 0.74 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' A' ' 56' ' ' HIS . 3.9 mm? -113.65 -59.69 1.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.8 tt -165.57 161.24 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.955 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.9 p -98.9 118.79 36.45 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.377 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.8 -18.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.474 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.33 -38.69 85.32 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.788 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.28 -39.03 85.97 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mmt -64.02 -33.49 75.85 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.057 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -80.13 -18.14 50.62 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.646 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.93 -29.73 70.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -71.3 -39.02 71.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 57.8 mt -62.68 -36.2 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -78.64 -27.04 45.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 -37.65 65.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.224 0.953 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -73.73 -15.86 61.2 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.152 0.907 . . . . 0.0 111.671 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.76 10.69 2.52 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 118.064 1.985 . . . . 0.0 118.064 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.44 ' CE2' ' SD ' ' A' ' 70' ' ' MET . 59.9 m-85 -118.92 75.09 13.47 Favored Pre-proline 0 N--CA 1.5 2.06 0 CA-C-N 118.407 1.104 . . . . 0.0 109.718 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -48.9 139.25 25.62 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.825 2.35 . . . . 0.0 111.253 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.91 133.24 54.41 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.045 0.926 . . . . 0.0 111.648 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.89 74.81 10.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.372 -2.194 . . . . 0.0 106.785 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-N 113.555 -1.657 . . . . 0.0 111.301 -179.852 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.505 ' CB ' HE22 ' A' ' 38' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 m -145.55 126.64 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.259 0.975 . . . . 0.0 109.767 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.3 m -94.48 115.7 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.66 110.49 19.83 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.372 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.442 ' C ' ' SD ' ' A' ' 13' ' ' MET . 2.3 mppt? -100.84 130.1 46.81 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 4.9 mpp? -144.25 139.13 28.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 65.1 tttp -105.15 151.53 23.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 125.149 1.53 . . . . 0.0 107.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -127.68 169.6 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 124.205 0.941 . . . . 0.0 110.729 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 31.5 tt0 -92.37 111.39 22.95 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.37 5.2 5.57 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-O 119.55 -0.583 . . . . 0.0 114.358 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.0 ttp . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -72.31 -13.54 61.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.369 -1.287 . . . . 0.0 113.379 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 p -55.33 -38.2 68.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.858 0.724 . . . . 0.0 109.476 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -77.12 -37.28 54.45 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.0 mt -61.0 -36.15 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 123.997 0.81 . . . . 0.0 110.882 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.76 -64.98 0.74 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.727 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.22 -18.98 73.68 Favored Glycine 0 N--CA 1.497 2.701 0 CA-C-N 113.593 -1.639 . . . . 0.0 114.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -77.15 -53.89 7.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.4 ' CG2' HG12 ' A' ' 51' ' ' ILE . 57.2 mt -69.84 -23.76 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.679 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.59 -13.79 83.12 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -95.32 2.3 54.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 124.333 0.666 . . . . 0.0 111.692 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.17 130.78 43.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -83.22 146.77 28.4 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.52 12.59 84.22 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.718 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.1 t -93.75 142.19 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.505 HE22 ' CB ' ' A' ' 8' ' ' GLU . 29.3 mt-30 -95.81 -81.97 0.39 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -97.15 154.81 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.1 115.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -151.88 167.09 29.44 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.2 t -136.96 147.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 124.624 1.203 . . . . 0.0 109.158 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 t -104.37 150.21 24.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.887 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -67.31 1.56 2.11 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.091 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -83.39 66.48 8.87 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 m120 54.35 71.93 0.49 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.715 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 41.71 47.2 3.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.803 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 39.6 tt0 -79.63 87.65 5.17 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.168 1.461 . . . . 0.0 107.284 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.37 138.67 45.46 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.721 -2.49 . . . . 0.0 114.721 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.2 m -140.5 90.57 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.1 mp -98.64 130.37 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.436 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.38 134.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -148.56 171.2 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.199 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.97 145.65 81.42 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 124.095 0.872 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -71.17 0.86 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.46 2.773 . . . . 0.0 115.432 -150.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.413 ' CD2' HD23 ' A' ' 57' ' ' LEU . 9.8 p-80 -154.17 23.46 0.49 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -88.49 -46.41 9.14 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.474 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -157.95 166.43 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 124.043 0.839 . . . . 0.0 111.482 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.423 ' H ' HG12 ' A' ' 58' ' ' ILE . 58.2 p -117.38 107.4 14.3 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.425 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.56 -26.93 32.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.234 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.21 -27.68 68.61 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.963 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.88 -41.37 78.43 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 mmt -61.84 -32.38 72.71 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.514 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -65.47 -34.71 78.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.976 0.798 . . . . 0.0 109.154 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.55 -34.75 77.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 123.492 0.495 . . . . 0.0 110.539 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -67.9 -38.71 83.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 124.162 0.914 . . . . 0.0 108.843 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 72' ' ' PHE . 83.5 mt -67.61 -28.63 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.236 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -86.52 -22.14 26.54 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.189 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.92 -36.74 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.05 0.843 . . . . 0.0 109.519 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -13.43 60.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.68 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -6.69 5.39 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 118.671 2.229 . . . . 0.0 118.671 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.0 m-30 -106.52 93.68 8.81 Favored Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 119.203 1.502 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -45.31 137.18 10.87 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.972 1.781 . . . . 0.0 109.577 166.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.13 126.35 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.521 1.138 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -85.46 91.18 8.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.37 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.498 1.953 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.806 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.53 0.681 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 m -129.84 146.54 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.2 m -128.59 99.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 124.66 1.225 . . . . 0.0 110.067 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' HD11 ' A' ' 11' ' ' LEU . 5.7 mp -104.81 120.12 40.63 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.051 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -99.86 90.05 4.29 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.892 0.745 . . . . 0.0 109.701 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -82.62 139.65 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -109.42 96.28 6.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.789 1.305 . . . . 0.0 113.728 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.1 t -60.94 159.64 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -82.59 109.69 17.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.16 -7.79 7.6 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.874 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 31.0 tpp . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.383 0.611 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.1 p -69.71 -0.47 7.03 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -66.01 -31.85 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -64.41 -37.69 88.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.203 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.26 -32.83 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 124.534 1.146 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.96 -70.36 0.17 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.145 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -12.4 66.87 Favored Glycine 0 N--CA 1.497 2.752 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.55 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -82.87 -59.49 2.48 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.906 0.86 . . . . 0.0 108.817 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.01 -2.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.023 -1.898 . . . . 0.0 112.59 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.83 -17.36 19.06 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.804 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -96.85 7.35 46.8 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.71 140.5 33.04 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -85.94 161.52 18.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.626 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.07 87.19 Favored Glycine 0 N--CA 1.489 2.168 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.1 t -111.81 145.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 124.626 0.839 . . . . 0.0 112.756 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -94.76 -83.22 0.35 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.408 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.5 tpp85 -98.16 163.17 12.85 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.023 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.05 117.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -153.26 112.7 3.83 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.369 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.4 t -93.4 150.53 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.952 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.5 t -109.03 141.32 41.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.581 1.176 . . . . 0.0 110.087 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.86 -21.68 31.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 124.35 1.031 . . . . 0.0 110.118 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.19 87.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.659 1.225 . . . . 0.0 108.708 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 52.51 40.25 29.41 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 45.63 47.7 11.44 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.436 1.112 . . . . 0.0 108.584 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.01 92.99 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.363 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.26 130.49 43.26 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.482 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.9 m -131.34 92.53 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -97.54 135.65 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.168 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 26.3 t -107.96 137.85 37.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -162.84 166.09 24.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.683 1.24 . . . . 0.0 113.679 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.08 132.55 39.45 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.079 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.18 38.36 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.368 2.712 . . . . 0.0 114.464 -155.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.48 ' CD2' HD22 ' A' ' 57' ' ' LEU . 28.3 p-80 -156.23 18.46 0.35 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -95.91 -56.2 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.445 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.19 164.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.027 0.829 . . . . 0.0 110.619 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -74.14 109.26 7.5 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.495 1.141 . . . . 0.0 110.019 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.62 -26.88 6.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 112.642 -2.072 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.23 -24.49 61.39 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.427 -1.26 . . . . 0.0 107.686 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.84 -38.09 79.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -63.17 -40.52 97.78 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.515 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -78.14 -10.92 59.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 124.279 0.987 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -74.49 -29.71 61.53 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.06 -30.62 71.11 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.381 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.89 -30.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 114.69 -1.141 . . . . 0.0 107.998 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.54 -24.1 36.81 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.695 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.49 -37.36 60.25 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.425 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -74.46 -12.2 60.43 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.737 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 1.59 9.33 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 116.797 1.479 . . . . 0.0 116.797 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -112.6 82.58 4.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 117.447 0.624 . . . . 0.0 109.503 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.51 130.12 34.99 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 121.819 1.679 . . . . 0.0 109.755 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -111.54 109.58 19.57 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.847 -1.979 . . . . 0.0 106.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -69.13 89.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 112.109 -2.314 . . . . 0.0 109.608 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 . . . . . 0 N--CA 1.505 2.316 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.69 124.07 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.765 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.6 m -100.69 101.82 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.293 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.98 116.89 33.66 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.78 111.86 23.62 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.416 ' SD ' HG12 ' A' ' 76' ' ' VAL . 31.9 mtm -114.33 143.77 44.34 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.538 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -120.11 98.04 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.0 t -70.67 168.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.615 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 36.6 tt0 -103.12 127.37 50.41 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.6 21.67 1.92 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.723 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.424 ' H ' ' C ' ' A' ' 16' ' ' GLU . 54.3 tpp . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.036 0.445 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -63.69 -12.09 31.38 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.3 t -59.21 -44.39 92.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 p -72.37 -31.07 65.27 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.08 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.426 ' HB ' HE22 ' A' ' 47' ' ' GLN . 45.4 mt -65.08 -36.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 123.889 0.743 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.11 -51.31 66.8 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -34.5 87.26 Favored Glycine 0 N--CA 1.495 2.591 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.084 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -63.52 -40.31 96.71 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.71 -32.33 44.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.873 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.73 -13.4 82.23 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.85 3.48 54.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.562 0.801 . . . . 0.0 110.569 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.28 119.46 24.62 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.15 148.19 32.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.087 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.05 -0.37 87.52 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -82.22 138.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 124.046 0.498 . . . . 0.0 110.227 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -95.63 -78.19 0.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -97.84 165.98 11.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.255 0.972 . . . . 0.0 109.856 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.39 111.36 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -124.42 69.46 1.09 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.145 0.974 . . . . 0.0 109.637 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.62 112.26 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 113.611 -1.631 . . . . 0.0 106.647 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 33.1 t -85.79 177.26 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.337 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.84 -168.02 1.64 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.98 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.72 -103.96 0.2 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.02 0.825 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -93.49 25.03 3.64 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.426 HE22 ' HB ' ' A' ' 27' ' ' ILE . 53.9 tt0 32.16 80.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' H ' ' HB3' ' A' ' 43' ' ' SER . 83.7 tt0 -75.97 90.38 2.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.62 113.39 13.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.408 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.7 m -122.01 78.13 1.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.021 -1.445 . . . . 0.0 107.452 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 51' ' ' ILE . 1.4 mp -90.16 136.5 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.213 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -113.71 140.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.52 162.89 40.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.37 1.044 . . . . 0.0 112.092 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -65.74 144.59 98.92 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.82 7.04 3.36 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.908 2.406 . . . . 0.0 114.294 -157.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.455 ' CD2' HD21 ' A' ' 57' ' ' LEU . 10.0 p-80 -156.96 19.66 0.31 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.455 HD21 ' CD2' ' A' ' 56' ' ' HIS . 3.3 mm? -86.06 -49.57 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.575 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.86 160.14 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 124.254 0.972 . . . . 0.0 110.761 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.8 m -98.8 110.82 23.37 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.76 -18.02 21.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.998 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.74 -32.48 74.0 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.951 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.94 -40.4 87.56 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.8 mmt -63.58 -33.77 76.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.756 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.96 -21.83 50.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.1 0.875 . . . . 0.0 109.738 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -66.37 -30.25 70.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.01 -40.76 78.49 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.425 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 78.6 mt -64.39 -31.94 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.112 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.58 -21.06 30.54 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.965 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.84 -38.09 46.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.026 0.829 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.3 ptm -74.15 -12.94 60.73 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.051 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 6.76 7.61 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -112.33 88.2 10.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -47.27 133.49 19.54 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 121.971 1.78 . . . . 0.0 109.222 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.88 123.81 33.62 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -82.55 64.46 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.338 -1.755 . . . . 0.0 108.681 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.416 HG12 ' SD ' ' A' ' 13' ' ' MET . 61.4 t . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 . . . . . 0 N--CA 1.506 2.362 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 m -117.29 153.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.291 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.21 68.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.315 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.27 109.35 1.1 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -81.66 82.86 7.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.481 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 11.0 ttp -80.13 125.55 29.96 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.269 1.033 . . . . 0.0 109.383 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.06 80.39 1.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 111.577 -2.556 . . . . 0.0 106.419 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -66.76 165.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.606 -1.634 . . . . 0.0 111.684 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -107.49 137.3 45.77 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.9 12.95 3.44 Favored Glycine 0 N--CA 1.49 2.251 0 O-C-N 123.801 0.688 . . . . 0.0 113.708 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.1 ttm . . . . . 0 N--CA 1.5 2.046 0 C-N-CA 123.732 0.813 . . . . 0.0 112.432 -179.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.5 p -62.88 -7.99 6.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.127 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.4 p -58.59 -34.78 71.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -71.21 -40.53 71.08 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.162 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.88 -35.71 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.913 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.7 -65.85 0.51 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.067 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.61 -22.83 70.13 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.895 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -70.86 -44.83 65.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.7 mt -72.58 -33.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.309 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.12 -14.59 71.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -95.45 3.03 54.67 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.101 -1.05 . . . . 0.0 111.622 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.45 116.38 25.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.04 0.447 . . . . 0.0 111.857 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.34 150.5 43.43 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.886 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.08 17.75 71.29 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 123.912 0.758 . . . . 0.0 111.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.66 137.48 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.506 HE22 ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -93.26 -81.98 0.35 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.764 1.29 . . . . 0.0 108.068 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.617 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 7.0 tpm_? -97.3 162.79 13.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.631 1.207 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.617 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.2 tt -158.45 111.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.647 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 139.74 9.62 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.373 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.2 t -108.03 158.08 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.561 -1.654 . . . . 0.0 112.653 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -135.23 176.52 8.6 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.473 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' N ' HD13 ' A' ' 44' ' ' LEU . 6.6 mp -67.69 -146.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.274 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 53.04 52.98 12.72 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.9 m120 55.19 84.41 0.07 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.347 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.417 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 3.1 tp-100 35.73 57.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.139 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.47 87.97 2.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -85.13 141.3 30.31 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.542 -1.663 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.5 m -135.77 70.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -73.91 138.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.437 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.3 t -114.7 135.79 53.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -163.83 169.6 18.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.668 1.23 . . . . 0.0 112.245 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.506 ' H ' HE22 ' A' ' 38' ' ' GLN . 5.1 pt20 -95.21 122.23 60.27 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 124.389 1.056 . . . . 0.0 108.524 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 -34.92 17.05 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.633 2.222 . . . . 0.0 112.392 -168.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.45 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 6.8 p-80 -57.13 -30.69 64.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -73.44 -47.39 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 tt -170.63 161.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.5 m -112.65 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.894 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.3 -13.8 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.292 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.6 -38.38 77.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.43 -41.42 89.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 mmt -65.47 -26.46 67.94 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.384 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -71.78 -30.0 65.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.311 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -63.61 -32.86 74.47 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.81 -39.85 87.87 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.366 1.041 . . . . 0.0 108.894 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.401 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 74.6 mt -65.14 -31.95 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.74 -19.68 30.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.88 41.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.072 0.858 . . . . 0.0 108.91 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.401 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.7 ptm -74.04 -12.09 60.52 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.648 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.31 9.11 8.86 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 117.834 1.894 . . . . 0.0 117.834 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.67 91.28 20.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -47.08 131.21 17.23 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.731 1.621 . . . . 0.0 108.788 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -129.27 104.6 7.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.463 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -85.45 92.3 8.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.431 -2.168 . . . . 0.0 109.113 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.693 179.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.58 0.705 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -64.55 125.2 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -94.63 69.56 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.416 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.24 117.12 8.07 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.031 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -104.96 105.68 15.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.392 1.058 . . . . 0.0 108.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.49 ' SD ' ' HG2' ' A' ' 64' ' ' LYS . 31.9 mtm -95.46 140.66 30.0 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -126.16 81.96 2.04 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.5 t -70.45 173.57 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.385 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 30.5 tt0 -100.23 111.22 23.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 103.52 -2.771 . . . . 0.0 103.52 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.18 -25.77 48.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.039 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 18' ' ' MET . 12.7 tmm? . . . . . 0 N--CA 1.497 1.876 0 O-C-N 124.519 0.776 . . . . 0.0 111.566 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 121.029 0.443 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 p -80.33 -2.98 47.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 m -61.14 -44.66 96.98 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.9 p -69.48 -34.5 74.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.352 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.44 -40.74 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.588 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -59.1 -55.93 28.78 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.645 0.736 . . . . 0.0 109.824 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.5 -30.9 75.72 Favored Glycine 0 N--CA 1.496 2.671 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.278 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -69.54 -42.46 74.57 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.96 -29.63 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.374 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.71 -24.0 76.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.39 -17.97 57.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.406 -0.897 . . . . 0.0 112.14 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.04 127.46 31.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.538 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.82 141.75 49.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.315 1.009 . . . . 0.0 109.764 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.91 11.62 70.0 Favored Glycine 0 N--CA 1.486 1.997 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.168 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.64 135.16 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.525 HE22 ' N ' ' A' ' 54' ' ' GLN . 2.4 mp0 -95.75 -78.14 0.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.17 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -96.97 154.73 17.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.718 1.261 . . . . 0.0 110.816 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 tt -155.21 121.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.314 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -150.6 153.39 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.426 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.2 t -129.59 133.98 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 124.259 0.974 . . . . 0.0 108.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.6 m -105.31 149.42 26.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.684 1.24 . . . . 0.0 110.218 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.5 4.69 0.71 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.08 68.43 9.99 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.3 m120 55.63 72.4 0.49 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.402 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 54.9 tp60 40.99 54.72 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.311 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.11 80.76 5.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.05 131.44 38.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.323 -2.217 . . . . 0.0 109.918 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -131.57 72.0 1.49 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.021 0.915 . . . . 0.0 109.81 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.76 137.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.015 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 t -114.05 146.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -165.56 177.05 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.763 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.525 ' N ' HE22 ' A' ' 38' ' ' GLN . 5.5 pt20 -86.9 125.78 65.5 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.58 68.02 8.2 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.235 2.623 . . . . 0.0 113.167 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 5.9 p-80 -172.23 -28.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.04 -44.62 38.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 123.965 0.791 . . . . 0.0 109.544 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -167.76 172.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.088 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 58' ' ' ILE . 51.5 m -119.22 110.89 17.55 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.01 -21.29 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.257 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.49 -39.31 91.77 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.756 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.79 -37.11 73.29 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -71.81 -22.45 61.56 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.583 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.49 ' HG2' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -97.84 -9.15 26.91 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.49 -32.88 74.46 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.413 HE21 ' CG1' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -60.75 -24.04 65.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 123.99 0.806 . . . . 0.0 110.516 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.413 ' CG1' HE21 ' A' ' 66' ' ' GLN . 81.1 mt -70.63 -33.17 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.4 -27.79 46.76 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.48 -35.31 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.691 1.244 . . . . 0.0 109.947 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' CE1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -69.72 -19.33 63.55 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 123.905 0.753 . . . . 0.0 110.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.85 3.3 5.01 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 118.429 -1.206 . . . . 0.0 116.041 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 3.4 m-30 -106.99 86.19 2.29 Favored Pre-proline 0 N--CA 1.5 2.039 0 CA-C-N 118.477 1.138 . . . . 0.0 108.649 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.59 130.77 34.71 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 121.094 1.196 . . . . 0.0 109.044 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.24 124.93 51.05 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.745 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.74 -48.12 41.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.591 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.44 HG21 ' NZ ' ' A' ' 64' ' ' LYS . 23.8 t . . . . . 0 N--CA 1.495 1.798 0 O-C-N 125.312 1.632 . . . . 0.0 113.499 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' CB ' HE22 ' A' ' 38' ' ' GLN . 10.3 pt-20 . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.99 150.24 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.052 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.71 57.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 124.409 1.068 . . . . 0.0 108.941 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.3 141.17 41.7 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.19 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -103.49 104.86 14.98 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.412 ' SD ' HG11 ' A' ' 76' ' ' VAL . 16.8 mmm -89.49 109.97 20.85 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.68 85.53 2.76 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.328 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.14 168.01 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.482 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.8 tt0 -110.94 142.15 43.42 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.5 ' H ' HD21 ' A' ' 46' ' ' ASN . . . -80.96 29.93 2.68 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.497 ' H ' ' C ' ' A' ' 16' ' ' GLU . 31.8 ttm . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 78.2 m . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.3 p -64.03 -7.61 9.13 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.769 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.6 p -62.27 -40.44 96.23 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 p -68.6 -33.62 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.298 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.54 -42.24 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.06 0.85 . . . . 0.0 108.939 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.35 -50.31 74.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.494 0.664 . . . . 0.0 110.828 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.32 -36.5 93.28 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.7 -1.591 . . . . 0.0 113.835 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.61 -51.34 10.8 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.997 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.18 1.48 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.56 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.21 -28.05 3.72 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.407 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -96.5 8.92 42.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.154 0.502 . . . . 0.0 111.811 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 135.54 43.06 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.309 1.052 . . . . 0.0 113.279 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -88.0 156.42 19.32 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.602 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.74 8.68 82.16 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.68 144.09 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.353 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.444 HE22 ' CB ' ' A' ' 8' ' ' GLU . 32.8 mt-30 -96.04 -82.31 0.39 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.176 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.59 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -97.97 169.13 9.85 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.54 1.15 . . . . 0.0 111.625 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.59 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 11.0 tt -153.78 131.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.497 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 140.28 38.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -140.08 137.16 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.842 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t -102.62 170.12 8.22 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.279 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -93.0 -166.22 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.805 -1.088 . . . . 0.0 108.406 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 58.54 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 17' ' ' GLY . 23.9 m120 -100.51 34.07 2.52 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.293 0.568 . . . . 0.0 111.006 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 33.96 58.73 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.559 -1.2 . . . . 0.0 114.213 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.67 96.89 2.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.45 121.79 36.35 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.512 -1.677 . . . . 0.0 111.552 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.3 m -115.27 93.92 4.5 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.15 136.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.928 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.1 t -101.79 132.41 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -155.84 176.64 12.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.65 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.11 112.06 57.06 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 112.422 -2.172 . . . . 0.0 107.074 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.61 -49.68 3.06 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.946 2.431 . . . . 0.0 110.225 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -57.83 -22.45 47.79 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 tp -90.12 -40.93 11.94 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.378 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 tt -161.78 162.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.586 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.7 p -126.94 109.19 11.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.622 1.201 . . . . 0.0 107.868 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.29 -17.16 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.72 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.94 -38.61 86.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -66.96 -40.58 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -64.03 -26.97 68.8 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.718 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -90.88 -19.62 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.827 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.5 -43.55 96.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.644 0.259 . . . . 0.0 111.292 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -66.89 -35.84 80.94 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.5 -31.53 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.703 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.03 -20.07 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.695 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.5 -36.24 38.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 124.024 0.827 . . . . 0.0 109.436 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.2 ptm -75.27 -11.36 60.05 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.15 0.906 . . . . 0.0 111.525 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 19.22 2.94 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 117.991 1.956 . . . . 0.0 117.991 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -125.0 73.89 65.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.4 132.1 15.51 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 122.185 1.923 . . . . 0.0 109.904 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -119.58 118.7 31.71 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.416 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -81.18 75.73 8.14 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.782 -2.463 . . . . 0.0 108.695 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.412 HG11 ' SD ' ' A' ' 13' ' ' MET . 74.9 t . . . . . 0 N--CA 1.497 1.875 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.756 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.727 0.775 . . . . 0.0 112.956 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 m -107.69 126.05 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 113.789 -1.55 . . . . 0.0 110.842 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.19 57.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.507 1.146 . . . . 0.0 109.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.89 135.33 56.46 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.892 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -105.12 140.05 38.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.422 ' SD ' HG12 ' A' ' 60' ' ' VAL . 4.4 mtt -139.21 131.5 28.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -119.03 95.81 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.521 1.138 . . . . 0.0 111.341 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.77 170.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-N 113.464 -1.698 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.1 tt0 -95.6 116.5 28.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.4 19.32 7.11 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-O 119.078 -0.845 . . . . 0.0 114.189 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 53.9 ttp . . . . . 0 N--CA 1.495 1.808 0 C-N-CA 124.408 1.083 . . . . 0.0 113.336 -179.878 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.7 p -66.6 -15.44 63.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.9 p -57.06 -38.91 73.94 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -83.33 -33.22 25.94 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.917 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.53 -30.0 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.931 0.769 . . . . 0.0 109.932 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -56.99 -67.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.77 -21.29 79.79 Favored Glycine 0 N--CA 1.494 2.549 0 CA-C-N 113.889 -1.505 . . . . 0.0 114.157 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -74.56 -52.79 10.84 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.49 -27.81 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.042 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.56 -16.22 78.19 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.155 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.21 2.02 54.82 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 124.183 0.578 . . . . 0.0 111.94 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.5 117.29 10.93 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.159 0.504 . . . . 0.0 112.228 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.83 145.98 55.51 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.286 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.91 86.67 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.757 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.26 132.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.101 0.477 . . . . 0.0 110.343 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' NE2' ' NE2' ' A' ' 54' ' ' GLN . 14.0 mm-40 -94.64 -76.4 0.49 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.133 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -97.65 165.87 11.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.203 0.94 . . . . 0.0 109.243 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 tt -155.98 131.51 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.578 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -157.93 84.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.346 1.07 . . . . 0.0 111.1 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.1 t -82.36 119.86 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -90.96 157.16 17.45 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.5 -110.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.428 -1.273 . . . . 0.0 107.745 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 p30 37.54 -122.82 0.22 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 119.237 0.926 . . . . 0.0 110.631 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -102.95 55.08 0.76 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 41.98 66.15 0.76 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.261 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -84.38 88.04 7.25 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 117.749 -1.58 . . . . 0.0 108.025 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 127.61 33.37 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 108.93 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -129.49 49.98 2.2 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.957 0.884 . . . . 0.0 108.986 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.27 147.16 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.565 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.5 t -113.91 144.32 21.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -156.39 157.83 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.346 1.029 . . . . 0.0 110.164 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' NE2' ' NE2' ' A' ' 38' ' ' GLN . 6.9 pt20 -86.26 146.39 42.33 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.42 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -58.98 155.25 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 123.03 2.487 . . . . 0.0 113.764 -161.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' CD2' HD23 ' A' ' 57' ' ' LEU . 7.9 p-80 52.86 -1.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' A' ' 56' ' ' HIS . 4.6 mm? -72.97 -40.21 65.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.88 0.764 . . . . 0.0 109.307 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -161.27 174.42 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.793 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.417 ' N ' HG13 ' A' ' 58' ' ' ILE . 68.3 m -139.14 108.5 6.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG12 ' SD ' ' A' ' 13' ' ' MET . 49.2 t -66.2 -19.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.527 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.54 -37.09 82.2 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -68.94 -39.38 79.6 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.2 mmt -66.26 -29.65 69.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.351 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -80.93 -21.89 40.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.731 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -63.96 -33.46 75.77 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -69.9 -39.58 76.13 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.75 -26.73 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.93 -1.486 . . . . 0.0 107.885 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.93 -21.12 25.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.245 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.27 -37.1 38.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.937 0.773 . . . . 0.0 108.959 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -12.03 60.29 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 124.27 0.982 . . . . 0.0 111.264 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.09 -7.06 6.06 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -103.66 95.27 7.16 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 119.076 1.438 . . . . 0.0 112.805 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -46.78 133.58 17.36 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.765 1.643 . . . . 0.0 109.519 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.46 112.28 17.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.64 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -78.45 84.25 4.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.669 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.626 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.45 ' CB ' HE22 ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.63 134.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 78.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 124.182 0.926 . . . . 0.0 111.089 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.32 138.91 36.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.338 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.74 117.78 33.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.452 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.3 mpp? -119.0 137.02 53.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -119.59 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.923 1.389 . . . . 0.0 110.768 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -65.38 167.81 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 18' ' ' MET . 39.2 tt0 -98.68 121.66 40.9 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.96 19.41 1.24 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.041 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.46 ' H ' ' C ' ' A' ' 16' ' ' GLU . 42.7 tpp . . . . . 0 N--CA 1.488 1.442 0 C-N-CA 124.949 1.299 . . . . 0.0 108.812 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 121.414 0.626 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -72.39 -0.99 13.91 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.6 t -61.79 -39.75 92.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -65.18 -34.35 78.17 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.51 -37.92 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.843 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -48.68 -61.5 2.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.9 0.75 . . . . 0.0 112.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.93 -29.24 71.94 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 114.045 -1.434 . . . . 0.0 112.781 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -70.43 -41.1 73.33 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.455 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.17 -33.88 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.6 76.95 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.69 -6.63 55.92 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.691 -0.755 . . . . 0.0 112.508 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.12 118.09 11.58 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.38 141.67 36.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.991 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.79 4.18 79.48 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.739 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.8 141.89 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.45 HE22 ' CB ' ' A' ' 8' ' ' GLU . 29.4 mt-30 -96.37 -79.44 0.45 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.781 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.426 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.6 tpm_? -96.81 159.63 14.81 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.84 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.426 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 5.4 tt -149.36 110.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -145.32 101.37 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.995 0.902 . . . . 0.0 111.237 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.3 t -93.65 149.3 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.293 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 t -111.66 144.53 40.77 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.879 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -25.76 60.28 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.421 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.45 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.074 0.859 . . . . 0.0 110.418 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.1 m120 45.18 53.31 8.02 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.446 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 44.38 49.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.963 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -74.07 89.7 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.5 130.19 37.59 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 111.828 -2.442 . . . . 0.0 114.085 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 m -132.07 74.54 1.59 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.62 1.2 . . . . 0.0 107.984 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 1.3 mp -83.58 132.03 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.869 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 42.7 t -105.13 138.61 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -156.63 179.65 9.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.543 1.152 . . . . 0.0 113.645 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -95.37 116.11 66.02 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.486 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.2 -54.59 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.87 2.38 . . . . 0.0 110.237 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -56.14 -22.42 28.37 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.053 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.07 -40.96 12.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.244 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 tt -163.88 162.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 124.451 1.095 . . . . 0.0 111.284 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -130.93 104.74 7.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -68.58 -17.9 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.393 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.7 -29.02 67.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.321 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.69 -41.2 79.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.5 mmt -62.53 -31.93 72.8 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.269 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -66.25 -34.06 77.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.991 0.807 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -61.24 -34.13 74.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.091 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -67.82 -38.69 83.55 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 124.252 0.97 . . . . 0.0 109.047 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.7 -33.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.23 -24.66 34.73 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.389 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.11 -36.43 58.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.23 0.956 . . . . 0.0 109.928 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -74.93 -13.63 60.55 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 123.805 0.69 . . . . 0.0 111.082 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.57 10.36 4.51 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 7.6 m-85 -118.34 88.37 32.98 Favored Pre-proline 0 N--CA 1.499 2.019 0 CA-C-N 118.268 1.034 . . . . 0.0 109.773 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -49.08 135.15 30.19 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.128 1.885 . . . . 0.0 109.408 173.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.21 122.08 30.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.749 1.28 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.63 77.94 9.77 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.131 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.532 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 N--CA 1.506 2.332 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.92 108.36 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 m -92.6 56.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.022 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 156.31 28.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -120.66 94.86 4.5 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.893 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.3 mtm -82.37 135.28 35.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -116.93 90.47 3.34 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.721 1.248 . . . . 0.0 113.11 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -54.02 167.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 112.722 -2.036 . . . . 0.0 115.126 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 18' ' ' MET . 33.4 tt0 -120.5 126.77 51.2 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.56 21.06 1.22 Allowed Glycine 0 N--CA 1.492 2.399 0 O-C-N 123.299 0.374 . . . . 0.0 113.407 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.452 ' H ' ' C ' ' A' ' 16' ' ' GLU . 36.0 ttp . . . . . 0 N--CA 1.496 1.859 0 O-C-N 124.295 0.644 . . . . 0.0 111.664 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.9 p -59.85 -8.79 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.651 -1.159 . . . . 0.0 113.419 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.2 p -56.25 -32.61 64.65 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.3 p -68.66 -39.78 80.47 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.386 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.3 mt -52.57 -30.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 124.502 1.126 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.25 -72.5 0.06 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.5 -12.77 80.29 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.533 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.83 -53.87 7.0 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.491 0.662 . . . . 0.0 109.301 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.16 -29.66 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.036 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.52 -14.68 81.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -95.49 1.05 53.83 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.72 -0.74 . . . . 0.0 112.805 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.413 HD21 ' SD ' ' A' ' 63' ' ' MET . 79.9 mt -72.29 125.34 27.11 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -83.89 144.5 29.17 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.531 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.95 10.7 84.69 Favored Glycine 0 N--CA 1.489 2.212 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.018 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.56 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -95.79 -83.83 0.36 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -98.45 166.59 11.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.592 1.182 . . . . 0.0 110.992 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.53 107.06 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -147.73 108.45 4.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.753 0.787 . . . . 0.0 110.845 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.8 t -97.18 139.68 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.79 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.1 t -100.63 171.07 7.94 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.773 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.4 mp -74.58 -115.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.168 -1.396 . . . . 0.0 108.183 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 p30 39.81 -133.32 0.22 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 119.272 0.942 . . . . 0.0 109.768 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -93.85 56.99 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 41.16 69.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.948 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.35 90.91 5.01 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.48 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.74 129.4 39.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.254 -1.794 . . . . 0.0 108.052 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -129.53 69.14 1.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.414 1.102 . . . . 0.0 108.859 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -81.87 126.89 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.387 -1.733 . . . . 0.0 107.488 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.1 t -98.5 133.51 40.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -154.05 171.75 18.59 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.495 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.1 114.07 60.34 Favored Pre-proline 0 N--CA 1.494 1.742 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.228 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -62.5 -50.71 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.847 2.365 . . . . 0.0 111.313 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -60.06 -26.89 66.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.279 -1.328 . . . . 0.0 113.287 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tp -88.16 -36.38 16.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.407 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.28 162.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.782 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.1 m -132.0 106.62 8.14 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.9 t -76.36 -15.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.94 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.72 -32.74 73.57 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -71.0 -45.3 64.24 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.2 tpt -58.95 -31.68 68.94 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.787 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.02 -30.89 58.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.163 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -59.95 -31.55 69.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.251 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.03 -38.13 75.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.4 mt -66.88 -30.21 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.96 -22.11 33.85 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.276 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.31 -37.39 44.77 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 124.195 0.934 . . . . 0.0 109.28 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.6 ptm -72.59 -13.62 61.43 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.254 0.971 . . . . 0.0 111.144 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.35 8.89 3.86 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -118.71 71.29 10.07 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 118.289 1.044 . . . . 0.0 110.325 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -47.69 130.55 18.86 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.184 1.923 . . . . 0.0 110.523 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -112.64 123.05 49.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.471 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -66.48 -3.01 5.29 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.954 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 N--CA 1.508 2.435 0 O-C-N 123.899 0.749 . . . . 0.0 111.782 179.772 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.94 136.64 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.782 -2.008 . . . . 0.0 109.65 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.89 51.85 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 122.644 1.211 . . . . 0.0 109.111 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.5 mt -71.34 151.84 43.77 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.774 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -117.59 149.56 40.45 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.754 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.0 141.74 51.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -127.97 84.16 2.22 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.739 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.2 t -62.99 170.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.459 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 34.0 tt0 -112.45 143.05 44.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.84 23.34 3.1 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.397 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.438 ' H ' ' C ' ' A' ' 16' ' ' GLU . 17.3 ttm . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.322 0.582 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.2 p -69.56 -6.98 34.49 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.725 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.8 m -57.49 -33.28 67.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.045 0.45 . . . . 0.0 109.909 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -67.79 -39.4 84.03 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.111 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.9 mt -52.66 -35.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.325 1.016 . . . . 0.0 111.699 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -49.84 -72.09 0.06 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.419 1.074 . . . . 0.0 112.162 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.74 -21.75 77.99 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.376 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -63.87 -40.57 96.85 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.8 -23.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.438 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.59 -12.23 83.89 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -91.88 -0.91 57.52 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.683 -0.759 . . . . 0.0 112.01 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.414 HD23 ' SD ' ' A' ' 63' ' ' MET . 89.5 mt -73.26 126.06 29.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -85.58 140.58 30.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.135 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.71 1.54 85.25 Favored Glycine 0 N--CA 1.491 2.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.899 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.47 144.52 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -96.1 -82.85 0.38 Allowed 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.481 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.602 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.639 1.212 . . . . 0.0 109.881 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.602 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 10.7 tt -154.06 122.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.79 162.87 39.44 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.46 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.6 t -137.54 133.47 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 124.491 1.119 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.2 m -100.12 148.81 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.664 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.65 3.85 0.47 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -86.62 68.66 10.22 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.25 69.84 0.69 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.53 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 40.44 50.94 2.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.423 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.74 85.23 3.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.79 128.13 34.68 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 112.675 -2.057 . . . . 0.0 113.793 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -118.58 72.26 0.87 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.834 0.709 . . . . 0.0 109.515 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.427 ' N ' HD13 ' A' ' 51' ' ' ILE . 1.9 mp -72.79 139.07 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.368 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.1 t -115.83 132.15 66.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -151.72 163.43 39.16 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.521 1.138 . . . . 0.0 113.089 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -62.87 149.96 88.7 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.157 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.37 -4.04 14.78 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.986 2.457 . . . . 0.0 114.404 -153.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -160.53 27.42 0.16 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.85 -47.26 9.85 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.519 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.33 161.77 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 124.155 0.909 . . . . 0.0 111.47 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -104.28 113.67 27.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.479 1.112 . . . . 0.0 110.974 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.5 t -71.24 -25.19 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.981 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.3 -24.5 65.02 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.523 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -70.49 -41.46 72.66 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -63.49 -38.58 91.66 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 2.9 mmmp? -62.83 -33.06 74.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.584 1.177 . . . . 0.0 109.864 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.77 -43.44 98.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -65.54 -36.7 84.56 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 124.275 0.985 . . . . 0.0 109.158 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.41 -32.74 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.9 -20.61 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.913 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.55 -36.76 32.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.043 0.84 . . . . 0.0 109.738 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.493 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 1.9 ppp? -77.03 -12.01 59.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.33 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.19 23.31 1.78 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 117.804 1.882 . . . . 0.0 117.804 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' SD ' ' A' ' 70' ' ' MET . 9.3 m-85 -131.84 83.22 57.84 Favored Pre-proline 0 N--CA 1.494 1.756 0 CA-C-N 117.58 0.69 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -47.49 134.49 20.97 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 122.026 1.817 . . . . 0.0 108.738 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.98 114.99 18.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.69 1.244 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -85.67 71.12 10.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 111.744 -2.48 . . . . 0.0 108.499 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.498 1.975 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.97 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.12 0.486 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -88.99 110.94 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.881 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.47 143.93 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.37 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 70.9 mt -127.99 152.73 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.903 0.752 . . . . 0.0 109.495 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' SD ' ' A' ' 13' ' ' MET . 63.6 tttm -147.96 109.25 4.32 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 2.9 mpp? -127.38 141.06 51.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.619 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -112.51 105.68 13.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.761 1.288 . . . . 0.0 109.033 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.2 t -70.05 160.52 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -90.58 108.21 19.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.99 -14.0 22.13 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.846 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.404 ' HE3' ' CD1' ' A' ' 72' ' ' PHE . 53.7 tpp . . . . . 0 N--CA 1.497 1.924 0 C-N-CA 123.984 0.914 . . . . 0.0 110.732 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.1 p -80.69 -7.93 59.48 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.9 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.6 t -59.67 -38.83 82.58 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -71.58 -33.88 69.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.85 -36.38 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.169 0.918 . . . . 0.0 110.49 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.06 -64.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.909 0.755 . . . . 0.0 111.319 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.28 -27.15 71.18 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.058 -1.428 . . . . 0.0 113.09 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.49 -40.55 80.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.39 -29.05 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.49 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.34 -13.85 77.02 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.07 -4.93 58.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.485 -0.858 . . . . 0.0 112.282 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.53 119.35 17.64 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.34 138.12 33.67 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.061 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.36 77.52 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.56 126.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -87.34 -75.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.551 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 4.6 tpm_? -97.48 156.22 16.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.551 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.6 tt -153.27 115.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.43 114.37 3.0 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.8 t -108.46 147.56 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.408 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -88.77 -178.21 5.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -104.2 179.57 4.23 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.861 -1.518 . . . . 0.0 108.408 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 56.71 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 124.304 1.003 . . . . 0.0 111.269 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.78 12.38 3.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 123.421 0.45 . . . . 0.0 109.997 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 35.24 50.31 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 124.395 1.06 . . . . 0.0 111.517 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.78 92.74 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.234 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.55 131.55 40.11 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.6 m -135.98 70.02 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.036 0.922 . . . . 0.0 108.67 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 1.3 mp -82.42 150.31 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.798 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -125.05 149.34 29.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -162.07 161.22 28.22 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 123.997 0.81 . . . . 0.0 108.885 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.89 159.55 75.96 Favored Pre-proline 0 N--CA 1.499 1.985 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.421 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -83.6 42.2 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.495 2.13 . . . . 0.0 114.217 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.513 ' CD2' HD21 ' A' ' 57' ' ' LEU . 27.8 p-80 -159.78 -4.53 0.07 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 118.734 2.865 . . . . 0.0 118.734 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD21 ' CD2' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -89.1 -55.78 3.54 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 120.349 1.431 . . . . 0.0 109.54 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -164.29 161.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -88.13 110.07 20.38 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.881 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -66.56 -29.24 45.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.741 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.27 -23.36 64.06 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.534 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -70.92 -43.47 68.17 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -29.4 69.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 124.359 1.037 . . . . 0.0 110.524 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -72.29 -28.36 63.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -69.85 -28.33 65.59 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.612 0.57 . . . . 0.0 110.066 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.57 -39.07 92.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 123.844 0.715 . . . . 0.0 109.094 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.25 -30.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.674 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.99 -24.52 24.65 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.023 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.97 -37.4 61.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 124.255 0.972 . . . . 0.0 109.356 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.23 -11.93 60.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.547 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.68 -3.88 8.65 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 1.9 m-30 -107.59 91.32 7.07 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 119.051 1.425 . . . . 0.0 109.272 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -50.74 132.21 35.89 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.71 1.607 . . . . 0.0 110.085 171.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -115.27 95.58 5.25 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.275 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.45 96.97 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 111.37 -2.65 . . . . 0.0 110.7 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.244 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.403 ' CB ' HE22 ' A' ' 38' ' ' GLN . 9.8 pt-20 . . . . . 0 N--CA 1.503 2.224 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.97 146.92 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.07 56.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.359 1.037 . . . . 0.0 109.825 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.8 mt -67.48 146.83 53.59 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.402 ' C ' ' SD ' ' A' ' 13' ' ' MET . 58.3 mmtt -106.91 136.47 46.7 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 3.5 mpp? -136.0 135.97 39.94 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -112.65 151.3 30.31 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.434 ' CG2' ' HZ3' ' A' ' 64' ' ' LYS . 2.1 t -131.36 167.48 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 124.579 1.174 . . . . 0.0 111.662 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -94.43 133.55 37.91 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.73 19.38 9.42 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.662 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttp . . . . . 0 N--CA 1.501 2.107 0 O-C-N 125.102 1.119 . . . . 0.0 113.059 -179.778 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 120.843 0.354 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -63.13 -15.25 56.14 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.546 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -53.14 -35.87 60.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 123.868 0.73 . . . . 0.0 109.751 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 p -73.79 -41.8 61.88 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.976 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.78 -36.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 124.292 0.995 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.22 -66.38 0.4 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.641 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.3 -12.15 84.61 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 114.002 -1.454 . . . . 0.0 115.033 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -84.45 -58.39 2.76 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -27.04 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.438 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.54 -12.05 80.89 Favored Glycine 0 N--CA 1.486 2.019 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.668 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.29 -7.81 57.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.191 0.519 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.05 141.32 50.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.18 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -77.18 145.01 37.92 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.746 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.94 9.13 85.26 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.167 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 t -79.75 133.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 124.263 0.625 . . . . 0.0 109.879 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.403 HE22 ' CB ' ' A' ' 8' ' ' GLU . 34.9 mt-30 -95.6 -82.13 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.635 -1.62 . . . . 0.0 107.609 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -98.49 164.87 12.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.445 1.09 . . . . 0.0 111.629 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 tt -147.47 117.74 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -142.53 74.4 1.44 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.802 1.287 . . . . 0.0 109.423 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.21 142.75 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.327 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.0 t -86.15 -179.6 6.76 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.506 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.7 179.83 4.16 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.762 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 47' ' ' GLN . 8.0 m-20 55.36 -90.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 124.232 0.957 . . . . 0.0 110.776 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.2 16.98 0.85 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.317 0.386 . . . . 0.0 110.623 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 45' ' ' ASP . 3.7 tp-100 29.07 54.11 0.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.459 1.104 . . . . 0.0 112.947 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.48 93.93 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.658 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.53 130.45 37.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.28 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -136.23 63.3 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.1 mp -72.22 135.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-N 113.879 -1.51 . . . . 0.0 108.476 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.02 135.24 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.94 162.77 40.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 124.816 1.323 . . . . 0.0 112.285 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -63.62 147.05 96.21 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.91 4.43 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.126 2.551 . . . . 0.0 114.462 -152.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -160.74 23.75 0.14 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.55 -45.74 13.2 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 59' ' ' SER . 8.3 tp -161.4 171.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.243 0.964 . . . . 0.0 110.707 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.408 ' N ' HG13 ' A' ' 58' ' ' ILE . 36.4 p -107.94 111.1 23.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.824 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.07 -28.17 29.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.313 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.45 -20.79 65.87 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.653 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.97 -43.06 65.77 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 mmt -64.13 -30.49 71.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.476 1.11 . . . . 0.0 109.562 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HZ3' ' CG2' ' A' ' 15' ' ' VAL . 3.0 mmmp? -64.02 -33.32 75.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.251 0.969 . . . . 0.0 109.119 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -65.26 -33.46 76.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.272 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -69.08 -39.06 79.27 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -66.48 -28.71 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.067 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.87 -22.6 25.65 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.088 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.5 47.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 123.993 0.808 . . . . 0.0 109.567 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -12.79 60.34 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.434 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.02 -4.81 6.42 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 118.899 2.319 . . . . 0.0 118.899 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -104.77 95.68 9.28 Favored Pre-proline 0 N--CA 1.504 2.251 0 CA-C-N 119.365 1.582 . . . . 0.0 110.494 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -51.13 134.04 42.64 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.403 1.402 . . . . 0.0 109.5 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.77 129.32 55.18 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.229 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.05 63.29 4.38 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 113.629 -1.623 . . . . 0.0 111.109 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.81 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.088 0.47 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.81 137.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.857 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.48 75.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.56 -20.8 65.04 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 50.52 94.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 13' ' ' MET . 2.9 mpp? -100.55 135.44 41.98 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.778 -1.555 . . . . 0.0 106.949 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -126.11 86.56 2.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 124.724 1.265 . . . . 0.0 107.712 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.1 t -65.19 165.64 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.638 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.458 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.4 tt0 -113.15 128.48 56.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.12 30.15 2.71 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 16' ' ' GLU . 58.7 ttm . . . . . 0 N--CA 1.495 1.813 0 C-N-CA 123.228 0.611 . . . . 0.0 110.207 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -75.51 -1.29 23.56 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.442 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -69.15 -27.81 65.87 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.3 p -66.33 -35.31 80.04 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.25 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.22 -33.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 124.819 1.324 . . . . 0.0 110.82 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -48.85 -73.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.803 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.29 -21.9 66.34 Favored Glycine 0 N--CA 1.497 2.755 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.564 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -64.2 -34.06 77.21 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.367 0.603 . . . . 0.0 109.729 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.8 -21.98 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.958 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.83 -14.62 80.66 Favored Glycine 0 N--CA 1.487 2.088 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.738 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.82 1.98 56.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 124.208 0.593 . . . . 0.0 111.714 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.89 102.18 5.45 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.592 0.71 . . . . 0.0 112.855 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -75.6 119.73 20.04 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.57 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.88 9.26 12.52 Favored Glycine 0 N--CA 1.485 1.903 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.52 138.22 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -95.13 -77.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.95 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -96.84 153.4 17.91 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.16 118.26 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.829 -0.749 . . . . 0.0 112.439 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.27 161.27 21.83 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.08 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.99 134.56 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.604 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -104.18 176.18 5.24 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.882 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 44' ' ' LEU . 7.1 mp -70.98 -150.37 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.512 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 53.41 58.03 5.6 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.976 0.893 . . . . 0.0 108.995 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 51.21 81.98 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.71 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 36.5 61.94 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.789 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.44 85.48 6.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -67.37 136.84 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 113.01 -1.905 . . . . 0.0 111.034 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.4 m -135.36 52.89 2.0 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -73.94 125.44 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.28 138.66 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.35 177.46 10.56 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 114.239 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -88.18 121.79 70.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 113.55 -1.659 . . . . 0.0 106.725 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -68.46 -54.96 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.275 1.983 . . . . 0.0 109.395 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -52.54 -26.02 12.03 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.86 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 tp -93.96 -47.61 6.63 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.17 168.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -132.14 111.25 11.29 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.438 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.02 -24.63 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.812 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.45 -18.94 54.53 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.719 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.96 -43.92 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -29.82 70.97 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.206 0.941 . . . . 0.0 109.727 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -64.04 -33.95 76.92 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.21 -32.0 73.29 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.504 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -69.65 -39.47 77.07 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.71 -28.44 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.842 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.901 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.5 -37.42 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 124.09 0.869 . . . . 0.0 109.271 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -12.7 60.45 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.653 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.89 -2.46 6.88 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -107.88 91.78 8.11 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 118.744 1.272 . . . . 0.0 110.344 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -47.16 134.76 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.041 1.828 . . . . 0.0 110.446 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -122.33 109.39 14.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 124.652 1.22 . . . . 0.0 108.37 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.29 79.64 7.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.175 -2.284 . . . . 0.0 108.878 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.494 1.773 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.964 -179.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.505 2.303 0 CA-C-O 121.001 0.429 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.32 130.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.68 91.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.977 0.894 . . . . 0.0 110.294 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.27 139.3 30.86 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -130.14 103.23 6.62 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.324 1.64 . . . . 0.0 106.87 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.542 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 50.6 mtp -104.87 145.44 30.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.54 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -119.7 87.79 2.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.287 0.992 . . . . 0.0 111.55 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.37 164.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 3.1 mp0 -116.67 154.83 29.87 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.222 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 18.12 5.23 Favored Glycine 0 N--CA 1.484 1.858 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.572 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' GLU . 55.7 ttm . . . . . 0 N--CA 1.501 2.084 0 O-C-N 125.508 1.357 . . . . 0.0 109.285 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -72.94 -4.69 33.7 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.1 t -62.81 -37.4 86.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -66.62 -35.28 79.79 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.5 mt -57.03 -39.37 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 124.197 0.936 . . . . 0.0 111.502 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -51.42 -67.98 0.21 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.791 0.682 . . . . 0.0 112.585 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.21 -23.39 78.13 Favored Glycine 0 N--CA 1.496 2.664 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.635 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.3 -50.26 41.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.44 -27.52 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.604 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.08 -12.21 83.55 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.2 1.57 54.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 124.337 0.669 . . . . 0.0 111.401 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.4 mt -74.78 131.36 40.74 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.836 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -83.05 160.23 21.98 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 124.147 0.904 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.46 11.03 71.6 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.49 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.07 146.99 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -95.86 -83.93 0.36 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.54 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 3.2 tpm_? -98.33 160.87 14.01 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.1 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.54 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -158.47 107.93 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HZ3' HH11 ' A' ' 39' ' ' ARG . 0.1 OUTLIER -137.65 160.01 40.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.597 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -139.68 149.68 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 124.183 0.927 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.5 t -110.47 140.49 44.67 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.082 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tt -50.39 -35.15 26.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.73 1.269 . . . . 0.0 110.247 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -53.57 85.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.465 1.103 . . . . 0.0 111.373 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 m120 41.57 60.5 2.12 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.962 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 42.18 48.68 4.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.526 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.68 89.97 2.28 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.75 146.02 31.22 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 112.094 -2.321 . . . . 0.0 114.519 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.4 m -138.77 78.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 51' ' ' ILE . 1.6 mp -88.74 136.24 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.066 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -107.91 135.21 47.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -154.98 172.35 18.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.05 116.99 67.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.17 -53.72 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.698 2.265 . . . . 0.0 110.129 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -57.73 -26.27 61.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.363 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.97 -38.15 14.68 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.791 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.66 159.88 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.377 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -129.3 95.93 4.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.91 -26.28 40.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 112.173 -2.285 . . . . 0.0 110.567 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.8 -35.14 70.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.174 0.921 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.16 -41.56 94.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.6 mmm -70.44 -27.35 64.18 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.51 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 71.8 mmtt -80.95 -18.61 46.46 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.506 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.46 -31.37 68.49 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -64.87 -35.39 80.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.002 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.72 -34.68 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -81.29 -20.32 41.08 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.581 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.55 36.52 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 ptm -75.56 -11.14 59.96 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.141 0.901 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.38 17.66 3.92 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -123.05 82.57 50.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -51.25 141.75 38.57 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.097 1.864 . . . . 0.0 108.337 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.33 125.44 42.28 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.331 1.02 . . . . 0.0 108.927 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -82.63 83.38 7.65 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.19 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.496 1.86 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.729 -179.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 N--CA 1.504 2.264 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.77 146.43 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.963 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.45 55.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.151 -1.386 . . . . 0.0 107.774 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.39 145.54 47.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.276 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 121.16 37.41 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.48 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.2 mpp? -126.19 132.4 51.78 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -119.11 90.53 3.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.686 1.241 . . . . 0.0 111.496 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -61.63 164.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.551 -1.659 . . . . 0.0 114.016 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 24.1 tt0 -90.96 110.52 21.78 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.14 -19.98 26.15 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.544 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.7 ttm . . . . . 0 N--CA 1.497 1.925 0 O-C-N 124.865 0.98 . . . . 0.0 111.919 179.913 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -65.91 -10.71 41.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.437 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.2 t -59.4 -35.02 73.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -75.13 -37.42 61.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.192 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.0 mt -61.58 -30.16 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 124.262 0.976 . . . . 0.0 109.836 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.08 -67.15 0.3 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.528 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.08 -10.14 84.09 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.771 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.68 -56.19 4.32 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.98 -30.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.352 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 -17.82 79.93 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 123.596 0.56 . . . . 0.0 111.902 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.56 -6.75 51.9 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.38 120.31 12.58 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -75.19 148.63 39.39 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.266 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.65 14.92 80.51 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 123.783 0.677 . . . . 0.0 111.831 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.3 128.7 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.189 0.519 . . . . 0.0 111.001 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.2 mm100 -87.45 -77.78 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.328 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.519 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.4 tpm_? -97.29 161.18 13.92 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.574 1.171 . . . . 0.0 110.039 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.519 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 8.6 tt -158.03 93.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -112.83 81.67 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.606 1.193 . . . . 0.0 110.434 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.0 t -84.62 133.0 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.984 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.6 t -81.32 166.58 20.36 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.742 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.33 -27.51 12.79 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.458 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -53.15 -68.48 0.17 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.063 0.852 . . . . 0.0 112.19 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.85 52.0 1.61 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 36.26 48.28 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.647 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -73.2 91.87 1.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.79 125.65 32.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.535 -2.12 . . . . 0.0 112.068 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -130.99 68.48 1.49 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.817 1.294 . . . . 0.0 107.578 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.415 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 1.4 mp -74.41 142.85 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.452 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 70.1 t -112.12 135.17 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -167.06 159.54 13.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.509 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -87.3 140.59 32.27 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 124.773 1.296 . . . . 0.0 108.887 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.58 -54.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.842 2.361 . . . . 0.0 113.782 -151.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.522 ' CD2' HD22 ' A' ' 57' ' ' LEU . 38.2 p-80 -61.66 -3.17 0.98 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.522 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.6 mm? -79.16 -52.33 8.31 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.2 tt -171.04 163.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.318 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.6 m -108.81 110.55 21.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.95 -23.03 25.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.445 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.89 -29.14 68.96 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.692 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.27 -39.18 75.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.84 63.85 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.203 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.85 -19.81 21.32 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.1 -43.88 85.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.015 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -29.24 70.11 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.136 0.897 . . . . 0.0 109.604 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -69.72 -33.61 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.02 -17.53 46.49 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.25 -37.56 28.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 124.42 1.075 . . . . 0.0 109.218 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -72.58 -14.12 61.55 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 124.051 0.845 . . . . 0.0 111.438 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.3 9.71 5.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 116.464 1.346 . . . . 0.0 116.464 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -113.92 78.31 4.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -50.55 135.85 40.87 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.272 1.982 . . . . 0.0 108.814 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.12 138.21 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.663 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -86.98 70.87 10.33 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 N--CA 1.488 1.448 0 CA-C-N 112.258 -2.247 . . . . 0.0 111.969 -179.761 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.007 0.432 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.2 105.02 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.992 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -83.79 58.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.705 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.61 147.15 32.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.615 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.61 142.67 43.62 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.987 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.7 mpp? -132.02 137.02 47.67 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -121.84 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.41 1.069 . . . . 0.0 113.38 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -58.68 167.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 29.9 tt0 -94.58 123.36 37.97 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.13 27.36 2.36 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 121.29 -0.481 . . . . 0.0 111.968 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 16' ' ' GLU . 47.4 tpp . . . . . 0 N--CA 1.49 1.531 0 C-N-CA 123.671 0.788 . . . . 0.0 109.168 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 120.809 0.337 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -62.3 -12.77 22.69 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -58.68 -41.65 86.7 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.4 p -73.06 -31.46 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.459 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.92 -26.6 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.496 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -49.78 -59.96 3.34 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.438 0.637 . . . . 0.0 109.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.23 -23.76 71.68 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -68.66 -49.19 61.09 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.43 -35.77 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 113.325 -1.762 . . . . 0.0 110.276 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.38 -19.91 79.73 Favored Glycine 0 N--CA 1.485 1.936 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.168 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -94.6 -4.48 47.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.44 136.32 53.94 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -88.93 139.54 30.35 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.922 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.16 7.11 88.83 Favored Glycine 0 N--CA 1.489 2.227 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.681 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.28 131.9 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-O 121.509 0.671 . . . . 0.0 110.919 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.4 -76.88 0.48 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.33 -1.759 . . . . 0.0 108.784 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -97.03 170.77 8.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.062 0.851 . . . . 0.0 110.382 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.87 129.17 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 123.891 0.744 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -156.01 92.1 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.215 1.007 . . . . 0.0 109.111 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.1 138.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.049 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -86.17 175.67 8.38 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.93 176.6 6.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.522 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.68 -87.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.509 1.131 . . . . 0.0 112.912 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -80.52 12.86 2.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.371 0.419 . . . . 0.0 111.341 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 36.85 60.42 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.377 1.048 . . . . 0.0 112.62 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.8 87.33 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.64 128.91 36.81 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.718 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -132.32 56.92 1.81 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.234 1.016 . . . . 0.0 108.715 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' N ' ' A' ' 51' ' ' ILE . 2.5 mp -69.07 142.24 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.427 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.7 t -107.01 140.06 26.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -155.77 163.32 39.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.398 1.061 . . . . 0.0 112.463 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -86.36 114.04 55.53 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.51 -32.55 70.33 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.486 2.124 . . . . 0.0 112.417 -162.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -60.97 -19.27 60.79 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -55.18 4.93 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.574 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -175.03 161.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 125.013 1.446 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -94.56 118.55 31.86 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.81 -18.26 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.83 -36.68 84.02 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -40.58 83.32 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -69.56 -16.35 63.4 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.614 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -97.3 -15.39 20.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -67.08 -37.05 83.31 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.354 0.409 . . . . 0.0 111.727 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -62.43 -36.74 83.33 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.726 0.642 . . . . 0.0 109.594 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -64.04 -34.55 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.2 -21.45 46.3 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.053 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.38 44.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.167 0.917 . . . . 0.0 109.625 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.2 ptm -74.87 -12.06 60.28 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.749 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.07 19.62 2.91 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 117.316 1.686 . . . . 0.0 117.316 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -124.63 70.93 57.82 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.07 133.7 41.54 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 122.236 1.958 . . . . 0.0 109.25 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -114.73 121.47 43.44 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.648 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -78.55 79.87 4.95 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.082 -2.326 . . . . 0.0 108.644 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.496 1.834 0 CA-C-N 113.483 -1.689 . . . . 0.0 109.948 -179.808 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.318 0.58 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.15 132.6 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.98 109.48 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.963 0.789 . . . . 0.0 108.921 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.28 156.07 32.0 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.535 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -130.01 109.11 10.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.709 1.256 . . . . 0.0 111.017 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mpp? -90.23 146.52 24.18 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -119.28 89.26 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 123.929 0.768 . . . . 0.0 112.731 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.0 t -72.57 167.34 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.807 0.813 . . . . 0.0 110.929 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.7 tt0 -110.34 107.6 17.38 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.85 5.83 0.77 Allowed Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.099 0.874 . . . . 0.0 115.026 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.489 1.512 0 O-C-N 124.094 0.526 . . . . 0.0 110.031 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.4 m . . . . . 0 N--CA 1.502 2.173 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -75.13 -6.38 49.28 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 p -58.6 -38.89 78.93 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 109.811 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.226 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.41 -49.16 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.199 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -41.79 -61.32 1.13 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.598 1.186 . . . . 0.0 113.679 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.72 -31.89 76.99 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.134 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -73.89 -35.58 64.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.1 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.25 -31.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.305 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.58 -18.76 77.39 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.87 -8.57 58.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.66 -0.77 . . . . 0.0 111.968 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.32 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -82.66 138.72 34.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.89 -0.58 76.59 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.259 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.9 t -84.27 144.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -96.19 -85.23 0.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -98.29 166.13 11.54 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.087 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.33 108.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -152.85 126.82 9.01 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.43 156.44 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.249 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.7 t -115.64 146.4 41.84 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.814 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -60.03 -8.13 2.17 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.19 77.49 4.69 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.731 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 51.47 66.04 1.31 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.677 0.751 . . . . 0.0 109.816 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 5.9 tp-100 42.92 50.65 5.27 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.745 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -74.78 84.64 2.16 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.63 144.34 52.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.722 -2.035 . . . . 0.0 112.481 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -141.46 64.95 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 51' ' ' ILE . 1.6 mp -80.5 135.02 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.039 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.7 t -104.71 138.56 28.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 103.509 -2.774 . . . . 0.0 103.509 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -150.18 171.31 17.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 124.351 1.032 . . . . 0.0 113.007 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.37 145.02 34.82 Favored Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.989 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -70.76 -67.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.796 2.331 . . . . 0.0 112.692 -158.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.463 ' CD2' HD22 ' A' ' 57' ' ' LEU . 26.9 p-80 -74.47 12.6 0.75 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.463 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -88.05 -60.95 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 tt -175.47 160.91 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 124.907 1.38 . . . . 0.0 110.21 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.9 p -103.89 119.18 38.38 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.237 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.83 -14.87 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.138 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.12 -14.78 26.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -68.06 -43.14 79.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.9 mmt -59.17 -40.07 84.5 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.82 67.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.704 1.252 . . . . 0.0 110.228 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -65.02 -46.4 81.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -66.24 -34.4 77.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.22 -32.97 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.85 -18.4 47.49 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.873 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.23 -37.58 32.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.061 0.851 . . . . 0.0 109.117 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptm -74.09 -12.29 60.56 Favored 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.068 0.855 . . . . 0.0 111.623 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.89 22.92 3.45 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -125.22 81.58 63.28 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -47.73 131.78 20.53 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.239 1.959 . . . . 0.0 110.116 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.3 117.19 26.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.915 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -83.78 69.5 10.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 112.228 -2.26 . . . . 0.0 108.942 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.338 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.324 0.583 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.5 m -70.2 121.77 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.7 m -90.17 65.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.18 116.98 6.5 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 130.69 41.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.9 mtp -125.53 135.71 52.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -121.47 92.55 3.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.219 0.949 . . . . 0.0 112.587 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.29 167.26 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.212 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.2 tt0 -108.31 115.59 30.39 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 102.584 -3.117 . . . . 0.0 102.584 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.95 8.43 0.39 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.418 ' H ' ' C ' ' A' ' 16' ' ' GLU . 46.8 ttm . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.896 0.379 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -69.78 -2.9 13.34 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.508 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.1 m -64.1 -34.27 77.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -65.49 -32.93 74.79 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.613 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.9 mt -57.43 -33.93 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 124.336 1.023 . . . . 0.0 111.01 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.45 -68.03 0.22 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 123.867 0.73 . . . . 0.0 111.777 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -23.04 75.71 Favored Glycine 0 N--CA 1.495 2.631 0 CA-C-N 114.466 -1.243 . . . . 0.0 115.431 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -69.71 -49.87 49.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -74.04 -27.17 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.556 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.35 -17.3 80.07 Favored Glycine 0 N--CA 1.487 2.055 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.47 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.4 -4.83 59.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.247 0.616 . . . . 0.0 111.614 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.33 126.68 30.53 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.853 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -74.5 145.04 43.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.219 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.94 13.67 82.36 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.346 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.7 t -87.2 135.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 124.258 0.622 . . . . 0.0 109.581 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -95.46 -79.27 0.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.594 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.514 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.9 tpm_? -97.99 163.23 12.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.449 1.093 . . . . 0.0 110.029 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.514 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 11.7 tt -157.25 95.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -105.17 156.03 18.48 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.224 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 50.6 t -144.54 133.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 124.52 1.138 . . . . 0.0 107.957 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -112.3 138.06 49.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.288 0.992 . . . . 0.0 108.961 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.3 mt -58.22 -19.19 31.85 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.771 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.34 87.98 0.63 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.149 0.906 . . . . 0.0 108.685 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.46 50.99 17.73 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.351 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 39.52 47.55 1.63 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.093 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -72.82 95.28 1.9 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -89.33 126.77 35.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.045 -1.889 . . . . 0.0 114.074 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.1 m -111.59 92.44 4.03 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.337 1.023 . . . . 0.0 109.199 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 51' ' ' ILE . 1.6 mp -92.19 141.49 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.894 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.64 141.91 41.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -161.75 162.67 29.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 124.201 0.938 . . . . 0.0 111.929 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -72.1 136.18 82.17 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-N 114.057 -1.428 . . . . 0.0 107.82 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.451 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -59.2 155.42 40.16 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.452 2.101 . . . . 0.0 110.953 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.451 ' CG ' ' O ' ' A' ' 55' ' ' PRO . 6.5 p-80 52.75 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 117.128 2.269 . . . . 0.0 117.128 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.81 -41.77 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.6 tt -169.5 160.92 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 124.451 1.094 . . . . 0.0 111.391 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.3 p -97.66 108.39 21.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.306 -1.316 . . . . 0.0 109.185 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.22 -27.7 16.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.751 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.43 -18.16 62.34 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -82.28 -42.27 19.05 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.486 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.3 tpt -67.77 -34.15 76.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.648 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -78.7 -18.0 55.02 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.995 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -58.88 -29.18 66.82 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.005 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.2 -33.8 76.13 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.423 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 85.8 mt -65.2 -31.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.67 -23.99 39.22 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.663 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.4 -37.89 56.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.069 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.2 ptm -73.6 -14.12 61.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.891 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.41 5.45 7.2 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -115.84 82.95 11.14 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -49.82 133.47 33.52 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.106 1.871 . . . . 0.0 109.943 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -121.35 115.9 23.81 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.05 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.51 71.38 7.36 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.416 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.848 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.43 0.633 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.5 113.69 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.921 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.25 56.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.69 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 153.4 42.07 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.227 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.84 140.95 48.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.607 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.6 mtm -134.8 138.51 44.32 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -122.93 90.72 3.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.309 1.005 . . . . 0.0 112.351 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -64.27 170.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.999 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.9 tt0 -116.41 107.65 15.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 100.242 -3.984 . . . . 0.0 100.242 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.06 1.33 0.61 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 115.536 0.974 . . . . 0.0 115.536 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 N--CA 1.5 2.045 0 C-N-CA 124.938 1.295 . . . . 0.0 109.066 -179.933 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.4 p -61.83 -10.45 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.3 m -56.4 -35.52 67.85 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.9 p -71.27 -39.38 71.6 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 53.3 mt -57.03 -30.12 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 124.322 1.014 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.96 -63.98 1.01 Allowed 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.937 0.773 . . . . 0.0 109.193 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -9.02 81.95 Favored Glycine 0 N--CA 1.493 2.448 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.485 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -77.98 -55.96 4.87 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.2 mt -70.98 -29.93 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.699 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.14 78.2 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.593 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -95.59 0.29 52.73 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.1 mt -68.69 114.34 6.97 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.207 0.527 . . . . 0.0 112.142 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.59 138.47 44.92 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.244 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.5 13.73 77.77 Favored Glycine 0 N--CA 1.489 2.21 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.759 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -91.45 143.68 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -95.93 -83.52 0.37 Allowed 'General case' 0 N--CA 1.485 1.31 0 O-C-N 124.228 0.955 . . . . 0.0 108.712 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -98.55 164.46 12.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 124.588 1.18 . . . . 0.0 111.36 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.4 tt -146.04 124.37 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -146.07 78.01 1.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.403 1.096 . . . . 0.0 112.216 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 51.9 t -82.84 130.49 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 t -84.56 -178.73 6.97 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.445 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 44' ' ' LEU . 2.6 mm? -100.83 -177.36 3.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.998 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 54.26 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.039 0.837 . . . . 0.0 112.697 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -84.8 11.91 8.32 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 37.97 50.9 1.36 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.236 1.017 . . . . 0.0 109.308 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -67.53 89.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.042 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -78.97 124.65 28.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 112.245 -2.252 . . . . 0.0 110.786 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.0 m -129.78 58.01 1.66 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.642 1.21 . . . . 0.0 108.748 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 51' ' ' ILE . 1.9 mp -66.92 140.84 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.839 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.8 t -106.11 136.1 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -157.21 167.91 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.48 -1.288 . . . . 0.0 114.12 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -84.12 127.58 66.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.27 -65.46 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.73 2.287 . . . . 0.0 114.014 -157.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.507 ' CD2' HD22 ' A' ' 57' ' ' LEU . 27.0 p-80 -68.95 -0.99 6.3 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.507 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.5 mm? -75.75 -48.14 23.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 tt -166.29 167.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.062 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.5 m -125.21 116.34 21.83 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.92 -17.93 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.377 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.86 -34.8 74.07 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -68.15 -41.41 81.66 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -34.94 79.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.893 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -66.62 -28.34 68.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.254 0.971 . . . . 0.0 110.102 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.31 -35.88 81.83 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.066 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -69.57 -38.6 77.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 124.411 1.069 . . . . 0.0 108.177 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.462 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 60.8 mt -65.91 -33.11 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 124.764 1.29 . . . . 0.0 108.073 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -82.84 -21.62 34.35 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.559 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.6 -37.53 42.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.053 0.845 . . . . 0.0 109.749 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 10.1 ptm -76.36 -11.94 59.98 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.08 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.28 17.44 2.69 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 118.31 2.084 . . . . 0.0 118.31 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -125.96 79.8 68.45 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-N 118.169 0.984 . . . . 0.0 109.444 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -47.4 136.81 19.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.6 2.2 . . . . 0.0 109.979 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.83 121.85 35.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.344 1.028 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -84.48 67.99 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.374 -2.194 . . . . 0.0 108.008 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.497 1.895 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.692 -179.909 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -72.97 109.49 6.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 123.892 0.407 . . . . 0.0 110.224 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.4 ptm -60.78 -32.31 71.64 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.161 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.56 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -105.73 79.01 1.39 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.886 0.851 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.45 -56.89 1.87 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.94 -22.14 78.36 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -151.29 177.21 10.48 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.537 -0.831 . . . . 0.0 110.308 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.85 152.69 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.689 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.19 127.12 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 124.082 0.864 . . . . 0.0 111.412 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.74 95.89 4.23 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.915 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -86.63 88.12 7.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 44.4 mtm -90.98 140.14 30.11 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.466 -1.697 . . . . 0.0 106.98 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -109.99 97.54 7.02 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.832 1.333 . . . . 0.0 114.051 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -63.39 169.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.799 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 31.5 tt0 -112.9 131.23 55.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 100.48 -3.896 . . . . 0.0 100.48 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.46 16.88 1.21 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.856 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.417 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 2.2 ttp 61.68 -78.78 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 124.087 0.955 . . . . 0.0 110.077 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.6 p -133.99 -48.26 0.8 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.2 t -173.16 53.35 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 53.57 68.62 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.518 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 m -53.98 -25.8 22.7 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.606 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' C ' ' H ' ' A' ' 25' ' ' SER . 75.2 m -145.85 -87.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.348 1.03 . . . . 0.0 109.365 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.5 p 52.58 -8.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 23' ' ' CYS . 50.6 m -77.33 -38.59 50.08 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 102.974 -2.973 . . . . 0.0 102.974 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.6 p -69.13 -33.16 73.03 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.016 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -68.23 -31.38 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.124 0.89 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.94 -58.87 6.24 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.37 -20.74 77.08 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.708 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -70.84 -52.95 17.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -64.9 -34.38 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.254 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.82 -17.56 79.73 Favored Glycine 0 N--CA 1.487 2.08 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.156 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -95.54 1.52 53.9 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.4 mt -71.22 128.73 36.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.205 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -78.74 159.27 28.02 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.38 1.086 . . . . 0.0 112.639 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.62 14.74 70.15 Favored Glycine 0 N--CA 1.488 2.13 0 CA-C-N 112.145 -2.298 . . . . 0.0 110.517 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.77 133.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 114.778 -0.711 . . . . 0.0 111.635 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -93.36 -77.22 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -96.92 160.24 14.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.75 119.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.558 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -138.95 152.07 47.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -141.37 124.12 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 t -80.19 179.64 7.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 123.812 0.695 . . . . 0.0 110.714 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 44' ' ' LEU . 2.5 mm? -100.27 173.53 6.56 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.802 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 56.59 -86.47 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 124.293 0.996 . . . . 0.0 112.11 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.25 10.61 4.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.2 0.313 . . . . 0.0 110.634 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 33.87 52.18 0.43 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.356 1.035 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.48 95.66 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.629 -1.623 . . . . 0.0 107.849 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.03 126.71 31.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.728 -2.033 . . . . 0.0 110.78 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.9 m -126.48 88.25 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.6 mp -110.41 137.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.863 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.46 137.82 38.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.06 157.07 39.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.398 1.061 . . . . 0.0 111.312 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -78.95 143.22 61.35 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -85.71 40.14 0.75 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.019 2.479 . . . . 0.0 113.476 -162.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.505 ' CD2' HD23 ' A' ' 57' ' ' LEU . 32.3 p-80 -151.07 16.06 0.74 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' A' ' 56' ' ' HIS . 3.9 mm? -113.65 -59.69 1.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.8 tt -165.57 161.24 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.955 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.9 p -98.9 118.79 36.45 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.377 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.8 -18.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.474 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.33 -38.69 85.32 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.788 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.28 -39.03 85.97 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mmt -64.02 -33.49 75.85 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.057 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -80.13 -18.14 50.62 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.646 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.93 -29.73 70.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -71.3 -39.02 71.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 57.8 mt -62.68 -36.2 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -78.64 -27.04 45.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 -37.65 65.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.224 0.953 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -73.73 -15.86 61.2 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.152 0.907 . . . . 0.0 111.671 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.76 10.69 2.52 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 118.064 1.985 . . . . 0.0 118.064 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.44 ' CE2' ' SD ' ' A' ' 70' ' ' MET . 59.9 m-85 -118.92 75.09 13.47 Favored Pre-proline 0 N--CA 1.5 2.06 0 CA-C-N 118.407 1.104 . . . . 0.0 109.718 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -48.9 139.25 25.62 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.825 2.35 . . . . 0.0 111.253 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.91 133.24 54.41 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.045 0.926 . . . . 0.0 111.648 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.89 74.81 10.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.372 -2.194 . . . . 0.0 106.785 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.52 137.27 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 113.555 -1.657 . . . . 0.0 111.301 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -74.84 -47.44 30.43 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.501 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.91 94.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.392 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -136.16 65.94 58.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.95 -51.41 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.919 2.413 . . . . 0.0 110.638 -171.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.41 -34.57 64.53 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.388 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -78.07 -33.11 51.01 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.565 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 tp -78.14 152.64 32.68 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.177 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m -144.71 -33.09 0.39 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.281 0.636 . . . . 0.0 109.785 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 ptp -157.79 164.07 37.4 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.57 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.44 -178.27 6.57 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.287 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -60.65 -20.25 60.31 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.433 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.24 32.26 18.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 124.172 0.92 . . . . 0.0 112.471 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.05 25.73 26.31 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.505 ' CB ' HE22 ' A' ' 38' ' ' GLN . 0.5 OUTLIER -156.67 157.21 34.79 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.938 -0.631 . . . . 0.0 111.436 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 m -145.55 126.64 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.259 0.975 . . . . 0.0 109.767 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.3 m -94.48 115.7 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.66 110.49 19.83 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.372 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' C ' ' SD ' ' A' ' 13' ' ' MET . 2.3 mppt? -100.84 130.1 46.81 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 4.9 mpp? -144.25 139.13 28.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 65.1 tttp -105.15 151.53 23.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 125.149 1.53 . . . . 0.0 107.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -127.68 169.6 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 124.205 0.941 . . . . 0.0 110.729 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 31.5 tt0 -92.37 111.39 22.95 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.37 5.2 5.57 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-O 119.55 -0.583 . . . . 0.0 114.358 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.0 ttp 44.48 101.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -49.82 -27.72 5.43 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.7 t -64.84 -55.52 19.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 123.709 0.63 . . . . 0.0 110.303 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.534 ' CG ' ' H ' ' A' ' 22' ' ' SER . 0.8 OUTLIER -163.88 -121.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.948 0.78 . . . . 0.0 108.904 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.534 ' H ' ' CG ' ' A' ' 21' ' ' HIS . 55.9 p -176.61 160.35 1.98 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.011 0.434 . . . . 0.0 110.016 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.8 t -146.0 26.93 1.2 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -72.31 -13.54 61.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.369 -1.287 . . . . 0.0 113.379 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 p -55.33 -38.2 68.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.858 0.724 . . . . 0.0 109.476 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -77.12 -37.28 54.45 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.0 mt -61.0 -36.15 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 123.997 0.81 . . . . 0.0 110.882 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.76 -64.98 0.74 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.727 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.22 -18.98 73.68 Favored Glycine 0 N--CA 1.497 2.701 0 CA-C-N 113.593 -1.639 . . . . 0.0 114.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -77.15 -53.89 7.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.4 ' CG2' HG12 ' A' ' 51' ' ' ILE . 57.2 mt -69.84 -23.76 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.679 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.59 -13.79 83.12 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -95.32 2.3 54.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 124.333 0.666 . . . . 0.0 111.692 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.17 130.78 43.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -83.22 146.77 28.4 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.52 12.59 84.22 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.718 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.1 t -93.75 142.19 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.505 HE22 ' CB ' ' A' ' 8' ' ' GLU . 29.3 mt-30 -95.81 -81.97 0.39 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -97.15 154.81 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.1 115.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -151.88 167.09 29.44 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.2 t -136.96 147.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 124.624 1.203 . . . . 0.0 109.158 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 t -104.37 150.21 24.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.887 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -67.31 1.56 2.11 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.091 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -83.39 66.48 8.87 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 m120 54.35 71.93 0.49 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.715 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 41.71 47.2 3.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.803 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 39.6 tt0 -79.63 87.65 5.17 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.168 1.461 . . . . 0.0 107.284 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.37 138.67 45.46 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.721 -2.49 . . . . 0.0 114.721 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.2 m -140.5 90.57 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.1 mp -98.64 130.37 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.436 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.38 134.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -148.56 171.2 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.199 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.97 145.65 81.42 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 124.095 0.872 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -71.17 0.86 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.46 2.773 . . . . 0.0 115.432 -150.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.413 ' CD2' HD23 ' A' ' 57' ' ' LEU . 9.8 p-80 -154.17 23.46 0.49 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -88.49 -46.41 9.14 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.474 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -157.95 166.43 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 124.043 0.839 . . . . 0.0 111.482 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.423 ' H ' HG12 ' A' ' 58' ' ' ILE . 58.2 p -117.38 107.4 14.3 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.425 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.56 -26.93 32.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.234 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.21 -27.68 68.61 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.963 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.88 -41.37 78.43 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 mmt -61.84 -32.38 72.71 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.514 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -65.47 -34.71 78.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.976 0.798 . . . . 0.0 109.154 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.55 -34.75 77.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 123.492 0.495 . . . . 0.0 110.539 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -67.9 -38.71 83.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 124.162 0.914 . . . . 0.0 108.843 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 72' ' ' PHE . 83.5 mt -67.61 -28.63 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.236 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -86.52 -22.14 26.54 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.189 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.92 -36.74 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.05 0.843 . . . . 0.0 109.519 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -13.43 60.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.68 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -6.69 5.39 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 118.671 2.229 . . . . 0.0 118.671 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.0 m-30 -106.52 93.68 8.81 Favored Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 119.203 1.502 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -45.31 137.18 10.87 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.972 1.781 . . . . 0.0 109.577 166.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.13 126.35 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.521 1.138 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -85.46 91.18 8.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.37 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.82 149.22 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.806 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.503 ' CG ' ' H ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -32.18 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' H ' ' CG ' ' A' ' 77' ' ' LYS . 6.7 ttpm? 58.61 -81.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -130.15 163.01 50.62 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 123.745 0.653 . . . . 0.0 110.359 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.35 138.55 61.16 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.358 2.039 . . . . 0.0 108.657 163.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -127.99 144.58 51.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.109 0.881 . . . . 0.0 109.714 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -58.57 -58.54 8.09 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.826 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.3 tp -155.41 76.75 0.97 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 N--CA 1.495 1.79 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.545 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -158.03 -51.89 0.07 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.1 mtp 54.7 20.78 3.13 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 124.532 1.145 . . . . 0.0 112.417 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.11 88.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.52 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -78.02 134.31 37.82 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.638 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.5 151.46 42.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.074 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.11 -165.51 13.21 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 123.957 0.786 . . . . 0.0 111.737 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -139.22 178.34 7.25 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.27 -0.965 . . . . 0.0 111.029 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 m -129.84 146.54 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.2 m -128.59 99.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 124.66 1.225 . . . . 0.0 110.067 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' HD11 ' A' ' 11' ' ' LEU . 5.7 mp -104.81 120.12 40.63 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.051 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -99.86 90.05 4.29 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.892 0.745 . . . . 0.0 109.701 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -82.62 139.65 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -109.42 96.28 6.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.789 1.305 . . . . 0.0 113.728 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.1 t -60.94 159.64 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -82.59 109.69 17.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.16 -7.79 7.6 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.874 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.448 ' HG3' ' H ' ' A' ' 19' ' ' THR . 31.0 tpp 63.34 -144.66 0.34 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.448 ' H ' ' HG3' ' A' ' 18' ' ' MET . 3.8 t -172.83 -40.41 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.9 p -75.5 -61.35 1.94 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.953 0.783 . . . . 0.0 110.618 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -150.43 119.81 6.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 p -96.54 101.54 13.17 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.949 0.781 . . . . 0.0 111.993 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.8 m -85.15 36.84 0.64 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.991 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.1 p -69.71 -0.47 7.03 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -66.01 -31.85 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -64.41 -37.69 88.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.203 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.26 -32.83 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 124.534 1.146 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.96 -70.36 0.17 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.145 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -12.4 66.87 Favored Glycine 0 N--CA 1.497 2.752 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.55 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -82.87 -59.49 2.48 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.906 0.86 . . . . 0.0 108.817 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.01 -2.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.023 -1.898 . . . . 0.0 112.59 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.83 -17.36 19.06 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.804 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -96.85 7.35 46.8 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.71 140.5 33.04 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -85.94 161.52 18.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.626 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.07 87.19 Favored Glycine 0 N--CA 1.489 2.168 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.1 t -111.81 145.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 124.626 0.839 . . . . 0.0 112.756 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -94.76 -83.22 0.35 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.5 tpp85 -98.16 163.17 12.85 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.023 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.05 117.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -153.26 112.7 3.83 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.369 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.4 t -93.4 150.53 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.952 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.5 t -109.03 141.32 41.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.581 1.176 . . . . 0.0 110.087 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.86 -21.68 31.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 124.35 1.031 . . . . 0.0 110.118 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.19 87.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.659 1.225 . . . . 0.0 108.708 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 52.51 40.25 29.41 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 45.63 47.7 11.44 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.436 1.112 . . . . 0.0 108.584 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.01 92.99 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.363 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.26 130.49 43.26 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.482 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.9 m -131.34 92.53 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -97.54 135.65 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.168 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 26.3 t -107.96 137.85 37.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -162.84 166.09 24.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.683 1.24 . . . . 0.0 113.679 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.08 132.55 39.45 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.079 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.18 38.36 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.368 2.712 . . . . 0.0 114.464 -155.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.48 ' CD2' HD22 ' A' ' 57' ' ' LEU . 28.3 p-80 -156.23 18.46 0.35 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.48 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -95.91 -56.2 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.445 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.19 164.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.027 0.829 . . . . 0.0 110.619 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -74.14 109.26 7.5 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.495 1.141 . . . . 0.0 110.019 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.62 -26.88 6.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 112.642 -2.072 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.23 -24.49 61.39 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.427 -1.26 . . . . 0.0 107.686 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.84 -38.09 79.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -63.17 -40.52 97.78 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.515 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -78.14 -10.92 59.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 124.279 0.987 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -74.49 -29.71 61.53 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.06 -30.62 71.11 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.381 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.89 -30.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 114.69 -1.141 . . . . 0.0 107.998 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.54 -24.1 36.81 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.695 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.49 -37.36 60.25 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.425 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -74.46 -12.2 60.43 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.737 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 1.59 9.33 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 116.797 1.479 . . . . 0.0 116.797 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -112.6 82.58 4.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 117.447 0.624 . . . . 0.0 109.503 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.51 130.12 34.99 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 121.819 1.679 . . . . 0.0 109.755 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -111.54 109.58 19.57 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.847 -1.979 . . . . 0.0 106.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -69.13 89.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 112.109 -2.314 . . . . 0.0 109.608 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.75 119.84 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -99.88 18.48 18.23 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 123.763 0.664 . . . . 0.0 112.006 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.37 122.94 1.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.966 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -172.31 66.31 0.38 Allowed Pre-proline 0 N--CA 1.498 1.966 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.279 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -68.01 177.63 4.18 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.862 2.375 . . . . 0.0 111.452 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -65.19 -62.15 1.71 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -149.43 137.3 20.39 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.271 0.982 . . . . 0.0 109.486 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.43 -31.52 71.46 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.101 0.875 . . . . 0.0 108.768 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 116.567 -1.682 . . . . 0.0 109.802 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t 56.76 92.06 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.687 0.874 . . . . 0.0 111.384 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.3 mtm 58.22 -170.7 0.11 Allowed 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.945 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.49 88.36 1.22 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.429 HE22 HH21 ' A' ' 39' ' ' ARG . 25.4 tt0 -64.68 115.38 5.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.454 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.83 -47.44 0.09 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.235 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.23 -99.02 0.07 OUTLIER Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 41.73 -176.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.69 124.07 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.765 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.6 m -100.69 101.82 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.293 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.98 116.89 33.66 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.78 111.86 23.62 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.416 ' SD ' HG12 ' A' ' 76' ' ' VAL . 31.9 mtm -114.33 143.77 44.34 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.538 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -120.11 98.04 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.0 t -70.67 168.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.615 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 36.6 tt0 -103.12 127.37 50.41 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.6 21.67 1.92 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.723 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.424 ' H ' ' C ' ' A' ' 16' ' ' GLU . 54.3 tpp 58.54 -114.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t 177.15 -43.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.8 t -78.98 -49.73 12.26 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.88 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -166.65 153.21 8.79 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.393 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -114.49 112.05 22.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.115 0.884 . . . . 0.0 110.53 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.4 m -85.82 23.62 1.41 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.954 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -63.69 -12.09 31.38 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.3 t -59.21 -44.39 92.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 p -72.37 -31.07 65.27 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.08 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.426 ' HB ' HE22 ' A' ' 47' ' ' GLN . 45.4 mt -65.08 -36.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 123.889 0.743 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.11 -51.31 66.8 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -34.5 87.26 Favored Glycine 0 N--CA 1.495 2.591 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.084 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -63.52 -40.31 96.71 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.71 -32.33 44.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.873 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.73 -13.4 82.23 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.85 3.48 54.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.562 0.801 . . . . 0.0 110.569 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.28 119.46 24.62 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.15 148.19 32.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.087 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.05 -0.37 87.52 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -82.22 138.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 124.046 0.498 . . . . 0.0 110.227 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -95.63 -78.19 0.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.429 HH21 HE22 ' A' ' 5' ' ' GLN . 8.6 tpp180 -97.84 165.98 11.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.255 0.972 . . . . 0.0 109.856 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.39 111.36 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -124.42 69.46 1.09 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.145 0.974 . . . . 0.0 109.637 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.62 112.26 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 113.611 -1.631 . . . . 0.0 106.647 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 33.1 t -85.79 177.26 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.337 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.84 -168.02 1.64 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.98 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.72 -103.96 0.2 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.02 0.825 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -93.49 25.03 3.64 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.426 HE22 ' HB ' ' A' ' 27' ' ' ILE . 53.9 tt0 32.16 80.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' H ' ' HB3' ' A' ' 43' ' ' SER . 83.7 tt0 -75.97 90.38 2.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.62 113.39 13.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.408 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.7 m -122.01 78.13 1.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.021 -1.445 . . . . 0.0 107.452 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 51' ' ' ILE . 1.4 mp -90.16 136.5 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.213 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -113.71 140.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.52 162.89 40.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.37 1.044 . . . . 0.0 112.092 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -65.74 144.59 98.92 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.82 7.04 3.36 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.908 2.406 . . . . 0.0 114.294 -157.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.455 ' CD2' HD21 ' A' ' 57' ' ' LEU . 10.0 p-80 -156.96 19.66 0.31 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.455 HD21 ' CD2' ' A' ' 56' ' ' HIS . 3.3 mm? -86.06 -49.57 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.575 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.86 160.14 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 124.254 0.972 . . . . 0.0 110.761 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.8 m -98.8 110.82 23.37 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.76 -18.02 21.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.998 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.74 -32.48 74.0 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.951 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.94 -40.4 87.56 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.8 mmt -63.58 -33.77 76.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.756 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.96 -21.83 50.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.1 0.875 . . . . 0.0 109.738 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -66.37 -30.25 70.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.01 -40.76 78.49 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.425 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 78.6 mt -64.39 -31.94 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.112 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.58 -21.06 30.54 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.965 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.84 -38.09 46.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.026 0.829 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.3 ptm -74.15 -12.94 60.73 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.051 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 6.76 7.61 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -112.33 88.2 10.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -47.27 133.49 19.54 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 121.971 1.78 . . . . 0.0 109.222 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.88 123.81 33.62 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -82.55 64.46 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.338 -1.755 . . . . 0.0 108.681 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.416 HG12 ' SD ' ' A' ' 13' ' ' MET . 61.4 t -68.42 149.5 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? 71.6 133.19 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt 65.08 165.13 0.16 Allowed 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -127.33 81.15 70.58 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.5 160.28 50.36 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.599 2.2 . . . . 0.0 109.765 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 61.15 165.38 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 124.47 1.106 . . . . 0.0 112.163 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -72.01 -48.0 47.89 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.664 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tt 56.3 -80.3 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 O-C-N 124.84 1.338 . . . . 0.0 111.705 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 116.681 -1.628 . . . . 0.0 110.605 -179.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -145.93 155.04 42.58 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 124.267 0.628 . . . . 0.0 109.881 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.7 mtp 58.6 -174.83 0.09 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 124.334 1.021 . . . . 0.0 112.152 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -149.24 -63.26 0.23 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.559 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -165.44 -60.94 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.014 0.821 . . . . 0.0 109.086 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.53 173.67 0.08 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 124.56 1.163 . . . . 0.0 112.743 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.56 32.8 0.02 OUTLIER Glycine 0 N--CA 1.497 2.713 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.422 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 43.1 177.76 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 m -117.29 153.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.291 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.21 68.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.315 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.27 109.35 1.1 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -81.66 82.86 7.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.481 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 11.0 ttp -80.13 125.55 29.96 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.269 1.033 . . . . 0.0 109.383 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.06 80.39 1.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 111.577 -2.556 . . . . 0.0 106.419 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -66.76 165.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.606 -1.634 . . . . 0.0 111.684 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -107.49 137.3 45.77 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.9 12.95 3.44 Favored Glycine 0 N--CA 1.49 2.251 0 O-C-N 123.801 0.688 . . . . 0.0 113.708 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.1 ttm 62.76 146.49 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 123.732 0.813 . . . . 0.0 112.432 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.1 p -59.87 -54.58 44.53 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.742 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.1 p -75.09 -75.49 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 123.787 0.679 . . . . 0.0 111.341 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -151.04 146.6 26.31 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 123.64 0.588 . . . . 0.0 109.798 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.7 p -79.14 165.94 22.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 123.866 0.729 . . . . 0.0 111.427 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m -155.25 37.93 0.39 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.5 p -62.88 -7.99 6.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.127 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.4 p -58.59 -34.78 71.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -71.21 -40.53 71.08 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.162 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.88 -35.71 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.913 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.7 -65.85 0.51 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.067 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.61 -22.83 70.13 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.895 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -70.86 -44.83 65.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.7 mt -72.58 -33.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.309 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.12 -14.59 71.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -95.45 3.03 54.67 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.101 -1.05 . . . . 0.0 111.622 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.45 116.38 25.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.04 0.447 . . . . 0.0 111.857 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.34 150.5 43.43 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.886 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.08 17.75 71.29 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 123.912 0.758 . . . . 0.0 111.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.66 137.48 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.506 HE22 ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -93.26 -81.98 0.35 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.764 1.29 . . . . 0.0 108.068 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.617 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 7.0 tpm_? -97.3 162.79 13.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.631 1.207 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.617 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.2 tt -158.45 111.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.647 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 139.74 9.62 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.373 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.2 t -108.03 158.08 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.561 -1.654 . . . . 0.0 112.653 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -135.23 176.52 8.6 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.473 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' N ' HD13 ' A' ' 44' ' ' LEU . 6.6 mp -67.69 -146.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.274 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 53.04 52.98 12.72 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.9 m120 55.19 84.41 0.07 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.347 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.417 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 3.1 tp-100 35.73 57.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.139 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.47 87.97 2.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -85.13 141.3 30.31 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.542 -1.663 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.5 m -135.77 70.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -73.91 138.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.437 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.3 t -114.7 135.79 53.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -163.83 169.6 18.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.668 1.23 . . . . 0.0 112.245 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.506 ' H ' HE22 ' A' ' 38' ' ' GLN . 5.1 pt20 -95.21 122.23 60.27 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 124.389 1.056 . . . . 0.0 108.524 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 -34.92 17.05 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.633 2.222 . . . . 0.0 112.392 -168.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.45 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 6.8 p-80 -57.13 -30.69 64.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -73.44 -47.39 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 tt -170.63 161.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.5 m -112.65 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.894 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.3 -13.8 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.292 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.6 -38.38 77.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.43 -41.42 89.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 mmt -65.47 -26.46 67.94 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.384 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -71.78 -30.0 65.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.311 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -63.61 -32.86 74.47 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.81 -39.85 87.87 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.366 1.041 . . . . 0.0 108.894 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.401 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 74.6 mt -65.14 -31.95 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.74 -19.68 30.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.88 41.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.072 0.858 . . . . 0.0 108.91 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.401 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.7 ptm -74.04 -12.09 60.52 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.648 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.31 9.11 8.86 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 117.834 1.894 . . . . 0.0 117.834 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.67 91.28 20.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -47.08 131.21 17.23 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.731 1.621 . . . . 0.0 108.788 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -129.27 104.6 7.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.463 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -85.45 92.3 8.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.431 -2.168 . . . . 0.0 109.113 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 t -85.75 71.77 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.693 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -106.98 80.55 1.44 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.79 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -69.6 91.26 0.59 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.012 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -138.17 105.94 7.96 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 113.334 -1.757 . . . . 0.0 107.536 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -65.87 -19.02 58.74 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.188 1.925 . . . . 0.0 110.918 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -66.04 -57.85 6.81 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.93 0.769 . . . . 0.0 110.349 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -146.04 103.52 3.75 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 124.047 0.842 . . . . 0.0 111.175 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -168.97 -84.04 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.453 ' HG ' ' H ' ' A' ' 6' ' ' ALA . 27.1 t 62.0 163.7 0.09 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 124.528 0.781 . . . . 0.0 112.264 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.11 -67.15 0.09 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.07 -24.23 8.14 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.362 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -62.47 -60.28 3.77 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.775 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.453 ' H ' ' HG ' ' A' ' 2' ' ' SER . . . 55.1 -87.22 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.66 1.225 . . . . 0.0 112.916 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.3 124.2 0.42 Allowed Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.91 129.66 39.13 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.58 0.705 . . . . 0.0 111.38 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -64.55 125.2 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -94.63 69.56 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.416 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.24 117.12 8.07 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.031 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -104.96 105.68 15.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.392 1.058 . . . . 0.0 108.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.49 ' SD ' ' HG2' ' A' ' 64' ' ' LYS . 31.9 mtm -95.46 140.66 30.0 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -126.16 81.96 2.04 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.5 t -70.45 173.57 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.385 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 30.5 tt0 -100.23 111.22 23.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 103.52 -2.771 . . . . 0.0 103.52 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.18 -25.77 48.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.039 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 18' ' ' MET . 12.7 tmm? 55.16 100.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.519 0.776 . . . . 0.0 111.566 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.546 ' HG1' ' H ' ' A' ' 21' ' ' HIS . 44.8 p 47.67 -165.15 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.736 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.6 t -62.93 -24.24 67.76 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.546 ' H ' ' HG1' ' A' ' 19' ' ' THR . 34.7 m80 -77.99 -177.69 5.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.302 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 78.6 p -169.76 -42.83 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.778 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 62.1 m 55.07 18.5 2.35 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.816 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 p -80.33 -2.98 47.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 m -61.14 -44.66 96.98 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.9 p -69.48 -34.5 74.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.352 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.44 -40.74 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.588 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -59.1 -55.93 28.78 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.645 0.736 . . . . 0.0 109.824 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.5 -30.9 75.72 Favored Glycine 0 N--CA 1.496 2.671 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.278 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -69.54 -42.46 74.57 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.96 -29.63 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.374 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.71 -24.0 76.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.39 -17.97 57.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.406 -0.897 . . . . 0.0 112.14 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.04 127.46 31.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.538 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.82 141.75 49.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.315 1.009 . . . . 0.0 109.764 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.91 11.62 70.0 Favored Glycine 0 N--CA 1.486 1.997 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.168 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.64 135.16 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.525 HE22 ' N ' ' A' ' 54' ' ' GLN . 2.4 mp0 -95.75 -78.14 0.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.17 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -96.97 154.73 17.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.718 1.261 . . . . 0.0 110.816 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 tt -155.21 121.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.314 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -150.6 153.39 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.426 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.2 t -129.59 133.98 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 124.259 0.974 . . . . 0.0 108.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.6 m -105.31 149.42 26.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.684 1.24 . . . . 0.0 110.218 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.5 4.69 0.71 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.08 68.43 9.99 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.3 m120 55.63 72.4 0.49 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 54.9 tp60 40.99 54.72 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.311 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -79.11 80.76 5.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.05 131.44 38.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.323 -2.217 . . . . 0.0 109.918 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -131.57 72.0 1.49 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.021 0.915 . . . . 0.0 109.81 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.76 137.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.015 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 t -114.05 146.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -165.56 177.05 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.763 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.525 ' N ' HE22 ' A' ' 38' ' ' GLN . 5.5 pt20 -86.9 125.78 65.5 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.58 68.02 8.2 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.235 2.623 . . . . 0.0 113.167 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 5.9 p-80 -172.23 -28.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.04 -44.62 38.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 123.965 0.791 . . . . 0.0 109.544 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -167.76 172.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.088 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 58' ' ' ILE . 51.5 m -119.22 110.89 17.55 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.01 -21.29 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.257 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.49 -39.31 91.77 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.756 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.79 -37.11 73.29 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -71.81 -22.45 61.56 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.583 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.49 ' HG2' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -97.84 -9.15 26.91 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.49 -32.88 74.46 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.413 HE21 ' CG1' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -60.75 -24.04 65.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 123.99 0.806 . . . . 0.0 110.516 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.413 ' CG1' HE21 ' A' ' 66' ' ' GLN . 81.1 mt -70.63 -33.17 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.4 -27.79 46.76 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.48 -35.31 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.691 1.244 . . . . 0.0 109.947 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' CE1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -69.72 -19.33 63.55 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 123.905 0.753 . . . . 0.0 110.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.85 3.3 5.01 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 118.429 -1.206 . . . . 0.0 116.041 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 3.4 m-30 -106.99 86.19 2.29 Favored Pre-proline 0 N--CA 1.5 2.039 0 CA-C-N 118.477 1.138 . . . . 0.0 108.649 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.59 130.77 34.71 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 121.094 1.196 . . . . 0.0 109.044 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.24 124.93 51.05 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.745 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.74 -48.12 41.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.591 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.44 HG21 ' NZ ' ' A' ' 64' ' ' LYS . 23.8 t 55.32 109.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 125.312 1.632 . . . . 0.0 113.499 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.56 -23.6 58.87 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.219 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.66 82.84 2.01 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -100.32 150.93 37.36 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.151 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -83.47 91.81 0.88 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.986 2.458 . . . . 0.0 109.916 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? 59.85 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 O-C-N 124.547 1.155 . . . . 0.0 110.376 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -60.45 169.3 1.76 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 123.569 0.543 . . . . 0.0 112.32 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -73.03 22.58 0.07 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.55 -1.204 . . . . 0.0 113.299 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 t 52.42 -133.5 1.8 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.25 0.618 . . . . 0.0 110.165 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.2 mtp 50.07 29.82 3.78 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.335 0.588 . . . . 0.0 111.859 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.28 -2.26 0.22 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.974 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -61.02 -49.45 77.36 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.643 0.59 . . . . 0.0 110.237 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.86 -27.4 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.126 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.54 38.3 51.87 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' CB ' HE22 ' A' ' 38' ' ' GLN . 10.3 pt-20 43.31 -178.44 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.99 150.24 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.052 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.71 57.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 124.409 1.068 . . . . 0.0 108.941 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.3 141.17 41.7 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.19 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -103.49 104.86 14.98 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.412 ' SD ' HG11 ' A' ' 76' ' ' VAL . 16.8 mmm -89.49 109.97 20.85 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.68 85.53 2.76 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.328 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.14 168.01 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.482 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.8 tt0 -110.94 142.15 43.42 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.5 ' H ' HD21 ' A' ' 46' ' ' ASN . . . -80.96 29.93 2.68 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.497 ' H ' ' C ' ' A' ' 16' ' ' GLU . 31.8 ttm 64.66 -129.03 0.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.7 p -143.04 -28.47 0.56 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 p -152.56 112.15 3.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.559 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 68.53 164.3 0.23 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 124.634 1.209 . . . . 0.0 110.72 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.6 m -148.08 166.94 26.3 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.818 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 78.2 m -144.51 50.68 1.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.384 -1.28 . . . . 0.0 107.825 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.3 p -64.03 -7.61 9.13 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.769 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.6 p -62.27 -40.44 96.23 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 p -68.6 -33.62 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.298 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.54 -42.24 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.06 0.85 . . . . 0.0 108.939 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.35 -50.31 74.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.494 0.664 . . . . 0.0 110.828 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.32 -36.5 93.28 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.7 -1.591 . . . . 0.0 113.835 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.61 -51.34 10.8 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.997 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.18 1.48 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.56 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.21 -28.05 3.72 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.407 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -96.5 8.92 42.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.154 0.502 . . . . 0.0 111.811 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.04 135.54 43.06 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.309 1.052 . . . . 0.0 113.279 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -88.0 156.42 19.32 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.602 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.74 8.68 82.16 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.68 144.09 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.353 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.444 HE22 ' CB ' ' A' ' 8' ' ' GLU . 32.8 mt-30 -96.04 -82.31 0.39 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.176 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.59 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -97.97 169.13 9.85 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.54 1.15 . . . . 0.0 111.625 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.59 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 11.0 tt -153.78 131.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.497 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 140.28 38.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -140.08 137.16 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.842 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t -102.62 170.12 8.22 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.279 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -93.0 -166.22 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.805 -1.088 . . . . 0.0 108.406 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 58.54 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 17' ' ' GLY . 23.9 m120 -100.51 34.07 2.52 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.293 0.568 . . . . 0.0 111.006 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 33.96 58.73 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.559 -1.2 . . . . 0.0 114.213 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.67 96.89 2.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.45 121.79 36.35 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.512 -1.677 . . . . 0.0 111.552 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.3 m -115.27 93.92 4.5 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.15 136.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.928 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.1 t -101.79 132.41 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -155.84 176.64 12.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.65 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.11 112.06 57.06 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 112.422 -2.172 . . . . 0.0 107.074 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.61 -49.68 3.06 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.946 2.431 . . . . 0.0 110.225 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -57.83 -22.45 47.79 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 tp -90.12 -40.93 11.94 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.378 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 tt -161.78 162.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.586 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.7 p -126.94 109.19 11.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.622 1.201 . . . . 0.0 107.868 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.29 -17.16 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.72 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.94 -38.61 86.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -66.96 -40.58 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -64.03 -26.97 68.8 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.718 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -90.88 -19.62 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.827 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.5 -43.55 96.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.644 0.259 . . . . 0.0 111.292 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -66.89 -35.84 80.94 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.6 mt -67.5 -31.53 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.703 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.03 -20.07 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.695 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.5 -36.24 38.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 124.024 0.827 . . . . 0.0 109.436 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.2 ptm -75.27 -11.36 60.05 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.15 0.906 . . . . 0.0 111.525 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 19.22 2.94 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 117.991 1.956 . . . . 0.0 117.991 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -125.0 73.89 65.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.4 132.1 15.51 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 122.185 1.923 . . . . 0.0 109.904 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -119.58 118.7 31.71 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.416 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -81.18 75.73 8.14 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.782 -2.463 . . . . 0.0 108.695 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.412 HG11 ' SD ' ' A' ' 13' ' ' MET . 74.9 t -83.6 156.45 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.756 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.0 tptp 65.07 137.86 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 124.935 1.397 . . . . 0.0 112.557 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.48 -48.63 76.71 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.898 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -81.58 155.66 71.08 Favored Pre-proline 0 N--CA 1.494 1.765 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.838 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.18 -65.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.472 2.114 . . . . 0.0 110.908 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -83.9 -113.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 45.11 47.86 9.8 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.794 0.806 . . . . 0.0 111.31 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.85 106.51 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.207 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 116.179 -1.867 . . . . 0.0 109.736 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 m 51.31 -98.96 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.508 0.77 . . . . 0.0 110.602 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.0 mtp -90.45 69.91 6.92 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.1 89.27 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.026 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -135.72 72.14 1.44 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.98 150.3 44.99 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 113.868 -1.514 . . . . 0.0 109.595 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.64 -47.04 3.39 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 168.63 8.62 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.956 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 m -107.69 126.05 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 113.789 -1.55 . . . . 0.0 110.842 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.19 57.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.507 1.146 . . . . 0.0 109.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.89 135.33 56.46 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.892 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -105.12 140.05 38.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.422 ' SD ' HG12 ' A' ' 60' ' ' VAL . 4.4 mtt -139.21 131.5 28.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -119.03 95.81 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.521 1.138 . . . . 0.0 111.341 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.77 170.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-N 113.464 -1.698 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.1 tt0 -95.6 116.5 28.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.4 19.32 7.11 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-O 119.078 -0.845 . . . . 0.0 114.189 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 53.9 ttp 28.29 -96.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.408 1.083 . . . . 0.0 113.336 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -178.26 103.14 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.495 0.497 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.5 m 26.21 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 22' ' ' SER . 53.7 t-80 -162.73 162.75 26.91 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.75 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 59.7 m -63.32 117.74 7.05 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.775 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 p -167.14 -67.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.962 0.789 . . . . 0.0 112.465 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.7 p -66.6 -15.44 63.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.9 p -57.06 -38.91 73.94 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -83.33 -33.22 25.94 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.917 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.53 -30.0 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.931 0.769 . . . . 0.0 109.932 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -56.99 -67.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.77 -21.29 79.79 Favored Glycine 0 N--CA 1.494 2.549 0 CA-C-N 113.889 -1.505 . . . . 0.0 114.157 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -74.56 -52.79 10.84 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.49 -27.81 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.042 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.56 -16.22 78.19 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.155 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.21 2.02 54.82 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 124.183 0.578 . . . . 0.0 111.94 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.5 117.29 10.93 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.159 0.504 . . . . 0.0 112.228 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.83 145.98 55.51 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.286 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.91 86.67 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.757 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.26 132.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.101 0.477 . . . . 0.0 110.343 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' NE2' ' NE2' ' A' ' 54' ' ' GLN . 14.0 mm-40 -94.64 -76.4 0.49 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.133 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -97.65 165.87 11.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.203 0.94 . . . . 0.0 109.243 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 tt -155.98 131.51 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.578 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -157.93 84.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.346 1.07 . . . . 0.0 111.1 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.1 t -82.36 119.86 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -90.96 157.16 17.45 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.5 -110.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.428 -1.273 . . . . 0.0 107.745 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 p30 37.54 -122.82 0.22 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 119.237 0.926 . . . . 0.0 110.631 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -102.95 55.08 0.76 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 41.98 66.15 0.76 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.261 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -84.38 88.04 7.25 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 117.749 -1.58 . . . . 0.0 108.025 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 127.61 33.37 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 108.93 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -129.49 49.98 2.2 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.957 0.884 . . . . 0.0 108.986 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.27 147.16 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.565 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.5 t -113.91 144.32 21.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -156.39 157.83 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.346 1.029 . . . . 0.0 110.164 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' NE2' ' NE2' ' A' ' 38' ' ' GLN . 6.9 pt20 -86.26 146.39 42.33 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.42 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -58.98 155.25 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 123.03 2.487 . . . . 0.0 113.764 -161.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' CD2' HD23 ' A' ' 57' ' ' LEU . 7.9 p-80 52.86 -1.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' A' ' 56' ' ' HIS . 4.6 mm? -72.97 -40.21 65.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.88 0.764 . . . . 0.0 109.307 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -161.27 174.42 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.793 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.417 ' N ' HG13 ' A' ' 58' ' ' ILE . 68.3 m -139.14 108.5 6.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG12 ' SD ' ' A' ' 13' ' ' MET . 49.2 t -66.2 -19.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.527 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.54 -37.09 82.2 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -68.94 -39.38 79.6 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.2 mmt -66.26 -29.65 69.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.351 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -80.93 -21.89 40.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.731 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -63.96 -33.46 75.77 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -69.9 -39.58 76.13 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.75 -26.73 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.93 -1.486 . . . . 0.0 107.885 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.93 -21.12 25.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.245 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.27 -37.1 38.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.937 0.773 . . . . 0.0 108.959 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -12.03 60.29 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 124.27 0.982 . . . . 0.0 111.264 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.09 -7.06 6.06 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -103.66 95.27 7.16 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 119.076 1.438 . . . . 0.0 112.805 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -46.78 133.58 17.36 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.765 1.643 . . . . 0.0 109.519 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.46 112.28 17.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.64 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -78.45 84.25 4.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.669 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -74.58 92.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.626 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -74.74 -16.34 60.74 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.449 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 mttp 53.7 -119.36 1.48 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 123.988 0.805 . . . . 0.0 109.336 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.423 ' N ' ' CD ' ' A' ' 80' ' ' PRO . 26.8 mm100 -99.18 -45.2 0.23 Allowed Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.896 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 79' ' ' GLN . 13.1 Cg_endo -87.49 114.54 1.0 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.993 2.462 . . . . 0.0 109.676 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -65.84 99.45 0.48 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -64.73 129.07 38.4 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.739 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 59.26 73.03 0.5 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 116.794 -1.574 . . . . 0.0 107.281 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.2 m -144.49 -70.11 0.29 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.4 ttm -166.31 -66.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.42 -49.93 6.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.114 0.884 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 52.22 86.44 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.875 1.359 . . . . 0.0 108.585 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.47 21.27 5.44 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.261 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.62 -17.15 66.53 Favored Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' CB ' HE22 ' A' ' 38' ' ' GLN . 0.2 OUTLIER -60.81 175.41 0.49 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.63 134.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 78.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 124.182 0.926 . . . . 0.0 111.089 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.32 138.91 36.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.338 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.74 117.78 33.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.452 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.3 mpp? -119.0 137.02 53.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -119.59 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.923 1.389 . . . . 0.0 110.768 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -65.38 167.81 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 18' ' ' MET . 39.2 tt0 -98.68 121.66 40.9 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.96 19.41 1.24 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.041 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.46 ' H ' ' C ' ' A' ' 16' ' ' GLU . 42.7 tpp 71.92 -80.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.949 1.299 . . . . 0.0 108.812 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 t 175.1 -32.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.038 0.836 . . . . 0.0 109.458 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.4 p -161.12 -7.3 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 124.057 0.848 . . . . 0.0 112.037 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -141.9 103.03 4.26 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.559 0.695 . . . . 0.0 110.418 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.1 p -108.32 102.66 11.76 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.948 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t -83.72 30.31 0.5 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.616 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -72.39 -0.99 13.91 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.6 t -61.79 -39.75 92.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -65.18 -34.35 78.17 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.51 -37.92 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.843 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -48.68 -61.5 2.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.9 0.75 . . . . 0.0 112.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.93 -29.24 71.94 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 114.045 -1.434 . . . . 0.0 112.781 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -70.43 -41.1 73.33 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.455 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.17 -33.88 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.6 76.95 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.69 -6.63 55.92 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.691 -0.755 . . . . 0.0 112.508 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.12 118.09 11.58 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.38 141.67 36.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.991 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.79 4.18 79.48 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.739 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.8 141.89 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.45 HE22 ' CB ' ' A' ' 8' ' ' GLU . 29.4 mt-30 -96.37 -79.44 0.45 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.781 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.426 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.6 tpm_? -96.81 159.63 14.81 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.84 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.426 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 5.4 tt -149.36 110.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -145.32 101.37 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.995 0.902 . . . . 0.0 111.237 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.3 t -93.65 149.3 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.293 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 t -111.66 144.53 40.77 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.879 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -25.76 60.28 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.421 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.45 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.074 0.859 . . . . 0.0 110.418 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.1 m120 45.18 53.31 8.02 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.446 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 44.38 49.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.963 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -74.07 89.7 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.5 130.19 37.59 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 111.828 -2.442 . . . . 0.0 114.085 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 m -132.07 74.54 1.59 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.62 1.2 . . . . 0.0 107.984 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 1.3 mp -83.58 132.03 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.869 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 42.7 t -105.13 138.61 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -156.63 179.65 9.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.543 1.152 . . . . 0.0 113.645 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -95.37 116.11 66.02 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.486 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.2 -54.59 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.87 2.38 . . . . 0.0 110.237 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -56.14 -22.42 28.37 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.053 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.07 -40.96 12.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.244 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 tt -163.88 162.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 124.451 1.095 . . . . 0.0 111.284 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -130.93 104.74 7.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -68.58 -17.9 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.393 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.7 -29.02 67.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.321 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.69 -41.2 79.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.5 mmt -62.53 -31.93 72.8 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.269 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -66.25 -34.06 77.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.991 0.807 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -61.24 -34.13 74.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.091 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -67.82 -38.69 83.55 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 124.252 0.97 . . . . 0.0 109.047 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.7 -33.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.23 -24.66 34.73 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.389 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.11 -36.43 58.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.23 0.956 . . . . 0.0 109.928 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -74.93 -13.63 60.55 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 123.805 0.69 . . . . 0.0 111.082 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.57 10.36 4.51 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 7.6 m-85 -118.34 88.37 32.98 Favored Pre-proline 0 N--CA 1.499 2.019 0 CA-C-N 118.268 1.034 . . . . 0.0 109.773 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -49.08 135.15 30.19 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.128 1.885 . . . . 0.0 109.408 173.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.21 122.08 30.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.749 1.28 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.63 77.94 9.77 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.131 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.93 113.59 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.532 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -81.93 -139.33 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.816 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.34 -117.02 1.12 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.991 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 48.04 76.48 0.54 Allowed Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 123.476 0.485 . . . . 0.0 110.189 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -67.33 -87.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.585 2.19 . . . . 0.0 111.143 -167.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -168.6 -157.14 0.19 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 123.567 0.542 . . . . 0.0 110.658 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 t80 66.51 140.78 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 124.443 1.097 . . . . 0.0 112.98 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -167.34 -62.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 116.602 -1.666 . . . . 0.0 109.84 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.2 p 51.15 9.7 0.06 Allowed 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.1 mmt -76.34 -46.43 27.6 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.13 -20.24 65.74 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.674 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -150.68 -102.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.07 -148.81 0.14 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.99 -114.21 0.08 OUTLIER Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 41.91 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.92 108.36 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 m -92.6 56.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.022 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 156.31 28.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -120.66 94.86 4.5 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.893 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.3 mtm -82.37 135.28 35.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -116.93 90.47 3.34 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.721 1.248 . . . . 0.0 113.11 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -54.02 167.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 112.722 -2.036 . . . . 0.0 115.126 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 18' ' ' MET . 33.4 tt0 -120.5 126.77 51.2 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.56 21.06 1.22 Allowed Glycine 0 N--CA 1.492 2.399 0 O-C-N 123.299 0.374 . . . . 0.0 113.407 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.452 ' H ' ' C ' ' A' ' 16' ' ' GLU . 36.0 ttp 54.15 19.12 2.0 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.295 0.644 . . . . 0.0 111.664 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 t 41.42 23.84 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 O-C-N 124.29 0.994 . . . . 0.0 113.103 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 t 179.08 125.98 0.06 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.479 ' CG ' ' N ' ' A' ' 22' ' ' SER . 83.3 t60 59.7 160.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 124.472 1.107 . . . . 0.0 113.754 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.479 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 54.6 p -139.48 86.44 2.12 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.133 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -78.15 10.37 3.02 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.979 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 22' ' ' SER . 69.9 p -59.85 -8.79 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.651 -1.159 . . . . 0.0 113.419 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.2 p -56.25 -32.61 64.65 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.3 p -68.66 -39.78 80.47 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.386 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.3 mt -52.57 -30.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 124.502 1.126 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.25 -72.5 0.06 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.5 -12.77 80.29 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.533 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.83 -53.87 7.0 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.491 0.662 . . . . 0.0 109.301 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.16 -29.66 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.036 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.52 -14.68 81.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -95.49 1.05 53.83 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.72 -0.74 . . . . 0.0 112.805 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.413 HD21 ' SD ' ' A' ' 63' ' ' MET . 79.9 mt -72.29 125.34 27.11 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -83.89 144.5 29.17 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.531 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.95 10.7 84.69 Favored Glycine 0 N--CA 1.489 2.212 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.018 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.56 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -95.79 -83.83 0.36 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -98.45 166.59 11.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.592 1.182 . . . . 0.0 110.992 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.53 107.06 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -147.73 108.45 4.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.753 0.787 . . . . 0.0 110.845 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.8 t -97.18 139.68 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.79 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.1 t -100.63 171.07 7.94 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.773 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.4 mp -74.58 -115.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.168 -1.396 . . . . 0.0 108.183 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 p30 39.81 -133.32 0.22 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 119.272 0.942 . . . . 0.0 109.768 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -93.85 56.99 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 41.16 69.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.948 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.35 90.91 5.01 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.48 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.74 129.4 39.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.254 -1.794 . . . . 0.0 108.052 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -129.53 69.14 1.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.414 1.102 . . . . 0.0 108.859 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -81.87 126.89 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.387 -1.733 . . . . 0.0 107.488 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.1 t -98.5 133.51 40.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -154.05 171.75 18.59 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.495 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.1 114.07 60.34 Favored Pre-proline 0 N--CA 1.494 1.742 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.228 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -62.5 -50.71 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.847 2.365 . . . . 0.0 111.313 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -60.06 -26.89 66.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.279 -1.328 . . . . 0.0 113.287 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tp -88.16 -36.38 16.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.407 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.28 162.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.782 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.1 m -132.0 106.62 8.14 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.9 t -76.36 -15.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.94 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.72 -32.74 73.57 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -71.0 -45.3 64.24 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.2 tpt -58.95 -31.68 68.94 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.787 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.02 -30.89 58.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.163 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -59.95 -31.55 69.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.251 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.03 -38.13 75.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.4 mt -66.88 -30.21 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.96 -22.11 33.85 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.276 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.31 -37.39 44.77 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 124.195 0.934 . . . . 0.0 109.28 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.6 ptm -72.59 -13.62 61.43 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.254 0.971 . . . . 0.0 111.144 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.35 8.89 3.86 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -118.71 71.29 10.07 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 118.289 1.044 . . . . 0.0 110.325 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -47.69 130.55 18.86 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.184 1.923 . . . . 0.0 110.523 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -112.64 123.05 49.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.471 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -66.48 -3.01 5.29 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.954 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 50.3 t 59.67 175.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 123.899 0.749 . . . . 0.0 111.782 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.475 ' CG ' ' H ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -58.52 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' H ' ' CG ' ' A' ' 77' ' ' LYS . 55.7 mtmt -63.91 160.13 18.32 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.071 0.396 . . . . 0.0 110.264 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -59.39 121.53 57.25 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 123.842 0.714 . . . . 0.0 109.817 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.66 112.42 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.107 1.871 . . . . 0.0 109.782 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -66.95 -7.31 21.28 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.537 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -59.58 138.7 57.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 123.828 0.705 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 pp -169.23 -21.47 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 113.953 -1.476 . . . . 0.0 109.706 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 116.83 -1.557 . . . . 0.0 108.831 179.918 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.8 t -159.04 130.73 6.4 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.2 tpp 51.05 45.75 27.36 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.293 0.995 . . . . 0.0 108.85 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 52.3 50.63 17.94 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 113.883 -1.508 . . . . 0.0 111.148 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -151.28 133.28 15.12 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.18 179.97 8.72 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.565 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.83 -163.41 24.82 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 42.41 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.94 136.64 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.782 -2.008 . . . . 0.0 109.65 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.89 51.85 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 122.644 1.211 . . . . 0.0 109.111 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.5 mt -71.34 151.84 43.77 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.774 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -117.59 149.56 40.45 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.754 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.0 141.74 51.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -127.97 84.16 2.22 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.739 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.2 t -62.99 170.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.459 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 34.0 tt0 -112.45 143.05 44.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.84 23.34 3.1 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.397 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.438 ' H ' ' C ' ' A' ' 16' ' ' GLU . 17.3 ttm 57.72 -107.12 0.35 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 p -154.5 133.79 12.57 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.7 t 55.32 -84.58 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 124.228 0.955 . . . . 0.0 113.266 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 22' ' ' SER . 83.5 t60 -97.45 171.18 8.55 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 85.0 p -150.51 126.04 10.2 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.065 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -91.92 45.77 1.24 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.639 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.2 p -69.56 -6.98 34.49 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.725 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.8 m -57.49 -33.28 67.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.045 0.45 . . . . 0.0 109.909 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -67.79 -39.4 84.03 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.111 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.9 mt -52.66 -35.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.325 1.016 . . . . 0.0 111.699 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -49.84 -72.09 0.06 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.419 1.074 . . . . 0.0 112.162 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.74 -21.75 77.99 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.376 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -63.87 -40.57 96.85 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.8 -23.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.438 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.59 -12.23 83.89 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -91.88 -0.91 57.52 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.683 -0.759 . . . . 0.0 112.01 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.414 HD23 ' SD ' ' A' ' 63' ' ' MET . 89.5 mt -73.26 126.06 29.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -85.58 140.58 30.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.135 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.71 1.54 85.25 Favored Glycine 0 N--CA 1.491 2.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.899 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.47 144.52 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -96.1 -82.85 0.38 Allowed 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.481 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.602 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.639 1.212 . . . . 0.0 109.881 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.602 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 10.7 tt -154.06 122.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.79 162.87 39.44 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.46 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.6 t -137.54 133.47 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 124.491 1.119 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.2 m -100.12 148.81 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.664 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.65 3.85 0.47 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -86.62 68.66 10.22 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.25 69.84 0.69 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.53 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 40.44 50.94 2.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.423 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -76.74 85.23 3.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.79 128.13 34.68 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 112.675 -2.057 . . . . 0.0 113.793 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -118.58 72.26 0.87 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.834 0.709 . . . . 0.0 109.515 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.427 ' N ' HD13 ' A' ' 51' ' ' ILE . 1.9 mp -72.79 139.07 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.368 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.1 t -115.83 132.15 66.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -151.72 163.43 39.16 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.521 1.138 . . . . 0.0 113.089 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -62.87 149.96 88.7 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.157 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.37 -4.04 14.78 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.986 2.457 . . . . 0.0 114.404 -153.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -160.53 27.42 0.16 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.85 -47.26 9.85 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.519 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.33 161.77 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 124.155 0.909 . . . . 0.0 111.47 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -104.28 113.67 27.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.479 1.112 . . . . 0.0 110.974 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.5 t -71.24 -25.19 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.981 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.3 -24.5 65.02 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.523 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -70.49 -41.46 72.66 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -63.49 -38.58 91.66 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 2.9 mmmp? -62.83 -33.06 74.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.584 1.177 . . . . 0.0 109.864 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.77 -43.44 98.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -65.54 -36.7 84.56 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 124.275 0.985 . . . . 0.0 109.158 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.41 -32.74 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.9 -20.61 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.913 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.55 -36.76 32.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.043 0.84 . . . . 0.0 109.738 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.493 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 1.9 ppp? -77.03 -12.01 59.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.33 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.19 23.31 1.78 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 117.804 1.882 . . . . 0.0 117.804 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' SD ' ' A' ' 70' ' ' MET . 9.3 m-85 -131.84 83.22 57.84 Favored Pre-proline 0 N--CA 1.494 1.756 0 CA-C-N 117.58 0.69 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -47.49 134.49 20.97 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 122.026 1.817 . . . . 0.0 108.738 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.98 114.99 18.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.69 1.244 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -85.67 71.12 10.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 111.744 -2.48 . . . . 0.0 108.499 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.08 96.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.97 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -82.59 80.48 8.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.707 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -73.25 -179.01 3.15 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.952 179.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -121.52 87.32 45.33 Favored Pre-proline 0 N--CA 1.501 2.112 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.358 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -81.29 -173.54 1.86 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.404 2.736 . . . . 0.0 110.567 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -157.71 112.51 2.68 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.594 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -87.48 132.93 33.85 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.686 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.63 58.99 1.55 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 124.195 0.934 . . . . 0.0 109.06 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt . . . . . 0 N--CA 1.504 2.235 0 CA-C-O 117.277 -1.345 . . . . 0.0 113.065 179.896 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -159.02 -64.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -91.57 67.21 5.48 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.18 75.05 1.0 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.088 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -70.77 112.54 7.05 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.846 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.16 150.2 35.42 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.381 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.36 34.63 0.05 OUTLIER Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.69 144.05 35.43 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.52 -0.84 . . . . 0.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -88.99 110.94 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.881 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.47 143.93 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.37 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 70.9 mt -127.99 152.73 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.903 0.752 . . . . 0.0 109.495 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' SD ' ' A' ' 13' ' ' MET . 63.6 tttm -147.96 109.25 4.32 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 2.9 mpp? -127.38 141.06 51.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.619 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -112.51 105.68 13.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.761 1.288 . . . . 0.0 109.033 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.2 t -70.05 160.52 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -90.58 108.21 19.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.99 -14.0 22.13 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.846 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.404 ' HE3' ' CD1' ' A' ' 72' ' ' PHE . 53.7 tpp 69.98 131.17 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.984 0.914 . . . . 0.0 110.732 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -83.65 47.82 1.34 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.805 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.5 p -164.02 -50.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.705 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -166.53 144.77 5.35 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 123.755 0.659 . . . . 0.0 109.932 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 m -107.01 102.65 11.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.388 1.055 . . . . 0.0 109.703 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t -89.32 43.36 1.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.1 p -80.69 -7.93 59.48 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.9 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.6 t -59.67 -38.83 82.58 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -71.58 -33.88 69.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.85 -36.38 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.169 0.918 . . . . 0.0 110.49 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.06 -64.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.909 0.755 . . . . 0.0 111.319 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.28 -27.15 71.18 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.058 -1.428 . . . . 0.0 113.09 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.49 -40.55 80.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.39 -29.05 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.49 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.34 -13.85 77.02 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.07 -4.93 58.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.485 -0.858 . . . . 0.0 112.282 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.53 119.35 17.64 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.34 138.12 33.67 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.061 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.36 77.52 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.56 126.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -87.34 -75.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.551 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 4.6 tpm_? -97.48 156.22 16.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.551 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.6 tt -153.27 115.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.43 114.37 3.0 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.8 t -108.46 147.56 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.408 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -88.77 -178.21 5.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -104.2 179.57 4.23 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.861 -1.518 . . . . 0.0 108.408 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 56.71 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 124.304 1.003 . . . . 0.0 111.269 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.78 12.38 3.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 123.421 0.45 . . . . 0.0 109.997 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 35.24 50.31 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 124.395 1.06 . . . . 0.0 111.517 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.78 92.74 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.234 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.55 131.55 40.11 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.6 m -135.98 70.02 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.036 0.922 . . . . 0.0 108.67 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 1.3 mp -82.42 150.31 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.798 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.4 t -125.05 149.34 29.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -162.07 161.22 28.22 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 123.997 0.81 . . . . 0.0 108.885 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.89 159.55 75.96 Favored Pre-proline 0 N--CA 1.499 1.985 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.421 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -83.6 42.2 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.495 2.13 . . . . 0.0 114.217 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.513 ' CD2' HD21 ' A' ' 57' ' ' LEU . 27.8 p-80 -159.78 -4.53 0.07 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 118.734 2.865 . . . . 0.0 118.734 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD21 ' CD2' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -89.1 -55.78 3.54 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 120.349 1.431 . . . . 0.0 109.54 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -164.29 161.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -88.13 110.07 20.38 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.881 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -66.56 -29.24 45.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.741 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.27 -23.36 64.06 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.534 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -70.92 -43.47 68.17 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -29.4 69.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 124.359 1.037 . . . . 0.0 110.524 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -72.29 -28.36 63.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -69.85 -28.33 65.59 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.612 0.57 . . . . 0.0 110.066 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.57 -39.07 92.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 123.844 0.715 . . . . 0.0 109.094 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.25 -30.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.674 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.99 -24.52 24.65 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.023 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.97 -37.4 61.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 124.255 0.972 . . . . 0.0 109.356 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.23 -11.93 60.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.547 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.68 -3.88 8.65 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 1.9 m-30 -107.59 91.32 7.07 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 119.051 1.425 . . . . 0.0 109.272 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -50.74 132.21 35.89 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.71 1.607 . . . . 0.0 110.085 171.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -115.27 95.58 5.25 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.275 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.45 96.97 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 111.37 -2.65 . . . . 0.0 110.7 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 t -60.98 153.6 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.244 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -137.08 -45.44 0.57 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.824 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -64.98 107.53 1.52 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HB3' ' HD3' ' A' ' 80' ' ' PRO . 4.3 tm0? -162.03 -50.88 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.425 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 79' ' ' GLN . 40.9 Cg_endo -86.38 -86.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.014 1.81 . . . . 0.0 108.118 -177.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -173.99 37.24 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 124.339 1.024 . . . . 0.0 108.781 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 56.16 60.08 3.38 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.769 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.1 mt -86.91 -60.86 1.86 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.317 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 114.704 -2.569 . . . . 0.0 111.482 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.016 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.1 p 41.64 -136.39 0.24 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 124.942 1.024 . . . . 0.0 111.767 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.1 mtm -67.4 -43.79 80.43 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.2 12.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.842 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.407 ' CD ' ' N ' ' A' ' 5' ' ' GLN . 8.0 mp0 -90.98 102.26 15.03 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.552 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.83 65.78 9.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.672 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.18 80.62 0.14 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.403 ' CB ' HE22 ' A' ' 38' ' ' GLN . 9.8 pt-20 42.34 -176.67 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.97 146.92 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.07 56.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.359 1.037 . . . . 0.0 109.825 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.8 mt -67.48 146.83 53.59 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' C ' ' SD ' ' A' ' 13' ' ' MET . 58.3 mmtt -106.91 136.47 46.7 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 3.5 mpp? -136.0 135.97 39.94 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -112.65 151.3 30.31 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.434 ' CG2' ' HZ3' ' A' ' 64' ' ' LYS . 2.1 t -131.36 167.48 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 124.579 1.174 . . . . 0.0 111.662 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -94.43 133.55 37.91 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.73 19.38 9.42 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.662 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttp 33.33 -88.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.102 1.119 . . . . 0.0 113.059 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.6 p -144.94 178.5 7.98 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.8 t -58.79 -24.91 62.55 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.766 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -91.52 44.75 1.19 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.904 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 76.8 p -63.6 158.13 22.02 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.814 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.8 m -120.79 30.14 7.04 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -63.13 -15.25 56.14 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.546 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -53.14 -35.87 60.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 123.868 0.73 . . . . 0.0 109.751 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 p -73.79 -41.8 61.88 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.976 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.78 -36.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 124.292 0.995 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.22 -66.38 0.4 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.641 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.3 -12.15 84.61 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 114.002 -1.454 . . . . 0.0 115.033 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -84.45 -58.39 2.76 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -27.04 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.438 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.54 -12.05 80.89 Favored Glycine 0 N--CA 1.486 2.019 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.668 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.29 -7.81 57.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.191 0.519 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 35.2 mt -58.05 141.32 50.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.18 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -77.18 145.01 37.92 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.746 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.94 9.13 85.26 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.167 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 t -79.75 133.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 124.263 0.625 . . . . 0.0 109.879 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.403 HE22 ' CB ' ' A' ' 8' ' ' GLU . 34.9 mt-30 -95.6 -82.13 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.635 -1.62 . . . . 0.0 107.609 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -98.49 164.87 12.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.445 1.09 . . . . 0.0 111.629 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 tt -147.47 117.74 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -142.53 74.4 1.44 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.802 1.287 . . . . 0.0 109.423 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.21 142.75 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.327 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.0 t -86.15 -179.6 6.76 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.506 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.7 179.83 4.16 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.762 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 47' ' ' GLN . 8.0 m-20 55.36 -90.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 124.232 0.957 . . . . 0.0 110.776 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.2 16.98 0.85 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.317 0.386 . . . . 0.0 110.623 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 45' ' ' ASP . 3.7 tp-100 29.07 54.11 0.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.459 1.104 . . . . 0.0 112.947 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.48 93.93 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.658 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.53 130.45 37.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.28 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -136.23 63.3 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.1 mp -72.22 135.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-N 113.879 -1.51 . . . . 0.0 108.476 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.02 135.24 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.94 162.77 40.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 124.816 1.323 . . . . 0.0 112.285 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -63.62 147.05 96.21 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.91 4.43 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.126 2.551 . . . . 0.0 114.462 -152.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -160.74 23.75 0.14 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.55 -45.74 13.2 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 59' ' ' SER . 8.3 tp -161.4 171.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.243 0.964 . . . . 0.0 110.707 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.408 ' N ' HG13 ' A' ' 58' ' ' ILE . 36.4 p -107.94 111.1 23.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.824 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.07 -28.17 29.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.313 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.45 -20.79 65.87 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.653 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.97 -43.06 65.77 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 mmt -64.13 -30.49 71.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.476 1.11 . . . . 0.0 109.562 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HZ3' ' CG2' ' A' ' 15' ' ' VAL . 3.0 mmmp? -64.02 -33.32 75.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.251 0.969 . . . . 0.0 109.119 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -65.26 -33.46 76.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.272 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -69.08 -39.06 79.27 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -66.48 -28.71 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.067 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.87 -22.6 25.65 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.088 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.5 47.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 123.993 0.808 . . . . 0.0 109.567 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -12.79 60.34 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.434 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.02 -4.81 6.42 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 118.899 2.319 . . . . 0.0 118.899 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -104.77 95.68 9.28 Favored Pre-proline 0 N--CA 1.504 2.251 0 CA-C-N 119.365 1.582 . . . . 0.0 110.494 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -51.13 134.04 42.64 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.403 1.402 . . . . 0.0 109.5 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.77 129.32 55.18 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.229 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.05 63.29 4.38 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 113.629 -1.623 . . . . 0.0 111.109 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.3 85.46 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -136.98 1.55 2.5 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.336 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HZ3' ' HB3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.7 119.59 15.07 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -113.32 -49.69 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.897 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.352 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -82.71 -78.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.866 1.711 . . . . 0.0 109.587 -173.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.16 -17.96 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 O-C-N 123.889 0.743 . . . . 0.0 110.632 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.8 t80 56.32 60.32 3.21 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 124.318 1.011 . . . . 0.0 109.653 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.5 tp -73.07 99.41 2.76 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.46 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 116.711 -1.614 . . . . 0.0 109.96 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 50.29 -122.58 1.89 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.263 0.625 . . . . 0.0 110.231 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 46.8 ttm -74.51 -41.53 60.51 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.79 -52.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.048 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.411 ' NE2' ' H ' ' A' ' 8' ' ' GLU . 58.7 tp60 53.17 97.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 124.62 1.2 . . . . 0.0 112.723 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.87 50.81 0.76 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.385 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.35 33.68 71.79 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' H ' ' NE2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -131.21 176.03 8.61 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.699 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.81 137.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.857 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.48 75.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.56 -20.8 65.04 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 50.52 94.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 13' ' ' MET . 2.9 mpp? -100.55 135.44 41.98 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.778 -1.555 . . . . 0.0 106.949 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -126.11 86.56 2.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 124.724 1.265 . . . . 0.0 107.712 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.1 t -65.19 165.64 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.638 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.458 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.4 tt0 -113.15 128.48 56.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.12 30.15 2.71 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.458 ' H ' ' C ' ' A' ' 16' ' ' GLU . 58.7 ttm 50.32 -100.01 0.08 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.228 0.611 . . . . 0.0 110.207 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.0 p -148.59 -46.39 0.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.9 t -93.54 -10.88 33.31 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.149 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.7 m80 59.31 -127.93 1.23 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.116 0.885 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 m 62.71 -173.28 0.15 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 123.595 0.559 . . . . 0.0 111.501 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t 57.9 0.32 0.11 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -75.51 -1.29 23.56 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.442 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -69.15 -27.81 65.87 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.3 p -66.33 -35.31 80.04 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.25 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.22 -33.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 124.819 1.324 . . . . 0.0 110.82 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -48.85 -73.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.803 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.29 -21.9 66.34 Favored Glycine 0 N--CA 1.497 2.755 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.564 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -64.2 -34.06 77.21 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.367 0.603 . . . . 0.0 109.729 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.8 -21.98 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.958 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.83 -14.62 80.66 Favored Glycine 0 N--CA 1.487 2.088 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.738 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.82 1.98 56.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 124.208 0.593 . . . . 0.0 111.714 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.89 102.18 5.45 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.592 0.71 . . . . 0.0 112.855 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -75.6 119.73 20.04 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.57 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.88 9.26 12.52 Favored Glycine 0 N--CA 1.485 1.903 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.52 138.22 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -95.13 -77.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.95 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -96.84 153.4 17.91 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.16 118.26 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.829 -0.749 . . . . 0.0 112.439 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.27 161.27 21.83 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.08 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.99 134.56 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.604 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -104.18 176.18 5.24 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.882 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 44' ' ' LEU . 7.1 mp -70.98 -150.37 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.512 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 53.41 58.03 5.6 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.976 0.893 . . . . 0.0 108.995 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 51.21 81.98 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.71 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 36.5 61.94 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.789 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.44 85.48 6.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -67.37 136.84 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 113.01 -1.905 . . . . 0.0 111.034 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.4 m -135.36 52.89 2.0 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -73.94 125.44 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.28 138.66 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.35 177.46 10.56 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 114.239 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -88.18 121.79 70.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 113.55 -1.659 . . . . 0.0 106.725 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -68.46 -54.96 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.275 1.983 . . . . 0.0 109.395 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -52.54 -26.02 12.03 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.86 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 tp -93.96 -47.61 6.63 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.17 168.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -132.14 111.25 11.29 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.438 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.02 -24.63 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.812 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.45 -18.94 54.53 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.719 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.96 -43.92 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -29.82 70.97 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.206 0.941 . . . . 0.0 109.727 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -64.04 -33.95 76.92 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.21 -32.0 73.29 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.504 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -69.65 -39.47 77.07 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.71 -28.44 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.842 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.901 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.5 -37.42 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 124.09 0.869 . . . . 0.0 109.271 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -12.7 60.45 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.653 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.89 -2.46 6.88 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -107.88 91.78 8.11 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 118.744 1.272 . . . . 0.0 110.344 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -47.16 134.76 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.041 1.828 . . . . 0.0 110.446 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -122.33 109.39 14.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 124.652 1.22 . . . . 0.0 108.37 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.29 79.64 7.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.175 -2.284 . . . . 0.0 108.878 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.27 152.55 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.964 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm 57.33 91.91 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.506 1.129 . . . . 0.0 110.509 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.67 127.29 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.17 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -62.27 118.16 37.29 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 124.413 1.071 . . . . 0.0 110.303 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.95 -127.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.543 2.162 . . . . 0.0 107.962 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 5.4 ttpm? 59.23 15.59 4.32 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 120.952 0.406 . . . . 0.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -127.1 -66.28 0.9 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.5 mp -70.8 -42.08 70.77 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.016 0.823 . . . . 0.0 109.185 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.5 mttp . . . . . 0 N--CA 1.498 1.962 0 O-C-N 124.873 1.358 . . . . 0.0 111.596 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 m -58.98 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.5 mtp -61.25 -15.39 34.35 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 123.729 0.643 . . . . 0.0 112.266 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -165.99 121.0 1.22 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -58.88 120.17 8.55 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 76.63 -33.59 0.21 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 125.214 1.571 . . . . 0.0 110.991 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.87 174.99 54.7 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 67.96 157.25 0.13 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 124.545 0.791 . . . . 0.0 111.335 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.32 130.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.68 91.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.977 0.894 . . . . 0.0 110.294 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.27 139.3 30.86 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -130.14 103.23 6.62 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.324 1.64 . . . . 0.0 106.87 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.542 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 50.6 mtp -104.87 145.44 30.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.54 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -119.7 87.79 2.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.287 0.992 . . . . 0.0 111.55 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.37 164.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 3.1 mp0 -116.67 154.83 29.87 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.222 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 18.12 5.23 Favored Glycine 0 N--CA 1.484 1.858 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.572 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' GLU . 55.7 ttm 74.44 -65.81 0.33 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 125.508 1.357 . . . . 0.0 109.285 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -165.18 -35.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 113.991 -1.459 . . . . 0.0 107.248 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -173.22 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.33 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -79.12 139.35 38.07 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.168 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.0 p -144.9 160.57 41.1 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -153.93 36.32 0.44 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 113.802 -1.545 . . . . 0.0 106.852 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -72.94 -4.69 33.7 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.1 t -62.81 -37.4 86.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -66.62 -35.28 79.79 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.5 mt -57.03 -39.37 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 124.197 0.936 . . . . 0.0 111.502 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -51.42 -67.98 0.21 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.791 0.682 . . . . 0.0 112.585 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.21 -23.39 78.13 Favored Glycine 0 N--CA 1.496 2.664 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.635 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.3 -50.26 41.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.6 mm -70.44 -27.52 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.604 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.08 -12.21 83.55 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.2 1.57 54.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 124.337 0.669 . . . . 0.0 111.401 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.4 mt -74.78 131.36 40.74 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.836 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -83.05 160.23 21.98 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 124.147 0.904 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.46 11.03 71.6 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.49 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.07 146.99 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -95.86 -83.93 0.36 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.54 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 3.2 tpm_? -98.33 160.87 14.01 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.1 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.54 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -158.47 107.93 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HZ3' HH11 ' A' ' 39' ' ' ARG . 0.1 OUTLIER -137.65 160.01 40.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.597 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -139.68 149.68 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 124.183 0.927 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.5 t -110.47 140.49 44.67 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.082 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tt -50.39 -35.15 26.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.73 1.269 . . . . 0.0 110.247 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -53.57 85.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.465 1.103 . . . . 0.0 111.373 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 m120 41.57 60.5 2.12 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.962 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 42.18 48.68 4.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.526 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.68 89.97 2.28 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.75 146.02 31.22 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 112.094 -2.321 . . . . 0.0 114.519 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.4 m -138.77 78.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 51' ' ' ILE . 1.6 mp -88.74 136.24 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.066 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -107.91 135.21 47.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -154.98 172.35 18.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.05 116.99 67.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.17 -53.72 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.698 2.265 . . . . 0.0 110.129 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -57.73 -26.27 61.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.363 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.97 -38.15 14.68 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.791 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.66 159.88 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.377 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -129.3 95.93 4.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.91 -26.28 40.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 112.173 -2.285 . . . . 0.0 110.567 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.8 -35.14 70.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.174 0.921 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.16 -41.56 94.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.6 mmm -70.44 -27.35 64.18 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.51 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 71.8 mmtt -80.95 -18.61 46.46 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.506 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.46 -31.37 68.49 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -64.87 -35.39 80.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.002 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.72 -34.68 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -81.29 -20.32 41.08 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.581 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.55 36.52 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 ptm -75.56 -11.14 59.96 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.141 0.901 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.38 17.66 3.92 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -123.05 82.57 50.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -51.25 141.75 38.57 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.097 1.864 . . . . 0.0 108.337 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.33 125.44 42.28 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.331 1.02 . . . . 0.0 108.927 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -82.63 83.38 7.65 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.19 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.98 157.55 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.729 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.0 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.605 1.19 . . . . 0.0 108.22 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -147.93 133.36 18.62 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.697 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -53.97 105.58 0.55 Allowed Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 124.553 1.158 . . . . 0.0 109.891 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -78.21 71.7 6.59 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 123.142 2.561 . . . . 0.0 112.476 -166.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -117.82 143.96 45.8 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -81.01 75.53 7.98 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.832 0.825 . . . . 0.0 109.359 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -166.0 93.7 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 116.735 -1.603 . . . . 0.0 110.397 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -75.1 87.71 2.41 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.405 ' C ' ' H ' ' A' ' 5' ' ' GLN . 8.2 tpt -126.45 -41.1 1.9 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.217 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.43 21.06 0.65 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 3' ' ' MET . 40.6 mt-30 -53.17 -49.6 66.32 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.514 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.06 36.85 0.69 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.53 79.64 1.37 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 45.36 175.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.77 146.43 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.963 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG23 HE22 ' A' ' 79' ' ' GLN . 35.9 m -131.45 55.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.151 -1.386 . . . . 0.0 107.774 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.39 145.54 47.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.276 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 121.16 37.41 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.48 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.2 mpp? -126.19 132.4 51.78 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -119.11 90.53 3.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.686 1.241 . . . . 0.0 111.496 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -61.63 164.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.551 -1.659 . . . . 0.0 114.016 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 24.1 tt0 -90.96 110.52 21.78 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.14 -19.98 26.15 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.544 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.7 ttm 61.13 109.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.865 0.98 . . . . 0.0 111.919 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 t -83.39 48.32 1.38 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.91 -1.495 . . . . 0.0 112.029 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.0 m -150.49 -42.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.869 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -166.37 156.74 12.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.316 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 24' ' ' THR . 49.9 m -134.04 96.09 3.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 123.939 0.774 . . . . 0.0 109.262 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 50.2 t -83.59 24.49 0.85 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.258 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 22' ' ' SER . 71.9 p -65.91 -10.71 41.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.437 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.2 t -59.4 -35.02 73.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -75.13 -37.42 61.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.192 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.0 mt -61.58 -30.16 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 124.262 0.976 . . . . 0.0 109.836 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.08 -67.15 0.3 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.528 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.08 -10.14 84.09 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.771 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.68 -56.19 4.32 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.98 -30.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.352 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 -17.82 79.93 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 123.596 0.56 . . . . 0.0 111.902 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.56 -6.75 51.9 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.38 120.31 12.58 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -75.19 148.63 39.39 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.266 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.65 14.92 80.51 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 123.783 0.677 . . . . 0.0 111.831 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.3 128.7 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.189 0.519 . . . . 0.0 111.001 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.447 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.2 mm100 -87.45 -77.78 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.328 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.519 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.4 tpm_? -97.29 161.18 13.92 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.574 1.171 . . . . 0.0 110.039 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.519 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 8.6 tt -158.03 93.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -112.83 81.67 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.606 1.193 . . . . 0.0 110.434 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.0 t -84.62 133.0 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.984 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.6 t -81.32 166.58 20.36 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.742 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.33 -27.51 12.79 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.458 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -53.15 -68.48 0.17 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.063 0.852 . . . . 0.0 112.19 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.85 52.0 1.61 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 36.26 48.28 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.647 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -73.2 91.87 1.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.79 125.65 32.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.535 -2.12 . . . . 0.0 112.068 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -130.99 68.48 1.49 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.817 1.294 . . . . 0.0 107.578 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.415 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 1.4 mp -74.41 142.85 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.452 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 70.1 t -112.12 135.17 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -167.06 159.54 13.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.509 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -87.3 140.59 32.27 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 124.773 1.296 . . . . 0.0 108.887 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.58 -54.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.842 2.361 . . . . 0.0 113.782 -151.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.522 ' CD2' HD22 ' A' ' 57' ' ' LEU . 38.2 p-80 -61.66 -3.17 0.98 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.522 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.6 mm? -79.16 -52.33 8.31 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.2 tt -171.04 163.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.318 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.6 m -108.81 110.55 21.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.95 -23.03 25.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.445 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.89 -29.14 68.96 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.692 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.27 -39.18 75.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.84 63.85 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.203 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.85 -19.81 21.32 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.1 -43.88 85.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.015 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -29.24 70.11 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.136 0.897 . . . . 0.0 109.604 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -69.72 -33.61 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.02 -17.53 46.49 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.25 -37.56 28.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 124.42 1.075 . . . . 0.0 109.218 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -72.58 -14.12 61.55 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 124.051 0.845 . . . . 0.0 111.438 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.3 9.71 5.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 116.464 1.346 . . . . 0.0 116.464 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -113.92 78.31 4.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -50.55 135.85 40.87 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.272 1.982 . . . . 0.0 108.814 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.12 138.21 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.663 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -86.98 70.87 10.33 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.36 131.72 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 112.258 -2.247 . . . . 0.0 111.969 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -100.09 99.56 10.3 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -54.73 -34.56 62.64 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.678 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.408 HE22 HG23 ' A' ' 10' ' ' VAL . 35.9 tt0 47.55 67.38 4.53 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 124.676 1.235 . . . . 0.0 110.957 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -62.89 137.0 60.21 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.556 2.171 . . . . 0.0 110.83 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.8 157.67 29.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.166 0.916 . . . . 0.0 109.874 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -25.79 101.49 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.139 1.525 . . . . 0.0 113.953 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.43 -39.33 93.62 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.95 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.1 tptt . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 116.698 -1.62 . . . . 0.0 109.423 179.838 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.7 t -86.22 129.79 34.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.41 0.712 . . . . 0.0 110.496 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.4 ttm -85.88 96.85 9.92 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.35 -153.58 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.278 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -130.51 -58.36 1.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.15 -26.4 11.12 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.776 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.65 45.5 3.5 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -156.89 145.94 20.18 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.977 -0.611 . . . . 0.0 111.68 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.2 105.02 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.992 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -83.79 58.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.705 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.61 147.15 32.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.615 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HZ3' ' HZ2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -111.61 142.67 43.62 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.987 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.7 mpp? -132.02 137.02 47.67 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -121.84 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.41 1.069 . . . . 0.0 113.38 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -58.68 167.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 29.9 tt0 -94.58 123.36 37.97 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.13 27.36 2.36 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 121.29 -0.481 . . . . 0.0 111.968 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 16' ' ' GLU . 47.4 tpp 58.22 -108.62 0.42 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.671 0.788 . . . . 0.0 109.168 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -178.31 -23.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 123.488 0.492 . . . . 0.0 111.179 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.3 p -159.16 -17.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -142.77 83.91 1.83 Allowed 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.532 0.682 . . . . 0.0 110.795 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.2 m -89.06 109.66 20.48 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.45 22.0 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -62.3 -12.77 22.69 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -58.68 -41.65 86.7 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.4 p -73.06 -31.46 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.459 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.92 -26.6 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.496 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -49.78 -59.96 3.34 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.438 0.637 . . . . 0.0 109.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.23 -23.76 71.68 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -68.66 -49.19 61.09 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.43 -35.77 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 113.325 -1.762 . . . . 0.0 110.276 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.38 -19.91 79.73 Favored Glycine 0 N--CA 1.485 1.936 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.168 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -94.6 -4.48 47.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.44 136.32 53.94 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -88.93 139.54 30.35 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.922 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.16 7.11 88.83 Favored Glycine 0 N--CA 1.489 2.227 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.681 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.28 131.9 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-O 121.509 0.671 . . . . 0.0 110.919 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.4 -76.88 0.48 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.33 -1.759 . . . . 0.0 108.784 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -97.03 170.77 8.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.062 0.851 . . . . 0.0 110.382 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.87 129.17 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 123.891 0.744 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -156.01 92.1 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.215 1.007 . . . . 0.0 109.111 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.1 138.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.049 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -86.17 175.67 8.38 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 mp -95.93 176.6 6.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.522 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.68 -87.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.509 1.131 . . . . 0.0 112.912 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -80.52 12.86 2.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.371 0.419 . . . . 0.0 111.341 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 36.85 60.42 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.377 1.048 . . . . 0.0 112.62 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.8 87.33 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.64 128.91 36.81 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.718 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -132.32 56.92 1.81 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.234 1.016 . . . . 0.0 108.715 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 ' N ' ' A' ' 51' ' ' ILE . 2.5 mp -69.07 142.24 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.427 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.7 t -107.01 140.06 26.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -155.77 163.32 39.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.398 1.061 . . . . 0.0 112.463 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -86.36 114.04 55.53 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.51 -32.55 70.33 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.486 2.124 . . . . 0.0 112.417 -162.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -60.97 -19.27 60.79 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -55.18 4.93 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.574 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -175.03 161.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 125.013 1.446 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -94.56 118.55 31.86 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.81 -18.26 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.83 -36.68 84.02 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -40.58 83.32 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -69.56 -16.35 63.4 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.614 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -97.3 -15.39 20.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -67.08 -37.05 83.31 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.354 0.409 . . . . 0.0 111.727 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -62.43 -36.74 83.33 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.726 0.642 . . . . 0.0 109.594 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -64.04 -34.55 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.2 -21.45 46.3 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.053 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.38 44.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.167 0.917 . . . . 0.0 109.625 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.2 ptm -74.87 -12.06 60.28 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.749 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.07 19.62 2.91 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 117.316 1.686 . . . . 0.0 117.316 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -124.63 70.93 57.82 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.07 133.7 41.54 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 122.236 1.958 . . . . 0.0 109.25 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -114.73 121.47 43.44 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.648 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -78.55 79.87 4.95 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.082 -2.326 . . . . 0.0 108.644 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t -97.78 137.71 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 113.483 -1.689 . . . . 0.0 109.948 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 77' ' ' LYS . 6.0 ttpm? -166.51 49.82 0.07 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 63.61 -84.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 113.641 -1.618 . . . . 0.0 107.301 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -131.42 80.09 68.24 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.72 75.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.933 2.422 . . . . 0.0 110.222 162.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.451 ' HZ2' ' HZ3' ' A' ' 12' ' ' LYS . 66.6 mttm -149.48 -32.28 0.21 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.107 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -64.32 169.49 4.6 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.44 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 pp -155.93 -174.6 5.02 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.772 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.256 -1.355 . . . . 0.0 109.586 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.3 p -159.29 171.07 20.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.019 0.481 . . . . 0.0 110.743 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 3' ' ' MET . 3.7 mpp? -75.9 163.53 27.11 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.283 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.11 -43.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.286 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -155.84 91.75 1.32 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.36 -28.88 63.31 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.059 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.69 -8.92 0.03 OUTLIER Glycine 0 N--CA 1.496 2.637 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -146.19 174.98 10.84 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.318 0.58 . . . . 0.0 111.046 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.15 132.6 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.98 109.48 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.963 0.789 . . . . 0.0 108.921 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.28 156.07 32.0 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.535 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -130.01 109.11 10.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.709 1.256 . . . . 0.0 111.017 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mpp? -90.23 146.52 24.18 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -119.28 89.26 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 123.929 0.768 . . . . 0.0 112.731 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.0 t -72.57 167.34 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.807 0.813 . . . . 0.0 110.929 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.7 tt0 -110.34 107.6 17.38 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.85 5.83 0.77 Allowed Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.099 0.874 . . . . 0.0 115.026 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttm 56.55 -108.24 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 124.094 0.526 . . . . 0.0 110.031 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t 174.69 172.87 0.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 t 66.59 -73.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 124.124 0.89 . . . . 0.0 110.881 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.423 ' ND1' ' SG ' ' A' ' 23' ' ' CYS . 19.1 t-160 -134.3 133.15 40.42 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.415 ' O ' ' CZ ' ' A' ' 72' ' ' PHE . 22.1 t -79.99 -35.53 37.32 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.041 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' ' ND1' ' A' ' 21' ' ' HIS . 54.4 m 58.5 3.8 0.31 Allowed 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -75.13 -6.38 49.28 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 p -58.6 -38.89 78.93 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 109.811 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.226 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.41 -49.16 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.199 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -41.79 -61.32 1.13 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.598 1.186 . . . . 0.0 113.679 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.72 -31.89 76.99 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.134 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -73.89 -35.58 64.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.1 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.0 mt -70.25 -31.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.305 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.58 -18.76 77.39 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.87 -8.57 58.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.66 -0.77 . . . . 0.0 111.968 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.32 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -82.66 138.72 34.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.89 -0.58 76.59 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.259 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.9 t -84.27 144.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -96.19 -85.23 0.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -98.29 166.13 11.54 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.087 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.33 108.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -152.85 126.82 9.01 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.43 156.44 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.249 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.7 t -115.64 146.4 41.84 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.814 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -60.03 -8.13 2.17 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.19 77.49 4.69 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.731 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 51.47 66.04 1.31 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.677 0.751 . . . . 0.0 109.816 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 5.9 tp-100 42.92 50.65 5.27 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.745 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -74.78 84.64 2.16 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.63 144.34 52.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.722 -2.035 . . . . 0.0 112.481 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -141.46 64.95 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 51' ' ' ILE . 1.6 mp -80.5 135.02 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.039 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 82.7 t -104.71 138.56 28.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 103.509 -2.774 . . . . 0.0 103.509 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -150.18 171.31 17.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 124.351 1.032 . . . . 0.0 113.007 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.37 145.02 34.82 Favored Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.989 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -70.76 -67.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.796 2.331 . . . . 0.0 112.692 -158.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.463 ' CD2' HD22 ' A' ' 57' ' ' LEU . 26.9 p-80 -74.47 12.6 0.75 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.463 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -88.05 -60.95 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 tt -175.47 160.91 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 124.907 1.38 . . . . 0.0 110.21 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.9 p -103.89 119.18 38.38 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.237 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.83 -14.87 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.138 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.12 -14.78 26.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -68.06 -43.14 79.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.9 mmt -59.17 -40.07 84.5 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.82 67.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.704 1.252 . . . . 0.0 110.228 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -65.02 -46.4 81.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -66.24 -34.4 77.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.22 -32.97 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.85 -18.4 47.49 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.873 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.23 -37.58 32.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.061 0.851 . . . . 0.0 109.117 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptm -74.09 -12.29 60.56 Favored 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.068 0.855 . . . . 0.0 111.623 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.89 22.92 3.45 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.415 ' CZ ' ' O ' ' A' ' 22' ' ' SER . 19.4 m-85 -125.22 81.58 63.28 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -47.73 131.78 20.53 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.239 1.959 . . . . 0.0 110.116 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.3 117.19 26.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.915 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -83.78 69.5 10.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 112.228 -2.26 . . . . 0.0 108.942 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.62 119.03 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -71.72 -33.87 69.1 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.691 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -69.32 170.15 10.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -111.34 161.0 27.16 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 113.108 -1.86 . . . . 0.0 107.616 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.99 -178.5 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.115 1.877 . . . . 0.0 111.411 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -60.45 143.53 53.19 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.858 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.418 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 61.5 t80 -121.34 -178.97 3.92 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.011 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 1.1 pt? 38.35 -143.2 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 123.919 0.888 . . . . 0.0 112.887 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 116.424 -1.751 . . . . 0.0 108.108 179.816 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.8 p -160.39 145.09 14.47 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.111 0.536 . . . . 0.0 110.189 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtm -61.79 -45.33 94.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.07 0.856 . . . . 0.0 109.707 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.35 159.82 24.29 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.61 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -152.63 62.15 0.8 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.37 48.89 1.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.941 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.52 -176.24 24.57 Favored Glycine 0 N--CA 1.494 2.537 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.996 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.45 127.79 24.48 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.951 -1.124 . . . . 0.0 109.829 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.5 m -70.2 121.77 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.7 m -90.17 65.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.18 116.98 6.5 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 130.69 41.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.9 mtp -125.53 135.71 52.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -121.47 92.55 3.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.219 0.949 . . . . 0.0 112.587 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.29 167.26 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.212 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.2 tt0 -108.31 115.59 30.39 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 102.584 -3.117 . . . . 0.0 102.584 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.95 8.43 0.39 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.418 ' H ' ' C ' ' A' ' 16' ' ' GLU . 46.8 ttm 62.12 -124.74 0.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 t -177.68 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.2 t -83.15 -113.63 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 123.917 0.76 . . . . 0.0 109.711 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -79.7 179.67 7.39 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -151.26 158.05 43.38 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.731 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.8 t -152.72 32.52 0.5 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.202 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -69.78 -2.9 13.34 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.508 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.1 m -64.1 -34.27 77.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -65.49 -32.93 74.79 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.613 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.9 mt -57.43 -33.93 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 124.336 1.023 . . . . 0.0 111.01 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.45 -68.03 0.22 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 123.867 0.73 . . . . 0.0 111.777 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -23.04 75.71 Favored Glycine 0 N--CA 1.495 2.631 0 CA-C-N 114.466 -1.243 . . . . 0.0 115.431 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -69.71 -49.87 49.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -74.04 -27.17 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.556 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.35 -17.3 80.07 Favored Glycine 0 N--CA 1.487 2.055 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.47 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.4 -4.83 59.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.247 0.616 . . . . 0.0 111.614 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.33 126.68 30.53 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.853 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -74.5 145.04 43.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.219 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.94 13.67 82.36 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.346 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.7 t -87.2 135.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 124.258 0.622 . . . . 0.0 109.581 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -95.46 -79.27 0.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.594 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.514 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.9 tpm_? -97.99 163.23 12.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.449 1.093 . . . . 0.0 110.029 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.514 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 11.7 tt -157.25 95.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -105.17 156.03 18.48 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.224 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 50.6 t -144.54 133.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 124.52 1.138 . . . . 0.0 107.957 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -112.3 138.06 49.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.288 0.992 . . . . 0.0 108.961 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.3 mt -58.22 -19.19 31.85 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.771 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.34 87.98 0.63 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.149 0.906 . . . . 0.0 108.685 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.46 50.99 17.73 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.351 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 39.52 47.55 1.63 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.093 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -72.82 95.28 1.9 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -89.33 126.77 35.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.045 -1.889 . . . . 0.0 114.074 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.1 m -111.59 92.44 4.03 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.337 1.023 . . . . 0.0 109.199 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 51' ' ' ILE . 1.6 mp -92.19 141.49 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.894 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.64 141.91 41.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -161.75 162.67 29.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 124.201 0.938 . . . . 0.0 111.929 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -72.1 136.18 82.17 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-N 114.057 -1.428 . . . . 0.0 107.82 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.451 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -59.2 155.42 40.16 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.452 2.101 . . . . 0.0 110.953 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.451 ' CG ' ' O ' ' A' ' 55' ' ' PRO . 6.5 p-80 52.75 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 117.128 2.269 . . . . 0.0 117.128 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.81 -41.77 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.6 tt -169.5 160.92 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 124.451 1.094 . . . . 0.0 111.391 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.3 p -97.66 108.39 21.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.306 -1.316 . . . . 0.0 109.185 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.22 -27.7 16.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.751 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.43 -18.16 62.34 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -82.28 -42.27 19.05 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.486 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.3 tpt -67.77 -34.15 76.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.648 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -78.7 -18.0 55.02 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.995 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -58.88 -29.18 66.82 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.005 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.2 -33.8 76.13 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.423 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 85.8 mt -65.2 -31.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.67 -23.99 39.22 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.663 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.4 -37.89 56.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.069 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.2 ptm -73.6 -14.12 61.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.891 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.41 5.45 7.2 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -115.84 82.95 11.14 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -49.82 133.47 33.52 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.106 1.871 . . . . 0.0 109.943 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -121.35 115.9 23.81 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.05 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.51 71.38 7.36 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.416 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -86.85 90.3 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -147.23 73.16 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.774 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -64.29 -46.65 82.72 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.917 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -136.57 72.69 56.73 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.933 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -68.29 -42.51 5.5 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.916 2.411 . . . . 0.0 111.529 -170.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? 66.23 2.9 2.51 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 124.73 1.269 . . . . 0.0 110.636 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -138.29 176.44 8.69 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.43 44.95 1.22 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.174 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.807 -1.568 . . . . 0.0 109.556 -179.917 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.9 m -82.27 98.3 8.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.304 0.649 . . . . 0.0 110.459 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.6 ptp -73.91 149.8 41.25 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.306 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.92 -47.81 0.05 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -136.28 -25.51 1.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.022 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.99 122.01 17.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 123.945 0.778 . . . . 0.0 110.072 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.97 160.67 45.0 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.532 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.2 175.67 9.58 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.891 -0.655 . . . . 0.0 111.717 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.5 113.69 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.921 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.25 56.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.69 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 153.4 42.07 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.227 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.84 140.95 48.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.607 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.6 mtm -134.8 138.51 44.32 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -122.93 90.72 3.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.309 1.005 . . . . 0.0 112.351 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -64.27 170.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.999 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.9 tt0 -116.41 107.65 15.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 100.242 -3.984 . . . . 0.0 100.242 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.06 1.33 0.61 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 115.536 0.974 . . . . 0.0 115.536 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.5 ttm 79.72 -58.48 0.37 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 124.938 1.295 . . . . 0.0 109.066 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 t -164.93 -38.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.011 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 t -170.02 19.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.21 0.944 . . . . 0.0 110.403 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.7 m80 70.53 153.53 0.12 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 123.968 0.793 . . . . 0.0 111.359 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.6 t -164.42 -69.55 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m -75.37 0.66 16.11 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.043 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.4 p -61.83 -10.45 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.3 m -56.4 -35.52 67.85 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.9 p -71.27 -39.38 71.6 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 53.3 mt -57.03 -30.12 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 124.322 1.014 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.96 -63.98 1.01 Allowed 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.937 0.773 . . . . 0.0 109.193 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -9.02 81.95 Favored Glycine 0 N--CA 1.493 2.448 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.485 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -77.98 -55.96 4.87 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.2 mt -70.98 -29.93 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.699 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.14 78.2 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.593 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -95.59 0.29 52.73 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.1 mt -68.69 114.34 6.97 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.207 0.527 . . . . 0.0 112.142 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.59 138.47 44.92 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.244 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.5 13.73 77.77 Favored Glycine 0 N--CA 1.489 2.21 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.759 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -91.45 143.68 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -95.93 -83.52 0.37 Allowed 'General case' 0 N--CA 1.485 1.31 0 O-C-N 124.228 0.955 . . . . 0.0 108.712 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -98.55 164.46 12.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 124.588 1.18 . . . . 0.0 111.36 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.4 tt -146.04 124.37 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -146.07 78.01 1.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.403 1.096 . . . . 0.0 112.216 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 51.9 t -82.84 130.49 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 t -84.56 -178.73 6.97 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.445 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 44' ' ' LEU . 2.6 mm? -100.83 -177.36 3.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.998 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 54.26 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.039 0.837 . . . . 0.0 112.697 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -84.8 11.91 8.32 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 37.97 50.9 1.36 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.236 1.017 . . . . 0.0 109.308 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -67.53 89.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.042 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -78.97 124.65 28.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 112.245 -2.252 . . . . 0.0 110.786 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.0 m -129.78 58.01 1.66 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.642 1.21 . . . . 0.0 108.748 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 51' ' ' ILE . 1.9 mp -66.92 140.84 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.839 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.8 t -106.11 136.1 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -157.21 167.91 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.48 -1.288 . . . . 0.0 114.12 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -84.12 127.58 66.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.27 -65.46 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.73 2.287 . . . . 0.0 114.014 -157.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.507 ' CD2' HD22 ' A' ' 57' ' ' LEU . 27.0 p-80 -68.95 -0.99 6.3 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.507 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.5 mm? -75.75 -48.14 23.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 tt -166.29 167.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.062 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.5 m -125.21 116.34 21.83 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.92 -17.93 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.377 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.86 -34.8 74.07 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -68.15 -41.41 81.66 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -34.94 79.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.893 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -66.62 -28.34 68.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.254 0.971 . . . . 0.0 110.102 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.31 -35.88 81.83 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.066 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -69.57 -38.6 77.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 124.411 1.069 . . . . 0.0 108.177 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.462 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 60.8 mt -65.91 -33.11 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 124.764 1.29 . . . . 0.0 108.073 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -82.84 -21.62 34.35 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.559 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.6 -37.53 42.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.053 0.845 . . . . 0.0 109.749 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 10.1 ptm -76.36 -11.94 59.98 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.08 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.28 17.44 2.69 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 118.31 2.084 . . . . 0.0 118.31 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -125.96 79.8 68.45 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-N 118.169 0.984 . . . . 0.0 109.444 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -47.4 136.81 19.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.6 2.2 . . . . 0.0 109.979 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.83 121.85 35.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.344 1.028 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -84.48 67.99 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.374 -2.194 . . . . 0.0 108.008 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.29 163.09 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.692 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -52.93 -28.1 21.94 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.419 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.1 -177.1 0.15 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.567 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 54.62 63.36 7.25 Favored Pre-proline 0 N--CA 1.498 1.968 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.014 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.19 162.74 34.55 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.871 2.38 . . . . 0.0 111.463 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 65.02 151.19 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.901 1.376 . . . . 0.0 111.598 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -148.48 120.97 8.5 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.547 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.404 HD21 ' N ' ' A' ' 83' ' ' LEU . 2.9 mm? 51.89 -89.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 124.534 1.146 . . . . 0.0 110.49 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 115.692 -2.099 . . . . 0.0 111.504 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.278 0.561 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.85 152.69 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.689 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.19 127.12 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 124.082 0.864 . . . . 0.0 111.412 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.74 95.89 4.23 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.915 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -86.63 88.12 7.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.415 ' HB2' ' HZ2' ' A' ' 64' ' ' LYS . 44.4 mtm -90.98 140.14 30.11 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.466 -1.697 . . . . 0.0 106.98 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.6 ttmm -109.99 97.54 7.02 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.832 1.333 . . . . 0.0 114.051 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -63.39 169.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.799 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 31.5 tt0 -112.9 131.23 55.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 100.48 -3.896 . . . . 0.0 100.48 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.46 16.88 1.21 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.856 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.455 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 2.2 ttp . . . . . 0 N--CA 1.5 2.058 0 C-N-CA 124.087 0.955 . . . . 0.0 110.077 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.404 ' C ' ' H ' ' A' ' 25' ' ' SER . 75.2 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.5 p 52.58 -8.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 23' ' ' CYS . 50.6 m -77.33 -38.59 50.08 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 102.974 -2.973 . . . . 0.0 102.974 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.6 p -69.13 -33.16 73.03 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.016 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -68.23 -31.38 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.124 0.89 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.94 -58.87 6.24 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.37 -20.74 77.08 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.708 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -70.84 -52.95 17.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -64.9 -34.38 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.254 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.82 -17.56 79.73 Favored Glycine 0 N--CA 1.487 2.08 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.156 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -95.54 1.52 53.9 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.4 mt -71.22 128.73 36.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.205 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -78.74 159.27 28.02 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.38 1.086 . . . . 0.0 112.639 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.62 14.74 70.15 Favored Glycine 0 N--CA 1.488 2.13 0 CA-C-N 112.145 -2.298 . . . . 0.0 110.517 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.77 133.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 114.778 -0.711 . . . . 0.0 111.635 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -93.36 -77.22 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 19.5 tpp85 -96.92 160.24 14.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.75 119.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.558 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -138.95 152.07 47.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -141.37 124.12 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 23.1 t -80.19 179.64 7.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 123.812 0.695 . . . . 0.0 110.714 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.497 ' N ' HD22 ' A' ' 44' ' ' LEU . 2.5 mm? -100.27 173.53 6.56 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.802 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 56.59 -86.47 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 124.293 0.996 . . . . 0.0 112.11 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.25 10.61 4.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.2 0.313 . . . . 0.0 110.634 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 33.87 52.18 0.43 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.356 1.035 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 43.0 tt0 -67.48 95.66 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.629 -1.623 . . . . 0.0 107.849 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -74.03 126.71 31.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.728 -2.033 . . . . 0.0 110.78 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.9 m -126.48 88.25 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.6 mp -110.41 137.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.863 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.1 t -108.46 137.82 38.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.06 157.07 39.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.398 1.061 . . . . 0.0 111.312 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.4 pt20 -78.95 143.22 61.35 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 60.6 Cg_endo -85.71 40.14 0.75 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.019 2.479 . . . . 0.0 113.476 -162.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -151.07 16.06 0.74 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.65 -59.69 1.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.8 tt -165.57 161.24 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.955 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.9 p -98.9 118.79 36.45 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.377 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.8 -18.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.474 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.33 -38.69 85.32 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.788 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.28 -39.03 85.97 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mmt -64.02 -33.49 75.85 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.057 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HZ2' ' HB2' ' A' ' 13' ' ' MET . 27.0 mtpt -80.13 -18.14 50.62 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.646 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.93 -29.73 70.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -71.3 -39.02 71.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 57.8 mt -62.68 -36.2 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -78.64 -27.04 45.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 -37.65 65.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.224 0.953 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -73.73 -15.86 61.2 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.152 0.907 . . . . 0.0 111.671 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.76 10.69 2.52 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 118.064 1.985 . . . . 0.0 118.064 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 18' ' ' MET . 59.9 m-85 -118.92 75.09 13.47 Favored Pre-proline 0 N--CA 1.5 2.06 0 CA-C-N 118.407 1.104 . . . . 0.0 109.718 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -48.9 139.25 25.62 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.825 2.35 . . . . 0.0 111.253 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -122.91 133.24 54.41 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.045 0.926 . . . . 0.0 111.648 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.89 74.81 10.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.372 -2.194 . . . . 0.0 106.785 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-N 113.555 -1.657 . . . . 0.0 111.301 -179.852 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' HB3' HE22 ' A' ' 38' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 53' ' ' TYR . 14.3 m -145.55 126.64 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.259 0.975 . . . . 0.0 109.767 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 11' ' ' LEU . 18.3 m -94.48 115.7 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 10' ' ' VAL . 3.1 mm? -114.66 110.49 19.83 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.372 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.442 ' C ' ' SD ' ' A' ' 13' ' ' MET . 2.3 mppt? -100.84 130.1 46.81 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 4.9 mpp? -144.25 139.13 28.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 65.1 tttp -105.15 151.53 23.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 125.149 1.53 . . . . 0.0 107.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -127.68 169.6 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 124.205 0.941 . . . . 0.0 110.729 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 18' ' ' MET . 31.5 tt0 -92.37 111.39 22.95 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.37 5.2 5.57 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-O 119.55 -0.583 . . . . 0.0 114.358 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.482 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 52.0 ttp . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -72.31 -13.54 61.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.369 -1.287 . . . . 0.0 113.379 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 p -55.33 -38.2 68.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.858 0.724 . . . . 0.0 109.476 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -77.12 -37.28 54.45 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.0 mt -61.0 -36.15 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 123.997 0.81 . . . . 0.0 110.882 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.76 -64.98 0.74 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.727 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.22 -18.98 73.68 Favored Glycine 0 N--CA 1.497 2.701 0 CA-C-N 113.593 -1.639 . . . . 0.0 114.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -77.15 -53.89 7.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.415 ' CG2' HG12 ' A' ' 51' ' ' ILE . 57.2 mt -69.84 -23.76 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.679 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.59 -13.79 83.12 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -95.32 2.3 54.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 124.333 0.666 . . . . 0.0 111.692 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.17 130.78 43.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -83.22 146.77 28.4 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.52 12.59 84.22 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.718 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.1 t -93.75 142.19 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.515 HE22 ' HB3' ' A' ' 8' ' ' GLU . 73.8 mt-30 -95.81 -81.97 0.39 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 12.8 tpt180 -97.15 154.81 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.1 115.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -151.88 167.09 29.44 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 57.2 t -136.96 147.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 124.624 1.203 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 37.7 t -104.37 150.21 24.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.887 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -67.31 1.56 2.11 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.091 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -83.39 66.48 8.87 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 m120 54.35 71.93 0.49 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.715 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 38.5 tp60 41.71 47.2 3.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.803 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 39.6 tt0 -79.63 87.65 5.17 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.168 1.461 . . . . 0.0 107.284 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.37 138.67 45.46 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.721 -2.49 . . . . 0.0 114.721 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.2 m -140.5 90.57 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.1 mp -98.64 130.37 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.436 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 39.5 t -106.38 134.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.4 p90 -148.56 171.2 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.199 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.97 145.65 81.42 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 124.095 0.872 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -71.17 0.86 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.46 2.773 . . . . 0.0 115.432 -150.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -154.17 23.46 0.49 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.49 -46.41 9.14 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.474 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.457 HG12 ' H ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -157.95 166.43 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 124.043 0.839 . . . . 0.0 111.482 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.457 ' H ' HG12 ' A' ' 58' ' ' ILE . 58.2 p -117.38 107.4 14.3 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.425 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.56 -26.93 32.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.234 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.21 -27.68 68.61 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.963 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.88 -41.37 78.43 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 mmt -61.84 -32.38 72.71 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.514 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -65.47 -34.71 78.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.976 0.798 . . . . 0.0 109.154 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.55 -34.75 77.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 123.492 0.495 . . . . 0.0 110.539 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -67.9 -38.71 83.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 124.162 0.914 . . . . 0.0 108.843 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 72' ' ' PHE . 83.5 mt -67.61 -28.63 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.236 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -86.52 -22.14 26.54 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.189 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.92 -36.74 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.05 0.843 . . . . 0.0 109.519 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -13.43 60.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.68 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -6.69 5.39 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 118.671 2.229 . . . . 0.0 118.671 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.0 m-30 -106.52 93.68 8.81 Favored Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 119.203 1.502 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -45.31 137.18 10.87 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.972 1.781 . . . . 0.0 109.577 166.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.13 126.35 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.521 1.138 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 39.7 m-85 -85.46 91.18 8.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.37 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.498 1.953 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.806 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.53 0.681 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 m -129.84 146.54 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.2 m -128.59 99.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 124.66 1.225 . . . . 0.0 110.067 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 11' ' ' LEU . 5.7 mp -104.81 120.12 40.63 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.051 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 2.3 mppt? -99.86 90.05 4.29 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.892 0.745 . . . . 0.0 109.701 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -82.62 139.65 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -109.42 96.28 6.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.789 1.305 . . . . 0.0 113.728 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.1 t -60.94 159.64 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 18' ' ' MET . 35.1 tt0 -82.59 109.69 17.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.16 -7.79 7.6 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.874 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.481 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 31.0 tpp . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.383 0.611 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.1 p -69.71 -0.47 7.03 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -66.01 -31.85 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -64.41 -37.69 88.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.203 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.26 -32.83 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 124.534 1.146 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.96 -70.36 0.17 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.145 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -12.4 66.87 Favored Glycine 0 N--CA 1.497 2.752 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.55 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -82.87 -59.49 2.48 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.906 0.86 . . . . 0.0 108.817 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.01 -2.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.023 -1.898 . . . . 0.0 112.59 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.83 -17.36 19.06 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.804 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -96.85 7.35 46.8 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -82.71 140.5 33.04 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -85.94 161.52 18.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.626 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.07 87.19 Favored Glycine 0 N--CA 1.489 2.168 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 34' ' ' LEU . 71.1 t -111.81 145.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 124.626 0.839 . . . . 0.0 112.756 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -94.76 -83.22 0.35 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.493 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.5 tpp85 -98.16 163.17 12.85 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.023 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' C ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -152.05 117.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -153.26 112.7 3.83 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.369 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 44.4 t -93.4 150.53 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.952 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.5 t -109.03 141.32 41.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.581 1.176 . . . . 0.0 110.087 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -56.86 -21.68 31.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 124.35 1.031 . . . . 0.0 110.118 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.19 87.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.659 1.225 . . . . 0.0 108.708 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 52.51 40.25 29.41 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 45.63 47.7 11.44 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.436 1.112 . . . . 0.0 108.584 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.01 92.99 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.363 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -67.26 130.49 43.26 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.482 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.9 m -131.34 92.53 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -97.54 135.65 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.168 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 26.3 t -107.96 137.85 37.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -162.84 166.09 24.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.683 1.24 . . . . 0.0 113.679 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.08 132.55 39.45 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.079 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.18 38.36 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.368 2.712 . . . . 0.0 114.464 -155.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.477 ' CD2' HD22 ' A' ' 57' ' ' LEU . 28.3 p-80 -156.23 18.46 0.35 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -95.91 -56.2 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.445 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.19 164.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.027 0.829 . . . . 0.0 110.619 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -74.14 109.26 7.5 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.495 1.141 . . . . 0.0 110.019 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.62 -26.88 6.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 112.642 -2.072 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.23 -24.49 61.39 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.427 -1.26 . . . . 0.0 107.686 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.84 -38.09 79.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -63.17 -40.52 97.78 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.515 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -78.14 -10.92 59.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 124.279 0.987 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -74.49 -29.71 61.53 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.06 -30.62 71.11 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.381 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.426 HG22 ' HB2' ' A' ' 72' ' ' PHE . 88.0 mt -65.89 -30.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 114.69 -1.141 . . . . 0.0 107.998 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.54 -24.1 36.81 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.695 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.49 -37.36 60.25 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.425 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -74.46 -12.2 60.43 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.737 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 1.59 9.33 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 116.797 1.479 . . . . 0.0 116.797 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.426 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.8 m-85 -112.6 82.58 4.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 117.447 0.624 . . . . 0.0 109.503 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.51 130.12 34.99 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 121.819 1.679 . . . . 0.0 109.755 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -111.54 109.58 19.57 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.847 -1.979 . . . . 0.0 106.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -69.13 89.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 112.109 -2.314 . . . . 0.0 109.608 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 . . . . . 0 N--CA 1.505 2.316 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.69 124.07 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.765 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.6 m -100.69 101.82 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.293 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.98 116.89 33.66 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -93.78 111.86 23.62 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.435 ' SD ' HG13 ' A' ' 76' ' ' VAL . 31.9 mtm -114.33 143.77 44.34 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.538 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -120.11 98.04 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.0 t -70.67 168.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.615 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 36.6 tt0 -103.12 127.37 50.41 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.6 21.67 1.92 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.723 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 16' ' ' GLU . 54.3 tpp . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.036 0.445 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -63.69 -12.09 31.38 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.3 t -59.21 -44.39 92.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 p -72.37 -31.07 65.27 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.08 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.494 HG21 HE22 ' A' ' 47' ' ' GLN . 45.4 mt -65.08 -36.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 123.889 0.743 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.11 -51.31 66.8 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -34.5 87.26 Favored Glycine 0 N--CA 1.495 2.591 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.084 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -63.52 -40.31 96.71 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.71 -32.33 44.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.873 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.73 -13.4 82.23 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -94.85 3.48 54.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.562 0.801 . . . . 0.0 110.569 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.28 119.46 24.62 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.15 148.19 32.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.087 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.05 -0.37 87.52 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -82.22 138.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 124.046 0.498 . . . . 0.0 110.227 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -95.63 -78.19 0.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -97.84 165.98 11.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.255 0.972 . . . . 0.0 109.856 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.39 111.36 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HB2' ' HB ' ' A' ' 50' ' ' THR . 60.0 mtpt -124.42 69.46 1.09 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.145 0.974 . . . . 0.0 109.637 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.62 112.26 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 113.611 -1.631 . . . . 0.0 106.647 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.485 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 33.1 t -85.79 177.26 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.337 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 44' ' ' LEU . 7.5 mp -96.84 -168.02 1.64 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.98 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.72 -103.96 0.2 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.02 0.825 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -93.49 25.03 3.64 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.494 HE22 HG21 ' A' ' 27' ' ' ILE . 15.2 tt0 32.16 80.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 43' ' ' SER . 83.7 tt0 -75.97 90.38 2.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.62 113.39 13.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.408 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 54.7 m -122.01 78.13 1.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.021 -1.445 . . . . 0.0 107.452 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -90.16 136.5 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.213 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -113.71 140.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.52 162.89 40.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.37 1.044 . . . . 0.0 112.092 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -65.74 144.59 98.92 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.82 7.04 3.36 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.908 2.406 . . . . 0.0 114.294 -157.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -156.96 19.66 0.31 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 3.3 mm? -86.06 -49.57 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.575 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.86 160.14 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 124.254 0.972 . . . . 0.0 110.761 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.8 m -98.8 110.82 23.37 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.76 -18.02 21.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.998 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.74 -32.48 74.0 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.951 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.94 -40.4 87.56 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.8 mmt -63.58 -33.77 76.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.756 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' HD12 ' A' ' 67' ' ' ILE . 14.1 mptt -77.96 -21.83 50.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.1 0.875 . . . . 0.0 109.738 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -66.37 -30.25 70.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -69.01 -40.76 78.49 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.432 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 78.6 mt -64.39 -31.94 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.112 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.58 -21.06 30.54 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.965 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.84 -38.09 46.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.026 0.829 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.3 ptm -74.15 -12.94 60.73 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.051 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 6.76 7.61 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -112.33 88.2 10.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -47.27 133.49 19.54 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 121.971 1.78 . . . . 0.0 109.222 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.88 123.81 33.62 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -82.55 64.46 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.338 -1.755 . . . . 0.0 108.681 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.435 HG13 ' SD ' ' A' ' 13' ' ' MET . 61.4 t . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 . . . . . 0 N--CA 1.506 2.362 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 m -117.29 153.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.291 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.21 68.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.315 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.27 109.35 1.1 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -81.66 82.86 7.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.499 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 11.0 ttp -80.13 125.55 29.96 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.269 1.033 . . . . 0.0 109.383 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.06 80.39 1.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 111.577 -2.556 . . . . 0.0 106.419 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -66.76 165.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.606 -1.634 . . . . 0.0 111.684 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 18' ' ' MET . 13.0 tp10 -107.49 137.3 45.77 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.9 12.95 3.44 Favored Glycine 0 N--CA 1.49 2.251 0 O-C-N 123.801 0.688 . . . . 0.0 113.708 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.422 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 38.1 ttm . . . . . 0 N--CA 1.5 2.046 0 C-N-CA 123.732 0.813 . . . . 0.0 112.432 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.5 p -62.88 -7.99 6.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.127 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.4 p -58.59 -34.78 71.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -71.21 -40.53 71.08 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.162 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.88 -35.71 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.913 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.7 -65.85 0.51 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.067 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.61 -22.83 70.13 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.895 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -70.86 -44.83 65.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.42 HG21 HG12 ' A' ' 51' ' ' ILE . 71.7 mt -72.58 -33.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.12 -14.59 71.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -95.45 3.03 54.67 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.101 -1.05 . . . . 0.0 111.622 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.45 116.38 25.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.04 0.447 . . . . 0.0 111.857 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -72.34 150.5 43.43 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.886 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.08 17.75 71.29 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 123.912 0.758 . . . . 0.0 111.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.66 137.48 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.552 HE22 ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -93.26 -81.98 0.35 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.764 1.29 . . . . 0.0 108.068 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 7.0 tpm_? -97.3 162.79 13.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.631 1.207 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.656 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.2 tt -158.45 111.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.647 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 139.74 9.62 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.373 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.2 t -108.03 158.08 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.561 -1.654 . . . . 0.0 112.653 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -135.23 176.52 8.6 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.473 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 44' ' ' LEU . 6.6 mp -67.69 -146.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.274 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 53.04 52.98 12.72 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 55.19 84.41 0.07 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.347 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 31.4 tp60 35.73 57.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.139 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.47 87.97 2.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -85.13 141.3 30.31 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.542 -1.663 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.5 m -135.77 70.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -73.91 138.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.437 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.3 t -114.7 135.79 53.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -163.83 169.6 18.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.668 1.23 . . . . 0.0 112.245 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.552 ' H ' HE22 ' A' ' 38' ' ' GLN . 5.1 pt20 -95.21 122.23 60.27 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 124.389 1.056 . . . . 0.0 108.524 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 -34.92 17.05 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.633 2.222 . . . . 0.0 112.392 -168.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.45 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 6.8 p-80 -57.13 -30.69 64.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -73.44 -47.39 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 tt -170.63 161.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.5 m -112.65 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.894 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.3 -13.8 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.292 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.6 -38.38 77.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.43 -41.42 89.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 mmt -65.47 -26.46 67.94 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.384 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -71.78 -30.0 65.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.311 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -63.61 -32.86 74.47 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -66.81 -39.85 87.87 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.366 1.041 . . . . 0.0 108.894 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.41 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 74.6 mt -65.14 -31.95 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.74 -19.68 30.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.88 41.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.072 0.858 . . . . 0.0 108.91 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.7 ptm -74.04 -12.09 60.52 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.648 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.31 9.11 8.86 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 117.834 1.894 . . . . 0.0 117.834 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.67 91.28 20.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -47.08 131.21 17.23 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.731 1.621 . . . . 0.0 108.788 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.27 104.6 7.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.463 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -85.45 92.3 8.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.431 -2.168 . . . . 0.0 109.113 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.693 179.902 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.428 ' HB3' HE21 ' A' ' 38' ' ' GLN . 9.9 pt-20 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.58 0.705 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 11' ' ' LEU . 17.5 m -64.55 125.2 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -94.63 69.56 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.416 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.419 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 3.9 mm? -66.24 117.12 8.07 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.031 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -104.96 105.68 15.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.392 1.058 . . . . 0.0 108.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.489 ' SD ' ' HG2' ' A' ' 64' ' ' LYS . 31.9 mtm -95.46 140.66 30.0 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -126.16 81.96 2.04 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.5 t -70.45 173.57 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.385 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 30.5 tt0 -100.23 111.22 23.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 103.52 -2.771 . . . . 0.0 103.52 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.18 -25.77 48.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.039 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 18' ' ' MET . 12.7 tmm? . . . . . 0 N--CA 1.497 1.876 0 O-C-N 124.519 0.776 . . . . 0.0 111.566 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 121.029 0.443 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 p -80.33 -2.98 47.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 m -61.14 -44.66 96.98 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.9 p -69.48 -34.5 74.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.352 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.44 -40.74 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.588 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -59.1 -55.93 28.78 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.645 0.736 . . . . 0.0 109.824 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.5 -30.9 75.72 Favored Glycine 0 N--CA 1.496 2.671 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.278 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' C ' ' HD3' ' A' ' 30' ' ' LYS . 7.7 tmtm? -69.54 -42.46 74.57 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.96 -29.63 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.374 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.71 -24.0 76.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.39 -17.97 57.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.406 -0.897 . . . . 0.0 112.14 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.04 127.46 31.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.538 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.82 141.75 49.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.315 1.009 . . . . 0.0 109.764 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.91 11.62 70.0 Favored Glycine 0 N--CA 1.486 1.997 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.168 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.64 135.16 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.566 HE22 ' N ' ' A' ' 54' ' ' GLN . 2.4 mp0 -95.75 -78.14 0.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.17 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.47 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 5.8 tpp180 -96.97 154.73 17.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.718 1.261 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.44 HG13 HG13 ' A' ' 51' ' ' ILE . 8.9 tt -155.21 121.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.314 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -150.6 153.39 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.426 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.2 t -129.59 133.98 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 124.259 0.974 . . . . 0.0 108.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 66.6 m -105.31 149.42 26.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.684 1.24 . . . . 0.0 110.218 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 44' ' ' LEU . 1.2 pp -66.5 4.69 0.71 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.08 68.43 9.99 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.3 m120 55.63 72.4 0.49 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 54.9 tp60 40.99 54.72 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.311 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 43' ' ' SER . 28.8 tt0 -79.11 80.76 5.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.05 131.44 38.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.323 -2.217 . . . . 0.0 109.918 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -131.57 72.0 1.49 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.021 0.915 . . . . 0.0 109.81 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.7 mp -81.76 137.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.015 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 10.9 t -114.05 146.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -165.56 177.05 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.763 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.566 ' N ' HE22 ' A' ' 38' ' ' GLN . 5.5 pt20 -86.9 125.78 65.5 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.58 68.02 8.2 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.235 2.623 . . . . 0.0 113.167 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 5.9 p-80 -172.23 -28.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.04 -44.62 38.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 123.965 0.791 . . . . 0.0 109.544 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -167.76 172.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.088 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.477 ' N ' HG13 ' A' ' 58' ' ' ILE . 51.5 m -119.22 110.89 17.55 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.01 -21.29 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.257 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.49 -39.31 91.77 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.756 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.79 -37.11 73.29 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -71.81 -22.45 61.56 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.583 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HG2' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -97.84 -9.15 26.91 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.49 -32.88 74.46 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -24.04 65.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 123.99 0.806 . . . . 0.0 110.516 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.436 HG22 ' HB2' ' A' ' 72' ' ' PHE . 81.1 mt -70.63 -33.17 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.4 -27.79 46.76 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.48 -35.31 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.691 1.244 . . . . 0.0 109.947 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' CE1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -69.72 -19.33 63.55 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 123.905 0.753 . . . . 0.0 110.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.85 3.3 5.01 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 118.429 -1.206 . . . . 0.0 116.041 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 3.4 m-30 -106.99 86.19 2.29 Favored Pre-proline 0 N--CA 1.5 2.039 0 CA-C-N 118.477 1.138 . . . . 0.0 108.649 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.59 130.77 34.71 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 121.094 1.196 . . . . 0.0 109.044 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.24 124.93 51.05 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.745 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.74 -48.12 41.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.591 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.462 HG21 ' NZ ' ' A' ' 64' ' ' LYS . 23.8 t . . . . . 0 N--CA 1.495 1.798 0 O-C-N 125.312 1.632 . . . . 0.0 113.499 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.99 150.24 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.052 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.71 57.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 124.409 1.068 . . . . 0.0 108.941 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.3 141.17 41.7 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.19 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -103.49 104.86 14.98 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.448 ' SD ' HG13 ' A' ' 76' ' ' VAL . 16.8 mmm -89.49 109.97 20.85 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.68 85.53 2.76 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.328 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.14 168.01 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.482 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.8 tt0 -110.94 142.15 43.42 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.96 29.93 2.68 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.465 ' H ' ' C ' ' A' ' 16' ' ' GLU . 31.8 ttm . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 78.2 m . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.3 p -64.03 -7.61 9.13 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.769 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.6 p -62.27 -40.44 96.23 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 p -68.6 -33.62 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.298 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.54 -42.24 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.06 0.85 . . . . 0.0 108.939 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.35 -50.31 74.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.494 0.664 . . . . 0.0 110.828 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.32 -36.5 93.28 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.7 -1.591 . . . . 0.0 113.835 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.61 -51.34 10.8 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.997 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.18 1.48 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.56 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.21 -28.05 3.72 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.407 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -96.5 8.92 42.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.154 0.502 . . . . 0.0 111.811 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -74.04 135.54 43.06 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.309 1.052 . . . . 0.0 113.279 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -88.0 156.42 19.32 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.602 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.74 8.68 82.16 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 34' ' ' LEU . 54.3 t -99.68 144.09 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -96.04 -82.31 0.39 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.176 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -97.97 169.13 9.85 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.54 1.15 . . . . 0.0 111.625 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.609 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 11.0 tt -153.78 131.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.497 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 140.28 38.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -140.08 137.16 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.842 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t -102.62 170.12 8.22 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.279 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 44' ' ' LEU . 7.3 mp -93.0 -166.22 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.805 -1.088 . . . . 0.0 108.406 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 58.54 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -100.51 34.07 2.52 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.293 0.568 . . . . 0.0 111.006 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 33.96 58.73 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.559 -1.2 . . . . 0.0 114.213 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.67 96.89 2.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.45 121.79 36.35 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.512 -1.677 . . . . 0.0 111.552 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.3 m -115.27 93.92 4.5 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 51' ' ' ILE . 1.7 mp -102.15 136.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.928 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 75.1 t -101.79 132.41 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -155.84 176.64 12.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.65 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.11 112.06 57.06 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 112.422 -2.172 . . . . 0.0 107.074 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.61 -49.68 3.06 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.946 2.431 . . . . 0.0 110.225 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -57.83 -22.45 47.79 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 57' ' ' LEU . 5.5 tp -90.12 -40.93 11.94 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.378 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 tt -161.78 162.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.586 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.7 p -126.94 109.19 11.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.622 1.201 . . . . 0.0 107.868 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.29 -17.16 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.72 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.94 -38.61 86.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -66.96 -40.58 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -64.03 -26.97 68.8 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.718 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -90.88 -19.62 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.827 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.5 -43.55 96.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.644 0.259 . . . . 0.0 111.292 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -66.89 -35.84 80.94 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.424 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 63.6 mt -67.5 -31.53 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.703 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.03 -20.07 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.695 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.5 -36.24 38.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 124.024 0.827 . . . . 0.0 109.436 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.424 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.2 ptm -75.27 -11.36 60.05 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.15 0.906 . . . . 0.0 111.525 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 19.22 2.94 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 117.991 1.956 . . . . 0.0 117.991 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB3' HG13 ' A' ' 15' ' ' VAL . 6.5 m-85 -125.0 73.89 65.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.4 132.1 15.51 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 122.185 1.923 . . . . 0.0 109.904 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.58 118.7 31.71 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.416 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -81.18 75.73 8.14 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.782 -2.463 . . . . 0.0 108.695 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG13 ' SD ' ' A' ' 13' ' ' MET . 74.9 t . . . . . 0 N--CA 1.497 1.875 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.756 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.727 0.775 . . . . 0.0 112.956 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 m -107.69 126.05 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 113.789 -1.55 . . . . 0.0 110.842 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.19 57.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.507 1.146 . . . . 0.0 109.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.89 135.33 56.46 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.892 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -105.12 140.05 38.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.432 ' SD ' HG12 ' A' ' 60' ' ' VAL . 4.4 mtt -139.21 131.5 28.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -119.03 95.81 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.521 1.138 . . . . 0.0 111.341 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.77 170.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-N 113.464 -1.698 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' A' ' 18' ' ' MET . 33.1 tt0 -95.6 116.5 28.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.4 19.32 7.11 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-O 119.078 -0.845 . . . . 0.0 114.189 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.444 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 53.9 ttp . . . . . 0 N--CA 1.495 1.808 0 C-N-CA 124.408 1.083 . . . . 0.0 113.336 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.7 p -66.6 -15.44 63.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.9 p -57.06 -38.91 73.94 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -83.33 -33.22 25.94 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.917 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.53 -30.0 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.931 0.769 . . . . 0.0 109.932 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -56.99 -67.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.77 -21.29 79.79 Favored Glycine 0 N--CA 1.494 2.549 0 CA-C-N 113.889 -1.505 . . . . 0.0 114.157 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -74.56 -52.79 10.84 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.49 -27.81 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.042 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.56 -16.22 78.19 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.155 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.21 2.02 54.82 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 124.183 0.578 . . . . 0.0 111.94 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.5 117.29 10.93 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.159 0.504 . . . . 0.0 112.228 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.457 ' H ' ' CD ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -64.83 145.98 55.51 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.286 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.91 86.67 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.757 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.26 132.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.101 0.477 . . . . 0.0 110.343 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -94.64 -76.4 0.49 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.133 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.416 ' H ' ' HB ' ' A' ' 52' ' ' VAL . 9.5 tpt180 -97.65 165.87 11.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.203 0.94 . . . . 0.0 109.243 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 tt -155.98 131.51 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.578 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -157.93 84.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.346 1.07 . . . . 0.0 111.1 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.1 t -82.36 119.86 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -90.96 157.16 17.45 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.5 -110.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.428 -1.273 . . . . 0.0 107.745 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 p30 37.54 -122.82 0.22 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 119.237 0.926 . . . . 0.0 110.631 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -102.95 55.08 0.76 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 41.98 66.15 0.76 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.261 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -84.38 88.04 7.25 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 117.749 -1.58 . . . . 0.0 108.025 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 127.61 33.37 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 108.93 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -129.49 49.98 2.2 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.957 0.884 . . . . 0.0 108.986 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.8 mp -68.27 147.16 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.565 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 39' ' ' ARG . 99.5 t -113.91 144.32 21.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -156.39 157.83 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.346 1.029 . . . . 0.0 110.164 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.41 ' HG3' HD23 ' A' ' 57' ' ' LEU . 8.4 pt20 -86.26 146.39 42.33 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.42 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -58.98 155.25 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 123.03 2.487 . . . . 0.0 113.764 -161.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.414 ' CG ' ' O ' ' A' ' 55' ' ' PRO . 19.2 p80 52.86 -1.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.41 HD23 ' HG3' ' A' ' 54' ' ' GLN . 4.6 mm? -72.97 -40.21 65.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.88 0.764 . . . . 0.0 109.307 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.481 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -161.27 174.42 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.793 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.481 ' N ' HG13 ' A' ' 58' ' ' ILE . 68.3 m -139.14 108.5 6.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 13' ' ' MET . 49.2 t -66.2 -19.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.527 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.54 -37.09 82.2 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -68.94 -39.38 79.6 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.2 mmt -66.26 -29.65 69.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.351 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -80.93 -21.89 40.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.731 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -63.96 -33.46 75.77 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -69.9 -39.58 76.13 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.75 -26.73 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.93 -1.486 . . . . 0.0 107.885 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.93 -21.12 25.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.245 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.27 -37.1 38.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.937 0.773 . . . . 0.0 108.959 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -12.03 60.29 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 124.27 0.982 . . . . 0.0 111.264 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.09 -7.06 6.06 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -103.66 95.27 7.16 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 119.076 1.438 . . . . 0.0 112.805 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -46.78 133.58 17.36 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.765 1.643 . . . . 0.0 109.519 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.46 112.28 17.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.64 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -78.45 84.25 4.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.669 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.626 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.63 134.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 78.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 124.182 0.926 . . . . 0.0 111.089 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.32 138.91 36.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.338 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.74 117.78 33.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.452 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.3 mpp? -119.0 137.02 53.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 40.6 ttmt -119.59 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.923 1.389 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -65.38 167.81 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 18' ' ' MET . 39.2 tt0 -98.68 121.66 40.9 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.96 19.41 1.24 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.041 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.456 ' CE ' ' CE1' ' A' ' 72' ' ' PHE . 42.7 tpp . . . . . 0 N--CA 1.488 1.442 0 C-N-CA 124.949 1.299 . . . . 0.0 108.812 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 121.414 0.626 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -72.39 -0.99 13.91 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.6 t -61.79 -39.75 92.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -65.18 -34.35 78.17 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.51 -37.92 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.843 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -48.68 -61.5 2.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.9 0.75 . . . . 0.0 112.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.93 -29.24 71.94 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 114.045 -1.434 . . . . 0.0 112.781 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -70.43 -41.1 73.33 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.455 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.17 -33.88 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.6 76.95 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -89.69 -6.63 55.92 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.691 -0.755 . . . . 0.0 112.508 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.12 118.09 11.58 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.38 141.67 36.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.991 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.79 4.18 79.48 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.739 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.8 141.89 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -96.37 -79.44 0.45 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.781 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.529 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 2.6 tpm_? -96.81 159.63 14.81 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.84 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.474 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 5.4 tt -149.36 110.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -145.32 101.37 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.995 0.902 . . . . 0.0 111.237 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 49.3 t -93.65 149.3 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.293 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 37.3 t -111.66 144.53 40.77 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -25.76 60.28 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.421 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.45 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.074 0.859 . . . . 0.0 110.418 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 45.18 53.31 8.02 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.446 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 44.38 49.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.963 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 35.4 tt0 -74.07 89.7 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -76.5 130.19 37.59 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 111.828 -2.442 . . . . 0.0 114.085 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 m -132.07 74.54 1.59 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.62 1.2 . . . . 0.0 107.984 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -83.58 132.03 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.869 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 42.7 t -105.13 138.61 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -156.63 179.65 9.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.543 1.152 . . . . 0.0 113.645 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -95.37 116.11 66.02 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.486 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.2 -54.59 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.87 2.38 . . . . 0.0 110.237 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -56.14 -22.42 28.37 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.053 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.07 -40.96 12.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.244 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 tt -163.88 162.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 124.451 1.095 . . . . 0.0 111.284 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -130.93 104.74 7.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -68.58 -17.9 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.393 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.7 -29.02 67.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.321 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.69 -41.2 79.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.5 mmt -62.53 -31.93 72.8 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.269 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -66.25 -34.06 77.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.991 0.807 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -61.24 -34.13 74.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.091 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -67.82 -38.69 83.55 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 124.252 0.97 . . . . 0.0 109.047 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.7 -33.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.23 -24.66 34.73 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.389 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.11 -36.43 58.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.23 0.956 . . . . 0.0 109.928 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -74.93 -13.63 60.55 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 123.805 0.69 . . . . 0.0 111.082 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.57 10.36 4.51 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 7.6 m-85 -118.34 88.37 32.98 Favored Pre-proline 0 N--CA 1.499 2.019 0 CA-C-N 118.268 1.034 . . . . 0.0 109.773 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -49.08 135.15 30.19 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.128 1.885 . . . . 0.0 109.408 173.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.21 122.08 30.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.749 1.28 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.63 77.94 9.77 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.131 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.532 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 N--CA 1.506 2.332 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.92 108.36 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 m -92.6 56.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.022 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -79.39 156.31 28.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 2.9 mptp? -120.66 94.86 4.5 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.893 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.3 mtm -82.37 135.28 35.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 62.8 tttp -116.93 90.47 3.34 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.721 1.248 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -54.02 167.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 112.722 -2.036 . . . . 0.0 115.126 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.446 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.4 tt0 -120.5 126.77 51.2 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.56 21.06 1.22 Allowed Glycine 0 N--CA 1.492 2.399 0 O-C-N 123.299 0.374 . . . . 0.0 113.407 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.425 ' H ' ' C ' ' A' ' 16' ' ' GLU . 36.0 ttp . . . . . 0 N--CA 1.496 1.859 0 O-C-N 124.295 0.644 . . . . 0.0 111.664 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.9 p -59.85 -8.79 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.651 -1.159 . . . . 0.0 113.419 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.2 p -56.25 -32.61 64.65 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.3 p -68.66 -39.78 80.47 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.386 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.3 mt -52.57 -30.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 124.502 1.126 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.25 -72.5 0.06 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.5 -12.77 80.29 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.533 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.83 -53.87 7.0 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.491 0.662 . . . . 0.0 109.301 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.16 -29.66 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.036 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.52 -14.68 81.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -95.49 1.05 53.83 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.72 -0.74 . . . . 0.0 112.805 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.422 HD21 ' SD ' ' A' ' 63' ' ' MET . 79.9 mt -72.29 125.34 27.11 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -83.89 144.5 29.17 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.531 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.95 10.7 84.69 Favored Glycine 0 N--CA 1.489 2.212 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.018 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.56 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -95.79 -83.83 0.36 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 19.4 tpp180 -98.45 166.59 11.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.592 1.182 . . . . 0.0 110.992 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.53 107.06 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -147.73 108.45 4.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.753 0.787 . . . . 0.0 110.845 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 54.8 t -97.18 139.68 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.1 t -100.63 171.07 7.94 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.773 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 44' ' ' LEU . 7.4 mp -74.58 -115.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.168 -1.396 . . . . 0.0 108.183 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 p30 39.81 -133.32 0.22 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 119.272 0.942 . . . . 0.0 109.768 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -93.85 56.99 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 41.16 69.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.948 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 36.2 tt0 -79.35 90.91 5.01 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.48 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -70.74 129.4 39.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.254 -1.794 . . . . 0.0 108.052 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -129.53 69.14 1.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.414 1.102 . . . . 0.0 108.859 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -81.87 126.89 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.387 -1.733 . . . . 0.0 107.488 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 72.1 t -98.5 133.51 40.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -154.05 171.75 18.59 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.495 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -91.1 114.07 60.34 Favored Pre-proline 0 N--CA 1.494 1.742 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.228 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -62.5 -50.71 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.847 2.365 . . . . 0.0 111.313 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -60.06 -26.89 66.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.279 -1.328 . . . . 0.0 113.287 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 57' ' ' LEU . 4.6 tp -88.16 -36.38 16.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.407 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.28 162.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.782 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.1 m -132.0 106.62 8.14 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.9 t -76.36 -15.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.94 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.72 -32.74 73.57 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -71.0 -45.3 64.24 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.2 tpt -58.95 -31.68 68.94 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.787 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -76.02 -30.89 58.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.163 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -59.95 -31.55 69.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.251 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.03 -38.13 75.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.415 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 69.4 mt -66.88 -30.21 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.96 -22.11 33.85 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.276 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.31 -37.39 44.77 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 124.195 0.934 . . . . 0.0 109.28 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.6 ptm -72.59 -13.62 61.43 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.254 0.971 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.35 8.89 3.86 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -118.71 71.29 10.07 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 118.289 1.044 . . . . 0.0 110.325 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -47.69 130.55 18.86 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.184 1.923 . . . . 0.0 110.523 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -112.64 123.05 49.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.471 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -66.48 -3.01 5.29 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.954 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 N--CA 1.508 2.435 0 O-C-N 123.899 0.749 . . . . 0.0 111.782 179.772 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.94 136.64 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.782 -2.008 . . . . 0.0 109.65 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.89 51.85 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 122.644 1.211 . . . . 0.0 109.111 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.5 mt -71.34 151.84 43.77 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.774 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -117.59 149.56 40.45 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.754 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.0 141.74 51.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.8 ttmt -127.97 84.16 2.22 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.2 t -62.99 170.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.459 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 34.0 tt0 -112.45 143.05 44.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.84 23.34 3.1 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.397 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.484 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 17.3 ttm . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.322 0.582 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.2 p -69.56 -6.98 34.49 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.725 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.8 m -57.49 -33.28 67.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.045 0.45 . . . . 0.0 109.909 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -67.79 -39.4 84.03 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.111 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.9 mt -52.66 -35.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.325 1.016 . . . . 0.0 111.699 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -49.84 -72.09 0.06 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.419 1.074 . . . . 0.0 112.162 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.74 -21.75 77.99 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.376 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -63.87 -40.57 96.85 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.8 -23.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.438 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.59 -12.23 83.89 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -91.88 -0.91 57.52 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.683 -0.759 . . . . 0.0 112.01 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 63' ' ' MET . 89.5 mt -73.26 126.06 29.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -85.58 140.58 30.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.135 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.71 1.54 85.25 Favored Glycine 0 N--CA 1.491 2.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.899 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.47 144.52 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -96.1 -82.85 0.38 Allowed 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.481 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.639 1.212 . . . . 0.0 109.881 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.656 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 10.7 tt -154.06 122.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.79 162.87 39.44 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.46 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.6 t -137.54 133.47 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 124.491 1.119 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 69.2 m -100.12 148.81 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.664 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.65 3.85 0.47 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -86.62 68.66 10.22 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.25 69.84 0.69 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.53 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 40.44 50.94 2.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.423 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 43' ' ' SER . 35.8 tt0 -76.74 85.23 3.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.79 128.13 34.68 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 112.675 -2.057 . . . . 0.0 113.793 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -118.58 72.26 0.87 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.834 0.709 . . . . 0.0 109.515 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.9 mp -72.79 139.07 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.368 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.1 t -115.83 132.15 66.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -151.72 163.43 39.16 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.521 1.138 . . . . 0.0 113.089 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -62.87 149.96 88.7 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.157 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.37 -4.04 14.78 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.986 2.457 . . . . 0.0 114.404 -153.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -160.53 27.42 0.16 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.85 -47.26 9.85 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.519 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.33 161.77 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 124.155 0.909 . . . . 0.0 111.47 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -104.28 113.67 27.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.479 1.112 . . . . 0.0 110.974 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.5 t -71.24 -25.19 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.981 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.3 -24.5 65.02 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.523 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -70.49 -41.46 72.66 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.49 -38.58 91.66 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 2.9 mmmp? -62.83 -33.06 74.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.584 1.177 . . . . 0.0 109.864 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.77 -43.44 98.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -65.54 -36.7 84.56 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 124.275 0.985 . . . . 0.0 109.158 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.41 -32.74 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.9 -20.61 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.913 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.55 -36.76 32.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.043 0.84 . . . . 0.0 109.738 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.493 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 1.9 ppp? -77.03 -12.01 59.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.33 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.19 23.31 1.78 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 117.804 1.882 . . . . 0.0 117.804 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' SD ' ' A' ' 70' ' ' MET . 9.3 m-85 -131.84 83.22 57.84 Favored Pre-proline 0 N--CA 1.494 1.756 0 CA-C-N 117.58 0.69 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -47.49 134.49 20.97 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 122.026 1.817 . . . . 0.0 108.738 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.98 114.99 18.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.69 1.244 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -85.67 71.12 10.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 111.744 -2.48 . . . . 0.0 108.499 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.498 1.975 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.97 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.12 0.486 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 9' ' ' VAL . 4.8 m -88.99 110.94 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.881 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.47 143.93 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.37 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 70.9 mt -127.99 152.73 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.903 0.752 . . . . 0.0 109.495 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' SD ' ' A' ' 13' ' ' MET . 63.6 tttm -147.96 109.25 4.32 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 2.9 mpp? -127.38 141.06 51.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.619 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' A' ' 14' ' ' LYS . 6.1 ttpm? -112.51 105.68 13.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.761 1.288 . . . . 0.0 109.033 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.2 t -70.05 160.52 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 18' ' ' MET . 33.0 tt0 -90.58 108.21 19.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.99 -14.0 22.13 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.846 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.436 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 53.7 tpp . . . . . 0 N--CA 1.497 1.924 0 C-N-CA 123.984 0.914 . . . . 0.0 110.732 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.1 p -80.69 -7.93 59.48 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.9 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.6 t -59.67 -38.83 82.58 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -71.58 -33.88 69.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.85 -36.38 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.169 0.918 . . . . 0.0 110.49 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.06 -64.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.909 0.755 . . . . 0.0 111.319 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.28 -27.15 71.18 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.058 -1.428 . . . . 0.0 113.09 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.49 -40.55 80.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.39 -29.05 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.49 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.34 -13.85 77.02 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.07 -4.93 58.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.485 -0.858 . . . . 0.0 112.282 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.405 HD21 ' SD ' ' A' ' 63' ' ' MET . 35.5 mt -73.53 119.35 17.64 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.34 138.12 33.67 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.061 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.36 77.52 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.56 126.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -87.34 -75.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.623 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 4.6 tpm_? -97.48 156.22 16.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.623 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.6 tt -153.27 115.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.43 114.37 3.0 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 34.8 t -108.46 147.56 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.408 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -88.77 -178.21 5.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -104.2 179.57 4.23 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.861 -1.518 . . . . 0.0 108.408 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 56.71 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 124.304 1.003 . . . . 0.0 111.269 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -80.78 12.38 3.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 123.421 0.45 . . . . 0.0 109.997 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 35.24 50.31 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 124.395 1.06 . . . . 0.0 111.517 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.78 92.74 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.234 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -75.55 131.55 40.11 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.357 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.6 m -135.98 70.02 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.036 0.922 . . . . 0.0 108.67 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -82.42 150.31 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.798 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 93.4 t -125.05 149.34 29.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 9' ' ' VAL . 6.8 p90 -162.07 161.22 28.22 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 123.997 0.81 . . . . 0.0 108.885 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.89 159.55 75.96 Favored Pre-proline 0 N--CA 1.499 1.985 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.421 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -83.6 42.2 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.495 2.13 . . . . 0.0 114.217 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -159.78 -4.53 0.07 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 118.734 2.865 . . . . 0.0 118.734 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -89.1 -55.78 3.54 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 120.349 1.431 . . . . 0.0 109.54 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -164.29 161.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -88.13 110.07 20.38 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.881 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -66.56 -29.24 45.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.741 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.27 -23.36 64.06 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.534 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -70.92 -43.47 68.17 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.405 ' SD ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -66.25 -29.4 69.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 124.359 1.037 . . . . 0.0 110.524 179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -72.29 -28.36 63.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -69.85 -28.33 65.59 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.612 0.57 . . . . 0.0 110.066 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.57 -39.07 92.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 123.844 0.715 . . . . 0.0 109.094 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.25 -30.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.674 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.99 -24.52 24.65 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.023 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.97 -37.4 61.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 124.255 0.972 . . . . 0.0 109.356 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.23 -11.93 60.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.547 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.68 -3.88 8.65 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 1.9 m-30 -107.59 91.32 7.07 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 119.051 1.425 . . . . 0.0 109.272 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -50.74 132.21 35.89 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.71 1.607 . . . . 0.0 110.085 171.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -115.27 95.58 5.25 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.275 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.45 96.97 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 111.37 -2.65 . . . . 0.0 110.7 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.244 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.503 2.224 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.97 146.92 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.07 56.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.359 1.037 . . . . 0.0 109.825 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.8 mt -67.48 146.83 53.59 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HD3' HG23 ' A' ' 50' ' ' THR . 58.3 mmtt -106.91 136.47 46.7 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 3.5 mpp? -136.0 135.97 39.94 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 62.4 tttm -112.65 151.3 30.31 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.525 ' CG2' ' HZ1' ' A' ' 64' ' ' LYS . 2.1 t -131.36 167.48 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 124.579 1.174 . . . . 0.0 111.662 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 18' ' ' MET . 13.0 tp10 -94.43 133.55 37.91 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.73 19.38 9.42 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.662 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.449 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 52.1 ttp . . . . . 0 N--CA 1.501 2.107 0 O-C-N 125.102 1.119 . . . . 0.0 113.059 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 120.843 0.354 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -63.13 -15.25 56.14 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.546 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -53.14 -35.87 60.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 123.868 0.73 . . . . 0.0 109.751 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 p -73.79 -41.8 61.88 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.976 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.78 -36.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 124.292 0.995 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.22 -66.38 0.4 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.641 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.3 -12.15 84.61 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 114.002 -1.454 . . . . 0.0 115.033 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -84.45 -58.39 2.76 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -27.04 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.438 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.54 -12.05 80.89 Favored Glycine 0 N--CA 1.486 2.019 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.668 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.29 -7.81 57.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.191 0.519 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' A' ' 37' ' ' VAL . 35.2 mt -58.05 141.32 50.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.18 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -77.18 145.01 37.92 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.746 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.94 9.13 85.26 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.167 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 34' ' ' LEU . 18.8 t -79.75 133.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 124.263 0.625 . . . . 0.0 109.879 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -95.6 -82.13 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.635 -1.62 . . . . 0.0 107.609 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.0 tpp180 -98.49 164.87 12.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.445 1.09 . . . . 0.0 111.629 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 tt -147.47 117.74 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -142.53 74.4 1.44 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.802 1.287 . . . . 0.0 109.423 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 40.1 t -83.21 142.75 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.327 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.0 t -86.15 -179.6 6.76 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.506 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.7 179.83 4.16 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.762 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 55.36 -90.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 124.232 0.957 . . . . 0.0 110.776 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.2 16.98 0.85 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.317 0.386 . . . . 0.0 110.623 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 29.07 54.11 0.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.459 1.104 . . . . 0.0 112.947 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.4 tt0 -67.48 93.93 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.658 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -76.53 130.45 37.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.28 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' HD3' ' A' ' 12' ' ' LYS . 98.1 m -136.23 63.3 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.1 mp -72.22 135.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-N 113.879 -1.51 . . . . 0.0 108.476 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 90.8 t -102.02 135.24 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.94 162.77 40.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 124.816 1.323 . . . . 0.0 112.285 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -63.62 147.05 96.21 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.91 4.43 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.126 2.551 . . . . 0.0 114.462 -152.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -160.74 23.75 0.14 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.55 -45.74 13.2 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 59' ' ' SER . 8.3 tp -161.4 171.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.243 0.964 . . . . 0.0 110.707 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.475 ' N ' HG13 ' A' ' 58' ' ' ILE . 36.4 p -107.94 111.1 23.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.824 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.07 -28.17 29.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.313 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.45 -20.79 65.87 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.653 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.97 -43.06 65.77 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 mmt -64.13 -30.49 71.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.476 1.11 . . . . 0.0 109.562 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.525 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 3.0 mmmp? -64.02 -33.32 75.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.251 0.969 . . . . 0.0 109.119 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -65.26 -33.46 76.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.272 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -69.08 -39.06 79.27 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -66.48 -28.71 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.067 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.87 -22.6 25.65 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.088 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.5 47.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 123.993 0.808 . . . . 0.0 109.567 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -12.79 60.34 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.434 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.02 -4.81 6.42 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 118.899 2.319 . . . . 0.0 118.899 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -104.77 95.68 9.28 Favored Pre-proline 0 N--CA 1.504 2.251 0 CA-C-N 119.365 1.582 . . . . 0.0 110.494 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -51.13 134.04 42.64 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.403 1.402 . . . . 0.0 109.5 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -118.77 129.32 55.18 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.229 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.05 63.29 4.38 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 113.629 -1.623 . . . . 0.0 111.109 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.81 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HB3' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.088 0.47 . . . . 0.0 111.699 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.81 137.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.857 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.48 75.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.56 -20.8 65.04 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 50.52 94.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 13' ' ' MET . 2.9 mpp? -100.55 135.44 41.98 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.778 -1.555 . . . . 0.0 106.949 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -126.11 86.56 2.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 124.724 1.265 . . . . 0.0 107.712 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.19 165.64 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.638 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.4 tt0 -113.15 128.48 56.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.12 30.15 2.71 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.43 ' H ' ' C ' ' A' ' 16' ' ' GLU . 58.7 ttm . . . . . 0 N--CA 1.495 1.813 0 C-N-CA 123.228 0.611 . . . . 0.0 110.207 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -75.51 -1.29 23.56 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.442 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -69.15 -27.81 65.87 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.3 p -66.33 -35.31 80.04 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.25 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.22 -33.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 124.819 1.324 . . . . 0.0 110.82 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -48.85 -73.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.803 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.29 -21.9 66.34 Favored Glycine 0 N--CA 1.497 2.755 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.564 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -64.2 -34.06 77.21 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.367 0.603 . . . . 0.0 109.729 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.8 -21.98 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.958 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.83 -14.62 80.66 Favored Glycine 0 N--CA 1.487 2.088 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.738 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.82 1.98 56.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 124.208 0.593 . . . . 0.0 111.714 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.89 102.18 5.45 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.592 0.71 . . . . 0.0 112.855 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -75.6 119.73 20.04 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.57 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.88 9.26 12.52 Favored Glycine 0 N--CA 1.485 1.903 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.52 138.22 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.453 HE21 ' HG2' ' A' ' 54' ' ' GLN . 6.5 mt-30 -95.13 -77.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -96.84 153.4 17.91 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.16 118.26 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.829 -0.749 . . . . 0.0 112.439 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.27 161.27 21.83 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.08 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.99 134.56 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.604 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -104.18 176.18 5.24 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.882 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 44' ' ' LEU . 7.1 mp -70.98 -150.37 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.512 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 53.41 58.03 5.6 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.976 0.893 . . . . 0.0 108.995 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 51.21 81.98 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.71 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 36.5 61.94 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.789 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.44 85.48 6.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -67.37 136.84 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 113.01 -1.905 . . . . 0.0 111.034 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.4 m -135.36 52.89 2.0 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -73.94 125.44 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.28 138.66 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.35 177.46 10.56 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 114.239 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.54 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 46.1 mt-30 -88.18 121.79 70.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 113.55 -1.659 . . . . 0.0 106.725 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -68.46 -54.96 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.275 1.983 . . . . 0.0 109.395 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 54' ' ' GLN . 24.7 p80 -52.54 -26.02 12.03 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.86 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 tp -93.96 -47.61 6.63 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.17 168.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -132.14 111.25 11.29 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.438 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.02 -24.63 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.812 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.45 -18.94 54.53 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.719 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.96 -43.92 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -29.82 70.97 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.206 0.941 . . . . 0.0 109.727 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -64.04 -33.95 76.92 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.21 -32.0 73.29 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.504 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -69.65 -39.47 77.07 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 72' ' ' PHE . 94.5 mt -67.71 -28.44 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.842 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.901 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.5 -37.42 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 124.09 0.869 . . . . 0.0 109.271 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -12.7 60.45 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.653 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.89 -2.46 6.88 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.6 m-30 -107.88 91.78 8.11 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 118.744 1.272 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -47.16 134.76 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.041 1.828 . . . . 0.0 110.446 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.33 109.39 14.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 124.652 1.22 . . . . 0.0 108.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.29 79.64 7.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.175 -2.284 . . . . 0.0 108.878 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.494 1.773 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.964 -179.914 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.505 2.303 0 CA-C-O 121.001 0.429 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.32 130.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.68 91.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.977 0.894 . . . . 0.0 110.294 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.27 139.3 30.86 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -130.14 103.23 6.62 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.324 1.64 . . . . 0.0 106.87 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.573 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 50.6 mtp -104.87 145.44 30.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.54 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 39.4 ttpt -119.7 87.79 2.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.287 0.992 . . . . 0.0 111.55 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.37 164.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 3.1 mp0 -116.67 154.83 29.87 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.222 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 18.12 5.23 Favored Glycine 0 N--CA 1.484 1.858 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.572 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 N--CA 1.501 2.084 0 O-C-N 125.508 1.357 . . . . 0.0 109.285 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -72.94 -4.69 33.7 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.1 t -62.81 -37.4 86.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -66.62 -35.28 79.79 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.5 mt -57.03 -39.37 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 124.197 0.936 . . . . 0.0 111.502 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -51.42 -67.98 0.21 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.791 0.682 . . . . 0.0 112.585 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.21 -23.39 78.13 Favored Glycine 0 N--CA 1.496 2.664 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.635 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.3 -50.26 41.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.408 HG13 ' HZ3' ' A' ' 64' ' ' LYS . 43.6 mm -70.44 -27.52 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.604 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.08 -12.21 83.55 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.2 1.57 54.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 124.337 0.669 . . . . 0.0 111.401 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.4 mt -74.78 131.36 40.74 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.836 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -83.05 160.23 21.98 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 124.147 0.904 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.46 11.03 71.6 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.49 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.07 146.99 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -95.86 -83.93 0.36 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.588 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 3.2 tpm_? -98.33 160.87 14.01 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.1 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.588 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -158.47 107.93 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HZ3' HH11 ' A' ' 39' ' ' ARG . 0.1 OUTLIER -137.65 160.01 40.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.597 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -139.68 149.68 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 124.183 0.927 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 33.5 t -110.47 140.49 44.67 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.082 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tt -50.39 -35.15 26.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.73 1.269 . . . . 0.0 110.247 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -53.57 85.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.465 1.103 . . . . 0.0 111.373 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 41.57 60.5 2.12 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.962 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 42.18 48.68 4.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.526 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 35.3 tt0 -74.68 89.97 2.28 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -80.75 146.02 31.22 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 112.094 -2.321 . . . . 0.0 114.519 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.4 m -138.77 78.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -88.74 136.24 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.066 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.3 t -107.91 135.21 47.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -154.98 172.35 18.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -90.05 116.99 67.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.17 -53.72 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.698 2.265 . . . . 0.0 110.129 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -57.73 -26.27 61.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.363 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.97 -38.15 14.68 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.791 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.66 159.88 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.377 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -129.3 95.93 4.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.91 -26.28 40.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 112.173 -2.285 . . . . 0.0 110.567 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.8 -35.14 70.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.174 0.921 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.16 -41.56 94.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.6 mmm -70.44 -27.35 64.18 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.51 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.573 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 71.8 mmtt -80.95 -18.61 46.46 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.506 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.46 -31.37 68.49 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -64.87 -35.39 80.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.002 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 72' ' ' PHE . 80.6 mt -64.72 -34.68 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -81.29 -20.32 41.08 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.581 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.55 36.52 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 ptm -75.56 -11.14 59.96 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.141 0.901 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.38 17.66 3.92 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' HB2' HG22 ' A' ' 67' ' ' ILE . 17.0 m-85 -123.05 82.57 50.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -51.25 141.75 38.57 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.097 1.864 . . . . 0.0 108.337 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -126.33 125.44 42.28 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.331 1.02 . . . . 0.0 108.927 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -82.63 83.38 7.65 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.19 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.496 1.86 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.729 -179.938 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 N--CA 1.504 2.264 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.77 146.43 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.963 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.45 55.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.151 -1.386 . . . . 0.0 107.774 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.39 145.54 47.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.276 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 121.16 37.41 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.48 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.2 mpp? -126.19 132.4 51.78 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 87.8 tttt -119.11 90.53 3.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.686 1.241 . . . . 0.0 111.496 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -61.63 164.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.551 -1.659 . . . . 0.0 114.016 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 18' ' ' MET . 24.1 tt0 -90.96 110.52 21.78 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.14 -19.98 26.15 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.544 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.451 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 60.7 ttm . . . . . 0 N--CA 1.497 1.925 0 O-C-N 124.865 0.98 . . . . 0.0 111.919 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -65.91 -10.71 41.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.437 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.2 t -59.4 -35.02 73.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -75.13 -37.42 61.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.192 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.0 mt -61.58 -30.16 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 124.262 0.976 . . . . 0.0 109.836 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.08 -67.15 0.3 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.528 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.08 -10.14 84.09 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.771 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -80.68 -56.19 4.32 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.98 -30.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.352 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 -17.82 79.93 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 123.596 0.56 . . . . 0.0 111.902 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.56 -6.75 51.9 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.38 120.31 12.58 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -75.19 148.63 39.39 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.266 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.65 14.92 80.51 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 123.783 0.677 . . . . 0.0 111.831 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.3 128.7 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.189 0.519 . . . . 0.0 111.001 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.2 mm100 -87.45 -77.78 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.328 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.584 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 2.4 tpm_? -97.29 161.18 13.92 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.574 1.171 . . . . 0.0 110.039 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.571 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 8.6 tt -158.03 93.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -112.83 81.67 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.606 1.193 . . . . 0.0 110.434 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 98.0 t -84.62 133.0 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.984 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 26.6 t -81.32 166.58 20.36 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.742 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.33 -27.51 12.79 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.458 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -53.15 -68.48 0.17 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.063 0.852 . . . . 0.0 112.19 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.85 52.0 1.61 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 36.26 48.28 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.647 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 45.0 tt0 -73.2 91.87 1.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -83.79 125.65 32.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.535 -2.12 . . . . 0.0 112.068 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -130.99 68.48 1.49 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.817 1.294 . . . . 0.0 107.578 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -74.41 142.85 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.452 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 70.1 t -112.12 135.17 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -167.06 159.54 13.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.509 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.409 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 2.5 pm0 -87.3 140.59 32.27 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 124.773 1.296 . . . . 0.0 108.887 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.58 -54.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.842 2.361 . . . . 0.0 113.782 -151.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.528 ' CD2' HD22 ' A' ' 57' ' ' LEU . 38.2 p-80 -61.66 -3.17 0.98 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.6 mm? -79.16 -52.33 8.31 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.2 tt -171.04 163.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.318 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.6 m -108.81 110.55 21.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.95 -23.03 25.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.445 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.89 -29.14 68.96 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.692 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.27 -39.18 75.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.84 63.85 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.203 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.85 -19.81 21.32 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.1 -43.88 85.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.015 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -65.06 -29.24 70.11 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.136 0.897 . . . . 0.0 109.604 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -69.72 -33.61 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.02 -17.53 46.49 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.25 -37.56 28.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 124.42 1.075 . . . . 0.0 109.218 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -72.58 -14.12 61.55 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 124.051 0.845 . . . . 0.0 111.438 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.3 9.71 5.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 116.464 1.346 . . . . 0.0 116.464 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -113.92 78.31 4.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -50.55 135.85 40.87 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.272 1.982 . . . . 0.0 108.814 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.12 138.21 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.663 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 35.6 m-85 -86.98 70.87 10.33 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 N--CA 1.488 1.448 0 CA-C-N 112.258 -2.247 . . . . 0.0 111.969 -179.761 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.007 0.432 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 53' ' ' TYR . 2.6 m -142.2 105.02 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.992 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -83.79 58.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.705 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.61 147.15 32.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.615 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.61 142.67 43.62 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.987 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.7 mpp? -132.02 137.02 47.67 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -121.84 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.41 1.069 . . . . 0.0 113.38 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -58.68 167.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 29.9 tt0 -94.58 123.36 37.97 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.13 27.36 2.36 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 121.29 -0.481 . . . . 0.0 111.968 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' GLU . 47.4 tpp . . . . . 0 N--CA 1.49 1.531 0 C-N-CA 123.671 0.788 . . . . 0.0 109.168 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 120.809 0.337 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -62.3 -12.77 22.69 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -58.68 -41.65 86.7 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.4 p -73.06 -31.46 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.459 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.92 -26.6 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.496 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -49.78 -59.96 3.34 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.438 0.637 . . . . 0.0 109.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.23 -23.76 71.68 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -68.66 -49.19 61.09 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.43 -35.77 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 113.325 -1.762 . . . . 0.0 110.276 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.38 -19.91 79.73 Favored Glycine 0 N--CA 1.485 1.936 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.168 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -94.6 -4.48 47.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.44 136.32 53.94 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -88.93 139.54 30.35 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.922 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.16 7.11 88.83 Favored Glycine 0 N--CA 1.489 2.227 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.681 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.28 131.9 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-O 121.509 0.671 . . . . 0.0 110.919 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -95.4 -76.88 0.48 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.33 -1.759 . . . . 0.0 108.784 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -97.03 170.77 8.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.062 0.851 . . . . 0.0 110.382 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.87 129.17 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 123.891 0.744 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.495 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -156.01 92.1 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.215 1.007 . . . . 0.0 109.111 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.1 138.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.049 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 22.7 t -86.17 175.67 8.38 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.444 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 44' ' ' LEU . 7.3 mp -95.93 176.6 6.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.522 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.68 -87.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.509 1.131 . . . . 0.0 112.912 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.52 12.86 2.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.371 0.419 . . . . 0.0 111.341 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 36.85 60.42 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.377 1.048 . . . . 0.0 112.62 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 43' ' ' SER . 35.0 tt0 -73.8 87.33 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -73.64 128.91 36.81 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -132.32 56.92 1.81 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.234 1.016 . . . . 0.0 108.715 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.5 mp -69.07 142.24 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.427 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.7 t -107.01 140.06 26.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 9' ' ' VAL . 39.3 p90 -155.77 163.32 39.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.398 1.061 . . . . 0.0 112.463 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -86.36 114.04 55.53 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.51 -32.55 70.33 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.486 2.124 . . . . 0.0 112.417 -162.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -60.97 -19.27 60.79 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -81.13 -55.18 4.93 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.574 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -175.03 161.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 125.013 1.446 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -94.56 118.55 31.86 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.81 -18.26 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.83 -36.68 84.02 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -40.58 83.32 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -69.56 -16.35 63.4 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.614 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 64' ' ' LYS . 3.8 mmmp? -97.3 -15.39 20.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -67.08 -37.05 83.31 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.354 0.409 . . . . 0.0 111.727 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -62.43 -36.74 83.33 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.726 0.642 . . . . 0.0 109.594 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -64.04 -34.55 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.2 -21.45 46.3 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.053 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.38 44.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.167 0.917 . . . . 0.0 109.625 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.2 ptm -74.87 -12.06 60.28 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.749 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.07 19.62 2.91 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 117.316 1.686 . . . . 0.0 117.316 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -124.63 70.93 57.82 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.07 133.7 41.54 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 122.236 1.958 . . . . 0.0 109.25 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -114.73 121.47 43.44 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.648 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -78.55 79.87 4.95 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.082 -2.326 . . . . 0.0 108.644 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.496 1.834 0 CA-C-N 113.483 -1.689 . . . . 0.0 109.948 -179.808 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.318 0.58 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.15 132.6 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.98 109.48 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.963 0.789 . . . . 0.0 108.921 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.28 156.07 32.0 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.535 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -130.01 109.11 10.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.709 1.256 . . . . 0.0 111.017 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mpp? -90.23 146.52 24.18 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -119.28 89.26 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 123.929 0.768 . . . . 0.0 112.731 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.0 t -72.57 167.34 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.807 0.813 . . . . 0.0 110.929 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.7 tt0 -110.34 107.6 17.38 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.85 5.83 0.77 Allowed Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.099 0.874 . . . . 0.0 115.026 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.489 1.512 0 O-C-N 124.094 0.526 . . . . 0.0 110.031 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.4 m . . . . . 0 N--CA 1.502 2.173 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -75.13 -6.38 49.28 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 p -58.6 -38.89 78.93 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 109.811 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.226 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.41 -49.16 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.199 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -41.79 -61.32 1.13 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.598 1.186 . . . . 0.0 113.679 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.72 -31.89 76.99 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.134 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -73.89 -35.58 64.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.1 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.444 HG21 HG12 ' A' ' 51' ' ' ILE . 44.0 mt -70.25 -31.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.305 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.58 -18.76 77.39 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.87 -8.57 58.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.66 -0.77 . . . . 0.0 111.968 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.32 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -82.66 138.72 34.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.89 -0.58 76.59 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.259 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.9 t -84.27 144.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -96.19 -85.23 0.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.456 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 20.8 tpp85 -98.29 166.13 11.54 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.087 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.33 108.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -152.85 126.82 9.01 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.43 156.44 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.249 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 38.7 t -115.64 146.4 41.84 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.814 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 44' ' ' LEU . 8.0 mp -60.03 -8.13 2.17 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.19 77.49 4.69 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.731 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 51.47 66.04 1.31 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.677 0.751 . . . . 0.0 109.816 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 42.7 tp60 42.92 50.65 5.27 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.745 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 37.1 tt0 -74.78 84.64 2.16 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -69.63 144.34 52.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.722 -2.035 . . . . 0.0 112.481 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -141.46 64.95 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -80.5 135.02 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.039 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 82.7 t -104.71 138.56 28.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 103.509 -2.774 . . . . 0.0 103.509 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -150.18 171.31 17.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 124.351 1.032 . . . . 0.0 113.007 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -88.37 145.02 34.82 Favored Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.989 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -70.76 -67.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.796 2.331 . . . . 0.0 112.692 -158.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.446 ' CD2' HD22 ' A' ' 57' ' ' LEU . 26.9 p-80 -74.47 12.6 0.75 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -88.05 -60.95 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 tt -175.47 160.91 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 124.907 1.38 . . . . 0.0 110.21 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.9 p -103.89 119.18 38.38 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.237 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.83 -14.87 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.138 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.12 -14.78 26.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -68.06 -43.14 79.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.475 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 3.9 mmt -59.17 -40.07 84.5 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.176 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.82 67.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.704 1.252 . . . . 0.0 110.228 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -65.02 -46.4 81.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.24 -34.4 77.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.22 -32.97 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.85 -18.4 47.49 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.873 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.23 -37.58 32.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.061 0.851 . . . . 0.0 109.117 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptm -74.09 -12.29 60.56 Favored 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.068 0.855 . . . . 0.0 111.623 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.89 22.92 3.45 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HB3' HG13 ' A' ' 15' ' ' VAL . 19.4 m-85 -125.22 81.58 63.28 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -47.73 131.78 20.53 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.239 1.959 . . . . 0.0 110.116 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.3 117.19 26.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.915 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -83.78 69.5 10.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 112.228 -2.26 . . . . 0.0 108.942 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.338 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.324 0.583 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.5 m -70.2 121.77 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.7 m -90.17 65.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.18 116.98 6.5 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 130.69 41.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.9 mtp -125.53 135.71 52.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 86.0 tttt -121.47 92.55 3.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.219 0.949 . . . . 0.0 112.587 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.29 167.26 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.212 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.2 tt0 -108.31 115.59 30.39 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 102.584 -3.117 . . . . 0.0 102.584 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.95 8.43 0.39 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.896 0.379 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -69.78 -2.9 13.34 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.508 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.1 m -64.1 -34.27 77.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -65.49 -32.93 74.79 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.613 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 30' ' ' LYS . 62.9 mt -57.43 -33.93 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 124.336 1.023 . . . . 0.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.45 -68.03 0.22 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 123.867 0.73 . . . . 0.0 111.777 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -23.04 75.71 Favored Glycine 0 N--CA 1.495 2.631 0 CA-C-N 114.466 -1.243 . . . . 0.0 115.431 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 27' ' ' ILE . 6.7 ttpm? -69.71 -49.87 49.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -74.04 -27.17 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.556 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.35 -17.3 80.07 Favored Glycine 0 N--CA 1.487 2.055 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.47 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -86.4 -4.83 59.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.247 0.616 . . . . 0.0 111.614 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 37' ' ' VAL . 95.9 mt -69.33 126.68 30.53 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.853 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -74.5 145.04 43.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.219 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.94 13.67 82.36 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.346 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' LEU . 38.7 t -87.2 135.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 124.258 0.622 . . . . 0.0 109.581 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -95.46 -79.27 0.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.594 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.562 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.9 tpm_? -97.99 163.23 12.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.449 1.093 . . . . 0.0 110.029 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.562 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 11.7 tt -157.25 95.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -105.17 156.03 18.48 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.224 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 50.6 t -144.54 133.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 124.52 1.138 . . . . 0.0 107.957 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -112.3 138.06 49.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.288 0.992 . . . . 0.0 108.961 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.3 mt -58.22 -19.19 31.85 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.771 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.34 87.98 0.63 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.149 0.906 . . . . 0.0 108.685 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.46 50.99 17.73 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.351 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 39.52 47.55 1.63 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.093 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 41.3 tt0 -72.82 95.28 1.9 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -89.33 126.77 35.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.045 -1.889 . . . . 0.0 114.074 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.1 m -111.59 92.44 4.03 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.337 1.023 . . . . 0.0 109.199 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -92.19 141.49 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.894 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 60.7 t -122.64 141.91 41.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -161.75 162.67 29.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 124.201 0.938 . . . . 0.0 111.929 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.1 136.18 82.17 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-N 114.057 -1.428 . . . . 0.0 107.82 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.451 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -59.2 155.42 40.16 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.452 2.101 . . . . 0.0 110.953 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.451 ' CG ' ' O ' ' A' ' 55' ' ' PRO . 16.3 p80 52.75 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 117.128 2.269 . . . . 0.0 117.128 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.81 -41.77 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.6 tt -169.5 160.92 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 124.451 1.094 . . . . 0.0 111.391 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.3 p -97.66 108.39 21.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.306 -1.316 . . . . 0.0 109.185 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.22 -27.7 16.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.751 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.43 -18.16 62.34 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -82.28 -42.27 19.05 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.3 tpt -67.77 -34.15 76.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.648 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -78.7 -18.0 55.02 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.995 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -58.88 -29.18 66.82 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.005 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.2 -33.8 76.13 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.441 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 85.8 mt -65.2 -31.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.67 -23.99 39.22 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.663 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.4 -37.89 56.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.069 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.441 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.2 ptm -73.6 -14.12 61.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.891 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.41 5.45 7.2 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.432 ' HB3' HG13 ' A' ' 15' ' ' VAL . 21.2 m-85 -115.84 82.95 11.14 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -49.82 133.47 33.52 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.106 1.871 . . . . 0.0 109.943 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -121.35 115.9 23.81 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.05 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.51 71.38 7.36 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.416 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.848 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.43 0.633 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.5 113.69 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.921 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.25 56.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.69 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 153.4 42.07 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.227 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.84 140.95 48.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.607 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.425 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 29.6 mtm -134.8 138.51 44.32 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -122.93 90.72 3.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.309 1.005 . . . . 0.0 112.351 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -64.27 170.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.999 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.9 tt0 -116.41 107.65 15.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 100.242 -3.984 . . . . 0.0 100.242 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.06 1.33 0.61 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 115.536 0.974 . . . . 0.0 115.536 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 N--CA 1.5 2.045 0 C-N-CA 124.938 1.295 . . . . 0.0 109.066 -179.933 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.4 p -61.83 -10.45 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.3 m -56.4 -35.52 67.85 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.9 p -71.27 -39.38 71.6 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 53.3 mt -57.03 -30.12 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 124.322 1.014 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.96 -63.98 1.01 Allowed 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.937 0.773 . . . . 0.0 109.193 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -9.02 81.95 Favored Glycine 0 N--CA 1.493 2.448 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.485 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -77.98 -55.96 4.87 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.2 mt -70.98 -29.93 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.699 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.14 78.2 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.593 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -95.59 0.29 52.73 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HB2' HG21 ' A' ' 37' ' ' VAL . 57.1 mt -68.69 114.34 6.97 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.207 0.527 . . . . 0.0 112.142 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.59 138.47 44.92 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.244 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.5 13.73 77.77 Favored Glycine 0 N--CA 1.489 2.21 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.759 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 34' ' ' LEU . 40.5 t -91.45 143.68 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -95.93 -83.52 0.37 Allowed 'General case' 0 N--CA 1.485 1.31 0 O-C-N 124.228 0.955 . . . . 0.0 108.712 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 7.7 tpt180 -98.55 164.46 12.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 124.588 1.18 . . . . 0.0 111.36 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.429 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 9.4 tt -146.04 124.37 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -146.07 78.01 1.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.403 1.096 . . . . 0.0 112.216 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 51.9 t -82.84 130.49 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 t -84.56 -178.73 6.97 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.445 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 44' ' ' LEU . 2.6 mm? -100.83 -177.36 3.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.998 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 54.26 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.039 0.837 . . . . 0.0 112.697 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -84.8 11.91 8.32 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.41 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 42.2 tt0 37.97 50.9 1.36 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.236 1.017 . . . . 0.0 109.308 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -67.53 89.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.042 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -78.97 124.65 28.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 112.245 -2.252 . . . . 0.0 110.786 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.0 m -129.78 58.01 1.66 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.642 1.21 . . . . 0.0 108.748 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.9 mp -66.92 140.84 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.839 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 89.8 t -106.11 136.1 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -157.21 167.91 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.48 -1.288 . . . . 0.0 114.12 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -84.12 127.58 66.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.27 -65.46 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.73 2.287 . . . . 0.0 114.014 -157.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.501 ' CD2' HD22 ' A' ' 57' ' ' LEU . 27.0 p-80 -68.95 -0.99 6.3 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.501 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.5 mm? -75.75 -48.14 23.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 tt -166.29 167.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.062 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.5 m -125.21 116.34 21.83 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.92 -17.93 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.377 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.86 -34.8 74.07 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -68.15 -41.41 81.66 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -34.94 79.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.893 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 34.1 mmtm -66.62 -28.34 68.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.254 0.971 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.31 -35.88 81.83 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.066 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -69.57 -38.6 77.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 124.411 1.069 . . . . 0.0 108.177 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 60.8 mt -65.91 -33.11 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 124.764 1.29 . . . . 0.0 108.073 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -82.84 -21.62 34.35 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.559 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.6 -37.53 42.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.053 0.845 . . . . 0.0 109.749 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.477 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 10.1 ptm -76.36 -11.94 59.98 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.08 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.28 17.44 2.69 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 118.31 2.084 . . . . 0.0 118.31 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -125.96 79.8 68.45 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-N 118.169 0.984 . . . . 0.0 109.444 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -47.4 136.81 19.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.6 2.2 . . . . 0.0 109.979 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.83 121.85 35.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.344 1.028 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -84.48 67.99 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.374 -2.194 . . . . 0.0 108.008 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.497 1.895 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.692 -179.909 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -72.97 109.49 6.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 123.892 0.407 . . . . 0.0 110.224 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.4 ptm -60.78 -32.31 71.64 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.161 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.56 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -105.73 79.01 1.39 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.886 0.851 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.45 -56.89 1.87 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.94 -22.14 78.36 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -151.29 177.21 10.48 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.537 -0.831 . . . . 0.0 110.308 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.85 152.69 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.689 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.19 127.12 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 124.082 0.864 . . . . 0.0 111.412 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.74 95.89 4.23 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.915 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -86.63 88.12 7.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.415 ' HB2' ' HZ2' ' A' ' 64' ' ' LYS . 44.4 mtm -90.98 140.14 30.11 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.466 -1.697 . . . . 0.0 106.98 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.6 ttmm -109.99 97.54 7.02 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.832 1.333 . . . . 0.0 114.051 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -63.39 169.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.799 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 31.5 tt0 -112.9 131.23 55.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 100.48 -3.896 . . . . 0.0 100.48 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.46 16.88 1.21 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.856 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.455 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 2.2 ttp 61.68 -78.78 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 124.087 0.955 . . . . 0.0 110.077 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.6 p -133.99 -48.26 0.8 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.2 t -173.16 53.35 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 53.57 68.62 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.518 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 m -53.98 -25.8 22.7 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.606 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.404 ' C ' ' H ' ' A' ' 25' ' ' SER . 75.2 m -145.85 -87.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.348 1.03 . . . . 0.0 109.365 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.5 p 52.58 -8.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 23' ' ' CYS . 50.6 m -77.33 -38.59 50.08 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 102.974 -2.973 . . . . 0.0 102.974 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.6 p -69.13 -33.16 73.03 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.016 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -68.23 -31.38 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.124 0.89 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.94 -58.87 6.24 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.37 -20.74 77.08 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.708 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -70.84 -52.95 17.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -64.9 -34.38 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.254 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.82 -17.56 79.73 Favored Glycine 0 N--CA 1.487 2.08 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.156 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -95.54 1.52 53.9 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.4 mt -71.22 128.73 36.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.205 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -78.74 159.27 28.02 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.38 1.086 . . . . 0.0 112.639 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.62 14.74 70.15 Favored Glycine 0 N--CA 1.488 2.13 0 CA-C-N 112.145 -2.298 . . . . 0.0 110.517 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.77 133.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 114.778 -0.711 . . . . 0.0 111.635 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -93.36 -77.22 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 19.5 tpp85 -96.92 160.24 14.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.75 119.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.558 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -138.95 152.07 47.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -141.37 124.12 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 23.1 t -80.19 179.64 7.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 123.812 0.695 . . . . 0.0 110.714 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.497 ' N ' HD22 ' A' ' 44' ' ' LEU . 2.5 mm? -100.27 173.53 6.56 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.802 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 56.59 -86.47 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 124.293 0.996 . . . . 0.0 112.11 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.25 10.61 4.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.2 0.313 . . . . 0.0 110.634 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 33.87 52.18 0.43 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.356 1.035 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 43.0 tt0 -67.48 95.66 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.629 -1.623 . . . . 0.0 107.849 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -74.03 126.71 31.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.728 -2.033 . . . . 0.0 110.78 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.9 m -126.48 88.25 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.6 mp -110.41 137.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.863 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.1 t -108.46 137.82 38.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.06 157.07 39.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.398 1.061 . . . . 0.0 111.312 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.4 pt20 -78.95 143.22 61.35 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 60.6 Cg_endo -85.71 40.14 0.75 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.019 2.479 . . . . 0.0 113.476 -162.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -151.07 16.06 0.74 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.65 -59.69 1.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.8 tt -165.57 161.24 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.955 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.9 p -98.9 118.79 36.45 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.377 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.8 -18.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.474 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.33 -38.69 85.32 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.788 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.28 -39.03 85.97 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mmt -64.02 -33.49 75.85 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.057 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HZ2' ' HB2' ' A' ' 13' ' ' MET . 27.0 mtpt -80.13 -18.14 50.62 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.646 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.93 -29.73 70.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -71.3 -39.02 71.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 57.8 mt -62.68 -36.2 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -78.64 -27.04 45.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 -37.65 65.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.224 0.953 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -73.73 -15.86 61.2 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.152 0.907 . . . . 0.0 111.671 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.76 10.69 2.52 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 118.064 1.985 . . . . 0.0 118.064 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 18' ' ' MET . 59.9 m-85 -118.92 75.09 13.47 Favored Pre-proline 0 N--CA 1.5 2.06 0 CA-C-N 118.407 1.104 . . . . 0.0 109.718 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -48.9 139.25 25.62 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.825 2.35 . . . . 0.0 111.253 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -122.91 133.24 54.41 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.045 0.926 . . . . 0.0 111.648 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.89 74.81 10.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.372 -2.194 . . . . 0.0 106.785 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.52 137.27 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 113.555 -1.657 . . . . 0.0 111.301 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -74.84 -47.44 30.43 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.501 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.91 94.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.392 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -136.16 65.94 58.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.95 -51.41 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.919 2.413 . . . . 0.0 110.638 -171.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -55.41 -34.57 64.53 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.388 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -78.07 -33.11 51.01 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.565 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 tp -78.14 152.64 32.68 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.177 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m -144.71 -33.09 0.39 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.281 0.636 . . . . 0.0 109.785 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 ptp -157.79 164.07 37.4 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.57 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.44 -178.27 6.57 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.287 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 7.3 pt20 -60.65 -20.25 60.31 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.433 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.24 32.26 18.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 124.172 0.92 . . . . 0.0 112.471 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' H ' ' HG3' ' A' ' 5' ' ' GLN . . . -103.05 25.73 26.31 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' HB3' HE22 ' A' ' 38' ' ' GLN . 0.5 OUTLIER -156.67 157.21 34.79 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.938 -0.631 . . . . 0.0 111.436 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 53' ' ' TYR . 14.3 m -145.55 126.64 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.259 0.975 . . . . 0.0 109.767 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 11' ' ' LEU . 18.3 m -94.48 115.7 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 10' ' ' VAL . 3.1 mm? -114.66 110.49 19.83 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.372 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' C ' ' SD ' ' A' ' 13' ' ' MET . 2.3 mppt? -100.84 130.1 46.81 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 4.9 mpp? -144.25 139.13 28.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 65.1 tttp -105.15 151.53 23.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 125.149 1.53 . . . . 0.0 107.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -127.68 169.6 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 124.205 0.941 . . . . 0.0 110.729 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 18' ' ' MET . 31.5 tt0 -92.37 111.39 22.95 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.37 5.2 5.57 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-O 119.55 -0.583 . . . . 0.0 114.358 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.482 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 52.0 ttp 44.48 101.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -49.82 -27.72 5.43 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.7 t -64.84 -55.52 19.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 123.709 0.63 . . . . 0.0 110.303 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.515 ' CG ' ' H ' ' A' ' 22' ' ' SER . 0.8 OUTLIER -163.88 -121.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.948 0.78 . . . . 0.0 108.904 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 21' ' ' HIS . 55.9 p -176.61 160.35 1.98 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.011 0.434 . . . . 0.0 110.016 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.8 t -146.0 26.93 1.2 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -72.31 -13.54 61.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.369 -1.287 . . . . 0.0 113.379 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 p -55.33 -38.2 68.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.858 0.724 . . . . 0.0 109.476 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -77.12 -37.28 54.45 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.0 mt -61.0 -36.15 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 123.997 0.81 . . . . 0.0 110.882 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.76 -64.98 0.74 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.727 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.22 -18.98 73.68 Favored Glycine 0 N--CA 1.497 2.701 0 CA-C-N 113.593 -1.639 . . . . 0.0 114.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -77.15 -53.89 7.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.415 ' CG2' HG12 ' A' ' 51' ' ' ILE . 57.2 mt -69.84 -23.76 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.679 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.59 -13.79 83.12 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -95.32 2.3 54.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 124.333 0.666 . . . . 0.0 111.692 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.17 130.78 43.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -83.22 146.77 28.4 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.52 12.59 84.22 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.718 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.1 t -93.75 142.19 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.515 HE22 ' HB3' ' A' ' 8' ' ' GLU . 73.8 mt-30 -95.81 -81.97 0.39 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 12.8 tpt180 -97.15 154.81 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.1 115.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -151.88 167.09 29.44 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 57.2 t -136.96 147.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 124.624 1.203 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 37.7 t -104.37 150.21 24.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.887 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -67.31 1.56 2.11 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.091 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -83.39 66.48 8.87 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 m120 54.35 71.93 0.49 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.715 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 38.5 tp60 41.71 47.2 3.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.803 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 39.6 tt0 -79.63 87.65 5.17 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.168 1.461 . . . . 0.0 107.284 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.37 138.67 45.46 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.721 -2.49 . . . . 0.0 114.721 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.2 m -140.5 90.57 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.1 mp -98.64 130.37 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.436 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 39.5 t -106.38 134.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.4 p90 -148.56 171.2 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.199 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.97 145.65 81.42 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 124.095 0.872 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -71.17 0.86 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.46 2.773 . . . . 0.0 115.432 -150.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -154.17 23.46 0.49 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.49 -46.41 9.14 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.474 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.457 HG12 ' H ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -157.95 166.43 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 124.043 0.839 . . . . 0.0 111.482 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.457 ' H ' HG12 ' A' ' 58' ' ' ILE . 58.2 p -117.38 107.4 14.3 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.425 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.56 -26.93 32.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.234 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.21 -27.68 68.61 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.963 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.88 -41.37 78.43 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 mmt -61.84 -32.38 72.71 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.514 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -65.47 -34.71 78.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.976 0.798 . . . . 0.0 109.154 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.55 -34.75 77.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 123.492 0.495 . . . . 0.0 110.539 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -67.9 -38.71 83.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 124.162 0.914 . . . . 0.0 108.843 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 72' ' ' PHE . 83.5 mt -67.61 -28.63 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.236 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -86.52 -22.14 26.54 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.189 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.92 -36.74 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.05 0.843 . . . . 0.0 109.519 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -13.43 60.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.68 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -6.69 5.39 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 118.671 2.229 . . . . 0.0 118.671 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.0 m-30 -106.52 93.68 8.81 Favored Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 119.203 1.502 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -45.31 137.18 10.87 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.972 1.781 . . . . 0.0 109.577 166.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.13 126.35 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.521 1.138 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 39.7 m-85 -85.46 91.18 8.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.37 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.82 149.22 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.806 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.493 ' CG ' ' H ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -32.18 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' H ' ' CG ' ' A' ' 77' ' ' LYS . 6.7 ttpm? 58.61 -81.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -130.15 163.01 50.62 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 123.745 0.653 . . . . 0.0 110.359 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.35 138.55 61.16 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.358 2.039 . . . . 0.0 108.657 163.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -127.99 144.58 51.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.109 0.881 . . . . 0.0 109.714 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -58.57 -58.54 8.09 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.826 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.3 tp -155.41 76.75 0.97 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 N--CA 1.495 1.79 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.545 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -158.03 -51.89 0.07 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.1 mtp 54.7 20.78 3.13 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 124.532 1.145 . . . . 0.0 112.417 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.11 88.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.52 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -78.02 134.31 37.82 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.638 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.5 151.46 42.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.074 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.11 -165.51 13.21 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 123.957 0.786 . . . . 0.0 111.737 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -139.22 178.34 7.25 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.27 -0.965 . . . . 0.0 111.029 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 m -129.84 146.54 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.2 m -128.59 99.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 124.66 1.225 . . . . 0.0 110.067 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 11' ' ' LEU . 5.7 mp -104.81 120.12 40.63 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.051 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 2.3 mppt? -99.86 90.05 4.29 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.892 0.745 . . . . 0.0 109.701 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -82.62 139.65 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -109.42 96.28 6.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.789 1.305 . . . . 0.0 113.728 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.1 t -60.94 159.64 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 18' ' ' MET . 35.1 tt0 -82.59 109.69 17.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.16 -7.79 7.6 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.874 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.481 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 31.0 tpp 63.34 -144.66 0.34 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 18' ' ' MET . 3.8 t -172.83 -40.41 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.9 p -75.5 -61.35 1.94 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.953 0.783 . . . . 0.0 110.618 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -150.43 119.81 6.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 p -96.54 101.54 13.17 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.949 0.781 . . . . 0.0 111.993 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.8 m -85.15 36.84 0.64 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.991 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.1 p -69.71 -0.47 7.03 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -66.01 -31.85 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -64.41 -37.69 88.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.203 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.26 -32.83 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 124.534 1.146 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.96 -70.36 0.17 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.145 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -12.4 66.87 Favored Glycine 0 N--CA 1.497 2.752 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.55 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -82.87 -59.49 2.48 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.906 0.86 . . . . 0.0 108.817 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.01 -2.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.023 -1.898 . . . . 0.0 112.59 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.83 -17.36 19.06 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.804 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -96.85 7.35 46.8 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -82.71 140.5 33.04 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -85.94 161.52 18.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.626 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.07 87.19 Favored Glycine 0 N--CA 1.489 2.168 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 34' ' ' LEU . 71.1 t -111.81 145.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 124.626 0.839 . . . . 0.0 112.756 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -94.76 -83.22 0.35 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.5 tpp85 -98.16 163.17 12.85 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.023 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' C ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -152.05 117.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -153.26 112.7 3.83 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.369 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 44.4 t -93.4 150.53 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.952 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.5 t -109.03 141.32 41.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.581 1.176 . . . . 0.0 110.087 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.4 mm? -56.86 -21.68 31.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 124.35 1.031 . . . . 0.0 110.118 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.19 87.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.659 1.225 . . . . 0.0 108.708 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 52.51 40.25 29.41 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 45.63 47.7 11.44 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.436 1.112 . . . . 0.0 108.584 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.01 92.99 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.363 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -67.26 130.49 43.26 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.482 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.9 m -131.34 92.53 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -97.54 135.65 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.168 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 26.3 t -107.96 137.85 37.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -162.84 166.09 24.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.683 1.24 . . . . 0.0 113.679 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.08 132.55 39.45 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.079 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.18 38.36 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.368 2.712 . . . . 0.0 114.464 -155.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.477 ' CD2' HD22 ' A' ' 57' ' ' LEU . 28.3 p-80 -156.23 18.46 0.35 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -95.91 -56.2 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.445 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.19 164.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.027 0.829 . . . . 0.0 110.619 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -74.14 109.26 7.5 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.495 1.141 . . . . 0.0 110.019 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.62 -26.88 6.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 112.642 -2.072 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.23 -24.49 61.39 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.427 -1.26 . . . . 0.0 107.686 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.84 -38.09 79.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -63.17 -40.52 97.78 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.515 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -78.14 -10.92 59.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 124.279 0.987 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -74.49 -29.71 61.53 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.06 -30.62 71.11 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.381 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.426 HG22 ' HB2' ' A' ' 72' ' ' PHE . 88.0 mt -65.89 -30.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 114.69 -1.141 . . . . 0.0 107.998 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.54 -24.1 36.81 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.695 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.49 -37.36 60.25 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.425 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -74.46 -12.2 60.43 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.737 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 1.59 9.33 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 116.797 1.479 . . . . 0.0 116.797 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.426 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.8 m-85 -112.6 82.58 4.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 117.447 0.624 . . . . 0.0 109.503 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.51 130.12 34.99 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 121.819 1.679 . . . . 0.0 109.755 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -111.54 109.58 19.57 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.847 -1.979 . . . . 0.0 106.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -69.13 89.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 112.109 -2.314 . . . . 0.0 109.608 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 78' ' ' LYS . 61.9 t -74.75 119.84 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -99.88 18.48 18.23 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 123.763 0.664 . . . . 0.0 112.006 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -167.37 122.94 1.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.966 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -172.31 66.31 0.38 Allowed Pre-proline 0 N--CA 1.498 1.966 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.279 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -68.01 177.63 4.18 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.862 2.375 . . . . 0.0 111.452 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -65.19 -62.15 1.71 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -149.43 137.3 20.39 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.271 0.982 . . . . 0.0 109.486 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.43 -31.52 71.46 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.101 0.875 . . . . 0.0 108.768 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 116.567 -1.682 . . . . 0.0 109.802 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.444 ' HA3' HH22 ' A' ' 39' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t 56.76 92.06 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.687 0.874 . . . . 0.0 111.384 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.3 mtm 58.22 -170.7 0.11 Allowed 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.945 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.49 88.36 1.22 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.474 HE22 HH21 ' A' ' 39' ' ' ARG . 25.4 tt0 -64.68 115.38 5.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.454 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.83 -47.44 0.09 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.235 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.23 -99.02 0.07 OUTLIER Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 41.73 -176.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.69 124.07 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.765 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.6 m -100.69 101.82 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.293 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.98 116.89 33.66 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -93.78 111.86 23.62 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.435 ' SD ' HG13 ' A' ' 76' ' ' VAL . 31.9 mtm -114.33 143.77 44.34 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.538 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -120.11 98.04 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.0 t -70.67 168.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.615 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 36.6 tt0 -103.12 127.37 50.41 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.6 21.67 1.92 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.723 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 16' ' ' GLU . 54.3 tpp 58.54 -114.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t 177.15 -43.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.8 t -78.98 -49.73 12.26 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.88 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -166.65 153.21 8.79 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.393 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -114.49 112.05 22.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.115 0.884 . . . . 0.0 110.53 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.4 m -85.82 23.62 1.41 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.954 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -63.69 -12.09 31.38 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.3 t -59.21 -44.39 92.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 p -72.37 -31.07 65.27 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.08 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.494 HG21 HE22 ' A' ' 47' ' ' GLN . 45.4 mt -65.08 -36.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 123.889 0.743 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.11 -51.31 66.8 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -34.5 87.26 Favored Glycine 0 N--CA 1.495 2.591 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.084 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -63.52 -40.31 96.71 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.71 -32.33 44.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.873 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.73 -13.4 82.23 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -94.85 3.48 54.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.562 0.801 . . . . 0.0 110.569 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.28 119.46 24.62 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.15 148.19 32.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.087 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.05 -0.37 87.52 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -82.22 138.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 124.046 0.498 . . . . 0.0 110.227 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -95.63 -78.19 0.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.474 HH21 HE22 ' A' ' 5' ' ' GLN . 8.6 tpp180 -97.84 165.98 11.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.255 0.972 . . . . 0.0 109.856 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.39 111.36 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HB2' ' HB ' ' A' ' 50' ' ' THR . 60.0 mtpt -124.42 69.46 1.09 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.145 0.974 . . . . 0.0 109.637 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.62 112.26 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 113.611 -1.631 . . . . 0.0 106.647 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.485 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 33.1 t -85.79 177.26 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.337 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 44' ' ' LEU . 7.5 mp -96.84 -168.02 1.64 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.98 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.72 -103.96 0.2 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.02 0.825 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -93.49 25.03 3.64 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.494 HE22 HG21 ' A' ' 27' ' ' ILE . 15.2 tt0 32.16 80.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 43' ' ' SER . 83.7 tt0 -75.97 90.38 2.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.62 113.39 13.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.408 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 54.7 m -122.01 78.13 1.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.021 -1.445 . . . . 0.0 107.452 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -90.16 136.5 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.213 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -113.71 140.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.52 162.89 40.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.37 1.044 . . . . 0.0 112.092 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -65.74 144.59 98.92 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.82 7.04 3.36 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.908 2.406 . . . . 0.0 114.294 -157.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -156.96 19.66 0.31 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 3.3 mm? -86.06 -49.57 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.575 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.86 160.14 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 124.254 0.972 . . . . 0.0 110.761 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.8 m -98.8 110.82 23.37 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.76 -18.02 21.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.998 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.74 -32.48 74.0 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.951 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.94 -40.4 87.56 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.8 mmt -63.58 -33.77 76.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.756 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' HD12 ' A' ' 67' ' ' ILE . 14.1 mptt -77.96 -21.83 50.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.1 0.875 . . . . 0.0 109.738 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -66.37 -30.25 70.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -69.01 -40.76 78.49 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.432 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 78.6 mt -64.39 -31.94 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.112 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.58 -21.06 30.54 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.965 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.84 -38.09 46.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.026 0.829 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.3 ptm -74.15 -12.94 60.73 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.051 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 6.76 7.61 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -112.33 88.2 10.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -47.27 133.49 19.54 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 121.971 1.78 . . . . 0.0 109.222 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.88 123.81 33.62 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -82.55 64.46 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.338 -1.755 . . . . 0.0 108.681 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.435 HG13 ' SD ' ' A' ' 13' ' ' MET . 61.4 t -68.42 149.5 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? 71.6 133.19 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt 65.08 165.13 0.16 Allowed 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -127.33 81.15 70.58 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.5 160.28 50.36 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.599 2.2 . . . . 0.0 109.765 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 61.15 165.38 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 124.47 1.106 . . . . 0.0 112.163 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -72.01 -48.0 47.89 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.664 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tt 56.3 -80.3 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 O-C-N 124.84 1.338 . . . . 0.0 111.705 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.449 ' H ' ' HD3' ' A' ' 84' ' ' LYS . 2.4 mppt? . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 116.681 -1.628 . . . . 0.0 110.605 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -145.93 155.04 42.58 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 124.267 0.628 . . . . 0.0 109.881 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.7 mtp 58.6 -174.83 0.09 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 124.334 1.021 . . . . 0.0 112.152 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -149.24 -63.26 0.23 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.559 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -165.44 -60.94 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.014 0.821 . . . . 0.0 109.086 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.53 173.67 0.08 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 124.56 1.163 . . . . 0.0 112.743 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.56 32.8 0.02 OUTLIER Glycine 0 N--CA 1.497 2.713 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.422 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 43.1 177.76 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 m -117.29 153.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.291 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.21 68.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.315 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.27 109.35 1.1 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -81.66 82.86 7.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.499 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 11.0 ttp -80.13 125.55 29.96 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.269 1.033 . . . . 0.0 109.383 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.06 80.39 1.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 111.577 -2.556 . . . . 0.0 106.419 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -66.76 165.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.606 -1.634 . . . . 0.0 111.684 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 18' ' ' MET . 13.0 tp10 -107.49 137.3 45.77 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.9 12.95 3.44 Favored Glycine 0 N--CA 1.49 2.251 0 O-C-N 123.801 0.688 . . . . 0.0 113.708 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.422 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 38.1 ttm 62.76 146.49 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 123.732 0.813 . . . . 0.0 112.432 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.1 p -59.87 -54.58 44.53 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.742 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.1 p -75.09 -75.49 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 123.787 0.679 . . . . 0.0 111.341 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -151.04 146.6 26.31 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 123.64 0.588 . . . . 0.0 109.798 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.7 p -79.14 165.94 22.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 123.866 0.729 . . . . 0.0 111.427 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m -155.25 37.93 0.39 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.5 p -62.88 -7.99 6.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.127 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.4 p -58.59 -34.78 71.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -71.21 -40.53 71.08 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.162 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.88 -35.71 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.913 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.7 -65.85 0.51 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.067 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.61 -22.83 70.13 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.895 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -70.86 -44.83 65.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.42 HG21 HG12 ' A' ' 51' ' ' ILE . 71.7 mt -72.58 -33.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.12 -14.59 71.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -95.45 3.03 54.67 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.101 -1.05 . . . . 0.0 111.622 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.45 116.38 25.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.04 0.447 . . . . 0.0 111.857 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -72.34 150.5 43.43 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.886 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.08 17.75 71.29 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 123.912 0.758 . . . . 0.0 111.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.66 137.48 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.552 HE22 ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -93.26 -81.98 0.35 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.764 1.29 . . . . 0.0 108.068 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 7.0 tpm_? -97.3 162.79 13.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.631 1.207 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.656 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.2 tt -158.45 111.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.647 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 139.74 9.62 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.373 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.2 t -108.03 158.08 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.561 -1.654 . . . . 0.0 112.653 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -135.23 176.52 8.6 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.473 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 44' ' ' LEU . 6.6 mp -67.69 -146.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.274 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 53.04 52.98 12.72 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 55.19 84.41 0.07 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.347 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 31.4 tp60 35.73 57.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.139 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.47 87.97 2.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -85.13 141.3 30.31 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.542 -1.663 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.5 m -135.77 70.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -73.91 138.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.437 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.3 t -114.7 135.79 53.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -163.83 169.6 18.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.668 1.23 . . . . 0.0 112.245 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.552 ' H ' HE22 ' A' ' 38' ' ' GLN . 5.1 pt20 -95.21 122.23 60.27 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 124.389 1.056 . . . . 0.0 108.524 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 -34.92 17.05 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.633 2.222 . . . . 0.0 112.392 -168.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.45 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 6.8 p-80 -57.13 -30.69 64.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -73.44 -47.39 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 tt -170.63 161.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.5 m -112.65 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.894 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.3 -13.8 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.292 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.6 -38.38 77.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.43 -41.42 89.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 mmt -65.47 -26.46 67.94 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.384 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -71.78 -30.0 65.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.311 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -63.61 -32.86 74.47 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -66.81 -39.85 87.87 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.366 1.041 . . . . 0.0 108.894 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.41 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 74.6 mt -65.14 -31.95 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.74 -19.68 30.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.88 41.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.072 0.858 . . . . 0.0 108.91 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.7 ptm -74.04 -12.09 60.52 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.648 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.31 9.11 8.86 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 117.834 1.894 . . . . 0.0 117.834 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.67 91.28 20.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -47.08 131.21 17.23 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.731 1.621 . . . . 0.0 108.788 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.27 104.6 7.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.463 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -85.45 92.3 8.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.431 -2.168 . . . . 0.0 109.113 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 t -85.75 71.77 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.693 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -106.98 80.55 1.44 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.79 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.527 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -69.6 91.26 0.59 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.012 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -138.17 105.94 7.96 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 113.334 -1.757 . . . . 0.0 107.536 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -65.87 -19.02 58.74 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.188 1.925 . . . . 0.0 110.918 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -66.04 -57.85 6.81 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.93 0.769 . . . . 0.0 110.349 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -146.04 103.52 3.75 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 124.047 0.842 . . . . 0.0 111.175 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -168.97 -84.04 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 t 62.0 163.7 0.09 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 124.528 0.781 . . . . 0.0 112.264 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.11 -67.15 0.09 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.07 -24.23 8.14 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.362 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.47 -60.28 3.77 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.775 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.1 -87.22 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.66 1.225 . . . . 0.0 112.916 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.3 124.2 0.42 Allowed Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.428 ' HB3' HE21 ' A' ' 38' ' ' GLN . 9.9 pt-20 -71.91 129.66 39.13 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.58 0.705 . . . . 0.0 111.38 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 11' ' ' LEU . 17.5 m -64.55 125.2 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -94.63 69.56 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.416 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.419 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 3.9 mm? -66.24 117.12 8.07 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.031 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -104.96 105.68 15.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.392 1.058 . . . . 0.0 108.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.489 ' SD ' ' HG2' ' A' ' 64' ' ' LYS . 31.9 mtm -95.46 140.66 30.0 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -126.16 81.96 2.04 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.5 t -70.45 173.57 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.385 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 30.5 tt0 -100.23 111.22 23.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 103.52 -2.771 . . . . 0.0 103.52 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.18 -25.77 48.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.039 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.414 ' O ' ' SD ' ' A' ' 18' ' ' MET . 12.7 tmm? 55.16 100.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.519 0.776 . . . . 0.0 111.566 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.8 p 47.67 -165.15 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.736 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.6 t -62.93 -24.24 67.76 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -77.99 -177.69 5.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.302 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 78.6 p -169.76 -42.83 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.778 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 62.1 m 55.07 18.5 2.35 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.816 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 p -80.33 -2.98 47.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 m -61.14 -44.66 96.98 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.9 p -69.48 -34.5 74.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.352 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.44 -40.74 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.588 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -59.1 -55.93 28.78 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.645 0.736 . . . . 0.0 109.824 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.5 -30.9 75.72 Favored Glycine 0 N--CA 1.496 2.671 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.278 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' C ' ' HD3' ' A' ' 30' ' ' LYS . 7.7 tmtm? -69.54 -42.46 74.57 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.96 -29.63 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.374 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.71 -24.0 76.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.39 -17.97 57.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.406 -0.897 . . . . 0.0 112.14 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.04 127.46 31.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.538 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.82 141.75 49.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.315 1.009 . . . . 0.0 109.764 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.91 11.62 70.0 Favored Glycine 0 N--CA 1.486 1.997 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.168 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.64 135.16 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.566 HE22 ' N ' ' A' ' 54' ' ' GLN . 2.4 mp0 -95.75 -78.14 0.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.17 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.47 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 5.8 tpp180 -96.97 154.73 17.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.718 1.261 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.44 HG13 HG13 ' A' ' 51' ' ' ILE . 8.9 tt -155.21 121.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.314 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -150.6 153.39 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.426 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.2 t -129.59 133.98 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 124.259 0.974 . . . . 0.0 108.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 66.6 m -105.31 149.42 26.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.684 1.24 . . . . 0.0 110.218 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 44' ' ' LEU . 1.2 pp -66.5 4.69 0.71 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.08 68.43 9.99 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.3 m120 55.63 72.4 0.49 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 54.9 tp60 40.99 54.72 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.311 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 43' ' ' SER . 28.8 tt0 -79.11 80.76 5.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.05 131.44 38.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.323 -2.217 . . . . 0.0 109.918 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -131.57 72.0 1.49 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.021 0.915 . . . . 0.0 109.81 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.7 mp -81.76 137.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.015 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 10.9 t -114.05 146.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -165.56 177.05 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.763 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.566 ' N ' HE22 ' A' ' 38' ' ' GLN . 5.5 pt20 -86.9 125.78 65.5 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.58 68.02 8.2 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.235 2.623 . . . . 0.0 113.167 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 5.9 p-80 -172.23 -28.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.04 -44.62 38.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 123.965 0.791 . . . . 0.0 109.544 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -167.76 172.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.088 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.477 ' N ' HG13 ' A' ' 58' ' ' ILE . 51.5 m -119.22 110.89 17.55 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.01 -21.29 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.257 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.49 -39.31 91.77 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.756 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.79 -37.11 73.29 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -71.81 -22.45 61.56 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.583 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HG2' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -97.84 -9.15 26.91 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.49 -32.88 74.46 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -24.04 65.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 123.99 0.806 . . . . 0.0 110.516 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.436 HG22 ' HB2' ' A' ' 72' ' ' PHE . 81.1 mt -70.63 -33.17 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.4 -27.79 46.76 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.48 -35.31 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.691 1.244 . . . . 0.0 109.947 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' CE1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -69.72 -19.33 63.55 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 123.905 0.753 . . . . 0.0 110.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.85 3.3 5.01 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 118.429 -1.206 . . . . 0.0 116.041 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 3.4 m-30 -106.99 86.19 2.29 Favored Pre-proline 0 N--CA 1.5 2.039 0 CA-C-N 118.477 1.138 . . . . 0.0 108.649 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.59 130.77 34.71 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 121.094 1.196 . . . . 0.0 109.044 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.24 124.93 51.05 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.745 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.74 -48.12 41.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.591 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.462 HG21 ' NZ ' ' A' ' 64' ' ' LYS . 23.8 t 55.32 109.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 125.312 1.632 . . . . 0.0 113.499 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.56 -23.6 58.87 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.219 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.66 82.84 2.01 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -100.32 150.93 37.36 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.151 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -83.47 91.81 0.88 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.986 2.458 . . . . 0.0 109.916 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? 59.85 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 O-C-N 124.547 1.155 . . . . 0.0 110.376 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -60.45 169.3 1.76 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 123.569 0.543 . . . . 0.0 112.32 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 83' ' ' LEU . 3.0 mm? -73.03 22.58 0.07 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.55 -1.204 . . . . 0.0 113.299 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 t 52.42 -133.5 1.8 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.25 0.618 . . . . 0.0 110.165 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.2 mtp 50.07 29.82 3.78 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.335 0.588 . . . . 0.0 111.859 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.28 -2.26 0.22 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.974 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -61.02 -49.45 77.36 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.643 0.59 . . . . 0.0 110.237 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.86 -27.4 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.126 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.54 38.3 51.87 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 43.31 -178.44 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.99 150.24 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.052 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.71 57.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 124.409 1.068 . . . . 0.0 108.941 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.3 141.17 41.7 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.19 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -103.49 104.86 14.98 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.448 ' SD ' HG13 ' A' ' 76' ' ' VAL . 16.8 mmm -89.49 109.97 20.85 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.68 85.53 2.76 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.328 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.14 168.01 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.482 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.8 tt0 -110.94 142.15 43.42 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.96 29.93 2.68 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.465 ' H ' ' C ' ' A' ' 16' ' ' GLU . 31.8 ttm 64.66 -129.03 0.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.406 ' H ' ' H ' ' A' ' 20' ' ' CYS . 52.7 p -143.04 -28.47 0.56 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' H ' ' H ' ' A' ' 19' ' ' THR . 25.7 p -152.56 112.15 3.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.559 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 68.53 164.3 0.23 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 124.634 1.209 . . . . 0.0 110.72 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.6 m -148.08 166.94 26.3 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.818 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 78.2 m -144.51 50.68 1.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.384 -1.28 . . . . 0.0 107.825 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.3 p -64.03 -7.61 9.13 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.769 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.6 p -62.27 -40.44 96.23 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 p -68.6 -33.62 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.298 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.54 -42.24 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.06 0.85 . . . . 0.0 108.939 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.35 -50.31 74.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.494 0.664 . . . . 0.0 110.828 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.32 -36.5 93.28 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.7 -1.591 . . . . 0.0 113.835 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.61 -51.34 10.8 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.997 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.18 1.48 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.56 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.21 -28.05 3.72 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.407 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -96.5 8.92 42.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.154 0.502 . . . . 0.0 111.811 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -74.04 135.54 43.06 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.309 1.052 . . . . 0.0 113.279 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -88.0 156.42 19.32 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.602 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.74 8.68 82.16 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 34' ' ' LEU . 54.3 t -99.68 144.09 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -96.04 -82.31 0.39 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.176 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -97.97 169.13 9.85 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.54 1.15 . . . . 0.0 111.625 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.609 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 11.0 tt -153.78 131.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.497 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 140.28 38.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -140.08 137.16 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.842 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t -102.62 170.12 8.22 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.279 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 44' ' ' LEU . 7.3 mp -93.0 -166.22 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.805 -1.088 . . . . 0.0 108.406 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 58.54 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -100.51 34.07 2.52 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.293 0.568 . . . . 0.0 111.006 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 33.96 58.73 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.559 -1.2 . . . . 0.0 114.213 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.67 96.89 2.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.45 121.79 36.35 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.512 -1.677 . . . . 0.0 111.552 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.3 m -115.27 93.92 4.5 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 51' ' ' ILE . 1.7 mp -102.15 136.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.928 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 75.1 t -101.79 132.41 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -155.84 176.64 12.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.65 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.11 112.06 57.06 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 112.422 -2.172 . . . . 0.0 107.074 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.61 -49.68 3.06 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.946 2.431 . . . . 0.0 110.225 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -57.83 -22.45 47.79 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 57' ' ' LEU . 5.5 tp -90.12 -40.93 11.94 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.378 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 tt -161.78 162.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.586 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.7 p -126.94 109.19 11.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.622 1.201 . . . . 0.0 107.868 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.29 -17.16 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.72 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.94 -38.61 86.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -66.96 -40.58 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -64.03 -26.97 68.8 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.718 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -90.88 -19.62 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.827 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.5 -43.55 96.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.644 0.259 . . . . 0.0 111.292 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -66.89 -35.84 80.94 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.424 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 63.6 mt -67.5 -31.53 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.703 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.03 -20.07 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.695 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.5 -36.24 38.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 124.024 0.827 . . . . 0.0 109.436 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.424 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.2 ptm -75.27 -11.36 60.05 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.15 0.906 . . . . 0.0 111.525 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 19.22 2.94 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 117.991 1.956 . . . . 0.0 117.991 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB3' HG13 ' A' ' 15' ' ' VAL . 6.5 m-85 -125.0 73.89 65.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.4 132.1 15.51 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 122.185 1.923 . . . . 0.0 109.904 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.58 118.7 31.71 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.416 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -81.18 75.73 8.14 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.782 -2.463 . . . . 0.0 108.695 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG13 ' SD ' ' A' ' 13' ' ' MET . 74.9 t -83.6 156.45 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.756 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HZ2' ' H ' ' A' ' 79' ' ' GLN . 28.0 tptp 65.07 137.86 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 124.935 1.397 . . . . 0.0 112.557 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.48 -48.63 76.71 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.898 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.525 ' H ' ' HZ2' ' A' ' 77' ' ' LYS . 62.6 mt-30 -81.58 155.66 71.08 Favored Pre-proline 0 N--CA 1.494 1.765 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.838 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.18 -65.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.472 2.114 . . . . 0.0 110.908 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -83.9 -113.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 45.11 47.86 9.8 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.794 0.806 . . . . 0.0 111.31 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.85 106.51 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.207 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 116.179 -1.867 . . . . 0.0 109.736 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 m 51.31 -98.96 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.508 0.77 . . . . 0.0 110.602 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.0 mtp -90.45 69.91 6.92 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.1 89.27 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.026 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -135.72 72.14 1.44 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.98 150.3 44.99 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 113.868 -1.514 . . . . 0.0 109.595 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.64 -47.04 3.39 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 168.63 8.62 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.956 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 m -107.69 126.05 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 113.789 -1.55 . . . . 0.0 110.842 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.435 ' CG2' HE22 ' A' ' 79' ' ' GLN . 33.0 m -104.19 57.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.507 1.146 . . . . 0.0 109.866 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.89 135.33 56.46 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.892 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -105.12 140.05 38.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.432 ' SD ' HG12 ' A' ' 60' ' ' VAL . 4.4 mtt -139.21 131.5 28.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -119.03 95.81 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.521 1.138 . . . . 0.0 111.341 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.77 170.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-N 113.464 -1.698 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' A' ' 18' ' ' MET . 33.1 tt0 -95.6 116.5 28.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.4 19.32 7.11 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-O 119.078 -0.845 . . . . 0.0 114.189 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.444 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 53.9 ttp 28.29 -96.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.408 1.083 . . . . 0.0 113.336 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -178.26 103.14 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.495 0.497 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.5 m 26.21 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 22' ' ' SER . 53.7 t-80 -162.73 162.75 26.91 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.75 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 59.7 m -63.32 117.74 7.05 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.775 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 p -167.14 -67.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.962 0.789 . . . . 0.0 112.465 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.7 p -66.6 -15.44 63.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.9 p -57.06 -38.91 73.94 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -83.33 -33.22 25.94 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.917 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.53 -30.0 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.931 0.769 . . . . 0.0 109.932 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -56.99 -67.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.77 -21.29 79.79 Favored Glycine 0 N--CA 1.494 2.549 0 CA-C-N 113.889 -1.505 . . . . 0.0 114.157 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -74.56 -52.79 10.84 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.49 -27.81 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.042 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.56 -16.22 78.19 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.155 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.21 2.02 54.82 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 124.183 0.578 . . . . 0.0 111.94 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.5 117.29 10.93 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.159 0.504 . . . . 0.0 112.228 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.457 ' H ' ' CD ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -64.83 145.98 55.51 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.286 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.91 86.67 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.757 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.26 132.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.101 0.477 . . . . 0.0 110.343 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -94.64 -76.4 0.49 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.133 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.416 ' H ' ' HB ' ' A' ' 52' ' ' VAL . 9.5 tpt180 -97.65 165.87 11.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.203 0.94 . . . . 0.0 109.243 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 tt -155.98 131.51 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.578 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -157.93 84.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.346 1.07 . . . . 0.0 111.1 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.1 t -82.36 119.86 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -90.96 157.16 17.45 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.5 -110.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.428 -1.273 . . . . 0.0 107.745 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 p30 37.54 -122.82 0.22 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 119.237 0.926 . . . . 0.0 110.631 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -102.95 55.08 0.76 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 41.98 66.15 0.76 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.261 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -84.38 88.04 7.25 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 117.749 -1.58 . . . . 0.0 108.025 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 127.61 33.37 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 108.93 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -129.49 49.98 2.2 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.957 0.884 . . . . 0.0 108.986 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.8 mp -68.27 147.16 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.565 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 39' ' ' ARG . 99.5 t -113.91 144.32 21.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -156.39 157.83 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.346 1.029 . . . . 0.0 110.164 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' HG3' HD23 ' A' ' 57' ' ' LEU . 8.4 pt20 -86.26 146.39 42.33 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.42 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -58.98 155.25 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 123.03 2.487 . . . . 0.0 113.764 -161.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.414 ' CG ' ' O ' ' A' ' 55' ' ' PRO . 19.2 p80 52.86 -1.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.41 HD23 ' HG3' ' A' ' 54' ' ' GLN . 4.6 mm? -72.97 -40.21 65.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.88 0.764 . . . . 0.0 109.307 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.481 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -161.27 174.42 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.793 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.481 ' N ' HG13 ' A' ' 58' ' ' ILE . 68.3 m -139.14 108.5 6.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 13' ' ' MET . 49.2 t -66.2 -19.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.527 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.54 -37.09 82.2 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -68.94 -39.38 79.6 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.2 mmt -66.26 -29.65 69.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.351 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -80.93 -21.89 40.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.731 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -63.96 -33.46 75.77 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -69.9 -39.58 76.13 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.75 -26.73 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.93 -1.486 . . . . 0.0 107.885 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.93 -21.12 25.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.245 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.27 -37.1 38.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.937 0.773 . . . . 0.0 108.959 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -12.03 60.29 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 124.27 0.982 . . . . 0.0 111.264 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.09 -7.06 6.06 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -103.66 95.27 7.16 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 119.076 1.438 . . . . 0.0 112.805 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -46.78 133.58 17.36 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.765 1.643 . . . . 0.0 109.519 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.46 112.28 17.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.64 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -78.45 84.25 4.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.669 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -74.58 92.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.626 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' HZ3' ' HB2' ' A' ' 77' ' ' LYS . 5.8 mtmp? -74.74 -16.34 60.74 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.449 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 mttp 53.7 -119.36 1.48 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 123.988 0.805 . . . . 0.0 109.336 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 26.8 mm100 -99.18 -45.2 0.23 Allowed Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.896 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 79' ' ' GLN . 13.1 Cg_endo -87.49 114.54 1.0 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.993 2.462 . . . . 0.0 109.676 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 2.4 mppt? -65.84 99.45 0.48 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -64.73 129.07 38.4 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.739 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 59.26 73.03 0.5 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 116.794 -1.574 . . . . 0.0 107.281 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.2 m -144.49 -70.11 0.29 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.4 ttm -166.31 -66.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.42 -49.93 6.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.114 0.884 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 52.22 86.44 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.875 1.359 . . . . 0.0 108.585 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.47 21.27 5.44 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.261 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.62 -17.15 66.53 Favored Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.81 175.41 0.49 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.63 134.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 78.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 124.182 0.926 . . . . 0.0 111.089 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.32 138.91 36.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.338 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.74 117.78 33.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.452 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.3 mpp? -119.0 137.02 53.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 40.6 ttmt -119.59 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.923 1.389 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -65.38 167.81 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 18' ' ' MET . 39.2 tt0 -98.68 121.66 40.9 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.96 19.41 1.24 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.041 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.456 ' CE ' ' CE1' ' A' ' 72' ' ' PHE . 42.7 tpp 71.92 -80.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.949 1.299 . . . . 0.0 108.812 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 t 175.1 -32.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.038 0.836 . . . . 0.0 109.458 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.4 p -161.12 -7.3 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 124.057 0.848 . . . . 0.0 112.037 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -141.9 103.03 4.26 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.559 0.695 . . . . 0.0 110.418 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.1 p -108.32 102.66 11.76 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.948 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t -83.72 30.31 0.5 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.616 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -72.39 -0.99 13.91 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.6 t -61.79 -39.75 92.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -65.18 -34.35 78.17 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.51 -37.92 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.843 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -48.68 -61.5 2.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.9 0.75 . . . . 0.0 112.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.93 -29.24 71.94 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 114.045 -1.434 . . . . 0.0 112.781 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -70.43 -41.1 73.33 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.455 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.17 -33.88 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.6 76.95 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -89.69 -6.63 55.92 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.691 -0.755 . . . . 0.0 112.508 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.12 118.09 11.58 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.38 141.67 36.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.991 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.79 4.18 79.48 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.739 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.8 141.89 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -96.37 -79.44 0.45 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.781 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.529 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 2.6 tpm_? -96.81 159.63 14.81 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.84 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.474 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 5.4 tt -149.36 110.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -145.32 101.37 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.995 0.902 . . . . 0.0 111.237 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 49.3 t -93.65 149.3 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.293 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 37.3 t -111.66 144.53 40.77 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -25.76 60.28 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.421 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.45 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.074 0.859 . . . . 0.0 110.418 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 45.18 53.31 8.02 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.446 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 44.38 49.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.963 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 35.4 tt0 -74.07 89.7 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -76.5 130.19 37.59 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 111.828 -2.442 . . . . 0.0 114.085 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 m -132.07 74.54 1.59 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.62 1.2 . . . . 0.0 107.984 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -83.58 132.03 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.869 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 42.7 t -105.13 138.61 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -156.63 179.65 9.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.543 1.152 . . . . 0.0 113.645 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -95.37 116.11 66.02 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.486 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.2 -54.59 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.87 2.38 . . . . 0.0 110.237 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -56.14 -22.42 28.37 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.053 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.07 -40.96 12.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.244 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 tt -163.88 162.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 124.451 1.095 . . . . 0.0 111.284 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -130.93 104.74 7.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -68.58 -17.9 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.393 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.7 -29.02 67.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.321 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.69 -41.2 79.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.5 mmt -62.53 -31.93 72.8 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.269 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -66.25 -34.06 77.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.991 0.807 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -61.24 -34.13 74.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.091 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -67.82 -38.69 83.55 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 124.252 0.97 . . . . 0.0 109.047 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.7 -33.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.23 -24.66 34.73 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.389 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.11 -36.43 58.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.23 0.956 . . . . 0.0 109.928 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -74.93 -13.63 60.55 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 123.805 0.69 . . . . 0.0 111.082 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.57 10.36 4.51 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 7.6 m-85 -118.34 88.37 32.98 Favored Pre-proline 0 N--CA 1.499 2.019 0 CA-C-N 118.268 1.034 . . . . 0.0 109.773 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -49.08 135.15 30.19 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.128 1.885 . . . . 0.0 109.408 173.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.21 122.08 30.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.749 1.28 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.63 77.94 9.77 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.131 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.93 113.59 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.532 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -81.93 -139.33 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.816 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.34 -117.02 1.12 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.991 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 48.04 76.48 0.54 Allowed Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 123.476 0.485 . . . . 0.0 110.189 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -67.33 -87.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.585 2.19 . . . . 0.0 111.143 -167.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -168.6 -157.14 0.19 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 123.567 0.542 . . . . 0.0 110.658 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 t80 66.51 140.78 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 124.443 1.097 . . . . 0.0 112.98 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -167.34 -62.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 116.602 -1.666 . . . . 0.0 109.84 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.2 p 51.15 9.7 0.06 Allowed 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.1 mmt -76.34 -46.43 27.6 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.13 -20.24 65.74 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.674 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -150.68 -102.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.07 -148.81 0.14 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.99 -114.21 0.08 OUTLIER Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 41.91 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.92 108.36 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 m -92.6 56.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.022 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -79.39 156.31 28.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 2.9 mptp? -120.66 94.86 4.5 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.893 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.3 mtm -82.37 135.28 35.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 62.8 tttp -116.93 90.47 3.34 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.721 1.248 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -54.02 167.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 112.722 -2.036 . . . . 0.0 115.126 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.446 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.4 tt0 -120.5 126.77 51.2 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.56 21.06 1.22 Allowed Glycine 0 N--CA 1.492 2.399 0 O-C-N 123.299 0.374 . . . . 0.0 113.407 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.425 ' H ' ' C ' ' A' ' 16' ' ' GLU . 36.0 ttp 54.15 19.12 2.0 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.295 0.644 . . . . 0.0 111.664 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 t 41.42 23.84 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 O-C-N 124.29 0.994 . . . . 0.0 113.103 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 t 179.08 125.98 0.06 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.479 ' CG ' ' N ' ' A' ' 22' ' ' SER . 83.3 t60 59.7 160.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 124.472 1.107 . . . . 0.0 113.754 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.479 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 54.6 p -139.48 86.44 2.12 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.133 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -78.15 10.37 3.02 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.979 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 22' ' ' SER . 69.9 p -59.85 -8.79 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.651 -1.159 . . . . 0.0 113.419 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.2 p -56.25 -32.61 64.65 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.3 p -68.66 -39.78 80.47 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.386 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.3 mt -52.57 -30.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 124.502 1.126 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.25 -72.5 0.06 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.5 -12.77 80.29 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.533 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.83 -53.87 7.0 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.491 0.662 . . . . 0.0 109.301 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.16 -29.66 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.036 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.52 -14.68 81.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -95.49 1.05 53.83 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.72 -0.74 . . . . 0.0 112.805 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.422 HD21 ' SD ' ' A' ' 63' ' ' MET . 79.9 mt -72.29 125.34 27.11 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -83.89 144.5 29.17 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.531 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.95 10.7 84.69 Favored Glycine 0 N--CA 1.489 2.212 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.018 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.56 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -95.79 -83.83 0.36 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 19.4 tpp180 -98.45 166.59 11.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.592 1.182 . . . . 0.0 110.992 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.53 107.06 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -147.73 108.45 4.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.753 0.787 . . . . 0.0 110.845 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 54.8 t -97.18 139.68 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.1 t -100.63 171.07 7.94 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.773 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.4 mp -74.58 -115.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.168 -1.396 . . . . 0.0 108.183 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 p30 39.81 -133.32 0.22 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 119.272 0.942 . . . . 0.0 109.768 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -93.85 56.99 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 41.16 69.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.948 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 36.2 tt0 -79.35 90.91 5.01 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.48 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -70.74 129.4 39.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.254 -1.794 . . . . 0.0 108.052 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -129.53 69.14 1.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.414 1.102 . . . . 0.0 108.859 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -81.87 126.89 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.387 -1.733 . . . . 0.0 107.488 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 72.1 t -98.5 133.51 40.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -154.05 171.75 18.59 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.495 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -91.1 114.07 60.34 Favored Pre-proline 0 N--CA 1.494 1.742 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.228 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -62.5 -50.71 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.847 2.365 . . . . 0.0 111.313 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -60.06 -26.89 66.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.279 -1.328 . . . . 0.0 113.287 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 57' ' ' LEU . 4.6 tp -88.16 -36.38 16.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.407 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.28 162.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.782 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.1 m -132.0 106.62 8.14 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.9 t -76.36 -15.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.94 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.72 -32.74 73.57 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -71.0 -45.3 64.24 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.2 tpt -58.95 -31.68 68.94 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.787 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -76.02 -30.89 58.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.163 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -59.95 -31.55 69.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.251 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.03 -38.13 75.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.415 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 69.4 mt -66.88 -30.21 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.96 -22.11 33.85 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.276 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.31 -37.39 44.77 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 124.195 0.934 . . . . 0.0 109.28 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.6 ptm -72.59 -13.62 61.43 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.254 0.971 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.35 8.89 3.86 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -118.71 71.29 10.07 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 118.289 1.044 . . . . 0.0 110.325 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -47.69 130.55 18.86 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.184 1.923 . . . . 0.0 110.523 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -112.64 123.05 49.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.471 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -66.48 -3.01 5.29 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.954 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 77' ' ' LYS . 50.3 t 59.67 175.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 123.899 0.749 . . . . 0.0 111.782 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.483 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -58.52 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' H ' ' CG ' ' A' ' 77' ' ' LYS . 55.7 mtmt -63.91 160.13 18.32 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.071 0.396 . . . . 0.0 110.264 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -59.39 121.53 57.25 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 123.842 0.714 . . . . 0.0 109.817 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.66 112.42 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.107 1.871 . . . . 0.0 109.782 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -66.95 -7.31 21.28 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.537 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -59.58 138.7 57.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 123.828 0.705 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 pp -169.23 -21.47 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 113.953 -1.476 . . . . 0.0 109.706 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 4.9 ttmp? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 116.83 -1.557 . . . . 0.0 108.831 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.8 t -159.04 130.73 6.4 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.2 tpp 51.05 45.75 27.36 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.293 0.995 . . . . 0.0 108.85 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 52.3 50.63 17.94 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 113.883 -1.508 . . . . 0.0 111.148 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -151.28 133.28 15.12 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.18 179.97 8.72 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.565 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.83 -163.41 24.82 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 42.41 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.94 136.64 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.782 -2.008 . . . . 0.0 109.65 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.89 51.85 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 122.644 1.211 . . . . 0.0 109.111 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.5 mt -71.34 151.84 43.77 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.774 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -117.59 149.56 40.45 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.754 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.0 141.74 51.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.8 ttmt -127.97 84.16 2.22 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.2 t -62.99 170.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.459 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 34.0 tt0 -112.45 143.05 44.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.84 23.34 3.1 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.397 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.484 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 17.3 ttm 57.72 -107.12 0.35 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 p -154.5 133.79 12.57 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.7 t 55.32 -84.58 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 124.228 0.955 . . . . 0.0 113.266 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 22' ' ' SER . 83.5 t60 -97.45 171.18 8.55 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 85.0 p -150.51 126.04 10.2 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.065 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -91.92 45.77 1.24 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.639 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.2 p -69.56 -6.98 34.49 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.725 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.8 m -57.49 -33.28 67.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.045 0.45 . . . . 0.0 109.909 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -67.79 -39.4 84.03 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.111 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.9 mt -52.66 -35.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.325 1.016 . . . . 0.0 111.699 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -49.84 -72.09 0.06 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.419 1.074 . . . . 0.0 112.162 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.74 -21.75 77.99 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.376 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -63.87 -40.57 96.85 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.8 -23.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.438 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.59 -12.23 83.89 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -91.88 -0.91 57.52 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.683 -0.759 . . . . 0.0 112.01 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 63' ' ' MET . 89.5 mt -73.26 126.06 29.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -85.58 140.58 30.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.135 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.71 1.54 85.25 Favored Glycine 0 N--CA 1.491 2.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.899 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.47 144.52 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -96.1 -82.85 0.38 Allowed 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.481 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.639 1.212 . . . . 0.0 109.881 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.656 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 10.7 tt -154.06 122.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.79 162.87 39.44 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.46 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.6 t -137.54 133.47 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 124.491 1.119 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 69.2 m -100.12 148.81 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.664 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.65 3.85 0.47 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -86.62 68.66 10.22 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.25 69.84 0.69 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.53 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 40.44 50.94 2.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.423 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 43' ' ' SER . 35.8 tt0 -76.74 85.23 3.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.79 128.13 34.68 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 112.675 -2.057 . . . . 0.0 113.793 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -118.58 72.26 0.87 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.834 0.709 . . . . 0.0 109.515 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.9 mp -72.79 139.07 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.368 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.1 t -115.83 132.15 66.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -151.72 163.43 39.16 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.521 1.138 . . . . 0.0 113.089 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -62.87 149.96 88.7 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.157 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.37 -4.04 14.78 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.986 2.457 . . . . 0.0 114.404 -153.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -160.53 27.42 0.16 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.85 -47.26 9.85 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.519 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.33 161.77 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 124.155 0.909 . . . . 0.0 111.47 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -104.28 113.67 27.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.479 1.112 . . . . 0.0 110.974 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.5 t -71.24 -25.19 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.981 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.3 -24.5 65.02 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.523 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -70.49 -41.46 72.66 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.49 -38.58 91.66 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 2.9 mmmp? -62.83 -33.06 74.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.584 1.177 . . . . 0.0 109.864 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.77 -43.44 98.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -65.54 -36.7 84.56 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 124.275 0.985 . . . . 0.0 109.158 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.41 -32.74 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.9 -20.61 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.913 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.55 -36.76 32.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.043 0.84 . . . . 0.0 109.738 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.493 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 1.9 ppp? -77.03 -12.01 59.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.33 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.19 23.31 1.78 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 117.804 1.882 . . . . 0.0 117.804 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' SD ' ' A' ' 70' ' ' MET . 9.3 m-85 -131.84 83.22 57.84 Favored Pre-proline 0 N--CA 1.494 1.756 0 CA-C-N 117.58 0.69 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -47.49 134.49 20.97 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 122.026 1.817 . . . . 0.0 108.738 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.98 114.99 18.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.69 1.244 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -85.67 71.12 10.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 111.744 -2.48 . . . . 0.0 108.499 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.08 96.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.97 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -82.59 80.48 8.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.707 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -73.25 -179.01 3.15 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.952 179.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -121.52 87.32 45.33 Favored Pre-proline 0 N--CA 1.501 2.112 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.358 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -81.29 -173.54 1.86 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.404 2.736 . . . . 0.0 110.567 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -157.71 112.51 2.68 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.594 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -87.48 132.93 33.85 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.686 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.63 58.99 1.55 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 124.195 0.934 . . . . 0.0 109.06 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt . . . . . 0 N--CA 1.504 2.235 0 CA-C-O 117.277 -1.345 . . . . 0.0 113.065 179.896 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -159.02 -64.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -91.57 67.21 5.48 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.18 75.05 1.0 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.088 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.77 112.54 7.05 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.846 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.16 150.2 35.42 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.381 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.36 34.63 0.05 OUTLIER Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.69 144.05 35.43 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.52 -0.84 . . . . 0.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 9' ' ' VAL . 4.8 m -88.99 110.94 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.881 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.47 143.93 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.37 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 70.9 mt -127.99 152.73 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.903 0.752 . . . . 0.0 109.495 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' SD ' ' A' ' 13' ' ' MET . 63.6 tttm -147.96 109.25 4.32 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 2.9 mpp? -127.38 141.06 51.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.619 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' A' ' 14' ' ' LYS . 6.1 ttpm? -112.51 105.68 13.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.761 1.288 . . . . 0.0 109.033 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.2 t -70.05 160.52 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 18' ' ' MET . 33.0 tt0 -90.58 108.21 19.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.99 -14.0 22.13 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.846 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.436 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 53.7 tpp 69.98 131.17 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.984 0.914 . . . . 0.0 110.732 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -83.65 47.82 1.34 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.805 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' SG ' ' HG3' ' A' ' 18' ' ' MET . 30.5 p -164.02 -50.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.705 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -166.53 144.77 5.35 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 123.755 0.659 . . . . 0.0 109.932 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 m -107.01 102.65 11.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.388 1.055 . . . . 0.0 109.703 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t -89.32 43.36 1.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.1 p -80.69 -7.93 59.48 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.9 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.6 t -59.67 -38.83 82.58 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -71.58 -33.88 69.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.85 -36.38 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.169 0.918 . . . . 0.0 110.49 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.06 -64.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.909 0.755 . . . . 0.0 111.319 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.28 -27.15 71.18 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.058 -1.428 . . . . 0.0 113.09 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.49 -40.55 80.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.39 -29.05 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.49 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.34 -13.85 77.02 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.07 -4.93 58.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.485 -0.858 . . . . 0.0 112.282 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.405 HD21 ' SD ' ' A' ' 63' ' ' MET . 35.5 mt -73.53 119.35 17.64 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.34 138.12 33.67 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.061 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.36 77.52 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.56 126.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -87.34 -75.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.623 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 4.6 tpm_? -97.48 156.22 16.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.623 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.6 tt -153.27 115.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.43 114.37 3.0 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 34.8 t -108.46 147.56 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.408 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -88.77 -178.21 5.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -104.2 179.57 4.23 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.861 -1.518 . . . . 0.0 108.408 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 56.71 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 124.304 1.003 . . . . 0.0 111.269 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -80.78 12.38 3.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 123.421 0.45 . . . . 0.0 109.997 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 35.24 50.31 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 124.395 1.06 . . . . 0.0 111.517 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.78 92.74 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.234 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -75.55 131.55 40.11 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.357 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.6 m -135.98 70.02 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.036 0.922 . . . . 0.0 108.67 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -82.42 150.31 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.798 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 93.4 t -125.05 149.34 29.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 9' ' ' VAL . 6.8 p90 -162.07 161.22 28.22 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 123.997 0.81 . . . . 0.0 108.885 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.89 159.55 75.96 Favored Pre-proline 0 N--CA 1.499 1.985 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.421 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -83.6 42.2 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.495 2.13 . . . . 0.0 114.217 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -159.78 -4.53 0.07 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 118.734 2.865 . . . . 0.0 118.734 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -89.1 -55.78 3.54 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 120.349 1.431 . . . . 0.0 109.54 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -164.29 161.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -88.13 110.07 20.38 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.881 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -66.56 -29.24 45.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.741 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.27 -23.36 64.06 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.534 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -70.92 -43.47 68.17 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.405 ' SD ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -66.25 -29.4 69.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 124.359 1.037 . . . . 0.0 110.524 179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -72.29 -28.36 63.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -69.85 -28.33 65.59 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.612 0.57 . . . . 0.0 110.066 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.57 -39.07 92.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 123.844 0.715 . . . . 0.0 109.094 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.25 -30.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.674 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.99 -24.52 24.65 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.023 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.97 -37.4 61.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 124.255 0.972 . . . . 0.0 109.356 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.23 -11.93 60.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.547 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.68 -3.88 8.65 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 1.9 m-30 -107.59 91.32 7.07 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 119.051 1.425 . . . . 0.0 109.272 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -50.74 132.21 35.89 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.71 1.607 . . . . 0.0 110.085 171.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -115.27 95.58 5.25 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.275 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.45 96.97 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 111.37 -2.65 . . . . 0.0 110.7 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 t -60.98 153.6 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.244 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -137.08 -45.44 0.57 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.824 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -64.98 107.53 1.52 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.492 ' HB3' ' HD3' ' A' ' 80' ' ' PRO . 4.3 tm0? -162.03 -50.88 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.425 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 79' ' ' GLN . 40.9 Cg_endo -86.38 -86.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.014 1.81 . . . . 0.0 108.118 -177.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -173.99 37.24 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 124.339 1.024 . . . . 0.0 108.781 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 56.16 60.08 3.38 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.769 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.1 mt -86.91 -60.86 1.86 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.317 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 114.704 -2.569 . . . . 0.0 111.482 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.016 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.1 p 41.64 -136.39 0.24 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 124.942 1.024 . . . . 0.0 111.767 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.1 mtm -67.4 -43.79 80.43 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.2 12.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.842 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.407 ' CD ' ' N ' ' A' ' 5' ' ' GLN . 8.0 mp0 -90.98 102.26 15.03 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.552 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.83 65.78 9.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.672 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.18 80.62 0.14 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 42.34 -176.67 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.97 146.92 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.07 56.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.359 1.037 . . . . 0.0 109.825 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.8 mt -67.48 146.83 53.59 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HD3' HG23 ' A' ' 50' ' ' THR . 58.3 mmtt -106.91 136.47 46.7 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 3.5 mpp? -136.0 135.97 39.94 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 62.4 tttm -112.65 151.3 30.31 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.525 ' CG2' ' HZ1' ' A' ' 64' ' ' LYS . 2.1 t -131.36 167.48 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 124.579 1.174 . . . . 0.0 111.662 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 18' ' ' MET . 13.0 tp10 -94.43 133.55 37.91 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.73 19.38 9.42 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.662 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.449 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 52.1 ttp 33.33 -88.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.102 1.119 . . . . 0.0 113.059 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.6 p -144.94 178.5 7.98 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.8 t -58.79 -24.91 62.55 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.766 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -91.52 44.75 1.19 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.904 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 76.8 p -63.6 158.13 22.02 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.814 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.8 m -120.79 30.14 7.04 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -63.13 -15.25 56.14 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.546 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -53.14 -35.87 60.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 123.868 0.73 . . . . 0.0 109.751 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 p -73.79 -41.8 61.88 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.976 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.78 -36.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 124.292 0.995 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.22 -66.38 0.4 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.641 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.3 -12.15 84.61 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 114.002 -1.454 . . . . 0.0 115.033 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -84.45 -58.39 2.76 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -27.04 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.438 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.54 -12.05 80.89 Favored Glycine 0 N--CA 1.486 2.019 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.668 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.29 -7.81 57.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.191 0.519 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' A' ' 37' ' ' VAL . 35.2 mt -58.05 141.32 50.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.18 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -77.18 145.01 37.92 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.746 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.94 9.13 85.26 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.167 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 34' ' ' LEU . 18.8 t -79.75 133.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 124.263 0.625 . . . . 0.0 109.879 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -95.6 -82.13 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.635 -1.62 . . . . 0.0 107.609 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.0 tpp180 -98.49 164.87 12.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.445 1.09 . . . . 0.0 111.629 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 tt -147.47 117.74 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -142.53 74.4 1.44 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.802 1.287 . . . . 0.0 109.423 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 40.1 t -83.21 142.75 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.327 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.0 t -86.15 -179.6 6.76 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.506 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.7 179.83 4.16 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.762 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 55.36 -90.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 124.232 0.957 . . . . 0.0 110.776 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.2 16.98 0.85 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.317 0.386 . . . . 0.0 110.623 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 29.07 54.11 0.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.459 1.104 . . . . 0.0 112.947 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.4 tt0 -67.48 93.93 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.658 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -76.53 130.45 37.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.28 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' HD3' ' A' ' 12' ' ' LYS . 98.1 m -136.23 63.3 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.1 mp -72.22 135.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-N 113.879 -1.51 . . . . 0.0 108.476 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 90.8 t -102.02 135.24 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.94 162.77 40.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 124.816 1.323 . . . . 0.0 112.285 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -63.62 147.05 96.21 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.91 4.43 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.126 2.551 . . . . 0.0 114.462 -152.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -160.74 23.75 0.14 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.55 -45.74 13.2 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 59' ' ' SER . 8.3 tp -161.4 171.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.243 0.964 . . . . 0.0 110.707 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.475 ' N ' HG13 ' A' ' 58' ' ' ILE . 36.4 p -107.94 111.1 23.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.824 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.07 -28.17 29.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.313 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.45 -20.79 65.87 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.653 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.97 -43.06 65.77 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 mmt -64.13 -30.49 71.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.476 1.11 . . . . 0.0 109.562 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.525 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 3.0 mmmp? -64.02 -33.32 75.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.251 0.969 . . . . 0.0 109.119 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -65.26 -33.46 76.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.272 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -69.08 -39.06 79.27 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -66.48 -28.71 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.067 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.87 -22.6 25.65 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.088 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.5 47.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 123.993 0.808 . . . . 0.0 109.567 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -12.79 60.34 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.434 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.02 -4.81 6.42 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 118.899 2.319 . . . . 0.0 118.899 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -104.77 95.68 9.28 Favored Pre-proline 0 N--CA 1.504 2.251 0 CA-C-N 119.365 1.582 . . . . 0.0 110.494 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -51.13 134.04 42.64 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.403 1.402 . . . . 0.0 109.5 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -118.77 129.32 55.18 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.229 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.05 63.29 4.38 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 113.629 -1.623 . . . . 0.0 111.109 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.3 85.46 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -136.98 1.55 2.5 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.336 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HZ2' ' HB3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.7 119.59 15.07 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' H ' ' CD ' ' A' ' 80' ' ' PRO . 24.5 mm100 -113.32 -49.69 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.897 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.352 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' CD ' ' H ' ' A' ' 79' ' ' GLN . 46.0 Cg_endo -82.71 -78.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.866 1.711 . . . . 0.0 109.587 -173.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.16 -17.96 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 O-C-N 123.889 0.743 . . . . 0.0 110.632 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.8 t80 56.32 60.32 3.21 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 124.318 1.011 . . . . 0.0 109.653 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.5 tp -73.07 99.41 2.76 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.46 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 116.711 -1.614 . . . . 0.0 109.96 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 50.29 -122.58 1.89 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.263 0.625 . . . . 0.0 110.231 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 46.8 ttm -74.51 -41.53 60.51 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.79 -52.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.048 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 53.17 97.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 124.62 1.2 . . . . 0.0 112.723 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.87 50.81 0.76 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.385 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.35 33.68 71.79 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HB3' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -131.21 176.03 8.61 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.699 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.81 137.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.857 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.48 75.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.56 -20.8 65.04 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 50.52 94.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 13' ' ' MET . 2.9 mpp? -100.55 135.44 41.98 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.778 -1.555 . . . . 0.0 106.949 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -126.11 86.56 2.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 124.724 1.265 . . . . 0.0 107.712 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.19 165.64 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.638 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.4 tt0 -113.15 128.48 56.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.12 30.15 2.71 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.43 ' H ' ' C ' ' A' ' 16' ' ' GLU . 58.7 ttm 50.32 -100.01 0.08 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.228 0.611 . . . . 0.0 110.207 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.0 p -148.59 -46.39 0.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.9 t -93.54 -10.88 33.31 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.149 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.7 m80 59.31 -127.93 1.23 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.116 0.885 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 m 62.71 -173.28 0.15 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 123.595 0.559 . . . . 0.0 111.501 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t 57.9 0.32 0.11 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -75.51 -1.29 23.56 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.442 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -69.15 -27.81 65.87 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.3 p -66.33 -35.31 80.04 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.25 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.22 -33.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 124.819 1.324 . . . . 0.0 110.82 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -48.85 -73.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.803 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.29 -21.9 66.34 Favored Glycine 0 N--CA 1.497 2.755 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.564 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -64.2 -34.06 77.21 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.367 0.603 . . . . 0.0 109.729 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.8 -21.98 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.958 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.83 -14.62 80.66 Favored Glycine 0 N--CA 1.487 2.088 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.738 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.82 1.98 56.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 124.208 0.593 . . . . 0.0 111.714 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.89 102.18 5.45 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.592 0.71 . . . . 0.0 112.855 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -75.6 119.73 20.04 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.57 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.88 9.26 12.52 Favored Glycine 0 N--CA 1.485 1.903 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.52 138.22 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.453 HE21 ' HG2' ' A' ' 54' ' ' GLN . 6.5 mt-30 -95.13 -77.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -96.84 153.4 17.91 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.16 118.26 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.829 -0.749 . . . . 0.0 112.439 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.27 161.27 21.83 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.08 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.99 134.56 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.604 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -104.18 176.18 5.24 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.882 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 44' ' ' LEU . 7.1 mp -70.98 -150.37 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.512 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 53.41 58.03 5.6 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.976 0.893 . . . . 0.0 108.995 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 51.21 81.98 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.71 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 36.5 61.94 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.789 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.44 85.48 6.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -67.37 136.84 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 113.01 -1.905 . . . . 0.0 111.034 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.4 m -135.36 52.89 2.0 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -73.94 125.44 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.28 138.66 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.35 177.46 10.56 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 114.239 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.54 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 46.1 mt-30 -88.18 121.79 70.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 113.55 -1.659 . . . . 0.0 106.725 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -68.46 -54.96 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.275 1.983 . . . . 0.0 109.395 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 54' ' ' GLN . 24.7 p80 -52.54 -26.02 12.03 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.86 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 tp -93.96 -47.61 6.63 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.17 168.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -132.14 111.25 11.29 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.438 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.02 -24.63 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.812 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.45 -18.94 54.53 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.719 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.96 -43.92 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -29.82 70.97 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.206 0.941 . . . . 0.0 109.727 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -64.04 -33.95 76.92 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.21 -32.0 73.29 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.504 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -69.65 -39.47 77.07 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 72' ' ' PHE . 94.5 mt -67.71 -28.44 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.842 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.901 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.5 -37.42 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 124.09 0.869 . . . . 0.0 109.271 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -12.7 60.45 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.653 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.89 -2.46 6.88 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.6 m-30 -107.88 91.78 8.11 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 118.744 1.272 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -47.16 134.76 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.041 1.828 . . . . 0.0 110.446 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.33 109.39 14.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 124.652 1.22 . . . . 0.0 108.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.29 79.64 7.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.175 -2.284 . . . . 0.0 108.878 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.27 152.55 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.964 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm 57.33 91.91 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.506 1.129 . . . . 0.0 110.509 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.67 127.29 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.17 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -62.27 118.16 37.29 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 124.413 1.071 . . . . 0.0 110.303 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.95 -127.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.543 2.162 . . . . 0.0 107.962 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 5.4 ttpm? 59.23 15.59 4.32 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 120.952 0.406 . . . . 0.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -127.1 -66.28 0.9 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 83' ' ' LEU . 8.5 mp -70.8 -42.08 70.77 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.016 0.823 . . . . 0.0 109.185 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.5 mttp . . . . . 0 N--CA 1.498 1.962 0 O-C-N 124.873 1.358 . . . . 0.0 111.596 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 m -58.98 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.5 mtp -61.25 -15.39 34.35 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 123.729 0.643 . . . . 0.0 112.266 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -165.99 121.0 1.22 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.88 120.17 8.55 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 76.63 -33.59 0.21 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 125.214 1.571 . . . . 0.0 110.991 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.87 174.99 54.7 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 67.96 157.25 0.13 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 124.545 0.791 . . . . 0.0 111.335 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.32 130.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.68 91.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.977 0.894 . . . . 0.0 110.294 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.27 139.3 30.86 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -130.14 103.23 6.62 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.324 1.64 . . . . 0.0 106.87 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.573 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 50.6 mtp -104.87 145.44 30.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.54 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 39.4 ttpt -119.7 87.79 2.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.287 0.992 . . . . 0.0 111.55 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.37 164.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 3.1 mp0 -116.67 154.83 29.87 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.222 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 18.12 5.23 Favored Glycine 0 N--CA 1.484 1.858 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.572 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.7 ttm 74.44 -65.81 0.33 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 125.508 1.357 . . . . 0.0 109.285 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -165.18 -35.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 113.991 -1.459 . . . . 0.0 107.248 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -173.22 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.33 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -79.12 139.35 38.07 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.168 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.0 p -144.9 160.57 41.1 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -153.93 36.32 0.44 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 113.802 -1.545 . . . . 0.0 106.852 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -72.94 -4.69 33.7 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.1 t -62.81 -37.4 86.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -66.62 -35.28 79.79 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.5 mt -57.03 -39.37 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 124.197 0.936 . . . . 0.0 111.502 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -51.42 -67.98 0.21 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.791 0.682 . . . . 0.0 112.585 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.21 -23.39 78.13 Favored Glycine 0 N--CA 1.496 2.664 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.635 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.3 -50.26 41.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.408 HG13 ' HZ3' ' A' ' 64' ' ' LYS . 43.6 mm -70.44 -27.52 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.604 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.08 -12.21 83.55 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.2 1.57 54.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 124.337 0.669 . . . . 0.0 111.401 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.4 mt -74.78 131.36 40.74 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.836 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -83.05 160.23 21.98 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 124.147 0.904 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.46 11.03 71.6 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.49 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.07 146.99 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -95.86 -83.93 0.36 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.588 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 3.2 tpm_? -98.33 160.87 14.01 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.1 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.588 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -158.47 107.93 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HZ3' HH11 ' A' ' 39' ' ' ARG . 0.1 OUTLIER -137.65 160.01 40.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.597 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -139.68 149.68 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 124.183 0.927 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 33.5 t -110.47 140.49 44.67 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.082 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tt -50.39 -35.15 26.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.73 1.269 . . . . 0.0 110.247 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -53.57 85.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.465 1.103 . . . . 0.0 111.373 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 41.57 60.5 2.12 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.962 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 42.18 48.68 4.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.526 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 35.3 tt0 -74.68 89.97 2.28 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -80.75 146.02 31.22 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 112.094 -2.321 . . . . 0.0 114.519 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.4 m -138.77 78.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -88.74 136.24 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.066 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.3 t -107.91 135.21 47.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -154.98 172.35 18.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -90.05 116.99 67.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.17 -53.72 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.698 2.265 . . . . 0.0 110.129 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -57.73 -26.27 61.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.363 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.97 -38.15 14.68 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.791 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.66 159.88 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.377 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -129.3 95.93 4.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.91 -26.28 40.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 112.173 -2.285 . . . . 0.0 110.567 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.8 -35.14 70.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.174 0.921 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.16 -41.56 94.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.6 mmm -70.44 -27.35 64.18 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.51 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.573 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 71.8 mmtt -80.95 -18.61 46.46 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.506 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.46 -31.37 68.49 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -64.87 -35.39 80.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.002 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 72' ' ' PHE . 80.6 mt -64.72 -34.68 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -81.29 -20.32 41.08 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.581 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.55 36.52 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 ptm -75.56 -11.14 59.96 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.141 0.901 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.38 17.66 3.92 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' HB2' HG22 ' A' ' 67' ' ' ILE . 17.0 m-85 -123.05 82.57 50.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -51.25 141.75 38.57 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.097 1.864 . . . . 0.0 108.337 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -126.33 125.44 42.28 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.331 1.02 . . . . 0.0 108.927 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -82.63 83.38 7.65 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.19 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.98 157.55 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.729 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.0 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.605 1.19 . . . . 0.0 108.22 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -147.93 133.36 18.62 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.697 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -53.97 105.58 0.55 Allowed Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 124.553 1.158 . . . . 0.0 109.891 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -78.21 71.7 6.59 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 123.142 2.561 . . . . 0.0 112.476 -166.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -117.82 143.96 45.8 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -81.01 75.53 7.98 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.832 0.825 . . . . 0.0 109.359 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -166.0 93.7 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.403 ' HB3' ' NZ ' ' A' ' 84' ' ' LYS . 8.6 mtpm? . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 116.735 -1.603 . . . . 0.0 110.397 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -75.1 87.71 2.41 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 tpt -126.45 -41.1 1.9 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.217 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.43 21.06 0.65 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.17 -49.6 66.32 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.514 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.06 36.85 0.69 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.53 79.64 1.37 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 45.36 175.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.77 146.43 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.963 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.461 HG23 HE22 ' A' ' 79' ' ' GLN . 35.9 m -131.45 55.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.151 -1.386 . . . . 0.0 107.774 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.39 145.54 47.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.276 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 121.16 37.41 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.48 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.2 mpp? -126.19 132.4 51.78 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 87.8 tttt -119.11 90.53 3.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.686 1.241 . . . . 0.0 111.496 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -61.63 164.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.551 -1.659 . . . . 0.0 114.016 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 18' ' ' MET . 24.1 tt0 -90.96 110.52 21.78 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.14 -19.98 26.15 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.544 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.451 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 60.7 ttm 61.13 109.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.865 0.98 . . . . 0.0 111.919 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 t -83.39 48.32 1.38 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.91 -1.495 . . . . 0.0 112.029 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.0 m -150.49 -42.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.869 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -166.37 156.74 12.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.316 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -134.04 96.09 3.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 123.939 0.774 . . . . 0.0 109.262 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 50.2 t -83.59 24.49 0.85 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.258 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -65.91 -10.71 41.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.437 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.2 t -59.4 -35.02 73.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -75.13 -37.42 61.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.192 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.0 mt -61.58 -30.16 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 124.262 0.976 . . . . 0.0 109.836 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.08 -67.15 0.3 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.528 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.08 -10.14 84.09 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.771 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -80.68 -56.19 4.32 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.98 -30.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.352 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 -17.82 79.93 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 123.596 0.56 . . . . 0.0 111.902 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.56 -6.75 51.9 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.38 120.31 12.58 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -75.19 148.63 39.39 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.266 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.65 14.92 80.51 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 123.783 0.677 . . . . 0.0 111.831 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.3 128.7 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.189 0.519 . . . . 0.0 111.001 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.2 mm100 -87.45 -77.78 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.328 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.584 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 2.4 tpm_? -97.29 161.18 13.92 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.574 1.171 . . . . 0.0 110.039 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.571 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 8.6 tt -158.03 93.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -112.83 81.67 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.606 1.193 . . . . 0.0 110.434 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 98.0 t -84.62 133.0 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.984 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 26.6 t -81.32 166.58 20.36 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.742 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.33 -27.51 12.79 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.458 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -53.15 -68.48 0.17 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.063 0.852 . . . . 0.0 112.19 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.85 52.0 1.61 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 36.26 48.28 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.647 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 45.0 tt0 -73.2 91.87 1.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -83.79 125.65 32.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.535 -2.12 . . . . 0.0 112.068 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -130.99 68.48 1.49 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.817 1.294 . . . . 0.0 107.578 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -74.41 142.85 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.452 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 70.1 t -112.12 135.17 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -167.06 159.54 13.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.509 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 2.5 pm0 -87.3 140.59 32.27 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 124.773 1.296 . . . . 0.0 108.887 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.58 -54.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.842 2.361 . . . . 0.0 113.782 -151.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.528 ' CD2' HD22 ' A' ' 57' ' ' LEU . 38.2 p-80 -61.66 -3.17 0.98 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.6 mm? -79.16 -52.33 8.31 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.2 tt -171.04 163.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.318 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.6 m -108.81 110.55 21.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.95 -23.03 25.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.445 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.89 -29.14 68.96 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.692 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.27 -39.18 75.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.84 63.85 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.203 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.85 -19.81 21.32 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.1 -43.88 85.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.015 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -65.06 -29.24 70.11 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.136 0.897 . . . . 0.0 109.604 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -69.72 -33.61 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.02 -17.53 46.49 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.25 -37.56 28.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 124.42 1.075 . . . . 0.0 109.218 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -72.58 -14.12 61.55 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 124.051 0.845 . . . . 0.0 111.438 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.3 9.71 5.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 116.464 1.346 . . . . 0.0 116.464 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -113.92 78.31 4.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -50.55 135.85 40.87 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.272 1.982 . . . . 0.0 108.814 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.12 138.21 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.663 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 35.6 m-85 -86.98 70.87 10.33 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.36 131.72 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 112.258 -2.247 . . . . 0.0 111.969 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -100.09 99.56 10.3 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -54.73 -34.56 62.64 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.678 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.461 HE22 HG23 ' A' ' 10' ' ' VAL . 35.9 tt0 47.55 67.38 4.53 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 124.676 1.235 . . . . 0.0 110.957 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -62.89 137.0 60.21 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.556 2.171 . . . . 0.0 110.83 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.8 157.67 29.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.166 0.916 . . . . 0.0 109.874 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -25.79 101.49 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.139 1.525 . . . . 0.0 113.953 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 83' ' ' LEU . 3.0 mm? -64.43 -39.33 93.62 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.95 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.1 tptt . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 116.698 -1.62 . . . . 0.0 109.423 179.838 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.7 t -86.22 129.79 34.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.41 0.712 . . . . 0.0 110.496 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.4 ttm -85.88 96.85 9.92 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.35 -153.58 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.278 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -130.51 -58.36 1.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.15 -26.4 11.12 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.776 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.65 45.5 3.5 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -156.89 145.94 20.18 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.977 -0.611 . . . . 0.0 111.68 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 53' ' ' TYR . 2.6 m -142.2 105.02 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.992 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -83.79 58.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.705 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.61 147.15 32.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.615 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.584 ' HZ3' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -111.61 142.67 43.62 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.987 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.7 mpp? -132.02 137.02 47.67 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -121.84 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.41 1.069 . . . . 0.0 113.38 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -58.68 167.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 29.9 tt0 -94.58 123.36 37.97 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.13 27.36 2.36 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 121.29 -0.481 . . . . 0.0 111.968 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' GLU . 47.4 tpp 58.22 -108.62 0.42 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.671 0.788 . . . . 0.0 109.168 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -178.31 -23.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 123.488 0.492 . . . . 0.0 111.179 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.3 p -159.16 -17.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -142.77 83.91 1.83 Allowed 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.532 0.682 . . . . 0.0 110.795 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.2 m -89.06 109.66 20.48 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.45 22.0 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -62.3 -12.77 22.69 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -58.68 -41.65 86.7 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.4 p -73.06 -31.46 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.459 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.92 -26.6 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.496 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -49.78 -59.96 3.34 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.438 0.637 . . . . 0.0 109.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.23 -23.76 71.68 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -68.66 -49.19 61.09 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.43 -35.77 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 113.325 -1.762 . . . . 0.0 110.276 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.38 -19.91 79.73 Favored Glycine 0 N--CA 1.485 1.936 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.168 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -94.6 -4.48 47.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.44 136.32 53.94 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -88.93 139.54 30.35 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.922 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.16 7.11 88.83 Favored Glycine 0 N--CA 1.489 2.227 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.681 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.28 131.9 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-O 121.509 0.671 . . . . 0.0 110.919 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -95.4 -76.88 0.48 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.33 -1.759 . . . . 0.0 108.784 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -97.03 170.77 8.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.062 0.851 . . . . 0.0 110.382 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.87 129.17 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 123.891 0.744 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.495 ' NZ ' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -156.01 92.1 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.215 1.007 . . . . 0.0 109.111 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.1 138.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.049 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 22.7 t -86.17 175.67 8.38 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.444 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 44' ' ' LEU . 7.3 mp -95.93 176.6 6.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.522 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.68 -87.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.509 1.131 . . . . 0.0 112.912 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.52 12.86 2.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.371 0.419 . . . . 0.0 111.341 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 36.85 60.42 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.377 1.048 . . . . 0.0 112.62 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 43' ' ' SER . 35.0 tt0 -73.8 87.33 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -73.64 128.91 36.81 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -132.32 56.92 1.81 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.234 1.016 . . . . 0.0 108.715 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.5 mp -69.07 142.24 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.427 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.7 t -107.01 140.06 26.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 9' ' ' VAL . 39.3 p90 -155.77 163.32 39.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.398 1.061 . . . . 0.0 112.463 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -86.36 114.04 55.53 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.51 -32.55 70.33 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.486 2.124 . . . . 0.0 112.417 -162.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -60.97 -19.27 60.79 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -81.13 -55.18 4.93 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.574 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -175.03 161.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 125.013 1.446 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -94.56 118.55 31.86 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.81 -18.26 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.83 -36.68 84.02 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -40.58 83.32 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -69.56 -16.35 63.4 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.614 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 64' ' ' LYS . 3.8 mmmp? -97.3 -15.39 20.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -67.08 -37.05 83.31 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.354 0.409 . . . . 0.0 111.727 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -62.43 -36.74 83.33 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.726 0.642 . . . . 0.0 109.594 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -64.04 -34.55 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.2 -21.45 46.3 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.053 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.38 44.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.167 0.917 . . . . 0.0 109.625 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.2 ptm -74.87 -12.06 60.28 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.749 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.07 19.62 2.91 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 117.316 1.686 . . . . 0.0 117.316 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -124.63 70.93 57.82 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.07 133.7 41.54 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 122.236 1.958 . . . . 0.0 109.25 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -114.73 121.47 43.44 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.648 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -78.55 79.87 4.95 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.082 -2.326 . . . . 0.0 108.644 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t -97.78 137.71 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 113.483 -1.689 . . . . 0.0 109.948 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 77' ' ' LYS . 6.0 ttpm? -166.51 49.82 0.07 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 63.61 -84.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 113.641 -1.618 . . . . 0.0 107.301 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -131.42 80.09 68.24 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.584 ' CD ' ' HZ3' ' A' ' 12' ' ' LYS . 5.3 Cg_exo -60.72 75.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.933 2.422 . . . . 0.0 110.222 162.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -149.48 -32.28 0.21 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.107 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -64.32 169.49 4.6 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.44 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 pp -155.93 -174.6 5.02 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.772 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.516 ' HA ' ' HE2' ' A' ' 84' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.256 -1.355 . . . . 0.0 109.586 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.3 p -159.29 171.07 20.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.019 0.481 . . . . 0.0 110.743 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 3' ' ' MET . 3.7 mpp? -75.9 163.53 27.11 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.283 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.11 -43.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.286 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -155.84 91.75 1.32 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.36 -28.88 63.31 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.059 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 8' ' ' GLU . . . 176.69 -8.92 0.03 OUTLIER Glycine 0 N--CA 1.496 2.637 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.83 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' H ' ' H ' ' A' ' 7' ' ' GLY . 11.9 pt-20 -146.19 174.98 10.84 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.318 0.58 . . . . 0.0 111.046 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.15 132.6 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.98 109.48 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.963 0.789 . . . . 0.0 108.921 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.28 156.07 32.0 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.535 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -130.01 109.11 10.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.709 1.256 . . . . 0.0 111.017 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.531 ' N ' ' SD ' ' A' ' 13' ' ' MET . 3.5 mpp? -90.23 146.52 24.18 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -119.28 89.26 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 123.929 0.768 . . . . 0.0 112.731 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.0 t -72.57 167.34 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.807 0.813 . . . . 0.0 110.929 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.7 tt0 -110.34 107.6 17.38 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.85 5.83 0.77 Allowed Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.099 0.874 . . . . 0.0 115.026 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttm 56.55 -108.24 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 124.094 0.526 . . . . 0.0 110.031 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t 174.69 172.87 0.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 t 66.59 -73.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 124.124 0.89 . . . . 0.0 110.881 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.598 ' CE1' ' HG ' ' A' ' 23' ' ' CYS . 19.1 t-160 -134.3 133.15 40.42 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.415 ' O ' ' CZ ' ' A' ' 72' ' ' PHE . 22.1 t -79.99 -35.53 37.32 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.041 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.598 ' HG ' ' CE1' ' A' ' 21' ' ' HIS . 54.4 m 58.5 3.8 0.31 Allowed 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -75.13 -6.38 49.28 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 p -58.6 -38.89 78.93 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 109.811 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.226 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.41 -49.16 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.199 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -41.79 -61.32 1.13 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.598 1.186 . . . . 0.0 113.679 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.72 -31.89 76.99 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.134 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -73.89 -35.58 64.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.1 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.444 HG21 HG12 ' A' ' 51' ' ' ILE . 44.0 mt -70.25 -31.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.305 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.58 -18.76 77.39 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.87 -8.57 58.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.66 -0.77 . . . . 0.0 111.968 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.32 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -82.66 138.72 34.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.89 -0.58 76.59 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.259 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.9 t -84.27 144.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -96.19 -85.23 0.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.456 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 20.8 tpp85 -98.29 166.13 11.54 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.087 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.33 108.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -152.85 126.82 9.01 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.43 156.44 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.249 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 38.7 t -115.64 146.4 41.84 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.814 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 44' ' ' LEU . 8.0 mp -60.03 -8.13 2.17 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.19 77.49 4.69 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.731 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 51.47 66.04 1.31 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.677 0.751 . . . . 0.0 109.816 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 42.7 tp60 42.92 50.65 5.27 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.745 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 37.1 tt0 -74.78 84.64 2.16 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -69.63 144.34 52.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.722 -2.035 . . . . 0.0 112.481 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -141.46 64.95 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -80.5 135.02 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.039 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 82.7 t -104.71 138.56 28.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 103.509 -2.774 . . . . 0.0 103.509 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -150.18 171.31 17.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 124.351 1.032 . . . . 0.0 113.007 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -88.37 145.02 34.82 Favored Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.989 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -70.76 -67.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.796 2.331 . . . . 0.0 112.692 -158.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.446 ' CD2' HD22 ' A' ' 57' ' ' LEU . 26.9 p-80 -74.47 12.6 0.75 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -88.05 -60.95 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 tt -175.47 160.91 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 124.907 1.38 . . . . 0.0 110.21 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.9 p -103.89 119.18 38.38 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.237 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.83 -14.87 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.138 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.12 -14.78 26.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -68.06 -43.14 79.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.475 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 3.9 mmt -59.17 -40.07 84.5 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.176 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.82 67.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.704 1.252 . . . . 0.0 110.228 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -65.02 -46.4 81.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -66.24 -34.4 77.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.22 -32.97 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.85 -18.4 47.49 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.873 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.23 -37.58 32.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.061 0.851 . . . . 0.0 109.117 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptm -74.09 -12.29 60.56 Favored 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.068 0.855 . . . . 0.0 111.623 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.89 22.92 3.45 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HB3' HG13 ' A' ' 15' ' ' VAL . 19.4 m-85 -125.22 81.58 63.28 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -47.73 131.78 20.53 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.239 1.959 . . . . 0.0 110.116 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.3 117.19 26.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.915 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -83.78 69.5 10.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 112.228 -2.26 . . . . 0.0 108.942 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.62 119.03 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -71.72 -33.87 69.1 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.691 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -69.32 170.15 10.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -111.34 161.0 27.16 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 113.108 -1.86 . . . . 0.0 107.616 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.99 -178.5 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.115 1.877 . . . . 0.0 111.411 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -60.45 143.53 53.19 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.858 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.418 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 61.5 t80 -121.34 -178.97 3.92 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.011 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 1.1 pt? 38.35 -143.2 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 123.919 0.888 . . . . 0.0 112.887 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 116.424 -1.751 . . . . 0.0 108.108 179.816 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.8 p -160.39 145.09 14.47 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.111 0.536 . . . . 0.0 110.189 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtm -61.79 -45.33 94.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.07 0.856 . . . . 0.0 109.707 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.35 159.82 24.29 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.61 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -152.63 62.15 0.8 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.37 48.89 1.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.941 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.52 -176.24 24.57 Favored Glycine 0 N--CA 1.494 2.537 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.996 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.45 127.79 24.48 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.951 -1.124 . . . . 0.0 109.829 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.5 m -70.2 121.77 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.7 m -90.17 65.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.18 116.98 6.5 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 130.69 41.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.9 mtp -125.53 135.71 52.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 86.0 tttt -121.47 92.55 3.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.219 0.949 . . . . 0.0 112.587 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.29 167.26 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.212 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.2 tt0 -108.31 115.59 30.39 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 102.584 -3.117 . . . . 0.0 102.584 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.95 8.43 0.39 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 46.8 ttm 62.12 -124.74 0.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 t -177.68 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.2 t -83.15 -113.63 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 123.917 0.76 . . . . 0.0 109.711 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -79.7 179.67 7.39 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -151.26 158.05 43.38 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.731 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.8 t -152.72 32.52 0.5 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.202 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -69.78 -2.9 13.34 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.508 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.1 m -64.1 -34.27 77.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -65.49 -32.93 74.79 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.613 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 30' ' ' LYS . 62.9 mt -57.43 -33.93 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 124.336 1.023 . . . . 0.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.45 -68.03 0.22 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 123.867 0.73 . . . . 0.0 111.777 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -23.04 75.71 Favored Glycine 0 N--CA 1.495 2.631 0 CA-C-N 114.466 -1.243 . . . . 0.0 115.431 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 27' ' ' ILE . 6.7 ttpm? -69.71 -49.87 49.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -74.04 -27.17 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.556 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.35 -17.3 80.07 Favored Glycine 0 N--CA 1.487 2.055 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.47 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -86.4 -4.83 59.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.247 0.616 . . . . 0.0 111.614 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 37' ' ' VAL . 95.9 mt -69.33 126.68 30.53 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.853 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -74.5 145.04 43.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.219 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.94 13.67 82.36 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.346 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' LEU . 38.7 t -87.2 135.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 124.258 0.622 . . . . 0.0 109.581 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -95.46 -79.27 0.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.594 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.562 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.9 tpm_? -97.99 163.23 12.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.449 1.093 . . . . 0.0 110.029 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.562 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 11.7 tt -157.25 95.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -105.17 156.03 18.48 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.224 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 50.6 t -144.54 133.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 124.52 1.138 . . . . 0.0 107.957 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -112.3 138.06 49.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.288 0.992 . . . . 0.0 108.961 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.3 mt -58.22 -19.19 31.85 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.771 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.34 87.98 0.63 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.149 0.906 . . . . 0.0 108.685 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.46 50.99 17.73 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.351 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 39.52 47.55 1.63 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.093 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 41.3 tt0 -72.82 95.28 1.9 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -89.33 126.77 35.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.045 -1.889 . . . . 0.0 114.074 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.1 m -111.59 92.44 4.03 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.337 1.023 . . . . 0.0 109.199 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -92.19 141.49 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.894 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 60.7 t -122.64 141.91 41.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -161.75 162.67 29.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 124.201 0.938 . . . . 0.0 111.929 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.1 136.18 82.17 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-N 114.057 -1.428 . . . . 0.0 107.82 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.451 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -59.2 155.42 40.16 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.452 2.101 . . . . 0.0 110.953 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.451 ' CG ' ' O ' ' A' ' 55' ' ' PRO . 16.3 p80 52.75 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 117.128 2.269 . . . . 0.0 117.128 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.81 -41.77 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.6 tt -169.5 160.92 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 124.451 1.094 . . . . 0.0 111.391 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.3 p -97.66 108.39 21.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.306 -1.316 . . . . 0.0 109.185 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.22 -27.7 16.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.751 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.43 -18.16 62.34 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -82.28 -42.27 19.05 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.3 tpt -67.77 -34.15 76.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.648 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -78.7 -18.0 55.02 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.995 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -58.88 -29.18 66.82 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.005 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.2 -33.8 76.13 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.441 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 85.8 mt -65.2 -31.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.67 -23.99 39.22 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.663 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.4 -37.89 56.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.069 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.441 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.2 ptm -73.6 -14.12 61.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.891 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.41 5.45 7.2 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.432 ' HB3' HG13 ' A' ' 15' ' ' VAL . 21.2 m-85 -115.84 82.95 11.14 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -49.82 133.47 33.52 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.106 1.871 . . . . 0.0 109.943 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -121.35 115.9 23.81 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.05 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.51 71.38 7.36 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.416 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -86.85 90.3 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -147.23 73.16 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.774 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -64.29 -46.65 82.72 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.917 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -136.57 72.69 56.73 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.933 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -68.29 -42.51 5.5 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.916 2.411 . . . . 0.0 111.529 -170.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? 66.23 2.9 2.51 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 124.73 1.269 . . . . 0.0 110.636 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -138.29 176.44 8.69 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.43 44.95 1.22 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.174 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.807 -1.568 . . . . 0.0 109.556 -179.917 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.9 m -82.27 98.3 8.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.304 0.649 . . . . 0.0 110.459 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.6 ptp -73.91 149.8 41.25 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.306 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.92 -47.81 0.05 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -136.28 -25.51 1.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.022 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.99 122.01 17.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 123.945 0.778 . . . . 0.0 110.072 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.97 160.67 45.0 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.532 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.2 175.67 9.58 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.891 -0.655 . . . . 0.0 111.717 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.5 113.69 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.921 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.25 56.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.69 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 153.4 42.07 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.227 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.84 140.95 48.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.607 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.425 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 29.6 mtm -134.8 138.51 44.32 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -122.93 90.72 3.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.309 1.005 . . . . 0.0 112.351 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -64.27 170.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.999 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.9 tt0 -116.41 107.65 15.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 100.242 -3.984 . . . . 0.0 100.242 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.06 1.33 0.61 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 115.536 0.974 . . . . 0.0 115.536 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.5 ttm 79.72 -58.48 0.37 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 124.938 1.295 . . . . 0.0 109.066 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 t -164.93 -38.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.011 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 t -170.02 19.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.21 0.944 . . . . 0.0 110.403 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.7 m80 70.53 153.53 0.12 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 123.968 0.793 . . . . 0.0 111.359 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.6 t -164.42 -69.55 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m -75.37 0.66 16.11 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.043 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.4 p -61.83 -10.45 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.3 m -56.4 -35.52 67.85 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.9 p -71.27 -39.38 71.6 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 53.3 mt -57.03 -30.12 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 124.322 1.014 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.96 -63.98 1.01 Allowed 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.937 0.773 . . . . 0.0 109.193 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -9.02 81.95 Favored Glycine 0 N--CA 1.493 2.448 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.485 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -77.98 -55.96 4.87 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.2 mt -70.98 -29.93 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.699 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.14 78.2 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.593 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -95.59 0.29 52.73 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HB2' HG21 ' A' ' 37' ' ' VAL . 57.1 mt -68.69 114.34 6.97 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.207 0.527 . . . . 0.0 112.142 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.59 138.47 44.92 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.244 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.5 13.73 77.77 Favored Glycine 0 N--CA 1.489 2.21 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.759 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 34' ' ' LEU . 40.5 t -91.45 143.68 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -95.93 -83.52 0.37 Allowed 'General case' 0 N--CA 1.485 1.31 0 O-C-N 124.228 0.955 . . . . 0.0 108.712 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 7.7 tpt180 -98.55 164.46 12.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 124.588 1.18 . . . . 0.0 111.36 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 9.4 tt -146.04 124.37 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -146.07 78.01 1.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.403 1.096 . . . . 0.0 112.216 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 51.9 t -82.84 130.49 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 t -84.56 -178.73 6.97 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.445 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 44' ' ' LEU . 2.6 mm? -100.83 -177.36 3.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.998 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 54.26 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.039 0.837 . . . . 0.0 112.697 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -84.8 11.91 8.32 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.41 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 42.2 tt0 37.97 50.9 1.36 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.236 1.017 . . . . 0.0 109.308 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -67.53 89.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.042 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -78.97 124.65 28.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 112.245 -2.252 . . . . 0.0 110.786 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.0 m -129.78 58.01 1.66 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.642 1.21 . . . . 0.0 108.748 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.9 mp -66.92 140.84 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.839 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 89.8 t -106.11 136.1 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -157.21 167.91 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.48 -1.288 . . . . 0.0 114.12 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -84.12 127.58 66.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.27 -65.46 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.73 2.287 . . . . 0.0 114.014 -157.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.501 ' CD2' HD22 ' A' ' 57' ' ' LEU . 27.0 p-80 -68.95 -0.99 6.3 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.501 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.5 mm? -75.75 -48.14 23.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 tt -166.29 167.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.062 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.5 m -125.21 116.34 21.83 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.92 -17.93 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.377 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.86 -34.8 74.07 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -68.15 -41.41 81.66 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -34.94 79.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.893 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 34.1 mmtm -66.62 -28.34 68.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.254 0.971 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.31 -35.88 81.83 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.066 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -69.57 -38.6 77.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 124.411 1.069 . . . . 0.0 108.177 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 60.8 mt -65.91 -33.11 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 124.764 1.29 . . . . 0.0 108.073 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -82.84 -21.62 34.35 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.559 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.6 -37.53 42.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.053 0.845 . . . . 0.0 109.749 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.477 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 10.1 ptm -76.36 -11.94 59.98 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.08 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.28 17.44 2.69 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 118.31 2.084 . . . . 0.0 118.31 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -125.96 79.8 68.45 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-N 118.169 0.984 . . . . 0.0 109.444 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -47.4 136.81 19.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.6 2.2 . . . . 0.0 109.979 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.83 121.85 35.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.344 1.028 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -84.48 67.99 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.374 -2.194 . . . . 0.0 108.008 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.29 163.09 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.692 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -52.93 -28.1 21.94 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.419 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.1 -177.1 0.15 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.567 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 54.62 63.36 7.25 Favored Pre-proline 0 N--CA 1.498 1.968 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.014 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.19 162.74 34.55 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.871 2.38 . . . . 0.0 111.463 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 65.02 151.19 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.901 1.376 . . . . 0.0 111.598 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -148.48 120.97 8.5 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.547 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 83' ' ' LEU . 2.9 mm? 51.89 -89.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 124.534 1.146 . . . . 0.0 110.49 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.445 ' HZ3' ' HA ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 115.692 -2.099 . . . . 0.0 111.504 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.278 0.561 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.85 152.69 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.689 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.19 127.12 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 124.082 0.864 . . . . 0.0 111.412 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.74 95.89 4.23 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.915 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -86.63 88.12 7.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.415 ' HB2' ' HZ2' ' A' ' 64' ' ' LYS . 44.4 mtm -90.98 140.14 30.11 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.466 -1.697 . . . . 0.0 106.98 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.6 ttmm -109.99 97.54 7.02 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.832 1.333 . . . . 0.0 114.051 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -63.39 169.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.799 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 31.5 tt0 -112.9 131.23 55.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 100.48 -3.896 . . . . 0.0 100.48 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.46 16.88 1.21 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.856 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.455 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 2.2 ttp . . . . . 0 N--CA 1.5 2.058 0 C-N-CA 124.087 0.955 . . . . 0.0 110.077 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.404 ' C ' ' H ' ' A' ' 25' ' ' SER . 75.2 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.5 p 52.58 -8.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 23' ' ' CYS . 50.6 m -77.33 -38.59 50.08 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 102.974 -2.973 . . . . 0.0 102.974 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.6 p -69.13 -33.16 73.03 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.016 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -68.23 -31.38 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.124 0.89 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.94 -58.87 6.24 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.37 -20.74 77.08 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.708 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -70.84 -52.95 17.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -64.9 -34.38 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.254 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.82 -17.56 79.73 Favored Glycine 0 N--CA 1.487 2.08 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.156 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -95.54 1.52 53.9 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.4 mt -71.22 128.73 36.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.205 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -78.74 159.27 28.02 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.38 1.086 . . . . 0.0 112.639 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.62 14.74 70.15 Favored Glycine 0 N--CA 1.488 2.13 0 CA-C-N 112.145 -2.298 . . . . 0.0 110.517 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.77 133.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 114.778 -0.711 . . . . 0.0 111.635 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -93.36 -77.22 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 19.5 tpp85 -96.92 160.24 14.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.75 119.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.558 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -138.95 152.07 47.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -141.37 124.12 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 23.1 t -80.19 179.64 7.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 123.812 0.695 . . . . 0.0 110.714 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.5 mm? -100.27 173.53 6.56 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.802 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 56.59 -86.47 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 124.293 0.996 . . . . 0.0 112.11 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.25 10.61 4.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.2 0.313 . . . . 0.0 110.634 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 33.87 52.18 0.43 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.356 1.035 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 43.0 tt0 -67.48 95.66 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.629 -1.623 . . . . 0.0 107.849 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -74.03 126.71 31.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.728 -2.033 . . . . 0.0 110.78 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.9 m -126.48 88.25 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.6 mp -110.41 137.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.863 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.1 t -108.46 137.82 38.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.06 157.07 39.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.398 1.061 . . . . 0.0 111.312 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.4 pt20 -78.95 143.22 61.35 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 60.6 Cg_endo -85.71 40.14 0.75 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.019 2.479 . . . . 0.0 113.476 -162.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.521 ' CD2' HD22 ' A' ' 57' ' ' LEU . 32.3 p-80 -151.07 16.06 0.74 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.521 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.9 mm? -113.65 -59.69 1.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.8 tt -165.57 161.24 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.955 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.9 p -98.9 118.79 36.45 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.377 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.8 -18.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.474 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.33 -38.69 85.32 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.788 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.28 -39.03 85.97 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mmt -64.02 -33.49 75.85 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.057 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HZ2' ' HB2' ' A' ' 13' ' ' MET . 27.0 mtpt -80.13 -18.14 50.62 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.646 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.93 -29.73 70.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -71.3 -39.02 71.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 57.8 mt -62.68 -36.2 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -78.64 -27.04 45.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 -37.65 65.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.224 0.953 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -73.73 -15.86 61.2 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.152 0.907 . . . . 0.0 111.671 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.76 10.69 2.52 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 118.064 1.985 . . . . 0.0 118.064 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 18' ' ' MET . 59.9 m-85 -118.92 75.09 13.47 Favored Pre-proline 0 N--CA 1.5 2.06 0 CA-C-N 118.407 1.104 . . . . 0.0 109.718 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -48.9 139.25 25.62 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.825 2.35 . . . . 0.0 111.253 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -122.91 133.24 54.41 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.045 0.926 . . . . 0.0 111.648 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.89 74.81 10.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.372 -2.194 . . . . 0.0 106.785 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-N 113.555 -1.657 . . . . 0.0 111.301 -179.852 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.55 ' CB ' HE22 ' A' ' 38' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 53' ' ' TYR . 14.3 m -145.55 126.64 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.259 0.975 . . . . 0.0 109.767 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 11' ' ' LEU . 18.3 m -94.48 115.7 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 10' ' ' VAL . 3.1 mm? -114.66 110.49 19.83 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.372 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.442 ' C ' ' SD ' ' A' ' 13' ' ' MET . 2.3 mppt? -100.84 130.1 46.81 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 4.9 mpp? -144.25 139.13 28.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 65.1 tttp -105.15 151.53 23.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 125.149 1.53 . . . . 0.0 107.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -127.68 169.6 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 124.205 0.941 . . . . 0.0 110.729 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 18' ' ' MET . 31.5 tt0 -92.37 111.39 22.95 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.37 5.2 5.57 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-O 119.55 -0.583 . . . . 0.0 114.358 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.482 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 52.0 ttp . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -72.31 -13.54 61.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.369 -1.287 . . . . 0.0 113.379 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 p -55.33 -38.2 68.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.858 0.724 . . . . 0.0 109.476 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -77.12 -37.28 54.45 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.0 mt -61.0 -36.15 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 123.997 0.81 . . . . 0.0 110.882 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.76 -64.98 0.74 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.727 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.22 -18.98 73.68 Favored Glycine 0 N--CA 1.497 2.701 0 CA-C-N 113.593 -1.639 . . . . 0.0 114.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -77.15 -53.89 7.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.415 ' CG2' HG12 ' A' ' 51' ' ' ILE . 57.2 mt -69.84 -23.76 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.679 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.59 -13.79 83.12 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -95.32 2.3 54.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 124.333 0.666 . . . . 0.0 111.692 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.17 130.78 43.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -83.22 146.77 28.4 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.52 12.59 84.22 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.718 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.1 t -93.75 142.19 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.55 HE22 ' CB ' ' A' ' 8' ' ' GLU . 29.3 mt-30 -95.81 -81.97 0.39 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 12.8 tpt180 -97.15 154.81 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.1 115.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -151.88 167.09 29.44 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 57.2 t -136.96 147.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 124.624 1.203 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 37.7 t -104.37 150.21 24.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.887 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -67.31 1.56 2.11 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.091 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -83.39 66.48 8.87 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 m120 54.35 71.93 0.49 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.715 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 5.3 tp-100 41.71 47.2 3.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.803 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 39.6 tt0 -79.63 87.65 5.17 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.168 1.461 . . . . 0.0 107.284 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.37 138.67 45.46 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.721 -2.49 . . . . 0.0 114.721 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.2 m -140.5 90.57 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.1 mp -98.64 130.37 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.436 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 39.5 t -106.38 134.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.4 p90 -148.56 171.2 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.199 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.97 145.65 81.42 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 124.095 0.872 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -71.17 0.86 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.46 2.773 . . . . 0.0 115.432 -150.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -154.17 23.46 0.49 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.49 -46.41 9.14 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.474 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.457 HG12 ' H ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -157.95 166.43 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 124.043 0.839 . . . . 0.0 111.482 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.457 ' H ' HG12 ' A' ' 58' ' ' ILE . 58.2 p -117.38 107.4 14.3 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.425 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.56 -26.93 32.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.234 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.21 -27.68 68.61 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.963 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.88 -41.37 78.43 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 mmt -61.84 -32.38 72.71 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.514 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -65.47 -34.71 78.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.976 0.798 . . . . 0.0 109.154 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.55 -34.75 77.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 123.492 0.495 . . . . 0.0 110.539 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -67.9 -38.71 83.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 124.162 0.914 . . . . 0.0 108.843 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 72' ' ' PHE . 83.5 mt -67.61 -28.63 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.236 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -86.52 -22.14 26.54 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.189 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.92 -36.74 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.05 0.843 . . . . 0.0 109.519 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -13.43 60.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.68 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -6.69 5.39 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 118.671 2.229 . . . . 0.0 118.671 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.0 m-30 -106.52 93.68 8.81 Favored Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 119.203 1.502 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -45.31 137.18 10.87 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.972 1.781 . . . . 0.0 109.577 166.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.13 126.35 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.521 1.138 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 39.7 m-85 -85.46 91.18 8.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.37 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.498 1.953 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.806 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.53 0.681 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 m -129.84 146.54 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.2 m -128.59 99.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 124.66 1.225 . . . . 0.0 110.067 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 11' ' ' LEU . 5.7 mp -104.81 120.12 40.63 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.051 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 2.3 mppt? -99.86 90.05 4.29 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.892 0.745 . . . . 0.0 109.701 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -82.62 139.65 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -109.42 96.28 6.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.789 1.305 . . . . 0.0 113.728 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.1 t -60.94 159.64 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 18' ' ' MET . 35.1 tt0 -82.59 109.69 17.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.16 -7.79 7.6 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.874 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.481 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 31.0 tpp . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.383 0.611 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.1 p -69.71 -0.47 7.03 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -66.01 -31.85 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -64.41 -37.69 88.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.203 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.26 -32.83 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 124.534 1.146 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.96 -70.36 0.17 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.145 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -12.4 66.87 Favored Glycine 0 N--CA 1.497 2.752 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.55 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -82.87 -59.49 2.48 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.906 0.86 . . . . 0.0 108.817 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.01 -2.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.023 -1.898 . . . . 0.0 112.59 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.83 -17.36 19.06 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.804 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -96.85 7.35 46.8 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -82.71 140.5 33.04 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -85.94 161.52 18.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.626 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.07 87.19 Favored Glycine 0 N--CA 1.489 2.168 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 34' ' ' LEU . 71.1 t -111.81 145.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 124.626 0.839 . . . . 0.0 112.756 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -94.76 -83.22 0.35 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.493 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.5 tpp85 -98.16 163.17 12.85 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.023 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' C ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -152.05 117.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -153.26 112.7 3.83 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.369 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 44.4 t -93.4 150.53 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.952 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.5 t -109.03 141.32 41.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.581 1.176 . . . . 0.0 110.087 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.4 mm? -56.86 -21.68 31.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 124.35 1.031 . . . . 0.0 110.118 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.19 87.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.659 1.225 . . . . 0.0 108.708 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 52.51 40.25 29.41 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 45.63 47.7 11.44 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.436 1.112 . . . . 0.0 108.584 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.01 92.99 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.363 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -67.26 130.49 43.26 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.482 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.9 m -131.34 92.53 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -97.54 135.65 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.168 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 26.3 t -107.96 137.85 37.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -162.84 166.09 24.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.683 1.24 . . . . 0.0 113.679 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.08 132.55 39.45 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.079 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.18 38.36 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.368 2.712 . . . . 0.0 114.464 -155.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.477 ' CD2' HD22 ' A' ' 57' ' ' LEU . 28.3 p-80 -156.23 18.46 0.35 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -95.91 -56.2 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.445 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.19 164.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.027 0.829 . . . . 0.0 110.619 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -74.14 109.26 7.5 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.495 1.141 . . . . 0.0 110.019 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.62 -26.88 6.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 112.642 -2.072 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.23 -24.49 61.39 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.427 -1.26 . . . . 0.0 107.686 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.84 -38.09 79.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -63.17 -40.52 97.78 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.515 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -78.14 -10.92 59.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 124.279 0.987 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -74.49 -29.71 61.53 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.06 -30.62 71.11 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.381 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.426 HG22 ' HB2' ' A' ' 72' ' ' PHE . 88.0 mt -65.89 -30.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 114.69 -1.141 . . . . 0.0 107.998 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.54 -24.1 36.81 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.695 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.49 -37.36 60.25 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.425 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -74.46 -12.2 60.43 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.737 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 1.59 9.33 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 116.797 1.479 . . . . 0.0 116.797 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.426 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.8 m-85 -112.6 82.58 4.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 117.447 0.624 . . . . 0.0 109.503 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.51 130.12 34.99 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 121.819 1.679 . . . . 0.0 109.755 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -111.54 109.58 19.57 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.847 -1.979 . . . . 0.0 106.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -69.13 89.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 112.109 -2.314 . . . . 0.0 109.608 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 . . . . . 0 N--CA 1.505 2.316 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.69 124.07 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.765 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.6 m -100.69 101.82 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.293 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.98 116.89 33.66 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -93.78 111.86 23.62 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.435 ' SD ' HG13 ' A' ' 76' ' ' VAL . 31.9 mtm -114.33 143.77 44.34 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.538 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -120.11 98.04 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.0 t -70.67 168.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.615 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 36.6 tt0 -103.12 127.37 50.41 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.6 21.67 1.92 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.723 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 16' ' ' GLU . 54.3 tpp . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.036 0.445 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -63.69 -12.09 31.38 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.3 t -59.21 -44.39 92.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 p -72.37 -31.07 65.27 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.08 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.499 ' HB ' HE22 ' A' ' 47' ' ' GLN . 45.4 mt -65.08 -36.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 123.889 0.743 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.11 -51.31 66.8 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -34.5 87.26 Favored Glycine 0 N--CA 1.495 2.591 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.084 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -63.52 -40.31 96.71 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.71 -32.33 44.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.873 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.73 -13.4 82.23 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -94.85 3.48 54.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.562 0.801 . . . . 0.0 110.569 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.28 119.46 24.62 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.15 148.19 32.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.087 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.05 -0.37 87.52 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -82.22 138.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 124.046 0.498 . . . . 0.0 110.227 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -95.63 -78.19 0.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -97.84 165.98 11.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.255 0.972 . . . . 0.0 109.856 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.39 111.36 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HB2' ' HB ' ' A' ' 50' ' ' THR . 60.0 mtpt -124.42 69.46 1.09 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.145 0.974 . . . . 0.0 109.637 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.427 ' CG1' HE21 ' A' ' 47' ' ' GLN . 58.8 t -82.62 112.26 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 113.611 -1.631 . . . . 0.0 106.647 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.485 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 33.1 t -85.79 177.26 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.337 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.5 mp -96.84 -168.02 1.64 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.98 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.72 -103.96 0.2 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.02 0.825 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -93.49 25.03 3.64 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.499 HE22 ' HB ' ' A' ' 27' ' ' ILE . 53.9 tt0 32.16 80.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 43' ' ' SER . 83.7 tt0 -75.97 90.38 2.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.62 113.39 13.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.408 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 54.7 m -122.01 78.13 1.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.021 -1.445 . . . . 0.0 107.452 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -90.16 136.5 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.213 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -113.71 140.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.52 162.89 40.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.37 1.044 . . . . 0.0 112.092 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -65.74 144.59 98.92 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.82 7.04 3.36 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.908 2.406 . . . . 0.0 114.294 -157.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.455 ' CD2' HD22 ' A' ' 57' ' ' LEU . 10.0 p-80 -156.96 19.66 0.31 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.3 mm? -86.06 -49.57 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.575 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.86 160.14 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 124.254 0.972 . . . . 0.0 110.761 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.8 m -98.8 110.82 23.37 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.76 -18.02 21.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.998 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.74 -32.48 74.0 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.951 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.94 -40.4 87.56 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.8 mmt -63.58 -33.77 76.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.756 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' HD12 ' A' ' 67' ' ' ILE . 14.1 mptt -77.96 -21.83 50.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.1 0.875 . . . . 0.0 109.738 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -66.37 -30.25 70.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.01 -40.76 78.49 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.432 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 78.6 mt -64.39 -31.94 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.112 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.58 -21.06 30.54 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.965 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.84 -38.09 46.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.026 0.829 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.3 ptm -74.15 -12.94 60.73 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.051 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 6.76 7.61 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -112.33 88.2 10.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -47.27 133.49 19.54 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 121.971 1.78 . . . . 0.0 109.222 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.88 123.81 33.62 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -82.55 64.46 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.338 -1.755 . . . . 0.0 108.681 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.435 HG13 ' SD ' ' A' ' 13' ' ' MET . 61.4 t . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 . . . . . 0 N--CA 1.506 2.362 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 m -117.29 153.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.291 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.21 68.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.315 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.27 109.35 1.1 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -81.66 82.86 7.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.499 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 11.0 ttp -80.13 125.55 29.96 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.269 1.033 . . . . 0.0 109.383 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.06 80.39 1.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 111.577 -2.556 . . . . 0.0 106.419 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -66.76 165.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.606 -1.634 . . . . 0.0 111.684 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 18' ' ' MET . 13.0 tp10 -107.49 137.3 45.77 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.491 ' H ' HD22 ' A' ' 46' ' ' ASN . . . -72.9 12.95 3.44 Favored Glycine 0 N--CA 1.49 2.251 0 O-C-N 123.801 0.688 . . . . 0.0 113.708 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.422 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 38.1 ttm . . . . . 0 N--CA 1.5 2.046 0 C-N-CA 123.732 0.813 . . . . 0.0 112.432 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.5 p -62.88 -7.99 6.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.127 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.4 p -58.59 -34.78 71.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -71.21 -40.53 71.08 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.162 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.88 -35.71 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.913 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.7 -65.85 0.51 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.067 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.61 -22.83 70.13 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.895 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -70.86 -44.83 65.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.42 HG21 HG12 ' A' ' 51' ' ' ILE . 71.7 mt -72.58 -33.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.12 -14.59 71.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -95.45 3.03 54.67 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.101 -1.05 . . . . 0.0 111.622 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.45 116.38 25.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.04 0.447 . . . . 0.0 111.857 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.34 150.5 43.43 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.886 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.08 17.75 71.29 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 123.912 0.758 . . . . 0.0 111.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.66 137.48 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.552 HE22 ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -93.26 -81.98 0.35 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.764 1.29 . . . . 0.0 108.068 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 7.0 tpm_? -97.3 162.79 13.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.631 1.207 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.656 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.2 tt -158.45 111.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.647 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 139.74 9.62 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.373 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.2 t -108.03 158.08 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.561 -1.654 . . . . 0.0 112.653 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -135.23 176.52 8.6 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.473 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.6 mp -67.69 -146.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.274 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 53.04 52.98 12.72 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.491 HD22 ' H ' ' A' ' 17' ' ' GLY . 6.9 m120 55.19 84.41 0.07 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.347 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 3.1 tp-100 35.73 57.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.139 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.47 87.97 2.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -85.13 141.3 30.31 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.542 -1.663 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.5 m -135.77 70.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -73.91 138.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.437 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.3 t -114.7 135.79 53.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -163.83 169.6 18.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.668 1.23 . . . . 0.0 112.245 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.552 ' H ' HE22 ' A' ' 38' ' ' GLN . 5.1 pt20 -95.21 122.23 60.27 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 124.389 1.056 . . . . 0.0 108.524 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 -34.92 17.05 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.633 2.222 . . . . 0.0 112.392 -168.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.45 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 6.8 p-80 -57.13 -30.69 64.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -73.44 -47.39 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 tt -170.63 161.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.5 m -112.65 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.894 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.3 -13.8 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.292 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.6 -38.38 77.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.43 -41.42 89.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 mmt -65.47 -26.46 67.94 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.384 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -71.78 -30.0 65.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.311 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -63.61 -32.86 74.47 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.81 -39.85 87.87 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.366 1.041 . . . . 0.0 108.894 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.41 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 74.6 mt -65.14 -31.95 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.74 -19.68 30.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.88 41.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.072 0.858 . . . . 0.0 108.91 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.7 ptm -74.04 -12.09 60.52 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.648 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.31 9.11 8.86 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 117.834 1.894 . . . . 0.0 117.834 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.67 91.28 20.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -47.08 131.21 17.23 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.731 1.621 . . . . 0.0 108.788 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.27 104.6 7.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.463 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -85.45 92.3 8.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.431 -2.168 . . . . 0.0 109.113 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.693 179.902 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.428 ' HB3' HE21 ' A' ' 38' ' ' GLN . 9.9 pt-20 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.58 0.705 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 11' ' ' LEU . 17.5 m -64.55 125.2 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -94.63 69.56 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.416 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.419 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 3.9 mm? -66.24 117.12 8.07 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.031 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -104.96 105.68 15.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.392 1.058 . . . . 0.0 108.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.489 ' SD ' ' HG2' ' A' ' 64' ' ' LYS . 31.9 mtm -95.46 140.66 30.0 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -126.16 81.96 2.04 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.5 t -70.45 173.57 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.385 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 30.5 tt0 -100.23 111.22 23.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 103.52 -2.771 . . . . 0.0 103.52 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.18 -25.77 48.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.039 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 18' ' ' MET . 12.7 tmm? . . . . . 0 N--CA 1.497 1.876 0 O-C-N 124.519 0.776 . . . . 0.0 111.566 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 121.029 0.443 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 p -80.33 -2.98 47.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 m -61.14 -44.66 96.98 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.9 p -69.48 -34.5 74.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.352 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.44 -40.74 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.588 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -59.1 -55.93 28.78 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.645 0.736 . . . . 0.0 109.824 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.5 -30.9 75.72 Favored Glycine 0 N--CA 1.496 2.671 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.278 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' C ' ' HD3' ' A' ' 30' ' ' LYS . 7.7 tmtm? -69.54 -42.46 74.57 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.96 -29.63 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.374 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.71 -24.0 76.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.39 -17.97 57.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.406 -0.897 . . . . 0.0 112.14 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.04 127.46 31.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.538 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.82 141.75 49.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.315 1.009 . . . . 0.0 109.764 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.91 11.62 70.0 Favored Glycine 0 N--CA 1.486 1.997 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.168 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.64 135.16 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.566 HE22 ' N ' ' A' ' 54' ' ' GLN . 2.4 mp0 -95.75 -78.14 0.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.17 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.47 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 5.8 tpp180 -96.97 154.73 17.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.718 1.261 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.44 HG13 HG13 ' A' ' 51' ' ' ILE . 8.9 tt -155.21 121.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.314 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -150.6 153.39 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.426 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.2 t -129.59 133.98 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 124.259 0.974 . . . . 0.0 108.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 66.6 m -105.31 149.42 26.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.684 1.24 . . . . 0.0 110.218 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 44' ' ' LEU . 1.2 pp -66.5 4.69 0.71 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.08 68.43 9.99 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.3 m120 55.63 72.4 0.49 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 54.9 tp60 40.99 54.72 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.311 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 43' ' ' SER . 28.8 tt0 -79.11 80.76 5.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.05 131.44 38.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.323 -2.217 . . . . 0.0 109.918 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -131.57 72.0 1.49 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.021 0.915 . . . . 0.0 109.81 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.7 mp -81.76 137.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.015 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 10.9 t -114.05 146.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -165.56 177.05 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.763 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.566 ' N ' HE22 ' A' ' 38' ' ' GLN . 5.5 pt20 -86.9 125.78 65.5 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.58 68.02 8.2 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.235 2.623 . . . . 0.0 113.167 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 5.9 p-80 -172.23 -28.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.04 -44.62 38.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 123.965 0.791 . . . . 0.0 109.544 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -167.76 172.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.088 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.477 ' N ' HG13 ' A' ' 58' ' ' ILE . 51.5 m -119.22 110.89 17.55 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.01 -21.29 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.257 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.49 -39.31 91.77 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.756 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.79 -37.11 73.29 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -71.81 -22.45 61.56 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.583 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HG2' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -97.84 -9.15 26.91 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.49 -32.88 74.46 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.449 HE21 ' CG1' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -60.75 -24.04 65.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 123.99 0.806 . . . . 0.0 110.516 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.449 ' CG1' HE21 ' A' ' 66' ' ' GLN . 81.1 mt -70.63 -33.17 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.4 -27.79 46.76 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.48 -35.31 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.691 1.244 . . . . 0.0 109.947 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' CE1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -69.72 -19.33 63.55 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 123.905 0.753 . . . . 0.0 110.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.85 3.3 5.01 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 118.429 -1.206 . . . . 0.0 116.041 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 3.4 m-30 -106.99 86.19 2.29 Favored Pre-proline 0 N--CA 1.5 2.039 0 CA-C-N 118.477 1.138 . . . . 0.0 108.649 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.59 130.77 34.71 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 121.094 1.196 . . . . 0.0 109.044 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.24 124.93 51.05 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.745 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.74 -48.12 41.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.591 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.462 HG21 ' NZ ' ' A' ' 64' ' ' LYS . 23.8 t . . . . . 0 N--CA 1.495 1.798 0 O-C-N 125.312 1.632 . . . . 0.0 113.499 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' CB ' HE22 ' A' ' 38' ' ' GLN . 10.3 pt-20 . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.99 150.24 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.052 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.71 57.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 124.409 1.068 . . . . 0.0 108.941 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.3 141.17 41.7 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.19 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -103.49 104.86 14.98 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.448 ' SD ' HG13 ' A' ' 76' ' ' VAL . 16.8 mmm -89.49 109.97 20.85 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.68 85.53 2.76 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.328 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.14 168.01 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.482 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.8 tt0 -110.94 142.15 43.42 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.581 ' H ' HD22 ' A' ' 46' ' ' ASN . . . -80.96 29.93 2.68 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.465 ' H ' ' C ' ' A' ' 16' ' ' GLU . 31.8 ttm . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 78.2 m . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.3 p -64.03 -7.61 9.13 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.769 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.6 p -62.27 -40.44 96.23 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 p -68.6 -33.62 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.298 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.54 -42.24 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.06 0.85 . . . . 0.0 108.939 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.35 -50.31 74.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.494 0.664 . . . . 0.0 110.828 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.32 -36.5 93.28 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.7 -1.591 . . . . 0.0 113.835 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.61 -51.34 10.8 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.997 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.18 1.48 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.56 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.21 -28.05 3.72 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.407 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -96.5 8.92 42.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.154 0.502 . . . . 0.0 111.811 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -74.04 135.54 43.06 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.309 1.052 . . . . 0.0 113.279 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -88.0 156.42 19.32 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.602 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.74 8.68 82.16 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 34' ' ' LEU . 54.3 t -99.68 144.09 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.487 HE22 ' CB ' ' A' ' 8' ' ' GLU . 32.8 mt-30 -96.04 -82.31 0.39 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.176 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -97.97 169.13 9.85 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.54 1.15 . . . . 0.0 111.625 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.609 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 11.0 tt -153.78 131.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.497 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 140.28 38.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -140.08 137.16 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.842 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t -102.62 170.12 8.22 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.279 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.3 mp -93.0 -166.22 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.805 -1.088 . . . . 0.0 108.406 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 58.54 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.581 HD22 ' H ' ' A' ' 17' ' ' GLY . 23.9 m120 -100.51 34.07 2.52 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.293 0.568 . . . . 0.0 111.006 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 33.96 58.73 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.559 -1.2 . . . . 0.0 114.213 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.67 96.89 2.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.45 121.79 36.35 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.512 -1.677 . . . . 0.0 111.552 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.3 m -115.27 93.92 4.5 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 51' ' ' ILE . 1.7 mp -102.15 136.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.928 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 75.1 t -101.79 132.41 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -155.84 176.64 12.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.65 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.11 112.06 57.06 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 112.422 -2.172 . . . . 0.0 107.074 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.61 -49.68 3.06 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.946 2.431 . . . . 0.0 110.225 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -57.83 -22.45 47.79 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 57' ' ' LEU . 5.5 tp -90.12 -40.93 11.94 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.378 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 tt -161.78 162.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.586 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.7 p -126.94 109.19 11.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.622 1.201 . . . . 0.0 107.868 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.29 -17.16 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.72 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.94 -38.61 86.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -66.96 -40.58 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -64.03 -26.97 68.8 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.718 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -90.88 -19.62 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.827 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.5 -43.55 96.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.644 0.259 . . . . 0.0 111.292 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -66.89 -35.84 80.94 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.424 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 63.6 mt -67.5 -31.53 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.703 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.03 -20.07 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.695 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.5 -36.24 38.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 124.024 0.827 . . . . 0.0 109.436 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.424 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.2 ptm -75.27 -11.36 60.05 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.15 0.906 . . . . 0.0 111.525 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 19.22 2.94 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 117.991 1.956 . . . . 0.0 117.991 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB3' HG13 ' A' ' 15' ' ' VAL . 6.5 m-85 -125.0 73.89 65.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.4 132.1 15.51 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 122.185 1.923 . . . . 0.0 109.904 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.58 118.7 31.71 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.416 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -81.18 75.73 8.14 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.782 -2.463 . . . . 0.0 108.695 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG13 ' SD ' ' A' ' 13' ' ' MET . 74.9 t . . . . . 0 N--CA 1.497 1.875 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.756 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.727 0.775 . . . . 0.0 112.956 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 m -107.69 126.05 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 113.789 -1.55 . . . . 0.0 110.842 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.19 57.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.507 1.146 . . . . 0.0 109.866 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.89 135.33 56.46 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.892 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -105.12 140.05 38.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.432 ' SD ' HG12 ' A' ' 60' ' ' VAL . 4.4 mtt -139.21 131.5 28.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -119.03 95.81 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.521 1.138 . . . . 0.0 111.341 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.77 170.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-N 113.464 -1.698 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' A' ' 18' ' ' MET . 33.1 tt0 -95.6 116.5 28.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.4 19.32 7.11 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-O 119.078 -0.845 . . . . 0.0 114.189 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.444 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 53.9 ttp . . . . . 0 N--CA 1.495 1.808 0 C-N-CA 124.408 1.083 . . . . 0.0 113.336 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.7 p -66.6 -15.44 63.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.9 p -57.06 -38.91 73.94 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -83.33 -33.22 25.94 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.917 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.53 -30.0 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.931 0.769 . . . . 0.0 109.932 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -56.99 -67.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.77 -21.29 79.79 Favored Glycine 0 N--CA 1.494 2.549 0 CA-C-N 113.889 -1.505 . . . . 0.0 114.157 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -74.56 -52.79 10.84 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.49 -27.81 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.042 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.56 -16.22 78.19 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.155 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.21 2.02 54.82 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 124.183 0.578 . . . . 0.0 111.94 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.5 117.29 10.93 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.159 0.504 . . . . 0.0 112.228 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.457 ' CD ' ' H ' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -64.83 145.98 55.51 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.286 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.91 86.67 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.757 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.26 132.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.101 0.477 . . . . 0.0 110.343 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' NE2' ' NE2' ' A' ' 54' ' ' GLN . 14.0 mm-40 -94.64 -76.4 0.49 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.133 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.416 ' H ' ' HB ' ' A' ' 52' ' ' VAL . 9.5 tpt180 -97.65 165.87 11.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.203 0.94 . . . . 0.0 109.243 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 tt -155.98 131.51 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.578 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -157.93 84.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.346 1.07 . . . . 0.0 111.1 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.1 t -82.36 119.86 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -90.96 157.16 17.45 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.5 -110.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.428 -1.273 . . . . 0.0 107.745 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 p30 37.54 -122.82 0.22 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 119.237 0.926 . . . . 0.0 110.631 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -102.95 55.08 0.76 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 41.98 66.15 0.76 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.261 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -84.38 88.04 7.25 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 117.749 -1.58 . . . . 0.0 108.025 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 127.61 33.37 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 108.93 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -129.49 49.98 2.2 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.957 0.884 . . . . 0.0 108.986 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.8 mp -68.27 147.16 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.565 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 39' ' ' ARG . 99.5 t -113.91 144.32 21.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -156.39 157.83 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.346 1.029 . . . . 0.0 110.164 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' NE2' ' NE2' ' A' ' 38' ' ' GLN . 6.9 pt20 -86.26 146.39 42.33 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.42 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -58.98 155.25 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 123.03 2.487 . . . . 0.0 113.764 -161.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.438 ' CD2' HD22 ' A' ' 57' ' ' LEU . 7.9 p-80 52.86 -1.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 56' ' ' HIS . 4.6 mm? -72.97 -40.21 65.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.88 0.764 . . . . 0.0 109.307 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.481 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -161.27 174.42 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.793 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.481 ' N ' HG13 ' A' ' 58' ' ' ILE . 68.3 m -139.14 108.5 6.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 13' ' ' MET . 49.2 t -66.2 -19.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.527 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.54 -37.09 82.2 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -68.94 -39.38 79.6 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.2 mmt -66.26 -29.65 69.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.351 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -80.93 -21.89 40.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.731 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -63.96 -33.46 75.77 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -69.9 -39.58 76.13 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.75 -26.73 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.93 -1.486 . . . . 0.0 107.885 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.93 -21.12 25.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.245 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.27 -37.1 38.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.937 0.773 . . . . 0.0 108.959 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -12.03 60.29 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 124.27 0.982 . . . . 0.0 111.264 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.09 -7.06 6.06 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -103.66 95.27 7.16 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 119.076 1.438 . . . . 0.0 112.805 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -46.78 133.58 17.36 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.765 1.643 . . . . 0.0 109.519 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.46 112.28 17.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.64 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -78.45 84.25 4.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.669 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.626 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' CB ' HE22 ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.63 134.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 78.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 124.182 0.926 . . . . 0.0 111.089 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.32 138.91 36.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.338 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.74 117.78 33.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.452 ' SD ' ' N ' ' A' ' 13' ' ' MET . 3.3 mpp? -119.0 137.02 53.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 40.6 ttmt -119.59 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.923 1.389 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -65.38 167.81 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 18' ' ' MET . 39.2 tt0 -98.68 121.66 40.9 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.96 19.41 1.24 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.041 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.456 ' CE ' ' CE1' ' A' ' 72' ' ' PHE . 42.7 tpp . . . . . 0 N--CA 1.488 1.442 0 C-N-CA 124.949 1.299 . . . . 0.0 108.812 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 121.414 0.626 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -72.39 -0.99 13.91 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.6 t -61.79 -39.75 92.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -65.18 -34.35 78.17 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.51 -37.92 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.843 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -48.68 -61.5 2.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.9 0.75 . . . . 0.0 112.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.93 -29.24 71.94 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 114.045 -1.434 . . . . 0.0 112.781 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -70.43 -41.1 73.33 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.455 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.17 -33.88 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.6 76.95 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -89.69 -6.63 55.92 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.691 -0.755 . . . . 0.0 112.508 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.12 118.09 11.58 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.38 141.67 36.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.991 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.79 4.18 79.48 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.739 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.8 141.89 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.492 HE22 ' CB ' ' A' ' 8' ' ' GLU . 29.4 mt-30 -96.37 -79.44 0.45 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.781 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.529 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 2.6 tpm_? -96.81 159.63 14.81 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.84 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.474 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 5.4 tt -149.36 110.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -145.32 101.37 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.995 0.902 . . . . 0.0 111.237 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 49.3 t -93.65 149.3 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.293 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 37.3 t -111.66 144.53 40.77 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -25.76 60.28 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.421 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.45 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.074 0.859 . . . . 0.0 110.418 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.1 m120 45.18 53.31 8.02 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.446 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 44.38 49.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.963 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 35.4 tt0 -74.07 89.7 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -76.5 130.19 37.59 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 111.828 -2.442 . . . . 0.0 114.085 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 m -132.07 74.54 1.59 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.62 1.2 . . . . 0.0 107.984 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -83.58 132.03 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.869 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 42.7 t -105.13 138.61 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -156.63 179.65 9.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.543 1.152 . . . . 0.0 113.645 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -95.37 116.11 66.02 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.486 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.2 -54.59 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.87 2.38 . . . . 0.0 110.237 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -56.14 -22.42 28.37 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.053 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.07 -40.96 12.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.244 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 tt -163.88 162.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 124.451 1.095 . . . . 0.0 111.284 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -130.93 104.74 7.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -68.58 -17.9 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.393 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.7 -29.02 67.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.321 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.69 -41.2 79.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.5 mmt -62.53 -31.93 72.8 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.269 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -66.25 -34.06 77.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.991 0.807 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -61.24 -34.13 74.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.091 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -67.82 -38.69 83.55 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 124.252 0.97 . . . . 0.0 109.047 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.7 -33.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.23 -24.66 34.73 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.389 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.11 -36.43 58.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.23 0.956 . . . . 0.0 109.928 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -74.93 -13.63 60.55 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 123.805 0.69 . . . . 0.0 111.082 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.57 10.36 4.51 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 7.6 m-85 -118.34 88.37 32.98 Favored Pre-proline 0 N--CA 1.499 2.019 0 CA-C-N 118.268 1.034 . . . . 0.0 109.773 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -49.08 135.15 30.19 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.128 1.885 . . . . 0.0 109.408 173.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.21 122.08 30.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.749 1.28 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.63 77.94 9.77 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.131 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.532 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 N--CA 1.506 2.332 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.92 108.36 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 m -92.6 56.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.022 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -79.39 156.31 28.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 2.9 mptp? -120.66 94.86 4.5 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.893 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.3 mtm -82.37 135.28 35.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 62.8 tttp -116.93 90.47 3.34 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.721 1.248 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -54.02 167.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 112.722 -2.036 . . . . 0.0 115.126 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.446 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.4 tt0 -120.5 126.77 51.2 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.56 21.06 1.22 Allowed Glycine 0 N--CA 1.492 2.399 0 O-C-N 123.299 0.374 . . . . 0.0 113.407 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.425 ' H ' ' C ' ' A' ' 16' ' ' GLU . 36.0 ttp . . . . . 0 N--CA 1.496 1.859 0 O-C-N 124.295 0.644 . . . . 0.0 111.664 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.9 p -59.85 -8.79 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.651 -1.159 . . . . 0.0 113.419 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.2 p -56.25 -32.61 64.65 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.3 p -68.66 -39.78 80.47 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.386 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.3 mt -52.57 -30.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 124.502 1.126 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.25 -72.5 0.06 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.5 -12.77 80.29 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.533 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.83 -53.87 7.0 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.491 0.662 . . . . 0.0 109.301 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.16 -29.66 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.036 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.52 -14.68 81.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -95.49 1.05 53.83 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.72 -0.74 . . . . 0.0 112.805 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.422 HD21 ' SD ' ' A' ' 63' ' ' MET . 79.9 mt -72.29 125.34 27.11 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -83.89 144.5 29.17 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.531 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.95 10.7 84.69 Favored Glycine 0 N--CA 1.489 2.212 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.018 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.56 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -95.79 -83.83 0.36 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 19.4 tpp180 -98.45 166.59 11.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.592 1.182 . . . . 0.0 110.992 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.53 107.06 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -147.73 108.45 4.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.753 0.787 . . . . 0.0 110.845 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 54.8 t -97.18 139.68 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.1 t -100.63 171.07 7.94 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.773 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.4 mp -74.58 -115.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.168 -1.396 . . . . 0.0 108.183 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 p30 39.81 -133.32 0.22 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 119.272 0.942 . . . . 0.0 109.768 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -93.85 56.99 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 41.16 69.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.948 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 36.2 tt0 -79.35 90.91 5.01 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.48 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -70.74 129.4 39.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.254 -1.794 . . . . 0.0 108.052 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -129.53 69.14 1.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.414 1.102 . . . . 0.0 108.859 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -81.87 126.89 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.387 -1.733 . . . . 0.0 107.488 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 72.1 t -98.5 133.51 40.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -154.05 171.75 18.59 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.495 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.1 114.07 60.34 Favored Pre-proline 0 N--CA 1.494 1.742 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.228 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -62.5 -50.71 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.847 2.365 . . . . 0.0 111.313 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -60.06 -26.89 66.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.279 -1.328 . . . . 0.0 113.287 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 57' ' ' LEU . 4.6 tp -88.16 -36.38 16.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.407 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.28 162.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.782 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.1 m -132.0 106.62 8.14 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.9 t -76.36 -15.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.94 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.72 -32.74 73.57 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -71.0 -45.3 64.24 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.472 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.2 tpt -58.95 -31.68 68.94 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.787 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -76.02 -30.89 58.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.163 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -59.95 -31.55 69.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.251 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.03 -38.13 75.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.415 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 69.4 mt -66.88 -30.21 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.96 -22.11 33.85 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.276 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.31 -37.39 44.77 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 124.195 0.934 . . . . 0.0 109.28 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.6 ptm -72.59 -13.62 61.43 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.254 0.971 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.35 8.89 3.86 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -118.71 71.29 10.07 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 118.289 1.044 . . . . 0.0 110.325 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -47.69 130.55 18.86 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.184 1.923 . . . . 0.0 110.523 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -112.64 123.05 49.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.471 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -66.48 -3.01 5.29 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.954 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 50.3 t . . . . . 0 N--CA 1.508 2.435 0 O-C-N 123.899 0.749 . . . . 0.0 111.782 179.772 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.94 136.64 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.782 -2.008 . . . . 0.0 109.65 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.89 51.85 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 122.644 1.211 . . . . 0.0 109.111 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.5 mt -71.34 151.84 43.77 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.774 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -117.59 149.56 40.45 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.754 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.0 141.74 51.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.8 ttmt -127.97 84.16 2.22 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.2 t -62.99 170.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.459 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 34.0 tt0 -112.45 143.05 44.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.84 23.34 3.1 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.397 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.484 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 17.3 ttm . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.322 0.582 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.2 p -69.56 -6.98 34.49 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.725 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.8 m -57.49 -33.28 67.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.045 0.45 . . . . 0.0 109.909 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -67.79 -39.4 84.03 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.111 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.9 mt -52.66 -35.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.325 1.016 . . . . 0.0 111.699 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -49.84 -72.09 0.06 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.419 1.074 . . . . 0.0 112.162 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.74 -21.75 77.99 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.376 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -63.87 -40.57 96.85 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.8 -23.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.438 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.59 -12.23 83.89 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -91.88 -0.91 57.52 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.683 -0.759 . . . . 0.0 112.01 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 63' ' ' MET . 89.5 mt -73.26 126.06 29.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -85.58 140.58 30.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.135 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.71 1.54 85.25 Favored Glycine 0 N--CA 1.491 2.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.899 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.47 144.52 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -96.1 -82.85 0.38 Allowed 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.481 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.639 1.212 . . . . 0.0 109.881 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.656 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 10.7 tt -154.06 122.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.79 162.87 39.44 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.46 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.6 t -137.54 133.47 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 124.491 1.119 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 69.2 m -100.12 148.81 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.664 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.65 3.85 0.47 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -86.62 68.66 10.22 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.25 69.84 0.69 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.53 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 40.44 50.94 2.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.423 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 43' ' ' SER . 35.8 tt0 -76.74 85.23 3.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.79 128.13 34.68 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 112.675 -2.057 . . . . 0.0 113.793 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -118.58 72.26 0.87 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.834 0.709 . . . . 0.0 109.515 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.9 mp -72.79 139.07 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.368 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.1 t -115.83 132.15 66.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -151.72 163.43 39.16 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.521 1.138 . . . . 0.0 113.089 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -62.87 149.96 88.7 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.157 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.37 -4.04 14.78 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.986 2.457 . . . . 0.0 114.404 -153.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -160.53 27.42 0.16 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.85 -47.26 9.85 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.519 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.33 161.77 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 124.155 0.909 . . . . 0.0 111.47 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -104.28 113.67 27.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.479 1.112 . . . . 0.0 110.974 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.5 t -71.24 -25.19 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.981 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.3 -24.5 65.02 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.523 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -70.49 -41.46 72.66 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.49 -38.58 91.66 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 2.9 mmmp? -62.83 -33.06 74.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.584 1.177 . . . . 0.0 109.864 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.77 -43.44 98.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -65.54 -36.7 84.56 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 124.275 0.985 . . . . 0.0 109.158 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.41 -32.74 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.9 -20.61 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.913 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.55 -36.76 32.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.043 0.84 . . . . 0.0 109.738 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.493 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 1.9 ppp? -77.03 -12.01 59.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.33 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.19 23.31 1.78 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 117.804 1.882 . . . . 0.0 117.804 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' SD ' ' A' ' 70' ' ' MET . 9.3 m-85 -131.84 83.22 57.84 Favored Pre-proline 0 N--CA 1.494 1.756 0 CA-C-N 117.58 0.69 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -47.49 134.49 20.97 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 122.026 1.817 . . . . 0.0 108.738 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.98 114.99 18.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.69 1.244 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -85.67 71.12 10.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 111.744 -2.48 . . . . 0.0 108.499 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.498 1.975 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.97 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.12 0.486 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 9' ' ' VAL . 4.8 m -88.99 110.94 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.881 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.47 143.93 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.37 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 70.9 mt -127.99 152.73 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.903 0.752 . . . . 0.0 109.495 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' SD ' ' A' ' 13' ' ' MET . 63.6 tttm -147.96 109.25 4.32 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 2.9 mpp? -127.38 141.06 51.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.619 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.411 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 6.1 ttpm? -112.51 105.68 13.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.761 1.288 . . . . 0.0 109.033 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.2 t -70.05 160.52 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 18' ' ' MET . 33.0 tt0 -90.58 108.21 19.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.99 -14.0 22.13 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.846 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.436 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 53.7 tpp . . . . . 0 N--CA 1.497 1.924 0 C-N-CA 123.984 0.914 . . . . 0.0 110.732 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.1 p -80.69 -7.93 59.48 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.9 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.6 t -59.67 -38.83 82.58 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -71.58 -33.88 69.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.85 -36.38 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.169 0.918 . . . . 0.0 110.49 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.06 -64.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.909 0.755 . . . . 0.0 111.319 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.28 -27.15 71.18 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.058 -1.428 . . . . 0.0 113.09 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.49 -40.55 80.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.39 -29.05 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.49 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.34 -13.85 77.02 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.07 -4.93 58.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.485 -0.858 . . . . 0.0 112.282 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.405 HD21 ' SD ' ' A' ' 63' ' ' MET . 35.5 mt -73.53 119.35 17.64 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.34 138.12 33.67 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.061 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.36 77.52 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.56 126.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -87.34 -75.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.623 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 4.6 tpm_? -97.48 156.22 16.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.623 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.6 tt -153.27 115.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.43 114.37 3.0 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 34.8 t -108.46 147.56 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.408 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -88.77 -178.21 5.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -104.2 179.57 4.23 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.861 -1.518 . . . . 0.0 108.408 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 56.71 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 124.304 1.003 . . . . 0.0 111.269 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.78 12.38 3.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 123.421 0.45 . . . . 0.0 109.997 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 35.24 50.31 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 124.395 1.06 . . . . 0.0 111.517 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.78 92.74 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.234 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -75.55 131.55 40.11 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.357 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.6 m -135.98 70.02 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.036 0.922 . . . . 0.0 108.67 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -82.42 150.31 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.798 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 93.4 t -125.05 149.34 29.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 9' ' ' VAL . 6.8 p90 -162.07 161.22 28.22 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 123.997 0.81 . . . . 0.0 108.885 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.89 159.55 75.96 Favored Pre-proline 0 N--CA 1.499 1.985 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.421 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -83.6 42.2 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.495 2.13 . . . . 0.0 114.217 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.536 ' CD2' HD22 ' A' ' 57' ' ' LEU . 27.8 p-80 -159.78 -4.53 0.07 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 118.734 2.865 . . . . 0.0 118.734 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -89.1 -55.78 3.54 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 120.349 1.431 . . . . 0.0 109.54 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -164.29 161.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -88.13 110.07 20.38 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.881 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -66.56 -29.24 45.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.741 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.27 -23.36 64.06 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.534 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -70.92 -43.47 68.17 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.405 ' SD ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -66.25 -29.4 69.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 124.359 1.037 . . . . 0.0 110.524 179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -72.29 -28.36 63.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -69.85 -28.33 65.59 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.612 0.57 . . . . 0.0 110.066 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.57 -39.07 92.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 123.844 0.715 . . . . 0.0 109.094 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.25 -30.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.674 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.99 -24.52 24.65 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.023 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.97 -37.4 61.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 124.255 0.972 . . . . 0.0 109.356 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.23 -11.93 60.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.547 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.68 -3.88 8.65 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 1.9 m-30 -107.59 91.32 7.07 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 119.051 1.425 . . . . 0.0 109.272 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -50.74 132.21 35.89 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.71 1.607 . . . . 0.0 110.085 171.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -115.27 95.58 5.25 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.275 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.45 96.97 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 111.37 -2.65 . . . . 0.0 110.7 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.244 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.443 ' CB ' HE22 ' A' ' 38' ' ' GLN . 9.8 pt-20 . . . . . 0 N--CA 1.503 2.224 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.97 146.92 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.07 56.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.359 1.037 . . . . 0.0 109.825 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.8 mt -67.48 146.83 53.59 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HD3' HG23 ' A' ' 50' ' ' THR . 58.3 mmtt -106.91 136.47 46.7 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 3.5 mpp? -136.0 135.97 39.94 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 62.4 tttm -112.65 151.3 30.31 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.525 ' CG2' ' HZ1' ' A' ' 64' ' ' LYS . 2.1 t -131.36 167.48 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 124.579 1.174 . . . . 0.0 111.662 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 18' ' ' MET . 13.0 tp10 -94.43 133.55 37.91 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.73 19.38 9.42 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.662 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.449 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 52.1 ttp . . . . . 0 N--CA 1.501 2.107 0 O-C-N 125.102 1.119 . . . . 0.0 113.059 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 120.843 0.354 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -63.13 -15.25 56.14 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.546 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -53.14 -35.87 60.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 123.868 0.73 . . . . 0.0 109.751 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 p -73.79 -41.8 61.88 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.976 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.78 -36.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 124.292 0.995 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.22 -66.38 0.4 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.641 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.3 -12.15 84.61 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 114.002 -1.454 . . . . 0.0 115.033 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -84.45 -58.39 2.76 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -27.04 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.438 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.54 -12.05 80.89 Favored Glycine 0 N--CA 1.486 2.019 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.668 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.29 -7.81 57.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.191 0.519 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' A' ' 37' ' ' VAL . 35.2 mt -58.05 141.32 50.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.18 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -77.18 145.01 37.92 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.746 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.94 9.13 85.26 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.167 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 34' ' ' LEU . 18.8 t -79.75 133.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 124.263 0.625 . . . . 0.0 109.879 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.443 HE22 ' CB ' ' A' ' 8' ' ' GLU . 34.9 mt-30 -95.6 -82.13 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.635 -1.62 . . . . 0.0 107.609 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.0 tpp180 -98.49 164.87 12.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.445 1.09 . . . . 0.0 111.629 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 tt -147.47 117.74 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -142.53 74.4 1.44 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.802 1.287 . . . . 0.0 109.423 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 40.1 t -83.21 142.75 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.327 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.0 t -86.15 -179.6 6.76 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.506 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.7 179.83 4.16 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.762 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 55.36 -90.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 124.232 0.957 . . . . 0.0 110.776 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.2 16.98 0.85 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.317 0.386 . . . . 0.0 110.623 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 29.07 54.11 0.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.459 1.104 . . . . 0.0 112.947 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.4 tt0 -67.48 93.93 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.658 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -76.53 130.45 37.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.28 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' HD3' ' A' ' 12' ' ' LYS . 98.1 m -136.23 63.3 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.1 mp -72.22 135.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-N 113.879 -1.51 . . . . 0.0 108.476 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 90.8 t -102.02 135.24 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.94 162.77 40.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 124.816 1.323 . . . . 0.0 112.285 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -63.62 147.05 96.21 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.91 4.43 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.126 2.551 . . . . 0.0 114.462 -152.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -160.74 23.75 0.14 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.55 -45.74 13.2 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 59' ' ' SER . 8.3 tp -161.4 171.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.243 0.964 . . . . 0.0 110.707 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.475 ' N ' HG13 ' A' ' 58' ' ' ILE . 36.4 p -107.94 111.1 23.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.824 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.07 -28.17 29.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.313 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.45 -20.79 65.87 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.653 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.97 -43.06 65.77 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 mmt -64.13 -30.49 71.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.476 1.11 . . . . 0.0 109.562 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.525 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 3.0 mmmp? -64.02 -33.32 75.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.251 0.969 . . . . 0.0 109.119 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -65.26 -33.46 76.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.272 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -69.08 -39.06 79.27 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -66.48 -28.71 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.067 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.87 -22.6 25.65 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.088 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.5 47.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 123.993 0.808 . . . . 0.0 109.567 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -12.79 60.34 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.434 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.02 -4.81 6.42 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 118.899 2.319 . . . . 0.0 118.899 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -104.77 95.68 9.28 Favored Pre-proline 0 N--CA 1.504 2.251 0 CA-C-N 119.365 1.582 . . . . 0.0 110.494 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -51.13 134.04 42.64 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.403 1.402 . . . . 0.0 109.5 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -118.77 129.32 55.18 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.229 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.05 63.29 4.38 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 113.629 -1.623 . . . . 0.0 111.109 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.81 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HB3' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.088 0.47 . . . . 0.0 111.699 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.81 137.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.857 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.48 75.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.56 -20.8 65.04 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 50.52 94.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.543 ' SD ' ' N ' ' A' ' 13' ' ' MET . 2.9 mpp? -100.55 135.44 41.98 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.778 -1.555 . . . . 0.0 106.949 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -126.11 86.56 2.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 124.724 1.265 . . . . 0.0 107.712 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.19 165.64 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.638 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.4 tt0 -113.15 128.48 56.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.12 30.15 2.71 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.43 ' H ' ' C ' ' A' ' 16' ' ' GLU . 58.7 ttm . . . . . 0 N--CA 1.495 1.813 0 C-N-CA 123.228 0.611 . . . . 0.0 110.207 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -75.51 -1.29 23.56 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.442 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -69.15 -27.81 65.87 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.3 p -66.33 -35.31 80.04 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.25 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.22 -33.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 124.819 1.324 . . . . 0.0 110.82 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -48.85 -73.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.803 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.29 -21.9 66.34 Favored Glycine 0 N--CA 1.497 2.755 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.564 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -64.2 -34.06 77.21 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.367 0.603 . . . . 0.0 109.729 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.8 -21.98 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.958 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.83 -14.62 80.66 Favored Glycine 0 N--CA 1.487 2.088 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.738 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.82 1.98 56.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 124.208 0.593 . . . . 0.0 111.714 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.89 102.18 5.45 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.592 0.71 . . . . 0.0 112.855 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -75.6 119.73 20.04 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.57 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.88 9.26 12.52 Favored Glycine 0 N--CA 1.485 1.903 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.52 138.22 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.453 HE21 ' HG2' ' A' ' 54' ' ' GLN . 6.5 mt-30 -95.13 -77.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -96.84 153.4 17.91 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.16 118.26 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.829 -0.749 . . . . 0.0 112.439 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.27 161.27 21.83 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.08 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.99 134.56 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.604 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -104.18 176.18 5.24 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.882 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.1 mp -70.98 -150.37 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.512 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 53.41 58.03 5.6 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.976 0.893 . . . . 0.0 108.995 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 51.21 81.98 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.71 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 36.5 61.94 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.789 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.44 85.48 6.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -67.37 136.84 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 113.01 -1.905 . . . . 0.0 111.034 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.4 m -135.36 52.89 2.0 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -73.94 125.44 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.28 138.66 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.35 177.46 10.56 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 114.239 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG2' HE21 ' A' ' 38' ' ' GLN . 46.1 mt-30 -88.18 121.79 70.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 113.55 -1.659 . . . . 0.0 106.725 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -68.46 -54.96 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.275 1.983 . . . . 0.0 109.395 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -52.54 -26.02 12.03 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.86 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 tp -93.96 -47.61 6.63 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.17 168.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -132.14 111.25 11.29 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.438 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.02 -24.63 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.812 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.45 -18.94 54.53 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.719 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.96 -43.92 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -29.82 70.97 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.206 0.941 . . . . 0.0 109.727 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -64.04 -33.95 76.92 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.21 -32.0 73.29 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.504 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -69.65 -39.47 77.07 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 72' ' ' PHE . 94.5 mt -67.71 -28.44 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.842 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.901 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.5 -37.42 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 124.09 0.869 . . . . 0.0 109.271 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -12.7 60.45 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.653 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.89 -2.46 6.88 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.6 m-30 -107.88 91.78 8.11 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 118.744 1.272 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -47.16 134.76 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.041 1.828 . . . . 0.0 110.446 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.33 109.39 14.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 124.652 1.22 . . . . 0.0 108.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.29 79.64 7.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.175 -2.284 . . . . 0.0 108.878 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.494 1.773 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.964 -179.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.505 2.303 0 CA-C-O 121.001 0.429 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.32 130.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.68 91.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.977 0.894 . . . . 0.0 110.294 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.27 139.3 30.86 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -130.14 103.23 6.62 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.324 1.64 . . . . 0.0 106.87 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.573 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 50.6 mtp -104.87 145.44 30.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.54 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 39.4 ttpt -119.7 87.79 2.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.287 0.992 . . . . 0.0 111.55 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.37 164.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 3.1 mp0 -116.67 154.83 29.87 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.222 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 18.12 5.23 Favored Glycine 0 N--CA 1.484 1.858 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.572 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 N--CA 1.501 2.084 0 O-C-N 125.508 1.357 . . . . 0.0 109.285 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -72.94 -4.69 33.7 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.1 t -62.81 -37.4 86.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -66.62 -35.28 79.79 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.5 mt -57.03 -39.37 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 124.197 0.936 . . . . 0.0 111.502 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -51.42 -67.98 0.21 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.791 0.682 . . . . 0.0 112.585 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.21 -23.39 78.13 Favored Glycine 0 N--CA 1.496 2.664 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.635 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.3 -50.26 41.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.408 HG13 ' HZ3' ' A' ' 64' ' ' LYS . 43.6 mm -70.44 -27.52 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.604 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.08 -12.21 83.55 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.2 1.57 54.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 124.337 0.669 . . . . 0.0 111.401 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.4 mt -74.78 131.36 40.74 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.836 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -83.05 160.23 21.98 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 124.147 0.904 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.46 11.03 71.6 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.49 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.07 146.99 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -95.86 -83.93 0.36 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.588 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 3.2 tpm_? -98.33 160.87 14.01 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.1 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.588 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -158.47 107.93 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HZ3' HH11 ' A' ' 39' ' ' ARG . 0.1 OUTLIER -137.65 160.01 40.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.597 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -139.68 149.68 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 124.183 0.927 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 33.5 t -110.47 140.49 44.67 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.082 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tt -50.39 -35.15 26.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.73 1.269 . . . . 0.0 110.247 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -53.57 85.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.465 1.103 . . . . 0.0 111.373 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 m120 41.57 60.5 2.12 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.962 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 42.18 48.68 4.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.526 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 35.3 tt0 -74.68 89.97 2.28 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -80.75 146.02 31.22 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 112.094 -2.321 . . . . 0.0 114.519 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.4 m -138.77 78.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -88.74 136.24 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.066 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.3 t -107.91 135.21 47.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -154.98 172.35 18.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.05 116.99 67.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.17 -53.72 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.698 2.265 . . . . 0.0 110.129 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -57.73 -26.27 61.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.363 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.97 -38.15 14.68 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.791 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.66 159.88 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.377 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -129.3 95.93 4.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.91 -26.28 40.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 112.173 -2.285 . . . . 0.0 110.567 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.8 -35.14 70.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.174 0.921 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.16 -41.56 94.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.6 mmm -70.44 -27.35 64.18 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.51 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.573 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 71.8 mmtt -80.95 -18.61 46.46 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.506 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.46 -31.37 68.49 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -64.87 -35.39 80.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.002 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 72' ' ' PHE . 80.6 mt -64.72 -34.68 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -81.29 -20.32 41.08 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.581 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.55 36.52 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 ptm -75.56 -11.14 59.96 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.141 0.901 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.38 17.66 3.92 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' HB2' HG22 ' A' ' 67' ' ' ILE . 17.0 m-85 -123.05 82.57 50.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -51.25 141.75 38.57 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.097 1.864 . . . . 0.0 108.337 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -126.33 125.44 42.28 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.331 1.02 . . . . 0.0 108.927 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -82.63 83.38 7.65 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.19 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.496 1.86 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.729 -179.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 N--CA 1.504 2.264 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.77 146.43 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.963 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.45 55.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.151 -1.386 . . . . 0.0 107.774 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.39 145.54 47.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.276 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 121.16 37.41 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 13' ' ' MET . 3.2 mpp? -126.19 132.4 51.78 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 87.8 tttt -119.11 90.53 3.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.686 1.241 . . . . 0.0 111.496 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -61.63 164.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.551 -1.659 . . . . 0.0 114.016 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 18' ' ' MET . 24.1 tt0 -90.96 110.52 21.78 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.14 -19.98 26.15 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.544 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.451 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 60.7 ttm . . . . . 0 N--CA 1.497 1.925 0 O-C-N 124.865 0.98 . . . . 0.0 111.919 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -65.91 -10.71 41.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.437 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.2 t -59.4 -35.02 73.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -75.13 -37.42 61.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.192 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.0 mt -61.58 -30.16 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 124.262 0.976 . . . . 0.0 109.836 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.08 -67.15 0.3 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.528 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.08 -10.14 84.09 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.771 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -80.68 -56.19 4.32 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.98 -30.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.352 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 -17.82 79.93 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 123.596 0.56 . . . . 0.0 111.902 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.56 -6.75 51.9 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.38 120.31 12.58 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -75.19 148.63 39.39 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.266 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.65 14.92 80.51 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 123.783 0.677 . . . . 0.0 111.831 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.3 128.7 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.189 0.519 . . . . 0.0 111.001 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.2 mm100 -87.45 -77.78 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.328 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.584 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 2.4 tpm_? -97.29 161.18 13.92 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.574 1.171 . . . . 0.0 110.039 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.571 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 8.6 tt -158.03 93.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -112.83 81.67 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.606 1.193 . . . . 0.0 110.434 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 98.0 t -84.62 133.0 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.984 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 26.6 t -81.32 166.58 20.36 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.742 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.33 -27.51 12.79 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.458 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -53.15 -68.48 0.17 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.063 0.852 . . . . 0.0 112.19 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.85 52.0 1.61 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 36.26 48.28 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.647 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 45.0 tt0 -73.2 91.87 1.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -83.79 125.65 32.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.535 -2.12 . . . . 0.0 112.068 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -130.99 68.48 1.49 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.817 1.294 . . . . 0.0 107.578 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -74.41 142.85 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.452 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 70.1 t -112.12 135.17 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -167.06 159.54 13.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.509 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.409 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 2.5 pm0 -87.3 140.59 32.27 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 124.773 1.296 . . . . 0.0 108.887 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.58 -54.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.842 2.361 . . . . 0.0 113.782 -151.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.528 ' CD2' HD22 ' A' ' 57' ' ' LEU . 38.2 p-80 -61.66 -3.17 0.98 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.6 mm? -79.16 -52.33 8.31 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.2 tt -171.04 163.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.318 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.6 m -108.81 110.55 21.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.95 -23.03 25.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.445 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.89 -29.14 68.96 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.692 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.27 -39.18 75.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.84 63.85 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.203 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.85 -19.81 21.32 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.1 -43.88 85.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.015 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -29.24 70.11 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.136 0.897 . . . . 0.0 109.604 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -69.72 -33.61 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.02 -17.53 46.49 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.25 -37.56 28.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 124.42 1.075 . . . . 0.0 109.218 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -72.58 -14.12 61.55 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 124.051 0.845 . . . . 0.0 111.438 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.3 9.71 5.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 116.464 1.346 . . . . 0.0 116.464 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -113.92 78.31 4.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -50.55 135.85 40.87 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.272 1.982 . . . . 0.0 108.814 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.12 138.21 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.663 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 35.6 m-85 -86.98 70.87 10.33 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 N--CA 1.488 1.448 0 CA-C-N 112.258 -2.247 . . . . 0.0 111.969 -179.761 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.007 0.432 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 53' ' ' TYR . 2.6 m -142.2 105.02 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.992 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -83.79 58.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.705 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.61 147.15 32.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.615 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.61 142.67 43.62 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.987 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 13' ' ' MET . 3.7 mpp? -132.02 137.02 47.67 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -121.84 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.41 1.069 . . . . 0.0 113.38 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -58.68 167.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 29.9 tt0 -94.58 123.36 37.97 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.13 27.36 2.36 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 121.29 -0.481 . . . . 0.0 111.968 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' GLU . 47.4 tpp . . . . . 0 N--CA 1.49 1.531 0 C-N-CA 123.671 0.788 . . . . 0.0 109.168 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 120.809 0.337 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -62.3 -12.77 22.69 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -58.68 -41.65 86.7 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.4 p -73.06 -31.46 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.459 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.92 -26.6 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.496 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -49.78 -59.96 3.34 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.438 0.637 . . . . 0.0 109.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.23 -23.76 71.68 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -68.66 -49.19 61.09 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.43 -35.77 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 113.325 -1.762 . . . . 0.0 110.276 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.38 -19.91 79.73 Favored Glycine 0 N--CA 1.485 1.936 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.168 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -94.6 -4.48 47.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.44 136.32 53.94 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -88.93 139.54 30.35 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.922 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.16 7.11 88.83 Favored Glycine 0 N--CA 1.489 2.227 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.681 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.28 131.9 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-O 121.509 0.671 . . . . 0.0 110.919 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.4 -76.88 0.48 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.33 -1.759 . . . . 0.0 108.784 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -97.03 170.77 8.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.062 0.851 . . . . 0.0 110.382 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.87 129.17 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 123.891 0.744 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.495 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -156.01 92.1 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.215 1.007 . . . . 0.0 109.111 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.1 138.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.049 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 22.7 t -86.17 175.67 8.38 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.444 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.3 mp -95.93 176.6 6.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.522 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.68 -87.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.509 1.131 . . . . 0.0 112.912 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -80.52 12.86 2.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.371 0.419 . . . . 0.0 111.341 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 36.85 60.42 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.377 1.048 . . . . 0.0 112.62 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 43' ' ' SER . 35.0 tt0 -73.8 87.33 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -73.64 128.91 36.81 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -132.32 56.92 1.81 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.234 1.016 . . . . 0.0 108.715 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.5 mp -69.07 142.24 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.427 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.7 t -107.01 140.06 26.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 9' ' ' VAL . 39.3 p90 -155.77 163.32 39.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.398 1.061 . . . . 0.0 112.463 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -86.36 114.04 55.53 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.51 -32.55 70.33 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.486 2.124 . . . . 0.0 112.417 -162.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -60.97 -19.27 60.79 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -81.13 -55.18 4.93 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.574 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -175.03 161.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 125.013 1.446 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -94.56 118.55 31.86 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.81 -18.26 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.83 -36.68 84.02 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -40.58 83.32 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -69.56 -16.35 63.4 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.614 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 64' ' ' LYS . 3.8 mmmp? -97.3 -15.39 20.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -67.08 -37.05 83.31 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.354 0.409 . . . . 0.0 111.727 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -62.43 -36.74 83.33 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.726 0.642 . . . . 0.0 109.594 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -64.04 -34.55 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.2 -21.45 46.3 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.053 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.38 44.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.167 0.917 . . . . 0.0 109.625 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.2 ptm -74.87 -12.06 60.28 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.749 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.07 19.62 2.91 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 117.316 1.686 . . . . 0.0 117.316 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -124.63 70.93 57.82 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.07 133.7 41.54 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 122.236 1.958 . . . . 0.0 109.25 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -114.73 121.47 43.44 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.648 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -78.55 79.87 4.95 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.082 -2.326 . . . . 0.0 108.644 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.496 1.834 0 CA-C-N 113.483 -1.689 . . . . 0.0 109.948 -179.808 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.318 0.58 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.15 132.6 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.98 109.48 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.963 0.789 . . . . 0.0 108.921 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.28 156.07 32.0 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.535 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -130.01 109.11 10.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.709 1.256 . . . . 0.0 111.017 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' A' ' 13' ' ' MET . 3.5 mpp? -90.23 146.52 24.18 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -119.28 89.26 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 123.929 0.768 . . . . 0.0 112.731 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.0 t -72.57 167.34 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.807 0.813 . . . . 0.0 110.929 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.7 tt0 -110.34 107.6 17.38 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.469 ' H ' HD22 ' A' ' 46' ' ' ASN . . . -63.85 5.83 0.77 Allowed Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.099 0.874 . . . . 0.0 115.026 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.489 1.512 0 O-C-N 124.094 0.526 . . . . 0.0 110.031 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.4 m . . . . . 0 N--CA 1.502 2.173 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -75.13 -6.38 49.28 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 p -58.6 -38.89 78.93 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 109.811 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.226 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.41 -49.16 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.199 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -41.79 -61.32 1.13 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.598 1.186 . . . . 0.0 113.679 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.72 -31.89 76.99 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.134 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -73.89 -35.58 64.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.1 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.444 HG21 HG12 ' A' ' 51' ' ' ILE . 44.0 mt -70.25 -31.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.305 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.58 -18.76 77.39 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.87 -8.57 58.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.66 -0.77 . . . . 0.0 111.968 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.32 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -82.66 138.72 34.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.89 -0.58 76.59 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.259 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.9 t -84.27 144.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -96.19 -85.23 0.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.456 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 20.8 tpp85 -98.29 166.13 11.54 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.087 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.33 108.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -152.85 126.82 9.01 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.43 156.44 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.249 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 38.7 t -115.64 146.4 41.84 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.814 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.0 mp -60.03 -8.13 2.17 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.19 77.49 4.69 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.731 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.469 HD22 ' H ' ' A' ' 17' ' ' GLY . 12.6 m120 51.47 66.04 1.31 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.677 0.751 . . . . 0.0 109.816 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 5.9 tp-100 42.92 50.65 5.27 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.745 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 37.1 tt0 -74.78 84.64 2.16 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -69.63 144.34 52.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.722 -2.035 . . . . 0.0 112.481 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -141.46 64.95 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -80.5 135.02 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.039 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 82.7 t -104.71 138.56 28.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 103.509 -2.774 . . . . 0.0 103.509 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -150.18 171.31 17.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 124.351 1.032 . . . . 0.0 113.007 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.37 145.02 34.82 Favored Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.989 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -70.76 -67.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.796 2.331 . . . . 0.0 112.692 -158.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.446 ' CD2' HD22 ' A' ' 57' ' ' LEU . 26.9 p-80 -74.47 12.6 0.75 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -88.05 -60.95 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 tt -175.47 160.91 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 124.907 1.38 . . . . 0.0 110.21 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.9 p -103.89 119.18 38.38 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.237 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.83 -14.87 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.138 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.12 -14.78 26.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -68.06 -43.14 79.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.475 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 3.9 mmt -59.17 -40.07 84.5 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.176 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.82 67.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.704 1.252 . . . . 0.0 110.228 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -65.02 -46.4 81.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -66.24 -34.4 77.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.22 -32.97 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.85 -18.4 47.49 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.873 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.23 -37.58 32.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.061 0.851 . . . . 0.0 109.117 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptm -74.09 -12.29 60.56 Favored 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.068 0.855 . . . . 0.0 111.623 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.89 22.92 3.45 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HB3' HG13 ' A' ' 15' ' ' VAL . 19.4 m-85 -125.22 81.58 63.28 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -47.73 131.78 20.53 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.239 1.959 . . . . 0.0 110.116 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.3 117.19 26.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.915 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -83.78 69.5 10.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 112.228 -2.26 . . . . 0.0 108.942 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.338 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.324 0.583 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.5 m -70.2 121.77 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.7 m -90.17 65.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.18 116.98 6.5 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 130.69 41.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.9 mtp -125.53 135.71 52.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 86.0 tttt -121.47 92.55 3.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.219 0.949 . . . . 0.0 112.587 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.29 167.26 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.212 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.2 tt0 -108.31 115.59 30.39 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 102.584 -3.117 . . . . 0.0 102.584 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.95 8.43 0.39 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.896 0.379 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -69.78 -2.9 13.34 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.508 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.1 m -64.1 -34.27 77.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -65.49 -32.93 74.79 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.613 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 30' ' ' LYS . 62.9 mt -57.43 -33.93 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 124.336 1.023 . . . . 0.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.45 -68.03 0.22 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 123.867 0.73 . . . . 0.0 111.777 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -23.04 75.71 Favored Glycine 0 N--CA 1.495 2.631 0 CA-C-N 114.466 -1.243 . . . . 0.0 115.431 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 27' ' ' ILE . 6.7 ttpm? -69.71 -49.87 49.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -74.04 -27.17 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.556 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.35 -17.3 80.07 Favored Glycine 0 N--CA 1.487 2.055 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.47 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -86.4 -4.83 59.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.247 0.616 . . . . 0.0 111.614 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 37' ' ' VAL . 95.9 mt -69.33 126.68 30.53 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.853 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -74.5 145.04 43.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.219 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.94 13.67 82.36 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.346 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' LEU . 38.7 t -87.2 135.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 124.258 0.622 . . . . 0.0 109.581 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -95.46 -79.27 0.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.594 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.562 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.9 tpm_? -97.99 163.23 12.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.449 1.093 . . . . 0.0 110.029 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.562 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 11.7 tt -157.25 95.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -105.17 156.03 18.48 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.224 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 50.6 t -144.54 133.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 124.52 1.138 . . . . 0.0 107.957 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -112.3 138.06 49.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.288 0.992 . . . . 0.0 108.961 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.3 mt -58.22 -19.19 31.85 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.771 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.34 87.98 0.63 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.149 0.906 . . . . 0.0 108.685 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.46 50.99 17.73 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.351 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 39.52 47.55 1.63 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.093 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 41.3 tt0 -72.82 95.28 1.9 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -89.33 126.77 35.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.045 -1.889 . . . . 0.0 114.074 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.1 m -111.59 92.44 4.03 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.337 1.023 . . . . 0.0 109.199 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -92.19 141.49 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.894 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 60.7 t -122.64 141.91 41.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -161.75 162.67 29.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 124.201 0.938 . . . . 0.0 111.929 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -72.1 136.18 82.17 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-N 114.057 -1.428 . . . . 0.0 107.82 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.451 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -59.2 155.42 40.16 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.452 2.101 . . . . 0.0 110.953 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.451 ' CG ' ' O ' ' A' ' 55' ' ' PRO . 6.5 p-80 52.75 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 117.128 2.269 . . . . 0.0 117.128 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.81 -41.77 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.6 tt -169.5 160.92 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 124.451 1.094 . . . . 0.0 111.391 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.3 p -97.66 108.39 21.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.306 -1.316 . . . . 0.0 109.185 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.22 -27.7 16.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.751 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.43 -18.16 62.34 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -82.28 -42.27 19.05 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.3 tpt -67.77 -34.15 76.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.648 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -78.7 -18.0 55.02 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.995 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -58.88 -29.18 66.82 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.005 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.2 -33.8 76.13 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.441 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 85.8 mt -65.2 -31.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.67 -23.99 39.22 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.663 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.4 -37.89 56.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.069 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.441 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.2 ptm -73.6 -14.12 61.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.891 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.41 5.45 7.2 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.432 ' HB3' HG13 ' A' ' 15' ' ' VAL . 21.2 m-85 -115.84 82.95 11.14 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -49.82 133.47 33.52 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.106 1.871 . . . . 0.0 109.943 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -121.35 115.9 23.81 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.05 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.51 71.38 7.36 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.416 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.848 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.43 0.633 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.5 113.69 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.921 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.25 56.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.69 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 153.4 42.07 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.227 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.84 140.95 48.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.607 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.425 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 29.6 mtm -134.8 138.51 44.32 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -122.93 90.72 3.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.309 1.005 . . . . 0.0 112.351 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -64.27 170.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.999 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.9 tt0 -116.41 107.65 15.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 100.242 -3.984 . . . . 0.0 100.242 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.06 1.33 0.61 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 115.536 0.974 . . . . 0.0 115.536 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 N--CA 1.5 2.045 0 C-N-CA 124.938 1.295 . . . . 0.0 109.066 -179.933 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.4 p -61.83 -10.45 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.3 m -56.4 -35.52 67.85 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.9 p -71.27 -39.38 71.6 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 53.3 mt -57.03 -30.12 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 124.322 1.014 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.96 -63.98 1.01 Allowed 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.937 0.773 . . . . 0.0 109.193 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -9.02 81.95 Favored Glycine 0 N--CA 1.493 2.448 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.485 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -77.98 -55.96 4.87 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.2 mt -70.98 -29.93 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.699 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.14 78.2 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.593 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -95.59 0.29 52.73 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HB2' HG21 ' A' ' 37' ' ' VAL . 57.1 mt -68.69 114.34 6.97 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.207 0.527 . . . . 0.0 112.142 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.59 138.47 44.92 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.244 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.5 13.73 77.77 Favored Glycine 0 N--CA 1.489 2.21 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.759 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 34' ' ' LEU . 40.5 t -91.45 143.68 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -95.93 -83.52 0.37 Allowed 'General case' 0 N--CA 1.485 1.31 0 O-C-N 124.228 0.955 . . . . 0.0 108.712 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 7.7 tpt180 -98.55 164.46 12.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 124.588 1.18 . . . . 0.0 111.36 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.429 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 9.4 tt -146.04 124.37 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -146.07 78.01 1.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.403 1.096 . . . . 0.0 112.216 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 51.9 t -82.84 130.49 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 t -84.56 -178.73 6.97 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.445 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.6 mm? -100.83 -177.36 3.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.998 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 54.26 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.039 0.837 . . . . 0.0 112.697 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -84.8 11.91 8.32 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.41 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 21.3 tt0 37.97 50.9 1.36 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.236 1.017 . . . . 0.0 109.308 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -67.53 89.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.042 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -78.97 124.65 28.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 112.245 -2.252 . . . . 0.0 110.786 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.0 m -129.78 58.01 1.66 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.642 1.21 . . . . 0.0 108.748 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.9 mp -66.92 140.84 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.839 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 89.8 t -106.11 136.1 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -157.21 167.91 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.48 -1.288 . . . . 0.0 114.12 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -84.12 127.58 66.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.27 -65.46 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.73 2.287 . . . . 0.0 114.014 -157.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.501 ' CD2' HD22 ' A' ' 57' ' ' LEU . 27.0 p-80 -68.95 -0.99 6.3 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.501 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.5 mm? -75.75 -48.14 23.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 tt -166.29 167.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.062 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.5 m -125.21 116.34 21.83 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.92 -17.93 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.377 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.86 -34.8 74.07 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -68.15 -41.41 81.66 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -34.94 79.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.893 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 34.1 mmtm -66.62 -28.34 68.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.254 0.971 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.31 -35.88 81.83 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.066 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -69.57 -38.6 77.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 124.411 1.069 . . . . 0.0 108.177 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 60.8 mt -65.91 -33.11 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 124.764 1.29 . . . . 0.0 108.073 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -82.84 -21.62 34.35 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.559 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.6 -37.53 42.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.053 0.845 . . . . 0.0 109.749 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.477 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 10.1 ptm -76.36 -11.94 59.98 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.08 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.28 17.44 2.69 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 118.31 2.084 . . . . 0.0 118.31 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -125.96 79.8 68.45 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-N 118.169 0.984 . . . . 0.0 109.444 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -47.4 136.81 19.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.6 2.2 . . . . 0.0 109.979 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.83 121.85 35.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.344 1.028 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -84.48 67.99 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.374 -2.194 . . . . 0.0 108.008 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.497 1.895 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.692 -179.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -72.97 109.49 6.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 123.892 0.407 . . . . 0.0 110.224 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.4 ptm -60.78 -32.31 71.64 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.161 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.56 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -105.73 79.01 1.39 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.886 0.851 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.45 -56.89 1.87 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.94 -22.14 78.36 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -151.29 177.21 10.48 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.537 -0.831 . . . . 0.0 110.308 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 m -138.85 152.69 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.689 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.19 127.12 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 124.082 0.864 . . . . 0.0 111.412 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.74 95.89 4.23 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.915 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -86.63 88.12 7.59 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.415 ' HB2' ' HZ2' ' A' ' 64' ' ' LYS . 44.4 mtm -90.98 140.14 30.11 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.466 -1.697 . . . . 0.0 106.98 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 24.6 ttmm -109.99 97.54 7.02 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.832 1.333 . . . . 0.0 114.051 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -63.39 169.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.799 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 31.5 tt0 -112.9 131.23 55.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 100.48 -3.896 . . . . 0.0 100.48 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.46 16.88 1.21 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.856 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.455 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 2.2 ttp 61.68 -78.78 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 124.087 0.955 . . . . 0.0 110.077 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.6 p -133.99 -48.26 0.8 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.2 t -173.16 53.35 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 53.57 68.62 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.518 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 m -53.98 -25.8 22.7 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.606 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.404 ' C ' ' H ' ' A' ' 25' ' ' SER . 75.2 m -145.85 -87.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.348 1.03 . . . . 0.0 109.365 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.5 p 52.58 -8.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 23' ' ' CYS . 50.6 m -77.33 -38.59 50.08 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 102.974 -2.973 . . . . 0.0 102.974 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.6 p -69.13 -33.16 73.03 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 112.874 -1.966 . . . . 0.0 108.016 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -68.23 -31.38 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.124 0.89 . . . . 0.0 110.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.94 -58.87 6.24 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.37 -20.74 77.08 Favored Glycine 0 N--CA 1.496 2.639 0 CA-C-N 113.346 -1.752 . . . . 0.0 112.708 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -70.84 -52.95 17.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -64.9 -34.38 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 112.912 -1.949 . . . . 0.0 111.254 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.82 -17.56 79.73 Favored Glycine 0 N--CA 1.487 2.08 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.156 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -95.54 1.52 53.9 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.4 mt -71.22 128.73 36.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.205 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -78.74 159.27 28.02 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.38 1.086 . . . . 0.0 112.639 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.62 14.74 70.15 Favored Glycine 0 N--CA 1.488 2.13 0 CA-C-N 112.145 -2.298 . . . . 0.0 110.517 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.77 133.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 114.778 -0.711 . . . . 0.0 111.635 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -93.36 -77.22 0.45 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 19.5 tpp85 -96.92 160.24 14.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.75 119.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.558 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -138.95 152.07 47.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -141.37 124.12 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 23.1 t -80.19 179.64 7.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 123.812 0.695 . . . . 0.0 110.714 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.5 mm? -100.27 173.53 6.56 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.802 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 56.59 -86.47 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 124.293 0.996 . . . . 0.0 112.11 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.25 10.61 4.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.2 0.313 . . . . 0.0 110.634 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 33.87 52.18 0.43 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 124.356 1.035 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 43.0 tt0 -67.48 95.66 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.629 -1.623 . . . . 0.0 107.849 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -74.03 126.71 31.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.728 -2.033 . . . . 0.0 110.78 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.9 m -126.48 88.25 2.8 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.6 mp -110.41 137.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.863 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.1 t -108.46 137.82 38.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.06 157.07 39.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.398 1.061 . . . . 0.0 111.312 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 7.4 pt20 -78.95 143.22 61.35 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 60.6 Cg_endo -85.71 40.14 0.75 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.019 2.479 . . . . 0.0 113.476 -162.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.521 ' CD2' HD22 ' A' ' 57' ' ' LEU . 32.3 p-80 -151.07 16.06 0.74 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.521 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.9 mm? -113.65 -59.69 1.98 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.8 tt -165.57 161.24 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.955 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.9 p -98.9 118.79 36.45 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.377 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.8 -18.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.474 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -67.33 -38.69 85.32 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.788 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -67.28 -39.03 85.97 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mmt -64.02 -33.49 75.85 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.057 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' HZ2' ' HB2' ' A' ' 13' ' ' MET . 27.0 mtpt -80.13 -18.14 50.62 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.646 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.93 -29.73 70.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -71.3 -39.02 71.72 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 57.8 mt -62.68 -36.2 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -78.64 -27.04 45.29 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.953 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 -37.65 65.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.224 0.953 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.44 ' SD ' ' CE2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -73.73 -15.86 61.2 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 124.152 0.907 . . . . 0.0 111.671 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.76 10.69 2.52 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 118.064 1.985 . . . . 0.0 118.064 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 18' ' ' MET . 59.9 m-85 -118.92 75.09 13.47 Favored Pre-proline 0 N--CA 1.5 2.06 0 CA-C-N 118.407 1.104 . . . . 0.0 109.718 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -48.9 139.25 25.62 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.825 2.35 . . . . 0.0 111.253 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -122.91 133.24 54.41 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.045 0.926 . . . . 0.0 111.648 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.89 74.81 10.1 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.372 -2.194 . . . . 0.0 106.785 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.52 137.27 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 113.555 -1.657 . . . . 0.0 111.301 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -74.84 -47.44 30.43 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.501 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.91 94.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.392 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -136.16 65.94 58.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.95 -51.41 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.919 2.413 . . . . 0.0 110.638 -171.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -55.41 -34.57 64.53 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.388 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -78.07 -33.11 51.01 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.565 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 tp -78.14 152.64 32.68 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.177 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m -144.71 -33.09 0.39 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.281 0.636 . . . . 0.0 109.785 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 ptp -157.79 164.07 37.4 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.57 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.44 -178.27 6.57 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.287 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 7.3 pt20 -60.65 -20.25 60.31 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.433 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.24 32.26 18.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 124.172 0.92 . . . . 0.0 112.471 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' H ' ' HG3' ' A' ' 5' ' ' GLN . . . -103.05 25.73 26.31 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.55 ' CB ' HE22 ' A' ' 38' ' ' GLN . 0.5 OUTLIER -156.67 157.21 34.79 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.938 -0.631 . . . . 0.0 111.436 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 53' ' ' TYR . 14.3 m -145.55 126.64 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.259 0.975 . . . . 0.0 109.767 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 11' ' ' LEU . 18.3 m -94.48 115.7 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 10' ' ' VAL . 3.1 mm? -114.66 110.49 19.83 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.372 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' C ' ' SD ' ' A' ' 13' ' ' MET . 2.3 mppt? -100.84 130.1 46.81 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.442 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 4.9 mpp? -144.25 139.13 28.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 65.1 tttp -105.15 151.53 23.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 125.149 1.53 . . . . 0.0 107.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -127.68 169.6 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 124.205 0.941 . . . . 0.0 110.729 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 18' ' ' MET . 31.5 tt0 -92.37 111.39 22.95 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.37 5.2 5.57 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-O 119.55 -0.583 . . . . 0.0 114.358 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.482 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 52.0 ttp 44.48 101.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -49.82 -27.72 5.43 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.7 t -64.84 -55.52 19.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 123.709 0.63 . . . . 0.0 110.303 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.515 ' CG ' ' H ' ' A' ' 22' ' ' SER . 0.8 OUTLIER -163.88 -121.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 123.948 0.78 . . . . 0.0 108.904 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 21' ' ' HIS . 55.9 p -176.61 160.35 1.98 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.011 0.434 . . . . 0.0 110.016 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.8 t -146.0 26.93 1.2 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -72.31 -13.54 61.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.369 -1.287 . . . . 0.0 113.379 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 p -55.33 -38.2 68.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.858 0.724 . . . . 0.0 109.476 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -77.12 -37.28 54.45 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.0 mt -61.0 -36.15 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 123.997 0.81 . . . . 0.0 110.882 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.76 -64.98 0.74 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.727 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.22 -18.98 73.68 Favored Glycine 0 N--CA 1.497 2.701 0 CA-C-N 113.593 -1.639 . . . . 0.0 114.174 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -77.15 -53.89 7.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.415 ' CG2' HG12 ' A' ' 51' ' ' ILE . 57.2 mt -69.84 -23.76 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.679 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.59 -13.79 83.12 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -95.32 2.3 54.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 124.333 0.666 . . . . 0.0 111.692 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.17 130.78 43.95 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -83.22 146.77 28.4 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.307 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.52 12.59 84.22 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.718 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.1 t -93.75 142.19 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.55 HE22 ' CB ' ' A' ' 8' ' ' GLU . 29.3 mt-30 -95.81 -81.97 0.39 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 12.8 tpt180 -97.15 154.81 17.14 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.1 115.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 104.743 -2.318 . . . . 0.0 104.743 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -151.88 167.09 29.44 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.398 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 57.2 t -136.96 147.12 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 124.624 1.203 . . . . 0.0 109.158 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 37.7 t -104.37 150.21 24.7 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.887 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -67.31 1.56 2.11 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.091 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -83.39 66.48 8.87 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 m120 54.35 71.93 0.49 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.715 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 5.3 tp-100 41.71 47.2 3.43 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.803 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 39.6 tt0 -79.63 87.65 5.17 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.168 1.461 . . . . 0.0 107.284 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.37 138.67 45.46 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 111.721 -2.49 . . . . 0.0 114.721 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.2 m -140.5 90.57 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.1 mp -98.64 130.37 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.436 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 39.5 t -106.38 134.6 47.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' HG22 ' A' ' 9' ' ' VAL . 40.4 p90 -148.56 171.2 16.52 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.199 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.97 145.65 81.42 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 124.095 0.872 . . . . 0.0 110.674 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -71.17 0.86 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.46 2.773 . . . . 0.0 115.432 -150.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -154.17 23.46 0.49 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.49 -46.41 9.14 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.474 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.457 HG12 ' H ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -157.95 166.43 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 124.043 0.839 . . . . 0.0 111.482 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.457 ' H ' HG12 ' A' ' 58' ' ' ILE . 58.2 p -117.38 107.4 14.3 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.425 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.56 -26.93 32.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.234 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.21 -27.68 68.61 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.963 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -68.88 -41.37 78.43 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.9 mmt -61.84 -32.38 72.71 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.514 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -65.47 -34.71 78.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.976 0.798 . . . . 0.0 109.154 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.55 -34.75 77.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 123.492 0.495 . . . . 0.0 110.539 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -67.9 -38.71 83.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 124.162 0.914 . . . . 0.0 108.843 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 72' ' ' PHE . 83.5 mt -67.61 -28.63 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.236 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -86.52 -22.14 26.54 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.189 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.92 -36.74 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.05 0.843 . . . . 0.0 109.519 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -13.43 60.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.68 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -6.69 5.39 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 118.671 2.229 . . . . 0.0 118.671 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.0 m-30 -106.52 93.68 8.81 Favored Pre-proline 0 N--CA 1.501 2.09 0 CA-C-N 119.203 1.502 . . . . 0.0 111.055 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -45.31 137.18 10.87 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.972 1.781 . . . . 0.0 109.577 166.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.13 126.35 45.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.521 1.138 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 39.7 m-85 -85.46 91.18 8.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.37 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.82 149.22 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.806 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.493 ' CG ' ' H ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -32.18 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' H ' ' CG ' ' A' ' 77' ' ' LYS . 6.7 ttpm? 58.61 -81.53 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -130.15 163.01 50.62 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 123.745 0.653 . . . . 0.0 110.359 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -64.35 138.55 61.16 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.358 2.039 . . . . 0.0 108.657 163.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -127.99 144.58 51.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.109 0.881 . . . . 0.0 109.714 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -58.57 -58.54 8.09 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.826 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.3 tp -155.41 76.75 0.97 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 N--CA 1.495 1.79 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.545 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -158.03 -51.89 0.07 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.1 mtp 54.7 20.78 3.13 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 124.532 1.145 . . . . 0.0 112.417 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.11 88.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.52 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -78.02 134.31 37.82 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.638 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.5 151.46 42.47 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.074 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.11 -165.51 13.21 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 123.957 0.786 . . . . 0.0 111.737 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -139.22 178.34 7.25 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.27 -0.965 . . . . 0.0 111.029 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.6 m -129.84 146.54 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.2 m -128.59 99.48 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 124.66 1.225 . . . . 0.0 110.067 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 11' ' ' LEU . 5.7 mp -104.81 120.12 40.63 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.051 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 2.3 mppt? -99.86 90.05 4.29 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 123.892 0.745 . . . . 0.0 109.701 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -82.62 139.65 33.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -109.42 96.28 6.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.789 1.305 . . . . 0.0 113.728 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.1 t -60.94 159.64 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 18' ' ' MET . 35.1 tt0 -82.59 109.69 17.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.16 -7.79 7.6 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.874 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.481 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 31.0 tpp 63.34 -144.66 0.34 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 18' ' ' MET . 3.8 t -172.83 -40.41 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.9 p -75.5 -61.35 1.94 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.953 0.783 . . . . 0.0 110.618 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -150.43 119.81 6.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 p -96.54 101.54 13.17 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.949 0.781 . . . . 0.0 111.993 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.8 m -85.15 36.84 0.64 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.991 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.1 p -69.71 -0.47 7.03 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.327 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.0 m -66.01 -31.85 72.98 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -64.41 -37.69 88.4 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.203 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 73.3 mt -53.26 -32.83 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 124.534 1.146 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -59.96 -70.36 0.17 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.145 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -12.4 66.87 Favored Glycine 0 N--CA 1.497 2.752 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.55 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -82.87 -59.49 2.48 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.906 0.86 . . . . 0.0 108.817 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.4 mm -80.01 -2.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.023 -1.898 . . . . 0.0 112.59 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.83 -17.36 19.06 Favored Glycine 0 N--CA 1.486 2.015 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.804 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -96.85 7.35 46.8 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -82.71 140.5 33.04 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -85.94 161.52 18.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.626 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.07 87.19 Favored Glycine 0 N--CA 1.489 2.168 0 CA-C-N 114.832 -1.077 . . . . 0.0 111.062 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 34' ' ' LEU . 71.1 t -111.81 145.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 124.626 0.839 . . . . 0.0 112.756 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -94.76 -83.22 0.35 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.5 tpp85 -98.16 163.17 12.85 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.023 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' C ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -152.05 117.03 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.0 pttt -153.26 112.7 3.83 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.369 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 44.4 t -93.4 150.53 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.952 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.5 t -109.03 141.32 41.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.581 1.176 . . . . 0.0 110.087 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.4 mm? -56.86 -21.68 31.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 124.35 1.031 . . . . 0.0 110.118 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.19 87.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.659 1.225 . . . . 0.0 108.708 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 52.51 40.25 29.41 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 45.63 47.7 11.44 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.436 1.112 . . . . 0.0 108.584 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.01 92.99 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.363 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -67.26 130.49 43.26 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.482 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.9 m -131.34 92.53 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -97.54 135.65 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 113.654 -1.612 . . . . 0.0 108.168 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 26.3 t -107.96 137.85 37.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -162.84 166.09 24.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 124.683 1.24 . . . . 0.0 113.679 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.08 132.55 39.45 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.079 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.18 38.36 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.368 2.712 . . . . 0.0 114.464 -155.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.477 ' CD2' HD22 ' A' ' 57' ' ' LEU . 28.3 p-80 -156.23 18.46 0.35 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -95.91 -56.2 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.445 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.19 164.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 124.027 0.829 . . . . 0.0 110.619 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -74.14 109.26 7.5 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.495 1.141 . . . . 0.0 110.019 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.62 -26.88 6.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 112.642 -2.072 . . . . 0.0 109.773 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.23 -24.49 61.39 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.427 -1.26 . . . . 0.0 107.686 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.84 -38.09 79.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -63.17 -40.52 97.78 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.515 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -78.14 -10.92 59.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 124.279 0.987 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -74.49 -29.71 61.53 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.06 -30.62 71.11 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.381 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.426 HG22 ' HB2' ' A' ' 72' ' ' PHE . 88.0 mt -65.89 -30.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 114.69 -1.141 . . . . 0.0 107.998 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -81.54 -24.1 36.81 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.695 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.49 -37.36 60.25 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.425 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -74.46 -12.2 60.43 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.737 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 1.59 9.33 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 116.797 1.479 . . . . 0.0 116.797 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.426 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.8 m-85 -112.6 82.58 4.94 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 117.447 0.624 . . . . 0.0 109.503 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.51 130.12 34.99 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 121.819 1.679 . . . . 0.0 109.755 174.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -111.54 109.58 19.57 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.847 -1.979 . . . . 0.0 106.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -69.13 89.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 112.109 -2.314 . . . . 0.0 109.608 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 78' ' ' LYS . 61.9 t -74.75 119.84 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -99.88 18.48 18.23 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 123.763 0.664 . . . . 0.0 112.006 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -167.37 122.94 1.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.966 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -172.31 66.31 0.38 Allowed Pre-proline 0 N--CA 1.498 1.966 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.279 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -68.01 177.63 4.18 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.862 2.375 . . . . 0.0 111.452 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -65.19 -62.15 1.71 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -149.43 137.3 20.39 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.271 0.982 . . . . 0.0 109.486 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.43 -31.52 71.46 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.101 0.875 . . . . 0.0 108.768 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 116.567 -1.682 . . . . 0.0 109.802 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.444 ' HA3' HH22 ' A' ' 39' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t 56.76 92.06 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.687 0.874 . . . . 0.0 111.384 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.3 mtm 58.22 -170.7 0.11 Allowed 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.945 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.49 88.36 1.22 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.474 HE22 HH21 ' A' ' 39' ' ' ARG . 25.4 tt0 -64.68 115.38 5.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.454 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.83 -47.44 0.09 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.235 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.23 -99.02 0.07 OUTLIER Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 41.73 -176.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.69 124.07 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.765 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.6 m -100.69 101.82 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.293 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.98 116.89 33.66 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -93.78 111.86 23.62 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.435 ' SD ' HG13 ' A' ' 76' ' ' VAL . 31.9 mtm -114.33 143.77 44.34 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.538 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -120.11 98.04 5.88 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.0 t -70.67 168.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.615 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 36.6 tt0 -103.12 127.37 50.41 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.6 21.67 1.92 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.723 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 16' ' ' GLU . 54.3 tpp 58.54 -114.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t 177.15 -43.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.8 t -78.98 -49.73 12.26 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.88 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -166.65 153.21 8.79 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.393 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -114.49 112.05 22.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.115 0.884 . . . . 0.0 110.53 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.4 m -85.82 23.62 1.41 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.954 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -63.69 -12.09 31.38 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.3 t -59.21 -44.39 92.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 p -72.37 -31.07 65.27 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.08 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.499 ' HB ' HE22 ' A' ' 47' ' ' GLN . 45.4 mt -65.08 -36.96 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 123.889 0.743 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.11 -51.31 66.8 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -34.5 87.26 Favored Glycine 0 N--CA 1.495 2.591 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.084 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -63.52 -40.31 96.71 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.71 -32.33 44.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.873 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.73 -13.4 82.23 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -94.85 3.48 54.94 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.562 0.801 . . . . 0.0 110.569 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.28 119.46 24.62 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.15 148.19 32.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.087 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.05 -0.37 87.52 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -82.22 138.06 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 124.046 0.498 . . . . 0.0 110.227 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -95.63 -78.19 0.46 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.474 HH21 HE22 ' A' ' 5' ' ' GLN . 8.6 tpp180 -97.84 165.98 11.68 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 124.255 0.972 . . . . 0.0 109.856 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.39 111.36 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HB2' ' HB ' ' A' ' 50' ' ' THR . 60.0 mtpt -124.42 69.46 1.09 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.145 0.974 . . . . 0.0 109.637 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.427 ' CG1' HE21 ' A' ' 47' ' ' GLN . 58.8 t -82.62 112.26 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 113.611 -1.631 . . . . 0.0 106.647 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.485 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 33.1 t -85.79 177.26 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.337 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.5 mp -96.84 -168.02 1.64 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.98 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 57.72 -103.96 0.2 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 124.02 0.825 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -93.49 25.03 3.64 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.499 HE22 ' HB ' ' A' ' 27' ' ' ILE . 53.9 tt0 32.16 80.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 43' ' ' SER . 83.7 tt0 -75.97 90.38 2.99 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.62 113.39 13.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.408 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 54.7 m -122.01 78.13 1.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.021 -1.445 . . . . 0.0 107.452 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -90.16 136.5 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.213 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -113.71 140.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.52 162.89 40.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.37 1.044 . . . . 0.0 112.092 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -65.74 144.59 98.92 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 113.567 -1.651 . . . . 0.0 110.031 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.82 7.04 3.36 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.908 2.406 . . . . 0.0 114.294 -157.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.455 ' CD2' HD22 ' A' ' 57' ' ' LEU . 10.0 p-80 -156.96 19.66 0.31 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.3 mm? -86.06 -49.57 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.575 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.7 tt -166.86 160.14 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 124.254 0.972 . . . . 0.0 110.761 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.8 m -98.8 110.82 23.37 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.76 -18.02 21.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.998 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.74 -32.48 74.0 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.951 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.94 -40.4 87.56 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.8 mmt -63.58 -33.77 76.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.756 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' HD12 ' A' ' 67' ' ' ILE . 14.1 mptt -77.96 -21.83 50.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.1 0.875 . . . . 0.0 109.738 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -66.37 -30.25 70.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -69.01 -40.76 78.49 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.432 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 78.6 mt -64.39 -31.94 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.112 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.58 -21.06 30.54 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.965 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.84 -38.09 46.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.026 0.829 . . . . 0.0 109.389 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.3 ptm -74.15 -12.94 60.73 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.051 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 6.76 7.61 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 117.893 1.917 . . . . 0.0 117.893 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -112.33 88.2 10.4 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -47.27 133.49 19.54 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 121.971 1.78 . . . . 0.0 109.222 170.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.88 123.81 33.62 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.768 -1.56 . . . . 0.0 108.805 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -82.55 64.46 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.338 -1.755 . . . . 0.0 108.681 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.435 HG13 ' SD ' ' A' ' 13' ' ' MET . 61.4 t -68.42 149.5 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? 71.6 133.19 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt 65.08 165.13 0.16 Allowed 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -127.33 81.15 70.58 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.5 160.28 50.36 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.599 2.2 . . . . 0.0 109.765 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? 61.15 165.38 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 124.47 1.106 . . . . 0.0 112.163 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -72.01 -48.0 47.89 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.664 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tt 56.3 -80.3 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 O-C-N 124.84 1.338 . . . . 0.0 111.705 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.449 ' H ' ' HD3' ' A' ' 84' ' ' LYS . 2.4 mppt? . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 116.681 -1.628 . . . . 0.0 110.605 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -145.93 155.04 42.58 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 124.267 0.628 . . . . 0.0 109.881 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.7 mtp 58.6 -174.83 0.09 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 124.334 1.021 . . . . 0.0 112.152 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -149.24 -63.26 0.23 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.559 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -165.44 -60.94 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.014 0.821 . . . . 0.0 109.086 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.53 173.67 0.08 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 124.56 1.163 . . . . 0.0 112.743 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.56 32.8 0.02 OUTLIER Glycine 0 N--CA 1.497 2.713 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.422 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 43.1 177.76 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 m -117.29 153.73 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.291 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.21 68.16 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.315 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.27 109.35 1.1 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -81.66 82.86 7.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.499 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 11.0 ttp -80.13 125.55 29.96 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.269 1.033 . . . . 0.0 109.383 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.06 80.39 1.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 111.577 -2.556 . . . . 0.0 106.419 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.1 t -66.76 165.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.606 -1.634 . . . . 0.0 111.684 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 18' ' ' MET . 13.0 tp10 -107.49 137.3 45.77 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.491 ' H ' HD22 ' A' ' 46' ' ' ASN . . . -72.9 12.95 3.44 Favored Glycine 0 N--CA 1.49 2.251 0 O-C-N 123.801 0.688 . . . . 0.0 113.708 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.422 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 38.1 ttm 62.76 146.49 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 123.732 0.813 . . . . 0.0 112.432 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.1 p -59.87 -54.58 44.53 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.742 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.1 p -75.09 -75.49 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 123.787 0.679 . . . . 0.0 111.341 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -151.04 146.6 26.31 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 123.64 0.588 . . . . 0.0 109.798 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 68.7 p -79.14 165.94 22.77 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 123.866 0.729 . . . . 0.0 111.427 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m -155.25 37.93 0.39 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.5 p -62.88 -7.99 6.18 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.127 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.4 p -58.59 -34.78 71.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -71.21 -40.53 71.08 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.162 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.88 -35.71 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.913 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -54.7 -65.85 0.51 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.067 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.61 -22.83 70.13 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.895 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -70.86 -44.83 65.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.42 HG21 HG12 ' A' ' 51' ' ' ILE . 71.7 mt -72.58 -33.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 114.082 -1.417 . . . . 0.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.12 -14.59 71.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -95.45 3.03 54.67 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.101 -1.05 . . . . 0.0 111.622 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.45 116.38 25.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.04 0.447 . . . . 0.0 111.857 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.34 150.5 43.43 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.886 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.08 17.75 71.29 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 123.912 0.758 . . . . 0.0 111.789 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.66 137.48 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.552 HE22 ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -93.26 -81.98 0.35 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 124.764 1.29 . . . . 0.0 108.068 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 7.0 tpm_? -97.3 162.79 13.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.631 1.207 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.656 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.2 tt -158.45 111.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.647 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 139.74 9.62 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.666 -0.814 . . . . 0.0 112.373 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.2 t -108.03 158.08 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 113.561 -1.654 . . . . 0.0 112.653 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.2 t -135.23 176.52 8.6 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.82 -1.991 . . . . 0.0 108.473 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.6 mp -67.69 -146.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.274 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 53.04 52.98 12.72 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.491 HD22 ' H ' ' A' ' 17' ' ' GLY . 6.9 m120 55.19 84.41 0.07 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.347 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 3.1 tp-100 35.73 57.97 0.91 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.139 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -75.47 87.97 2.63 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -85.13 141.3 30.31 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.542 -1.663 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.5 m -135.77 70.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -73.91 138.37 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.437 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 59.3 t -114.7 135.79 53.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -163.83 169.6 18.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 124.668 1.23 . . . . 0.0 112.245 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.552 ' H ' HE22 ' A' ' 38' ' ' GLN . 5.1 pt20 -95.21 122.23 60.27 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 124.389 1.056 . . . . 0.0 108.524 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 -34.92 17.05 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.633 2.222 . . . . 0.0 112.392 -168.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.45 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 6.8 p-80 -57.13 -30.69 64.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -73.44 -47.39 42.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 tt -170.63 161.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 113.705 -1.589 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.5 m -112.65 114.0 26.41 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.577 -1.192 . . . . 0.0 107.894 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -69.3 -13.8 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.292 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.6 -38.38 77.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.43 -41.42 89.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 33.0 mmt -65.47 -26.46 67.94 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.384 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -71.78 -30.0 65.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.311 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -63.61 -32.86 74.47 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -66.81 -39.85 87.87 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.366 1.041 . . . . 0.0 108.894 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.41 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 74.6 mt -65.14 -31.95 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.74 -19.68 30.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.282 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.88 41.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.072 0.858 . . . . 0.0 108.91 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.7 ptm -74.04 -12.09 60.52 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.648 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.31 9.11 8.86 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 117.834 1.894 . . . . 0.0 117.834 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.67 91.28 20.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -47.08 131.21 17.23 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.731 1.621 . . . . 0.0 108.788 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.27 104.6 7.61 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.463 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -85.45 92.3 8.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 112.431 -2.168 . . . . 0.0 109.113 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.2 t -85.75 71.77 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.693 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -106.98 80.55 1.44 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.79 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.527 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -69.6 91.26 0.59 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.012 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -138.17 105.94 7.96 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-N 113.334 -1.757 . . . . 0.0 107.536 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -65.87 -19.02 58.74 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.188 1.925 . . . . 0.0 110.918 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -66.04 -57.85 6.81 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.93 0.769 . . . . 0.0 110.349 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -146.04 103.52 3.75 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 124.047 0.842 . . . . 0.0 111.175 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -168.97 -84.04 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 t 62.0 163.7 0.09 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 124.528 0.781 . . . . 0.0 112.264 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.11 -67.15 0.09 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.07 -24.23 8.14 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.362 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -62.47 -60.28 3.77 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.775 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.1 -87.22 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.66 1.225 . . . . 0.0 112.916 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.3 124.2 0.42 Allowed Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.428 ' HB3' HE21 ' A' ' 38' ' ' GLN . 9.9 pt-20 -71.91 129.66 39.13 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.58 0.705 . . . . 0.0 111.38 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 11' ' ' LEU . 17.5 m -64.55 125.2 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -94.63 69.56 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.416 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.419 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 3.9 mm? -66.24 117.12 8.07 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.031 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -104.96 105.68 15.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 124.392 1.058 . . . . 0.0 108.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.489 ' SD ' ' HG2' ' A' ' 64' ' ' LYS . 31.9 mtm -95.46 140.66 30.0 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -126.16 81.96 2.04 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.5 t -70.45 173.57 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.385 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 30.5 tt0 -100.23 111.22 23.49 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 103.52 -2.771 . . . . 0.0 103.52 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.18 -25.77 48.21 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.039 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.414 ' SD ' ' O ' ' A' ' 18' ' ' MET . 12.7 tmm? 55.16 100.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.519 0.776 . . . . 0.0 111.566 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.8 p 47.67 -165.15 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.736 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.6 t -62.93 -24.24 67.76 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -77.99 -177.69 5.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.302 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 78.6 p -169.76 -42.83 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.778 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 62.1 m 55.07 18.5 2.35 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.816 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 p -80.33 -2.98 47.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.4 m -61.14 -44.66 96.98 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.9 p -69.48 -34.5 74.44 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.352 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.44 -40.74 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.588 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -59.1 -55.93 28.78 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.645 0.736 . . . . 0.0 109.824 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.5 -30.9 75.72 Favored Glycine 0 N--CA 1.496 2.671 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.278 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' C ' ' HD3' ' A' ' 30' ' ' LYS . 7.7 tmtm? -69.54 -42.46 74.57 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.96 -29.63 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.374 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.71 -24.0 76.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.39 -17.97 57.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.406 -0.897 . . . . 0.0 112.14 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.04 127.46 31.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.538 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -71.82 141.75 49.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.315 1.009 . . . . 0.0 109.764 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.91 11.62 70.0 Favored Glycine 0 N--CA 1.486 1.997 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.168 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.64 135.16 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.566 HE22 ' N ' ' A' ' 54' ' ' GLN . 2.4 mp0 -95.75 -78.14 0.46 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.17 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.47 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 5.8 tpp180 -96.97 154.73 17.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.718 1.261 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.44 HG13 HG13 ' A' ' 51' ' ' ILE . 8.9 tt -155.21 121.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.314 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -150.6 153.39 35.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.426 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.2 t -129.59 133.98 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 124.259 0.974 . . . . 0.0 108.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 66.6 m -105.31 149.42 26.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.684 1.24 . . . . 0.0 110.218 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 44' ' ' LEU . 1.2 pp -66.5 4.69 0.71 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -87.08 68.43 9.99 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.3 m120 55.63 72.4 0.49 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 54.9 tp60 40.99 54.72 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.311 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 43' ' ' SER . 28.8 tt0 -79.11 80.76 5.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.05 131.44 38.41 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.323 -2.217 . . . . 0.0 109.918 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -131.57 72.0 1.49 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.021 0.915 . . . . 0.0 109.81 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.7 mp -81.76 137.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 114.022 -1.445 . . . . 0.0 109.015 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 10.9 t -114.05 146.9 18.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -165.56 177.05 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.763 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.566 ' N ' HE22 ' A' ' 38' ' ' GLN . 5.5 pt20 -86.9 125.78 65.5 Favored Pre-proline 0 N--CA 1.498 1.97 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.58 68.02 8.2 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.235 2.623 . . . . 0.0 113.167 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.471 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 5.9 p-80 -172.23 -28.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -76.04 -44.62 38.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 123.965 0.791 . . . . 0.0 109.544 -179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -167.76 172.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.088 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.477 ' N ' HG13 ' A' ' 58' ' ' ILE . 51.5 m -119.22 110.89 17.55 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.01 -21.29 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.257 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.49 -39.31 91.77 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.756 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.79 -37.11 73.29 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -71.81 -22.45 61.56 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.583 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HG2' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -97.84 -9.15 26.91 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.49 -32.88 74.46 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.449 HE21 ' CG1' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -60.75 -24.04 65.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 123.99 0.806 . . . . 0.0 110.516 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.449 ' CG1' HE21 ' A' ' 66' ' ' GLN . 81.1 mt -70.63 -33.17 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.4 -27.79 46.76 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.48 -35.31 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.691 1.244 . . . . 0.0 109.947 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.505 ' SD ' ' CE1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -69.72 -19.33 63.55 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 123.905 0.753 . . . . 0.0 110.464 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.85 3.3 5.01 Favored Glycine 0 N--CA 1.493 2.492 0 CA-C-O 118.429 -1.206 . . . . 0.0 116.041 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 3.4 m-30 -106.99 86.19 2.29 Favored Pre-proline 0 N--CA 1.5 2.039 0 CA-C-N 118.477 1.138 . . . . 0.0 108.649 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -51.59 130.77 34.71 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 121.094 1.196 . . . . 0.0 109.044 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.24 124.93 51.05 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.745 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.74 -48.12 41.19 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.591 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.462 HG21 ' NZ ' ' A' ' 64' ' ' LYS . 23.8 t 55.32 109.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 125.312 1.632 . . . . 0.0 113.499 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.56 -23.6 58.87 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.219 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.66 82.84 2.01 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -100.32 150.93 37.36 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.151 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -83.47 91.81 0.88 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.986 2.458 . . . . 0.0 109.916 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? 59.85 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 O-C-N 124.547 1.155 . . . . 0.0 110.376 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -60.45 169.3 1.76 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 123.569 0.543 . . . . 0.0 112.32 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 83' ' ' LEU . 3.0 mm? -73.03 22.58 0.07 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.55 -1.204 . . . . 0.0 113.299 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 t 52.42 -133.5 1.8 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.25 0.618 . . . . 0.0 110.165 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.2 mtp 50.07 29.82 3.78 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.335 0.588 . . . . 0.0 111.859 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.28 -2.26 0.22 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.974 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -61.02 -49.45 77.36 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 123.643 0.59 . . . . 0.0 110.237 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.86 -27.4 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.126 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.54 38.3 51.87 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' CB ' HE22 ' A' ' 38' ' ' GLN . 10.3 pt-20 43.31 -178.44 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.99 150.24 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-N 113.551 -1.659 . . . . 0.0 110.052 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.71 57.46 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 124.409 1.068 . . . . 0.0 108.941 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.3 141.17 41.7 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.263 -1.335 . . . . 0.0 114.19 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -103.49 104.86 14.98 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.448 ' SD ' HG13 ' A' ' 76' ' ' VAL . 16.8 mmm -89.49 109.97 20.85 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 103.329 -2.841 . . . . 0.0 103.329 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.68 85.53 2.76 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.328 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.14 168.01 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.482 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.8 tt0 -110.94 142.15 43.42 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.581 ' H ' HD22 ' A' ' 46' ' ' ASN . . . -80.96 29.93 2.68 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.465 ' H ' ' C ' ' A' ' 16' ' ' GLU . 31.8 ttm 64.66 -129.03 0.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.406 ' H ' ' H ' ' A' ' 20' ' ' CYS . 52.7 p -143.04 -28.47 0.56 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' H ' ' H ' ' A' ' 19' ' ' THR . 25.7 p -152.56 112.15 3.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.559 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 68.53 164.3 0.23 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 124.634 1.209 . . . . 0.0 110.72 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.6 m -148.08 166.94 26.3 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.818 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 78.2 m -144.51 50.68 1.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.384 -1.28 . . . . 0.0 107.825 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.3 p -64.03 -7.61 9.13 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.769 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.6 p -62.27 -40.44 96.23 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.6 p -68.6 -33.62 74.37 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.298 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.3 mt -67.54 -42.24 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.06 0.85 . . . . 0.0 108.939 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.35 -50.31 74.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.494 0.664 . . . . 0.0 110.828 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.32 -36.5 93.28 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.7 -1.591 . . . . 0.0 113.835 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -77.61 -51.34 10.8 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.997 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -73.18 1.48 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.56 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.21 -28.05 3.72 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.407 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -96.5 8.92 42.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.154 0.502 . . . . 0.0 111.811 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -74.04 135.54 43.06 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.309 1.052 . . . . 0.0 113.279 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -88.0 156.42 19.32 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 112.695 -2.048 . . . . 0.0 111.602 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.74 8.68 82.16 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 34' ' ' LEU . 54.3 t -99.68 144.09 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 114.55 -0.825 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.487 HE22 ' CB ' ' A' ' 8' ' ' GLU . 32.8 mt-30 -96.04 -82.31 0.39 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.176 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -97.97 169.13 9.85 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 124.54 1.15 . . . . 0.0 111.625 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.609 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 11.0 tt -153.78 131.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.497 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 140.28 38.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -140.08 137.16 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.842 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t -102.62 170.12 8.22 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.279 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.3 mp -93.0 -166.22 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.805 -1.088 . . . . 0.0 108.406 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 58.54 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.581 HD22 ' H ' ' A' ' 17' ' ' GLY . 23.9 m120 -100.51 34.07 2.52 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.293 0.568 . . . . 0.0 111.006 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 33.96 58.73 0.59 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.559 -1.2 . . . . 0.0 114.213 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.67 96.89 2.56 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.45 121.79 36.35 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.512 -1.677 . . . . 0.0 111.552 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.3 m -115.27 93.92 4.5 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 51' ' ' ILE . 1.7 mp -102.15 136.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.928 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 75.1 t -101.79 132.41 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 102.857 -3.016 . . . . 0.0 102.857 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -155.84 176.64 12.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.21 -1.396 . . . . 0.0 114.65 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -95.11 112.06 57.06 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 112.422 -2.172 . . . . 0.0 107.074 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.61 -49.68 3.06 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.946 2.431 . . . . 0.0 110.225 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -57.83 -22.45 47.79 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.334 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 57' ' ' LEU . 5.5 tp -90.12 -40.93 11.94 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.378 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.4 tt -161.78 162.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.586 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.7 p -126.94 109.19 11.67 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.622 1.201 . . . . 0.0 107.868 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.29 -17.16 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.72 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.94 -38.61 86.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -66.96 -40.58 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -64.03 -26.97 68.8 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.718 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -90.88 -19.62 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.827 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.5 -43.55 96.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.644 0.259 . . . . 0.0 111.292 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -66.89 -35.84 80.94 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.424 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 63.6 mt -67.5 -31.53 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.409 -1.269 . . . . 0.0 107.703 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.03 -20.07 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.695 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.5 -36.24 38.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 124.024 0.827 . . . . 0.0 109.436 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.424 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 6.2 ptm -75.27 -11.36 60.05 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 124.15 0.906 . . . . 0.0 111.525 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.25 19.22 2.94 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 117.991 1.956 . . . . 0.0 117.991 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB3' HG13 ' A' ' 15' ' ' VAL . 6.5 m-85 -125.0 73.89 65.9 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.4 132.1 15.51 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 122.185 1.923 . . . . 0.0 109.904 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.58 118.7 31.71 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.416 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -81.18 75.73 8.14 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 111.782 -2.463 . . . . 0.0 108.695 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG13 ' SD ' ' A' ' 13' ' ' MET . 74.9 t -83.6 156.45 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.756 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HZ2' ' H ' ' A' ' 79' ' ' GLN . 28.0 tptp 65.07 137.86 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 124.935 1.397 . . . . 0.0 112.557 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.48 -48.63 76.71 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.898 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.525 ' H ' ' HZ2' ' A' ' 77' ' ' LYS . 62.6 mt-30 -81.58 155.66 71.08 Favored Pre-proline 0 N--CA 1.494 1.765 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.838 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.18 -65.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.472 2.114 . . . . 0.0 110.908 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -83.9 -113.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 45.11 47.86 9.8 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.794 0.806 . . . . 0.0 111.31 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.85 106.51 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.978 -1.464 . . . . 0.0 108.207 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 116.179 -1.867 . . . . 0.0 109.736 -179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 m 51.31 -98.96 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.508 0.77 . . . . 0.0 110.602 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.0 mtp -90.45 69.91 6.92 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.1 89.27 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.026 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -135.72 72.14 1.44 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.98 150.3 44.99 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 113.868 -1.514 . . . . 0.0 109.595 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.64 -47.04 3.39 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 168.63 8.62 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.956 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 m -107.69 126.05 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 113.789 -1.55 . . . . 0.0 110.842 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.435 ' CG2' HE22 ' A' ' 79' ' ' GLN . 33.0 m -104.19 57.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.507 1.146 . . . . 0.0 109.866 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.6 mt -63.89 135.33 56.46 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 113.981 -1.463 . . . . 0.0 112.892 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -105.12 140.05 38.87 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.432 ' SD ' HG12 ' A' ' 60' ' ' VAL . 4.4 mtt -139.21 131.5 28.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -119.03 95.81 4.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.521 1.138 . . . . 0.0 111.341 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.77 170.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-N 113.464 -1.698 . . . . 0.0 112.031 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' A' ' 18' ' ' MET . 33.1 tt0 -95.6 116.5 28.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.4 19.32 7.11 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-O 119.078 -0.845 . . . . 0.0 114.189 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.444 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 53.9 ttp 28.29 -96.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.408 1.083 . . . . 0.0 113.336 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -178.26 103.14 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 123.495 0.497 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.5 m 26.21 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 22' ' ' SER . 53.7 t-80 -162.73 162.75 26.91 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.75 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 59.7 m -63.32 117.74 7.05 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.775 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.4 p -167.14 -67.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.962 0.789 . . . . 0.0 112.465 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.7 p -66.6 -15.44 63.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.9 p -57.06 -38.91 73.94 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -83.33 -33.22 25.94 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.917 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.53 -30.0 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.931 0.769 . . . . 0.0 109.932 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -56.99 -67.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.77 -21.29 79.79 Favored Glycine 0 N--CA 1.494 2.549 0 CA-C-N 113.889 -1.505 . . . . 0.0 114.157 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -74.56 -52.79 10.84 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.49 -27.81 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.042 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.56 -16.22 78.19 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.155 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.21 2.02 54.82 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 124.183 0.578 . . . . 0.0 111.94 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.5 117.29 10.93 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.159 0.504 . . . . 0.0 112.228 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.457 ' CD ' ' H ' ' A' ' 35' ' ' GLN . 0.7 OUTLIER -64.83 145.98 55.51 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.286 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.91 86.67 Favored Glycine 0 N--CA 1.488 2.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.757 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.26 132.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.101 0.477 . . . . 0.0 110.343 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' NE2' ' NE2' ' A' ' 54' ' ' GLN . 14.0 mm-40 -94.64 -76.4 0.49 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.133 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.416 ' H ' ' HB ' ' A' ' 52' ' ' VAL . 9.5 tpt180 -97.65 165.87 11.77 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.203 0.94 . . . . 0.0 109.243 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 tt -155.98 131.51 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.578 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -157.93 84.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.346 1.07 . . . . 0.0 111.1 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.1 t -82.36 119.86 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -90.96 157.16 17.45 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.5 -110.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.428 -1.273 . . . . 0.0 107.745 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 p30 37.54 -122.82 0.22 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 119.237 0.926 . . . . 0.0 110.631 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -102.95 55.08 0.76 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 41.98 66.15 0.76 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.261 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -84.38 88.04 7.25 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 117.749 -1.58 . . . . 0.0 108.025 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 127.61 33.37 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.996 -1.911 . . . . 0.0 108.93 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -129.49 49.98 2.2 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.957 0.884 . . . . 0.0 108.986 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.8 mp -68.27 147.16 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.565 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 39' ' ' ARG . 99.5 t -113.91 144.32 21.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -156.39 157.83 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 124.346 1.029 . . . . 0.0 110.164 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' NE2' ' NE2' ' A' ' 38' ' ' GLN . 6.9 pt20 -86.26 146.39 42.33 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.42 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -58.98 155.25 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 123.03 2.487 . . . . 0.0 113.764 -161.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.438 ' CD2' HD22 ' A' ' 57' ' ' LEU . 7.9 p-80 52.86 -1.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 56' ' ' HIS . 4.6 mm? -72.97 -40.21 65.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 118.88 0.764 . . . . 0.0 109.307 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.481 HG13 ' N ' ' A' ' 59' ' ' SER . 7.6 tp -161.27 174.42 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.793 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.481 ' N ' HG13 ' A' ' 58' ' ' ILE . 68.3 m -139.14 108.5 6.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 13' ' ' MET . 49.2 t -66.2 -19.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.207 -1.36 . . . . 0.0 108.527 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.54 -37.09 82.2 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -68.94 -39.38 79.6 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.2 mmt -66.26 -29.65 69.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.351 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -80.93 -21.89 40.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.731 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -63.96 -33.46 75.77 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -69.9 -39.58 76.13 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.75 -26.73 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 113.93 -1.486 . . . . 0.0 107.885 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.93 -21.12 25.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.245 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.27 -37.1 38.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 123.937 0.773 . . . . 0.0 108.959 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -12.03 60.29 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 124.27 0.982 . . . . 0.0 111.264 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 130.09 -7.06 6.06 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 118.487 2.155 . . . . 0.0 118.487 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -103.66 95.27 7.16 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 119.076 1.438 . . . . 0.0 112.805 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -46.78 133.58 17.36 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.765 1.643 . . . . 0.0 109.519 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.46 112.28 17.87 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.64 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -78.45 84.25 4.62 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.056 -1.884 . . . . 0.0 109.669 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -74.58 92.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.626 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' HB2' ' HZ3' ' A' ' 77' ' ' LYS . 5.8 mtmp? -74.74 -16.34 60.74 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.449 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 mttp 53.7 -119.36 1.48 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 123.988 0.805 . . . . 0.0 109.336 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.466 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 26.8 mm100 -99.18 -45.2 0.23 Allowed Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.896 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 79' ' ' GLN . 13.1 Cg_endo -87.49 114.54 1.0 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.993 2.462 . . . . 0.0 109.676 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 2.4 mppt? -65.84 99.45 0.48 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -64.73 129.07 38.4 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.739 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 59.26 73.03 0.5 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 116.794 -1.574 . . . . 0.0 107.281 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.2 m -144.49 -70.11 0.29 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.4 ttm -166.31 -66.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.42 -49.93 6.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.114 0.884 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 52.22 86.44 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.875 1.359 . . . . 0.0 108.585 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.47 21.27 5.44 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.261 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.62 -17.15 66.53 Favored Glycine 0 N--CA 1.498 2.812 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' CB ' HE22 ' A' ' 38' ' ' GLN . 0.2 OUTLIER -60.81 175.41 0.49 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.63 134.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.79 78.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 124.182 0.926 . . . . 0.0 111.089 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.32 138.91 36.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.338 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -112.74 117.78 33.17 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.452 ' SD ' ' N ' ' A' ' 13' ' ' MET . 3.3 mpp? -119.0 137.02 53.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 40.6 ttmt -119.59 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.923 1.389 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -65.38 167.81 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.431 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 18' ' ' MET . 39.2 tt0 -98.68 121.66 40.9 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.96 19.41 1.24 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.041 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.456 ' CE ' ' CE1' ' A' ' 72' ' ' PHE . 42.7 tpp 71.92 -80.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.949 1.299 . . . . 0.0 108.812 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 t 175.1 -32.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.038 0.836 . . . . 0.0 109.458 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.4 p -161.12 -7.3 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 124.057 0.848 . . . . 0.0 112.037 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -141.9 103.03 4.26 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.559 0.695 . . . . 0.0 110.418 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.1 p -108.32 102.66 11.76 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.948 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t -83.72 30.31 0.5 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.616 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -72.39 -0.99 13.91 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.994 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.6 t -61.79 -39.75 92.82 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -65.18 -34.35 78.17 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.834 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.51 -37.92 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.843 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -48.68 -61.5 2.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.9 0.75 . . . . 0.0 112.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.93 -29.24 71.94 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 114.045 -1.434 . . . . 0.0 112.781 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -70.43 -41.1 73.33 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.455 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.17 -33.88 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.85 -17.6 76.95 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -89.69 -6.63 55.92 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.691 -0.755 . . . . 0.0 112.508 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.12 118.09 11.58 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -79.38 141.67 36.68 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.991 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.79 4.18 79.48 Favored Glycine 0 N--CA 1.489 2.186 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.739 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.8 141.89 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.492 HE22 ' CB ' ' A' ' 8' ' ' GLU . 29.4 mt-30 -96.37 -79.44 0.45 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.781 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.529 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 2.6 tpm_? -96.81 159.63 14.81 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.84 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.474 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 5.4 tt -149.36 110.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -145.32 101.37 3.59 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.995 0.902 . . . . 0.0 111.237 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 49.3 t -93.65 149.3 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.293 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 37.3 t -111.66 144.53 40.77 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.879 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.49 -25.76 60.28 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.421 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.45 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.074 0.859 . . . . 0.0 110.418 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.1 m120 45.18 53.31 8.02 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.446 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 44.38 49.92 8.02 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.963 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 35.4 tt0 -74.07 89.7 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -76.5 130.19 37.59 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 111.828 -2.442 . . . . 0.0 114.085 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 m -132.07 74.54 1.59 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.62 1.2 . . . . 0.0 107.984 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -83.58 132.03 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.869 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 42.7 t -105.13 138.61 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -156.63 179.65 9.06 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.543 1.152 . . . . 0.0 113.645 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -95.37 116.11 66.02 Favored Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.486 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.2 -54.59 0.8 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.87 2.38 . . . . 0.0 110.237 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -56.14 -22.42 28.37 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 113.606 -1.634 . . . . 0.0 113.053 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.07 -40.96 12.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.244 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 tt -163.88 162.38 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 124.451 1.095 . . . . 0.0 111.284 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -130.93 104.74 7.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -68.58 -17.9 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.393 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.7 -29.02 67.81 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.321 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.69 -41.2 79.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.5 mmt -62.53 -31.93 72.8 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.269 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -66.25 -34.06 77.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 123.991 0.807 . . . . 0.0 109.497 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -61.24 -34.13 74.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.091 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -67.82 -38.69 83.55 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 124.252 0.97 . . . . 0.0 109.047 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.7 -33.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.23 -24.66 34.73 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.389 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.11 -36.43 58.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.23 0.956 . . . . 0.0 109.928 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -74.93 -13.63 60.55 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 123.805 0.69 . . . . 0.0 111.082 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.57 10.36 4.51 Favored Glycine 0 N--CA 1.499 2.869 0 N-CA-C 117.705 1.842 . . . . 0.0 117.705 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 7.6 m-85 -118.34 88.37 32.98 Favored Pre-proline 0 N--CA 1.499 2.019 0 CA-C-N 118.268 1.034 . . . . 0.0 109.773 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -49.08 135.15 30.19 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.128 1.885 . . . . 0.0 109.408 173.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -128.21 122.08 30.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.749 1.28 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.63 77.94 9.77 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.131 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.93 113.59 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.532 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -81.93 -139.33 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.816 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.34 -117.02 1.12 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.991 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 48.04 76.48 0.54 Allowed Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 123.476 0.485 . . . . 0.0 110.189 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -67.33 -87.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.585 2.19 . . . . 0.0 111.143 -167.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -168.6 -157.14 0.19 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 123.567 0.542 . . . . 0.0 110.658 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 t80 66.51 140.78 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 124.443 1.097 . . . . 0.0 112.98 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -167.34 -62.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 116.602 -1.666 . . . . 0.0 109.84 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.2 p 51.15 9.7 0.06 Allowed 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.1 mmt -76.34 -46.43 27.6 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.13 -20.24 65.74 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.674 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -150.68 -102.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.07 -148.81 0.14 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.99 -114.21 0.08 OUTLIER Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 41.91 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 m -139.92 108.36 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.677 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.0 m -92.6 56.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.022 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -79.39 156.31 28.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 2.9 mptp? -120.66 94.86 4.5 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.893 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.3 mtm -82.37 135.28 35.21 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 62.8 tttp -116.93 90.47 3.34 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.721 1.248 . . . . 0.0 113.11 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -54.02 167.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 112.722 -2.036 . . . . 0.0 115.126 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.446 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.4 tt0 -120.5 126.77 51.2 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 102.664 -3.087 . . . . 0.0 102.664 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.56 21.06 1.22 Allowed Glycine 0 N--CA 1.492 2.399 0 O-C-N 123.299 0.374 . . . . 0.0 113.407 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.425 ' H ' ' C ' ' A' ' 16' ' ' GLU . 36.0 ttp 54.15 19.12 2.0 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.295 0.644 . . . . 0.0 111.664 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 t 41.42 23.84 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 O-C-N 124.29 0.994 . . . . 0.0 113.103 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 t 179.08 125.98 0.06 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.479 ' CG ' ' N ' ' A' ' 22' ' ' SER . 83.3 t60 59.7 160.01 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 124.472 1.107 . . . . 0.0 113.754 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.479 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 54.6 p -139.48 86.44 2.12 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.133 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -78.15 10.37 3.02 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.979 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 22' ' ' SER . 69.9 p -59.85 -8.79 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.651 -1.159 . . . . 0.0 113.419 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.2 p -56.25 -32.61 64.65 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.3 p -68.66 -39.78 80.47 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.386 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.3 mt -52.57 -30.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 124.502 1.126 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.25 -72.5 0.06 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.264 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.5 -12.77 80.29 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.533 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.83 -53.87 7.0 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.491 0.662 . . . . 0.0 109.301 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.16 -29.66 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 113.771 -1.559 . . . . 0.0 112.036 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.52 -14.68 81.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -95.49 1.05 53.83 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.72 -0.74 . . . . 0.0 112.805 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.422 HD21 ' SD ' ' A' ' 63' ' ' MET . 79.9 mt -72.29 125.34 27.11 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -83.89 144.5 29.17 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.531 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.95 10.7 84.69 Favored Glycine 0 N--CA 1.489 2.212 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.018 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.56 145.71 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -95.79 -83.83 0.36 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 19.4 tpp180 -98.45 166.59 11.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 124.592 1.182 . . . . 0.0 110.992 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.53 107.06 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -147.73 108.45 4.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.753 0.787 . . . . 0.0 110.845 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 54.8 t -97.18 139.68 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.1 t -100.63 171.07 7.94 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.773 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.4 mp -74.58 -115.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.168 -1.396 . . . . 0.0 108.183 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 p30 39.81 -133.32 0.22 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 119.272 0.942 . . . . 0.0 109.768 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -93.85 56.99 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 41.16 69.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.948 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 36.2 tt0 -79.35 90.91 5.01 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.209 -1.396 . . . . 0.0 108.48 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -70.74 129.4 39.02 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.254 -1.794 . . . . 0.0 108.052 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.3 m -129.53 69.14 1.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.414 1.102 . . . . 0.0 108.859 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -81.87 126.89 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.387 -1.733 . . . . 0.0 107.488 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 72.1 t -98.5 133.51 40.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -154.05 171.75 18.59 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.495 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.1 114.07 60.34 Favored Pre-proline 0 N--CA 1.494 1.742 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.228 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -62.5 -50.71 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.847 2.365 . . . . 0.0 111.313 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -60.06 -26.89 66.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.279 -1.328 . . . . 0.0 113.287 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 57' ' ' LEU . 4.6 tp -88.16 -36.38 16.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.407 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.28 162.49 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.782 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.1 m -132.0 106.62 8.14 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.9 t -76.36 -15.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.94 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.72 -32.74 73.57 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -71.0 -45.3 64.24 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.472 ' HA ' ' CE ' ' A' ' 63' ' ' MET . 1.2 tpt -58.95 -31.68 68.94 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.787 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -76.02 -30.89 58.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.163 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -59.95 -31.55 69.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.251 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.03 -38.13 75.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.415 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 69.4 mt -66.88 -30.21 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -82.96 -22.11 33.85 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.276 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.31 -37.39 44.77 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 124.195 0.934 . . . . 0.0 109.28 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.6 ptm -72.59 -13.62 61.43 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.254 0.971 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.35 8.89 3.86 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -118.71 71.29 10.07 Favored Pre-proline 0 N--CA 1.496 1.855 0 CA-C-N 118.289 1.044 . . . . 0.0 110.325 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -47.69 130.55 18.86 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.184 1.923 . . . . 0.0 110.523 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -112.64 123.05 49.44 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.471 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -66.48 -3.01 5.29 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 111.99 -2.368 . . . . 0.0 113.954 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 77' ' ' LYS . 50.3 t 59.67 175.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 123.899 0.749 . . . . 0.0 111.782 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.483 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -58.52 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' H ' ' CG ' ' A' ' 77' ' ' LYS . 55.7 mtmt -63.91 160.13 18.32 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.071 0.396 . . . . 0.0 110.264 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -59.39 121.53 57.25 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 123.842 0.714 . . . . 0.0 109.817 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.66 112.42 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.107 1.871 . . . . 0.0 109.782 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -66.95 -7.31 21.28 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.537 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -59.58 138.7 57.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 123.828 0.705 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 pp -169.23 -21.47 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 113.953 -1.476 . . . . 0.0 109.706 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 4.9 ttmp? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 116.83 -1.557 . . . . 0.0 108.831 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.8 t -159.04 130.73 6.4 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.2 tpp 51.05 45.75 27.36 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.293 0.995 . . . . 0.0 108.85 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 52.3 50.63 17.94 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 113.883 -1.508 . . . . 0.0 111.148 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -151.28 133.28 15.12 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.18 179.97 8.72 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.565 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.83 -163.41 24.82 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 42.41 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.94 136.64 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.782 -2.008 . . . . 0.0 109.65 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.89 51.85 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 122.644 1.211 . . . . 0.0 109.111 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.5 mt -71.34 151.84 43.77 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.774 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -117.59 149.56 40.45 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.754 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.406 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -125.0 141.74 51.94 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 36.8 ttmt -127.97 84.16 2.22 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.739 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.2 t -62.99 170.38 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.459 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 34.0 tt0 -112.45 143.05 44.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -78.84 23.34 3.1 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.397 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.484 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 17.3 ttm 57.72 -107.12 0.35 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 p -154.5 133.79 12.57 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.7 t 55.32 -84.58 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 124.228 0.955 . . . . 0.0 113.266 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.453 ' CG ' ' N ' ' A' ' 22' ' ' SER . 83.5 t60 -97.45 171.18 8.55 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' ' CG ' ' A' ' 21' ' ' HIS . 85.0 p -150.51 126.04 10.2 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.065 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -91.92 45.77 1.24 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.639 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.2 p -69.56 -6.98 34.49 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.725 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.8 m -57.49 -33.28 67.84 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.045 0.45 . . . . 0.0 109.909 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.9 p -67.79 -39.4 84.03 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.111 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.9 mt -52.66 -35.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 124.325 1.016 . . . . 0.0 111.699 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -49.84 -72.09 0.06 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.419 1.074 . . . . 0.0 112.162 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.74 -21.75 77.99 Favored Glycine 0 N--CA 1.497 2.731 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.376 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -63.87 -40.57 96.85 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.8 -23.63 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.438 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.59 -12.23 83.89 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -91.88 -0.91 57.52 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.683 -0.759 . . . . 0.0 112.01 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' A' ' 63' ' ' MET . 89.5 mt -73.26 126.06 29.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -85.58 140.58 30.5 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.135 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.71 1.54 85.25 Favored Glycine 0 N--CA 1.491 2.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.899 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.47 144.52 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -96.1 -82.85 0.38 Allowed 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.481 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 6.5 tpm_? -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 124.639 1.212 . . . . 0.0 109.881 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.656 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 10.7 tt -154.06 122.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.79 162.87 39.44 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.46 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 61.6 t -137.54 133.47 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 124.491 1.119 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 69.2 m -100.12 148.81 24.17 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.664 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.65 3.85 0.47 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -86.62 68.66 10.22 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.25 69.84 0.69 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.53 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 40.44 50.94 2.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.423 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 43' ' ' SER . 35.8 tt0 -76.74 85.23 3.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -73.79 128.13 34.68 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 112.675 -2.057 . . . . 0.0 113.793 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 50.9 m -118.58 72.26 0.87 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.834 0.709 . . . . 0.0 109.515 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.9 mp -72.79 139.07 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.368 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.1 t -115.83 132.15 66.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -151.72 163.43 39.16 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.521 1.138 . . . . 0.0 113.089 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -62.87 149.96 88.7 Favored Pre-proline 0 N--CA 1.493 1.683 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.157 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.37 -4.04 14.78 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.986 2.457 . . . . 0.0 114.404 -153.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -160.53 27.42 0.16 Allowed 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.85 -47.26 9.85 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.519 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.33 161.77 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 124.155 0.909 . . . . 0.0 111.47 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.0 p -104.28 113.67 27.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 124.479 1.112 . . . . 0.0 110.974 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.5 t -71.24 -25.19 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.981 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.3 -24.5 65.02 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.523 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -70.49 -41.46 72.66 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.44 ' SD ' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -63.49 -38.58 91.66 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 2.9 mmmp? -62.83 -33.06 74.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.584 1.177 . . . . 0.0 109.864 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.77 -43.44 98.79 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -65.54 -36.7 84.56 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 124.275 0.985 . . . . 0.0 109.158 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.6 mt -67.41 -32.74 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.9 -20.61 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.913 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.55 -36.76 32.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.043 0.84 . . . . 0.0 109.738 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.493 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 1.9 ppp? -77.03 -12.01 59.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.33 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.19 23.31 1.78 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 117.804 1.882 . . . . 0.0 117.804 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.493 ' CD2' ' SD ' ' A' ' 70' ' ' MET . 9.3 m-85 -131.84 83.22 57.84 Favored Pre-proline 0 N--CA 1.494 1.756 0 CA-C-N 117.58 0.69 . . . . 0.0 109.701 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -47.49 134.49 20.97 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 122.026 1.817 . . . . 0.0 108.738 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -126.98 114.99 18.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.69 1.244 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -85.67 71.12 10.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 111.744 -2.48 . . . . 0.0 108.499 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.2 t -62.08 96.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.97 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -82.59 80.48 8.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.707 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -73.25 -179.01 3.15 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.952 179.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -121.52 87.32 45.33 Favored Pre-proline 0 N--CA 1.501 2.112 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.358 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -81.29 -173.54 1.86 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.404 2.736 . . . . 0.0 110.567 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -157.71 112.51 2.68 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.594 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -87.48 132.93 33.85 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.686 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.63 58.99 1.55 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 124.195 0.934 . . . . 0.0 109.06 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt . . . . . 0 N--CA 1.504 2.235 0 CA-C-O 117.277 -1.345 . . . . 0.0 113.065 179.896 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -159.02 -64.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -91.57 67.21 5.48 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.18 75.05 1.0 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.088 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -70.77 112.54 7.05 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.846 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.16 150.2 35.42 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.381 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.36 34.63 0.05 OUTLIER Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.69 144.05 35.43 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.52 -0.84 . . . . 0.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 9' ' ' VAL . 4.8 m -88.99 110.94 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.881 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.47 143.93 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.37 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HB3' ' SD ' ' A' ' 13' ' ' MET . 70.9 mt -127.99 152.73 47.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.903 0.752 . . . . 0.0 109.495 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' SD ' ' A' ' 13' ' ' MET . 63.6 tttm -147.96 109.25 4.32 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 11' ' ' LEU . 2.9 mpp? -127.38 141.06 51.79 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.566 -1.652 . . . . 0.0 109.619 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.411 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 6.1 ttpm? -112.51 105.68 13.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.761 1.288 . . . . 0.0 109.033 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 2.2 t -70.05 160.52 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 18' ' ' MET . 33.0 tt0 -90.58 108.21 19.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.99 -14.0 22.13 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.846 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.436 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 53.7 tpp 69.98 131.17 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.984 0.914 . . . . 0.0 110.732 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -83.65 47.82 1.34 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.805 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' SG ' ' HG3' ' A' ' 18' ' ' MET . 30.5 p -164.02 -50.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.705 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -166.53 144.77 5.35 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 123.755 0.659 . . . . 0.0 109.932 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 m -107.01 102.65 11.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.388 1.055 . . . . 0.0 109.703 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.3 t -89.32 43.36 1.14 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.1 p -80.69 -7.93 59.48 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.9 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.6 t -59.67 -38.83 82.58 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -71.58 -33.88 69.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.85 -36.38 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 124.169 0.918 . . . . 0.0 110.49 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -52.06 -64.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.909 0.755 . . . . 0.0 111.319 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.28 -27.15 71.18 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.058 -1.428 . . . . 0.0 113.09 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.49 -40.55 80.88 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -76.39 -29.05 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.49 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.34 -13.85 77.02 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -88.07 -4.93 58.72 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.485 -0.858 . . . . 0.0 112.282 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.405 HD21 ' SD ' ' A' ' 63' ' ' MET . 35.5 mt -73.53 119.35 17.64 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.34 138.12 33.67 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.061 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -8.36 77.52 Favored Glycine 0 N--CA 1.486 1.981 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.56 126.69 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -87.34 -75.91 0.39 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.623 ' HE ' ' H ' ' A' ' 40' ' ' ILE . 4.6 tpm_? -97.48 156.22 16.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.623 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 8.6 tt -153.27 115.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.43 114.37 3.0 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 34.8 t -108.46 147.56 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.408 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -88.77 -178.21 5.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.6 mt -104.2 179.57 4.23 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.861 -1.518 . . . . 0.0 108.408 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 56.71 -87.85 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 124.304 1.003 . . . . 0.0 111.269 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.78 12.38 3.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 123.421 0.45 . . . . 0.0 109.997 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 35.24 50.31 0.51 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 124.395 1.06 . . . . 0.0 111.517 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.78 92.74 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.234 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -75.55 131.55 40.11 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.357 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.6 m -135.98 70.02 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.036 0.922 . . . . 0.0 108.67 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.3 mp -82.42 150.31 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.798 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 93.4 t -125.05 149.34 29.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 9' ' ' VAL . 6.8 p90 -162.07 161.22 28.22 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 123.997 0.81 . . . . 0.0 108.885 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.89 159.55 75.96 Favored Pre-proline 0 N--CA 1.499 1.985 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.421 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -83.6 42.2 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.495 2.13 . . . . 0.0 114.217 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.536 ' CD2' HD22 ' A' ' 57' ' ' LEU . 27.8 p-80 -159.78 -4.53 0.07 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 118.734 2.865 . . . . 0.0 118.734 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -89.1 -55.78 3.54 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 120.349 1.431 . . . . 0.0 109.54 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -164.29 161.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -88.13 110.07 20.38 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.881 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 65.5 t -66.56 -29.24 45.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.494 -1.684 . . . . 0.0 108.741 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.27 -23.36 64.06 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.534 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -70.92 -43.47 68.17 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.405 ' SD ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -66.25 -29.4 69.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 124.359 1.037 . . . . 0.0 110.524 179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -72.29 -28.36 63.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -69.85 -28.33 65.59 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.612 0.57 . . . . 0.0 110.066 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.57 -39.07 92.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 123.844 0.715 . . . . 0.0 109.094 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.25 -30.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.674 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -86.99 -24.52 24.65 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.023 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.97 -37.4 61.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 124.255 0.972 . . . . 0.0 109.356 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.23 -11.93 60.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.547 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.68 -3.88 8.65 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 1.9 m-30 -107.59 91.32 7.07 Favored Pre-proline 0 N--CA 1.5 2.073 0 CA-C-N 119.051 1.425 . . . . 0.0 109.272 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -50.74 132.21 35.89 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.71 1.607 . . . . 0.0 110.085 171.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -115.27 95.58 5.25 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.275 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.45 96.97 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 111.37 -2.65 . . . . 0.0 110.7 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.2 t -60.98 153.6 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.244 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -137.08 -45.44 0.57 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.824 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -64.98 107.53 1.52 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.492 ' HB3' ' HD3' ' A' ' 80' ' ' PRO . 4.3 tm0? -162.03 -50.88 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.425 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 79' ' ' GLN . 40.9 Cg_endo -86.38 -86.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.014 1.81 . . . . 0.0 108.118 -177.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -173.99 37.24 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 124.339 1.024 . . . . 0.0 108.781 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 56.16 60.08 3.38 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.769 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.1 mt -86.91 -60.86 1.86 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.317 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 114.704 -2.569 . . . . 0.0 111.482 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.016 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.1 p 41.64 -136.39 0.24 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 124.942 1.024 . . . . 0.0 111.767 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.1 mtm -67.4 -43.79 80.43 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.2 12.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.842 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.407 ' CD ' ' N ' ' A' ' 5' ' ' GLN . 8.0 mp0 -90.98 102.26 15.03 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.552 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.83 65.78 9.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.672 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.18 80.62 0.14 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.443 ' CB ' HE22 ' A' ' 38' ' ' GLN . 9.8 pt-20 42.34 -176.67 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -141.97 146.92 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 112.663 -2.062 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.07 56.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.359 1.037 . . . . 0.0 109.825 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.8 mt -67.48 146.83 53.59 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HD3' HG23 ' A' ' 50' ' ' THR . 58.3 mmtt -106.91 136.47 46.7 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 12' ' ' LYS . 3.5 mpp? -136.0 135.97 39.94 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 62.4 tttm -112.65 151.3 30.31 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.525 ' CG2' ' HZ1' ' A' ' 64' ' ' LYS . 2.1 t -131.36 167.48 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 124.579 1.174 . . . . 0.0 111.662 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 18' ' ' MET . 13.0 tp10 -94.43 133.55 37.91 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.73 19.38 9.42 Favored Glycine 0 N--CA 1.483 1.811 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.662 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.449 ' H ' ' HG3' ' A' ' 16' ' ' GLU . 52.1 ttp 33.33 -88.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 125.102 1.119 . . . . 0.0 113.059 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.6 p -144.94 178.5 7.98 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.8 t -58.79 -24.91 62.55 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.766 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -91.52 44.75 1.19 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.904 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 76.8 p -63.6 158.13 22.02 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.814 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.8 m -120.79 30.14 7.04 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -63.13 -15.25 56.14 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.546 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -53.14 -35.87 60.19 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 123.868 0.73 . . . . 0.0 109.751 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 p -73.79 -41.8 61.88 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.976 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.78 -36.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 124.292 0.995 . . . . 0.0 110.968 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.22 -66.38 0.4 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.641 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.3 -12.15 84.61 Favored Glycine 0 N--CA 1.498 2.784 0 CA-C-N 114.002 -1.454 . . . . 0.0 115.033 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -84.45 -58.39 2.76 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -27.04 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.438 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.54 -12.05 80.89 Favored Glycine 0 N--CA 1.486 2.019 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.668 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -78.29 -7.81 57.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.191 0.519 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' A' ' 37' ' ' VAL . 35.2 mt -58.05 141.32 50.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.18 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -77.18 145.01 37.92 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.273 -1.331 . . . . 0.0 112.746 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.94 9.13 85.26 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.167 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 34' ' ' LEU . 18.8 t -79.75 133.17 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 124.263 0.625 . . . . 0.0 109.879 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.443 HE22 ' CB ' ' A' ' 8' ' ' GLU . 34.9 mt-30 -95.6 -82.13 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.635 -1.62 . . . . 0.0 107.609 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 21.0 tpp180 -98.49 164.87 12.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 124.445 1.09 . . . . 0.0 111.629 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.0 tt -147.47 117.74 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -142.53 74.4 1.44 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.802 1.287 . . . . 0.0 109.423 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 40.1 t -83.21 142.75 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.327 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.0 t -86.15 -179.6 6.76 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.506 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.7 179.83 4.16 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.762 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 55.36 -90.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 124.232 0.957 . . . . 0.0 110.776 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.2 16.98 0.85 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.317 0.386 . . . . 0.0 110.623 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 29.07 54.11 0.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.459 1.104 . . . . 0.0 112.947 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.4 tt0 -67.48 93.93 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.658 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -76.53 130.45 37.93 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.011 -1.904 . . . . 0.0 112.28 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' HD3' ' A' ' 12' ' ' LYS . 98.1 m -136.23 63.3 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.1 mp -72.22 135.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-N 113.879 -1.51 . . . . 0.0 108.476 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 90.8 t -102.02 135.24 39.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -152.94 162.77 40.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 124.816 1.323 . . . . 0.0 112.285 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -63.62 147.05 96.21 Favored Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.91 4.43 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.126 2.551 . . . . 0.0 114.462 -152.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -160.74 23.75 0.14 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.55 -45.74 13.2 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 59' ' ' SER . 8.3 tp -161.4 171.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 124.243 0.964 . . . . 0.0 110.707 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.475 ' N ' HG13 ' A' ' 58' ' ' ILE . 36.4 p -107.94 111.1 23.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.824 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.07 -28.17 29.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 113.436 -1.711 . . . . 0.0 108.313 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.45 -20.79 65.87 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.902 -1.499 . . . . 0.0 109.653 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.97 -43.06 65.77 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 34.0 mmt -64.13 -30.49 71.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.476 1.11 . . . . 0.0 109.562 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.525 ' HZ1' ' CG2' ' A' ' 15' ' ' VAL . 3.0 mmmp? -64.02 -33.32 75.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.251 0.969 . . . . 0.0 109.119 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -65.26 -33.46 76.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.272 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -69.08 -39.06 79.27 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.5 mt -66.48 -28.71 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.067 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.87 -22.6 25.65 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.088 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.5 47.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 123.993 0.808 . . . . 0.0 109.567 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -12.79 60.34 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.434 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.02 -4.81 6.42 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 118.899 2.319 . . . . 0.0 118.899 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -104.77 95.68 9.28 Favored Pre-proline 0 N--CA 1.504 2.251 0 CA-C-N 119.365 1.582 . . . . 0.0 110.494 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -51.13 134.04 42.64 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.403 1.402 . . . . 0.0 109.5 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -118.77 129.32 55.18 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.229 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -92.05 63.29 4.38 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 113.629 -1.623 . . . . 0.0 111.109 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.3 85.46 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -136.98 1.55 2.5 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.336 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HB3' ' HZ2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.7 119.59 15.07 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' H ' ' CD ' ' A' ' 80' ' ' PRO . 81.6 mm-40 -113.32 -49.69 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.897 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.352 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' CD ' ' H ' ' A' ' 79' ' ' GLN . 46.0 Cg_endo -82.71 -78.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.866 1.711 . . . . 0.0 109.587 -173.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.16 -17.96 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 O-C-N 123.889 0.743 . . . . 0.0 110.632 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 62.8 t80 56.32 60.32 3.21 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 124.318 1.011 . . . . 0.0 109.653 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.5 tp -73.07 99.41 2.76 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.46 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 116.711 -1.614 . . . . 0.0 109.96 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 50.29 -122.58 1.89 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.263 0.625 . . . . 0.0 110.231 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 46.8 ttm -74.51 -41.53 60.51 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.79 -52.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.048 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.404 ' NE2' ' H ' ' A' ' 8' ' ' GLU . 58.7 tp60 53.17 97.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 124.62 1.2 . . . . 0.0 112.723 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.87 50.81 0.76 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.385 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.35 33.68 71.79 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.404 ' H ' ' NE2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -131.21 176.03 8.61 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.699 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.3 m -148.81 137.89 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.857 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.48 75.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.56 -20.8 65.04 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 50.52 94.62 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.543 ' SD ' ' N ' ' A' ' 13' ' ' MET . 2.9 mpp? -100.55 135.44 41.98 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.778 -1.555 . . . . 0.0 106.949 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -126.11 86.56 2.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 124.724 1.265 . . . . 0.0 107.712 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.19 165.64 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.638 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 18' ' ' MET . 35.4 tt0 -113.15 128.48 56.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.12 30.15 2.71 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.43 ' H ' ' C ' ' A' ' 16' ' ' GLU . 58.7 ttm 50.32 -100.01 0.08 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.228 0.611 . . . . 0.0 110.207 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.0 p -148.59 -46.39 0.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.9 t -93.54 -10.88 33.31 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.149 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.7 m80 59.31 -127.93 1.23 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.116 0.885 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.5 m 62.71 -173.28 0.15 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 123.595 0.559 . . . . 0.0 111.501 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t 57.9 0.32 0.11 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -75.51 -1.29 23.56 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.442 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.2 t -69.15 -27.81 65.87 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.3 p -66.33 -35.31 80.04 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.25 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.22 -33.1 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 124.819 1.324 . . . . 0.0 110.82 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -48.85 -73.71 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.803 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.29 -21.9 66.34 Favored Glycine 0 N--CA 1.497 2.755 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.564 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -64.2 -34.06 77.21 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.367 0.603 . . . . 0.0 109.729 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.7 mm -104.8 -21.98 5.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.958 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.83 -14.62 80.66 Favored Glycine 0 N--CA 1.487 2.088 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.738 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -93.82 1.98 56.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 124.208 0.593 . . . . 0.0 111.714 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.89 102.18 5.45 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.592 0.71 . . . . 0.0 112.855 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -75.6 119.73 20.04 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.57 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.88 9.26 12.52 Favored Glycine 0 N--CA 1.485 1.903 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.52 138.22 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.453 HE21 ' HG2' ' A' ' 54' ' ' GLN . 6.5 mt-30 -95.13 -77.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.95 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -96.84 153.4 17.91 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.1 tt -153.16 118.26 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.829 -0.749 . . . . 0.0 112.439 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.27 161.27 21.83 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.08 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.3 t -123.99 134.56 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.604 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -104.18 176.18 5.24 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.882 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.1 mp -70.98 -150.37 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.512 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t70 53.41 58.03 5.6 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.976 0.893 . . . . 0.0 108.995 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 51.21 81.98 0.06 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.71 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 36.5 61.94 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.789 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.44 85.48 6.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -67.37 136.84 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 113.01 -1.905 . . . . 0.0 111.034 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.4 m -135.36 52.89 2.0 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -73.94 125.44 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -99.28 138.66 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -152.35 177.46 10.56 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 114.239 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HG2' HE21 ' A' ' 38' ' ' GLN . 46.1 mt-30 -88.18 121.79 70.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 113.55 -1.659 . . . . 0.0 106.725 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -68.46 -54.96 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.275 1.983 . . . . 0.0 109.395 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -52.54 -26.02 12.03 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 113.492 -1.685 . . . . 0.0 113.86 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 tp -93.96 -47.61 6.63 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.6 tt -154.17 168.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -132.14 111.25 11.29 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.438 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.02 -24.63 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.812 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.45 -18.94 54.53 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.719 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.96 -43.92 61.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -29.82 70.97 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 124.206 0.941 . . . . 0.0 109.727 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -64.04 -33.95 76.92 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.21 -32.0 73.29 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.504 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -69.65 -39.47 77.07 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 72' ' ' PHE . 94.5 mt -67.71 -28.44 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.23 -1.35 . . . . 0.0 107.842 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.901 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.5 -37.42 43.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 124.09 0.869 . . . . 0.0 109.271 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -12.7 60.45 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.653 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.89 -2.46 6.88 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB2' HG22 ' A' ' 67' ' ' ILE . 6.6 m-30 -107.88 91.78 8.11 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 118.744 1.272 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -47.16 134.76 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.041 1.828 . . . . 0.0 110.446 169.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -122.33 109.39 14.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 124.652 1.22 . . . . 0.0 108.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.29 79.64 7.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.175 -2.284 . . . . 0.0 108.878 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.27 152.55 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.964 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm 57.33 91.91 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 124.506 1.129 . . . . 0.0 110.509 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -62.67 127.29 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.17 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -62.27 118.16 37.29 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 124.413 1.071 . . . . 0.0 110.303 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.95 -127.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.543 2.162 . . . . 0.0 107.962 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.533 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 5.4 ttpm? 59.23 15.59 4.32 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 120.952 0.406 . . . . 0.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -127.1 -66.28 0.9 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 83' ' ' LEU . 8.5 mp -70.8 -42.08 70.77 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.016 0.823 . . . . 0.0 109.185 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.5 mttp . . . . . 0 N--CA 1.498 1.962 0 O-C-N 124.873 1.358 . . . . 0.0 111.596 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 m -58.98 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.5 mtp -61.25 -15.39 34.35 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 123.729 0.643 . . . . 0.0 112.266 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -165.99 121.0 1.22 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -58.88 120.17 8.55 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 76.63 -33.59 0.21 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 125.214 1.571 . . . . 0.0 110.991 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.87 174.99 54.7 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 67.96 157.25 0.13 Allowed 'General case' 0 N--CA 1.505 2.303 0 O-C-N 124.545 0.791 . . . . 0.0 111.335 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.32 130.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m -101.68 91.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.977 0.894 . . . . 0.0 110.294 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.27 139.3 30.86 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.539 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -130.14 103.23 6.62 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.324 1.64 . . . . 0.0 106.87 179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.573 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 50.6 mtp -104.87 145.44 30.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.54 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 39.4 ttpt -119.7 87.79 2.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 124.287 0.992 . . . . 0.0 111.55 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -60.37 164.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 3.1 mp0 -116.67 154.83 29.87 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.222 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 18.12 5.23 Favored Glycine 0 N--CA 1.484 1.858 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.572 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.7 ttm 74.44 -65.81 0.33 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 125.508 1.357 . . . . 0.0 109.285 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -165.18 -35.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 113.991 -1.459 . . . . 0.0 107.248 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.4 t -173.22 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.33 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -79.12 139.35 38.07 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.168 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.0 p -144.9 160.57 41.1 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -153.93 36.32 0.44 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 113.802 -1.545 . . . . 0.0 106.852 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -72.94 -4.69 33.7 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.1 t -62.81 -37.4 86.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.4 p -66.62 -35.28 79.79 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.5 mt -57.03 -39.37 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 124.197 0.936 . . . . 0.0 111.502 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -51.42 -67.98 0.21 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.791 0.682 . . . . 0.0 112.585 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.21 -23.39 78.13 Favored Glycine 0 N--CA 1.496 2.664 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.635 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.3 -50.26 41.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.408 HG13 ' HZ3' ' A' ' 64' ' ' LYS . 43.6 mm -70.44 -27.52 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 113.211 -1.813 . . . . 0.0 109.604 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.08 -12.21 83.55 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.2 1.57 54.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 124.337 0.669 . . . . 0.0 111.401 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.4 mt -74.78 131.36 40.74 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.836 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -83.05 160.23 21.98 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 124.147 0.904 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.46 11.03 71.6 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 113.291 -1.777 . . . . 0.0 110.49 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.07 146.99 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -95.86 -83.93 0.36 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.588 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 3.2 tpm_? -98.33 160.87 14.01 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.1 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.588 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -158.47 107.93 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HZ3' HH11 ' A' ' 39' ' ' ARG . 0.1 OUTLIER -137.65 160.01 40.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.597 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -139.68 149.68 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 124.183 0.927 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 33.5 t -110.47 140.49 44.67 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.082 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 tt -50.39 -35.15 26.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 124.73 1.269 . . . . 0.0 110.247 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -53.57 85.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.465 1.103 . . . . 0.0 111.373 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 m120 41.57 60.5 2.12 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.962 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 42.18 48.68 4.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.526 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 35.3 tt0 -74.68 89.97 2.28 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -80.75 146.02 31.22 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 112.094 -2.321 . . . . 0.0 114.519 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.4 m -138.77 78.02 1.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.481 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -88.74 136.24 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.066 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 98.3 t -107.91 135.21 47.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -154.98 172.35 18.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.05 116.99 67.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.17 -53.72 0.79 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.698 2.265 . . . . 0.0 110.129 -170.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -57.73 -26.27 61.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.363 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.97 -38.15 14.68 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.791 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.66 159.88 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.377 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.4 m -129.3 95.93 4.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.91 -26.28 40.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 112.173 -2.285 . . . . 0.0 110.567 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.8 -35.14 70.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 124.174 0.921 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -65.16 -41.56 94.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.6 mmm -70.44 -27.35 64.18 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.51 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.573 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 71.8 mmtt -80.95 -18.61 46.46 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.506 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.46 -31.37 68.49 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -64.87 -35.39 80.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.002 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 72' ' ' PHE . 80.6 mt -64.72 -34.68 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -81.29 -20.32 41.08 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.581 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.49 -37.55 36.52 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.2 ptm -75.56 -11.14 59.96 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.141 0.901 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.38 17.66 3.92 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' HB2' HG22 ' A' ' 67' ' ' ILE . 17.0 m-85 -123.05 82.57 50.93 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -51.25 141.75 38.57 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.097 1.864 . . . . 0.0 108.337 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -126.33 125.44 42.28 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 124.331 1.02 . . . . 0.0 108.927 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -82.63 83.38 7.65 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 113.575 -1.648 . . . . 0.0 108.19 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.98 157.55 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.729 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.0 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.605 1.19 . . . . 0.0 108.22 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -147.93 133.36 18.62 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.413 -1.267 . . . . 0.0 107.697 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -53.97 105.58 0.55 Allowed Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 124.553 1.158 . . . . 0.0 109.891 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -78.21 71.7 6.59 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 123.142 2.561 . . . . 0.0 112.476 -166.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -117.82 143.96 45.8 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -81.01 75.53 7.98 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.832 0.825 . . . . 0.0 109.359 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -166.0 93.7 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.403 ' HB3' ' NZ ' ' A' ' 84' ' ' LYS . 8.6 mtpm? . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 116.735 -1.603 . . . . 0.0 110.397 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -75.1 87.71 2.41 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 tpt -126.45 -41.1 1.9 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.217 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.43 21.06 0.65 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.17 -49.6 66.32 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.514 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.06 36.85 0.69 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.021 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.53 79.64 1.37 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 45.36 175.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.77 146.43 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.963 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.461 HG23 HE22 ' A' ' 79' ' ' GLN . 35.9 m -131.45 55.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.151 -1.386 . . . . 0.0 107.774 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.39 145.54 47.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 113.811 -1.541 . . . . 0.0 112.276 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.97 121.16 37.41 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 13' ' ' MET . 3.2 mpp? -126.19 132.4 51.78 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 87.8 tttt -119.11 90.53 3.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.686 1.241 . . . . 0.0 111.496 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -61.63 164.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 113.551 -1.659 . . . . 0.0 114.016 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 18' ' ' MET . 24.1 tt0 -90.96 110.52 21.78 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.14 -19.98 26.15 Favored Glycine 0 N--CA 1.499 2.856 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.544 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.451 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 60.7 ttm 61.13 109.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.865 0.98 . . . . 0.0 111.919 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.9 t -83.39 48.32 1.38 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 113.91 -1.495 . . . . 0.0 112.029 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.0 m -150.49 -42.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.869 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -166.37 156.74 12.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.316 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -134.04 96.09 3.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 123.939 0.774 . . . . 0.0 109.262 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 50.2 t -83.59 24.49 0.85 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.258 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -65.91 -10.71 41.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.437 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.2 t -59.4 -35.02 73.17 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.9 p -75.13 -37.42 61.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.192 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 69.0 mt -61.58 -30.16 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 124.262 0.976 . . . . 0.0 109.836 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.08 -67.15 0.3 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.528 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.08 -10.14 84.09 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.083 -1.417 . . . . 0.0 113.771 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -80.68 -56.19 4.32 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.98 -30.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.352 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 -17.82 79.93 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 123.596 0.56 . . . . 0.0 111.902 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.56 -6.75 51.9 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.38 120.31 12.58 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -75.19 148.63 39.39 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.266 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.65 14.92 80.51 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 123.783 0.677 . . . . 0.0 111.831 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -104.3 128.7 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.189 0.519 . . . . 0.0 111.001 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HA ' ' NE2' ' A' ' 38' ' ' GLN . 3.2 mm100 -87.45 -77.78 0.33 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.328 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.584 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 2.4 tpm_? -97.29 161.18 13.92 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.574 1.171 . . . . 0.0 110.039 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.571 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 8.6 tt -158.03 93.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -112.83 81.67 1.53 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.606 1.193 . . . . 0.0 110.434 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 98.0 t -84.62 133.0 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.984 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 26.6 t -81.32 166.58 20.36 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.742 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.33 -27.51 12.79 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.458 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -53.15 -68.48 0.17 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 124.063 0.852 . . . . 0.0 112.19 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.85 52.0 1.61 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 36.26 48.28 0.55 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.647 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 45.0 tt0 -73.2 91.87 1.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -83.79 125.65 32.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.535 -2.12 . . . . 0.0 112.068 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -130.99 68.48 1.49 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.817 1.294 . . . . 0.0 107.578 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.4 mp -74.41 142.85 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 112.846 -1.979 . . . . 0.0 111.452 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 70.1 t -112.12 135.17 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -167.06 159.54 13.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.509 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 2.5 pm0 -87.3 140.59 32.27 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 124.773 1.296 . . . . 0.0 108.887 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.58 -54.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.842 2.361 . . . . 0.0 113.782 -151.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.528 ' CD2' HD22 ' A' ' 57' ' ' LEU . 38.2 p-80 -61.66 -3.17 0.98 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.6 mm? -79.16 -52.33 8.31 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.2 tt -171.04 163.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.318 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.6 m -108.81 110.55 21.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.95 -23.03 25.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.445 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.89 -29.14 68.96 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.692 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.27 -39.18 75.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.84 63.85 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.203 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.85 -19.81 21.32 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.1 -43.88 85.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.015 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -29.24 70.11 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.136 0.897 . . . . 0.0 109.604 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -69.72 -33.61 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.02 -17.53 46.49 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.522 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.25 -37.56 28.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 124.42 1.075 . . . . 0.0 109.218 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -72.58 -14.12 61.55 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 124.051 0.845 . . . . 0.0 111.438 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.3 9.71 5.41 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 116.464 1.346 . . . . 0.0 116.464 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -113.92 78.31 4.08 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -50.55 135.85 40.87 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.272 1.982 . . . . 0.0 108.814 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.12 138.21 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.663 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 35.6 m-85 -86.98 70.87 10.33 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.36 131.72 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 112.258 -2.247 . . . . 0.0 111.969 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -100.09 99.56 10.3 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -54.73 -34.56 62.64 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.678 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.461 HE22 HG23 ' A' ' 10' ' ' VAL . 35.9 tt0 47.55 67.38 4.53 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 124.676 1.235 . . . . 0.0 110.957 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -62.89 137.0 60.21 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.556 2.171 . . . . 0.0 110.83 -175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -65.8 157.67 29.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.166 0.916 . . . . 0.0 109.874 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -25.79 101.49 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.139 1.525 . . . . 0.0 113.953 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 83' ' ' LEU . 3.0 mm? -64.43 -39.33 93.62 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.95 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.1 tptt . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 116.698 -1.62 . . . . 0.0 109.423 179.838 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.7 t -86.22 129.79 34.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.41 0.712 . . . . 0.0 110.496 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.4 ttm -85.88 96.85 9.92 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.35 -153.58 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.278 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -130.51 -58.36 1.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.15 -26.4 11.12 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.776 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.65 45.5 3.5 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -156.89 145.94 20.18 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 114.977 -0.611 . . . . 0.0 111.68 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 53' ' ' TYR . 2.6 m -142.2 105.02 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.992 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -83.79 58.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.705 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.61 147.15 32.18 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.615 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.584 ' HZ3' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -111.61 142.67 43.62 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.73 -1.577 . . . . 0.0 108.987 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 13' ' ' MET . 3.7 mpp? -132.02 137.02 47.67 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -121.84 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 124.41 1.069 . . . . 0.0 113.38 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -58.68 167.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 29.9 tt0 -94.58 123.36 37.97 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.13 27.36 2.36 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 121.29 -0.481 . . . . 0.0 111.968 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.419 ' H ' ' C ' ' A' ' 16' ' ' GLU . 47.4 tpp 58.22 -108.62 0.42 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.671 0.788 . . . . 0.0 109.168 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -178.31 -23.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 123.488 0.492 . . . . 0.0 111.179 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.3 p -159.16 -17.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -142.77 83.91 1.83 Allowed 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.532 0.682 . . . . 0.0 110.795 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.2 m -89.06 109.66 20.48 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.45 22.0 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 p -62.3 -12.77 22.69 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -58.68 -41.65 86.7 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.4 p -73.06 -31.46 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.459 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.92 -26.6 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.496 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -49.78 -59.96 3.34 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.438 0.637 . . . . 0.0 109.723 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.23 -23.76 71.68 Favored Glycine 0 N--CA 1.493 2.485 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -68.66 -49.19 61.09 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.43 -35.77 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 113.325 -1.762 . . . . 0.0 110.276 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.38 -19.91 79.73 Favored Glycine 0 N--CA 1.485 1.936 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.168 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -94.6 -4.48 47.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.44 136.32 53.94 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -88.93 139.54 30.35 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.922 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.16 7.11 88.83 Favored Glycine 0 N--CA 1.489 2.227 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.681 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.28 131.9 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-O 121.509 0.671 . . . . 0.0 110.919 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.4 -76.88 0.48 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.33 -1.759 . . . . 0.0 108.784 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -97.03 170.77 8.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.062 0.851 . . . . 0.0 110.382 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.87 129.17 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 123.891 0.744 . . . . 0.0 111.113 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.495 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -156.01 92.1 1.33 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.215 1.007 . . . . 0.0 109.111 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.1 138.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.049 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' A' ' 48' ' ' GLU . 22.7 t -86.17 175.67 8.38 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.444 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.3 mp -95.93 176.6 6.05 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.522 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.68 -87.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 124.509 1.131 . . . . 0.0 112.912 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -80.52 12.86 2.78 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 123.371 0.419 . . . . 0.0 111.341 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 36.85 60.42 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.377 1.048 . . . . 0.0 112.62 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 43' ' ' SER . 35.0 tt0 -73.8 87.33 1.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -73.64 128.91 36.81 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 112.847 -1.978 . . . . 0.0 110.718 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -132.32 56.92 1.81 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.234 1.016 . . . . 0.0 108.715 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 51' ' ' ILE . 2.5 mp -69.07 142.24 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.427 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.7 t -107.01 140.06 26.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 9' ' ' VAL . 39.3 p90 -155.77 163.32 39.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.398 1.061 . . . . 0.0 112.463 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -86.36 114.04 55.53 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.51 -32.55 70.33 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.486 2.124 . . . . 0.0 112.417 -162.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -60.97 -19.27 60.79 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -81.13 -55.18 4.93 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.574 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.6 tt -175.03 161.98 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 125.013 1.446 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -94.56 118.55 31.86 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.81 -18.26 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.83 -36.68 84.02 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -40.58 83.32 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.1 mmt -69.56 -16.35 63.4 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.614 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 64' ' ' LYS . 3.8 mmmp? -97.3 -15.39 20.79 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -67.08 -37.05 83.31 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.354 0.409 . . . . 0.0 111.727 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -62.43 -36.74 83.33 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.726 0.642 . . . . 0.0 109.594 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -64.04 -34.55 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.2 -21.45 46.3 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.053 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.38 44.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.167 0.917 . . . . 0.0 109.625 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.2 ptm -74.87 -12.06 60.28 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.749 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.07 19.62 2.91 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 117.316 1.686 . . . . 0.0 117.316 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -124.63 70.93 57.82 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.07 133.7 41.54 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 122.236 1.958 . . . . 0.0 109.25 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -114.73 121.47 43.44 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.648 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -78.55 79.87 4.95 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 112.082 -2.326 . . . . 0.0 108.644 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.9 t -97.78 137.71 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 113.483 -1.689 . . . . 0.0 109.948 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 77' ' ' LYS . 6.0 ttpm? -166.51 49.82 0.07 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 63.61 -84.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 113.641 -1.618 . . . . 0.0 107.301 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -131.42 80.09 68.24 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.584 ' CD ' ' HZ3' ' A' ' 12' ' ' LYS . 5.3 Cg_exo -60.72 75.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.933 2.422 . . . . 0.0 110.222 162.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -149.48 -32.28 0.21 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.107 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -64.32 169.49 4.6 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.44 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 pp -155.93 -174.6 5.02 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.772 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.516 ' HA ' ' HE2' ' A' ' 84' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.256 -1.355 . . . . 0.0 109.586 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.3 p -159.29 171.07 20.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 124.019 0.481 . . . . 0.0 110.743 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 3' ' ' MET . 3.7 mpp? -75.9 163.53 27.11 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.283 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.11 -43.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.286 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -155.84 91.75 1.32 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.36 -28.88 63.31 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.059 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 8' ' ' GLU . . . 176.69 -8.92 0.03 OUTLIER Glycine 0 N--CA 1.496 2.637 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.83 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' H ' ' H ' ' A' ' 7' ' ' GLY . 11.9 pt-20 -146.19 174.98 10.84 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.318 0.58 . . . . 0.0 111.046 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.15 132.6 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.98 109.48 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 123.963 0.789 . . . . 0.0 108.921 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.28 156.07 32.0 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.535 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -130.01 109.11 10.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.709 1.256 . . . . 0.0 111.017 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' A' ' 13' ' ' MET . 3.5 mpp? -90.23 146.52 24.18 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -119.28 89.26 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 123.929 0.768 . . . . 0.0 112.731 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 47' ' ' GLN . 2.0 t -72.57 167.34 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.807 0.813 . . . . 0.0 110.929 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.7 tt0 -110.34 107.6 17.38 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 101.401 -3.555 . . . . 0.0 101.401 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.469 ' H ' HD22 ' A' ' 46' ' ' ASN . . . -63.85 5.83 0.77 Allowed Glycine 0 N--CA 1.494 2.533 0 O-C-N 124.099 0.874 . . . . 0.0 115.026 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttm 56.55 -108.24 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 124.094 0.526 . . . . 0.0 110.031 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t 174.69 172.87 0.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 t 66.59 -73.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 124.124 0.89 . . . . 0.0 110.881 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.598 ' CE1' ' HG ' ' A' ' 23' ' ' CYS . 19.1 t-160 -134.3 133.15 40.42 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.415 ' O ' ' CZ ' ' A' ' 72' ' ' PHE . 22.1 t -79.99 -35.53 37.32 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.041 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.598 ' HG ' ' CE1' ' A' ' 21' ' ' HIS . 54.4 m 58.5 3.8 0.31 Allowed 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -75.13 -6.38 49.28 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 p -58.6 -38.89 78.93 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.318 0.58 . . . . 0.0 109.811 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -70.72 -35.12 72.56 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.226 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.41 -49.16 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.199 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -41.79 -61.32 1.13 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 124.598 1.186 . . . . 0.0 113.679 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.72 -31.89 76.99 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.134 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -73.89 -35.58 64.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.1 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.444 HG21 HG12 ' A' ' 51' ' ' ILE . 44.0 mt -70.25 -31.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.305 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.58 -18.76 77.39 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.87 -8.57 58.73 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.66 -0.77 . . . . 0.0 111.968 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.32 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -82.66 138.72 34.05 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.89 -0.58 76.59 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.259 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.9 t -84.27 144.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -96.19 -85.23 0.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.456 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 20.8 tpp85 -98.29 166.13 11.54 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.087 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.8 tt -152.33 108.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -152.85 126.82 9.01 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.872 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.43 156.44 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.249 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 38.7 t -115.64 146.4 41.84 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.814 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.0 mp -60.03 -8.13 2.17 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -78.19 77.49 4.69 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.731 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.469 HD22 ' H ' ' A' ' 17' ' ' GLY . 12.6 m120 51.47 66.04 1.31 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.677 0.751 . . . . 0.0 109.816 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 5.9 tp-100 42.92 50.65 5.27 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.745 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 37.1 tt0 -74.78 84.64 2.16 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -69.63 144.34 52.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.722 -2.035 . . . . 0.0 112.481 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -141.46 64.95 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -80.5 135.02 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.039 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 82.7 t -104.71 138.56 28.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 103.509 -2.774 . . . . 0.0 103.509 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -150.18 171.31 17.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 124.351 1.032 . . . . 0.0 113.007 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -88.37 145.02 34.82 Favored Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 114.722 -1.127 . . . . 0.0 108.989 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -70.76 -67.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.796 2.331 . . . . 0.0 112.692 -158.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.446 ' CD2' HD22 ' A' ' 57' ' ' LEU . 26.9 p-80 -74.47 12.6 0.75 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.7 mm? -88.05 -60.95 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 tt -175.47 160.91 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 124.907 1.38 . . . . 0.0 110.21 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.9 p -103.89 119.18 38.38 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.237 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -64.83 -14.87 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.138 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.12 -14.78 26.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -68.06 -43.14 79.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.475 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 3.9 mmt -59.17 -40.07 84.5 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.176 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.82 67.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.704 1.252 . . . . 0.0 110.228 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -65.02 -46.4 81.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -66.24 -34.4 77.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.376 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 95.6 mt -67.22 -32.97 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.85 -18.4 47.49 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.873 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.23 -37.58 32.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.061 0.851 . . . . 0.0 109.117 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptm -74.09 -12.29 60.56 Favored 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.068 0.855 . . . . 0.0 111.623 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.89 22.92 3.45 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HB3' HG13 ' A' ' 15' ' ' VAL . 19.4 m-85 -125.22 81.58 63.28 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -47.73 131.78 20.53 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.239 1.959 . . . . 0.0 110.116 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.3 117.19 26.37 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.915 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -83.78 69.5 10.22 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 112.228 -2.26 . . . . 0.0 108.942 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.62 119.03 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.338 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -71.72 -33.87 69.1 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.691 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -69.32 170.15 10.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -111.34 161.0 27.16 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 113.108 -1.86 . . . . 0.0 107.616 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -62.99 -178.5 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.115 1.877 . . . . 0.0 111.411 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -60.45 143.53 53.19 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.858 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.418 ' CG ' ' N ' ' A' ' 83' ' ' LEU . 61.5 t80 -121.34 -178.97 3.92 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.011 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 82' ' ' TYR . 1.1 pt? 38.35 -143.2 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 123.919 0.888 . . . . 0.0 112.887 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 116.424 -1.751 . . . . 0.0 108.108 179.816 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.8 p -160.39 145.09 14.47 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.111 0.536 . . . . 0.0 110.189 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.1 mtm -61.79 -45.33 94.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 124.07 0.856 . . . . 0.0 109.707 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.35 159.82 24.29 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.61 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -152.63 62.15 0.8 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.37 48.89 1.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.941 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.52 -176.24 24.57 Favored Glycine 0 N--CA 1.494 2.537 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.996 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.45 127.79 24.48 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.951 -1.124 . . . . 0.0 109.829 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.5 m -70.2 121.77 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.7 m -90.17 65.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.18 116.98 6.5 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 130.69 41.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.9 mtp -125.53 135.71 52.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 86.0 tttt -121.47 92.55 3.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.219 0.949 . . . . 0.0 112.587 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -67.29 167.26 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.212 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.2 tt0 -108.31 115.59 30.39 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 102.584 -3.117 . . . . 0.0 102.584 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.95 8.43 0.39 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 114.988 0.755 . . . . 0.0 114.988 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 46.8 ttm 62.12 -124.74 0.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 t -177.68 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.2 t -83.15 -113.63 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 123.917 0.76 . . . . 0.0 109.711 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -79.7 179.67 7.39 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -151.26 158.05 43.38 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.731 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.8 t -152.72 32.52 0.5 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.202 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -69.78 -2.9 13.34 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.508 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.1 m -64.1 -34.27 77.67 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 p -65.49 -32.93 74.79 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.613 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 30' ' ' LYS . 62.9 mt -57.43 -33.93 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 124.336 1.023 . . . . 0.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.45 -68.03 0.22 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 123.867 0.73 . . . . 0.0 111.777 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.0 -23.04 75.71 Favored Glycine 0 N--CA 1.495 2.631 0 CA-C-N 114.466 -1.243 . . . . 0.0 115.431 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 27' ' ' ILE . 6.7 ttpm? -69.71 -49.87 49.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -74.04 -27.17 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.556 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.35 -17.3 80.07 Favored Glycine 0 N--CA 1.487 2.055 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.47 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -86.4 -4.83 59.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.247 0.616 . . . . 0.0 111.614 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 37' ' ' VAL . 95.9 mt -69.33 126.68 30.53 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.853 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -74.5 145.04 43.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.219 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.94 13.67 82.36 Favored Glycine 0 N--CA 1.491 2.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.346 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 34' ' ' LEU . 38.7 t -87.2 135.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 124.258 0.622 . . . . 0.0 109.581 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -95.46 -79.27 0.44 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.594 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.562 ' CZ ' ' H ' ' A' ' 40' ' ' ILE . 2.9 tpm_? -97.99 163.23 12.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 124.449 1.093 . . . . 0.0 110.029 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.562 ' H ' ' CZ ' ' A' ' 39' ' ' ARG . 11.7 tt -157.25 95.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -105.17 156.03 18.48 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.224 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 50.6 t -144.54 133.38 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 124.52 1.138 . . . . 0.0 107.957 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.6 t -112.3 138.06 49.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.288 0.992 . . . . 0.0 108.961 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.3 mt -58.22 -19.19 31.85 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.771 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.34 87.98 0.63 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.149 0.906 . . . . 0.0 108.685 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.46 50.99 17.73 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.351 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 39.52 47.55 1.63 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.093 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 41.3 tt0 -72.82 95.28 1.9 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -89.33 126.77 35.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.045 -1.889 . . . . 0.0 114.074 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.1 m -111.59 92.44 4.03 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.337 1.023 . . . . 0.0 109.199 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.6 mp -92.19 141.49 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.894 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 60.7 t -122.64 141.91 41.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -161.75 162.67 29.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 124.201 0.938 . . . . 0.0 111.929 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -72.1 136.18 82.17 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-N 114.057 -1.428 . . . . 0.0 107.82 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.451 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 6.5 Cg_endo -59.2 155.42 40.16 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.452 2.101 . . . . 0.0 110.953 -176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.451 ' CG ' ' O ' ' A' ' 55' ' ' PRO . 6.5 p-80 52.75 5.15 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 117.128 2.269 . . . . 0.0 117.128 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.81 -41.77 51.83 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.6 tt -169.5 160.92 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 124.451 1.094 . . . . 0.0 111.391 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.3 p -97.66 108.39 21.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.306 -1.316 . . . . 0.0 109.185 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.22 -27.7 16.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.751 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.43 -18.16 62.34 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -82.28 -42.27 19.05 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.527 ' CE ' ' HA ' ' A' ' 63' ' ' MET . 1.3 tpt -67.77 -34.15 76.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.648 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -78.7 -18.0 55.02 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.995 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -58.88 -29.18 66.82 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.436 -0.905 . . . . 0.0 109.005 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.2 -33.8 76.13 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.863 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.441 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 85.8 mt -65.2 -31.96 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.67 -23.99 39.22 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.663 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.4 -37.89 56.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.069 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.441 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 5.2 ptm -73.6 -14.12 61.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.891 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.41 5.45 7.2 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 116.942 1.537 . . . . 0.0 116.942 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.432 ' HB3' HG13 ' A' ' 15' ' ' VAL . 21.2 m-85 -115.84 82.95 11.14 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -49.82 133.47 33.52 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.106 1.871 . . . . 0.0 109.943 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . . . -121.35 115.9 23.81 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.05 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.51 71.38 7.36 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.416 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -86.85 90.3 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -147.23 73.16 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.774 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -64.29 -46.65 82.72 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.917 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -136.57 72.69 56.73 Favored Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.933 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -68.29 -42.51 5.5 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.916 2.411 . . . . 0.0 111.529 -170.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? 66.23 2.9 2.51 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 124.73 1.269 . . . . 0.0 110.636 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -138.29 176.44 8.69 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.43 44.95 1.22 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.174 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.807 -1.568 . . . . 0.0 109.556 -179.917 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.9 m -82.27 98.3 8.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.304 0.649 . . . . 0.0 110.459 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.6 ptp -73.91 149.8 41.25 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.306 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.92 -47.81 0.05 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -136.28 -25.51 1.18 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.022 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.99 122.01 17.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 123.945 0.778 . . . . 0.0 110.072 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.97 160.67 45.0 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.532 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.2 175.67 9.58 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.891 -0.655 . . . . 0.0 111.717 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.5 113.69 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.921 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.25 56.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.69 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 153.4 42.07 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.227 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.84 140.95 48.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.607 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.425 ' SD ' ' HG3' ' A' ' 64' ' ' LYS . 29.6 mtm -134.8 138.51 44.32 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -122.93 90.72 3.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 124.309 1.005 . . . . 0.0 112.351 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 16' ' ' GLU . 2.1 t -64.27 170.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.999 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 33.9 tt0 -116.41 107.65 15.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 100.242 -3.984 . . . . 0.0 100.242 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.06 1.33 0.61 Allowed Glycine 0 N--CA 1.497 2.762 0 N-CA-C 115.536 0.974 . . . . 0.0 115.536 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.5 ttm 79.72 -58.48 0.37 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 124.938 1.295 . . . . 0.0 109.066 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 t -164.93 -38.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.011 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 t -170.02 19.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.21 0.944 . . . . 0.0 110.403 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.7 m80 70.53 153.53 0.12 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 123.968 0.793 . . . . 0.0 111.359 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.6 t -164.42 -69.55 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 82.4 m -75.37 0.66 16.11 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.043 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.4 p -61.83 -10.45 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.3 m -56.4 -35.52 67.85 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.9 p -71.27 -39.38 71.6 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 53.3 mt -57.03 -30.12 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 124.322 1.014 . . . . 0.0 111.091 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.96 -63.98 1.01 Allowed 'General case' 0 N--CA 1.484 1.239 0 O-C-N 123.937 0.773 . . . . 0.0 109.193 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -9.02 81.95 Favored Glycine 0 N--CA 1.493 2.448 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.485 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -77.98 -55.96 4.87 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.2 mt -70.98 -29.93 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.699 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.14 78.2 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.593 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -95.59 0.29 52.73 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HB2' HG21 ' A' ' 37' ' ' VAL . 57.1 mt -68.69 114.34 6.97 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.207 0.527 . . . . 0.0 112.142 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.59 138.47 44.92 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.244 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.5 13.73 77.77 Favored Glycine 0 N--CA 1.489 2.21 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.759 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 34' ' ' LEU . 40.5 t -91.45 143.68 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -95.93 -83.52 0.37 Allowed 'General case' 0 N--CA 1.485 1.31 0 O-C-N 124.228 0.955 . . . . 0.0 108.712 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 7.7 tpt180 -98.55 164.46 12.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 124.588 1.18 . . . . 0.0 111.36 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 9.4 tt -146.04 124.37 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -146.07 78.01 1.51 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.403 1.096 . . . . 0.0 112.216 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 51.9 t -82.84 130.49 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 t -84.56 -178.73 6.97 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.445 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.6 mm? -100.83 -177.36 3.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.998 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 54.26 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.039 0.837 . . . . 0.0 112.697 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -84.8 11.91 8.32 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.41 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 21.3 tt0 37.97 50.9 1.36 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.236 1.017 . . . . 0.0 109.308 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -67.53 89.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.042 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . . . -78.97 124.65 28.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 112.245 -2.252 . . . . 0.0 110.786 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.0 m -129.78 58.01 1.66 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.642 1.21 . . . . 0.0 108.748 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.9 mp -66.92 140.84 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.839 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 89.8 t -106.11 136.1 41.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -157.21 167.91 28.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.48 -1.288 . . . . 0.0 114.12 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -84.12 127.58 66.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.27 -65.46 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.73 2.287 . . . . 0.0 114.014 -157.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.501 ' CD2' HD22 ' A' ' 57' ' ' LEU . 27.0 p-80 -68.95 -0.99 6.3 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.501 HD22 ' CD2' ' A' ' 56' ' ' HIS . 3.5 mm? -75.75 -48.14 23.03 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 tt -166.29 167.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.062 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.5 m -125.21 116.34 21.83 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.92 -17.93 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.377 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.86 -34.8 74.07 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -68.15 -41.41 81.66 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -34.94 79.3 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.893 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HG3' ' SD ' ' A' ' 13' ' ' MET . 34.1 mmtm -66.62 -28.34 68.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 124.254 0.971 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -63.31 -35.88 81.83 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.066 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -69.57 -38.6 77.44 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 124.411 1.069 . . . . 0.0 108.177 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HA ' ' SD ' ' A' ' 70' ' ' MET . 60.8 mt -65.91 -33.11 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 124.764 1.29 . . . . 0.0 108.073 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -82.84 -21.62 34.35 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.559 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.6 -37.53 42.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.053 0.845 . . . . 0.0 109.749 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.477 ' SD ' ' HA ' ' A' ' 67' ' ' ILE . 10.1 ptm -76.36 -11.94 59.98 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.08 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.28 17.44 2.69 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 118.31 2.084 . . . . 0.0 118.31 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -125.96 79.8 68.45 Favored Pre-proline 0 N--CA 1.496 1.846 0 CA-C-N 118.169 0.984 . . . . 0.0 109.444 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -47.4 136.81 19.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.6 2.2 . . . . 0.0 109.979 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.83 121.85 35.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 124.344 1.028 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -84.48 67.99 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.374 -2.194 . . . . 0.0 108.008 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.29 163.09 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.692 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -52.93 -28.1 21.94 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.419 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.1 -177.1 0.15 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.567 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 54.62 63.36 7.25 Favored Pre-proline 0 N--CA 1.498 1.968 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.014 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.19 162.74 34.55 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.871 2.38 . . . . 0.0 111.463 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 65.02 151.19 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.901 1.376 . . . . 0.0 111.598 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -148.48 120.97 8.5 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.547 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 83' ' ' LEU . 2.9 mm? 51.89 -89.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 124.534 1.146 . . . . 0.0 110.49 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.445 ' HZ3' ' HA ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 115.692 -2.099 . . . . 0.0 111.504 179.843 . . . . . . . . 2 2 . 1 stop_ save_